data_2vxf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2vxf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.753 0.311 . . . . 0.91000000000000003 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -82.84 133.2 35.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.034 -0.53 . . . . 2.5800000000000001 110.402 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.0 mt -135.85 147.25 28.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 1.0800000000000001 110.434 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.0 t -114.68 132.57 56.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.754 -0.657 . . . . 0.81999999999999995 109.893 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.2 tp -124.45 137.4 54.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.414 . . . . 1.1100000000000001 110.519 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mt -111.96 122.02 65.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.373 -0.602 . . . . 1.01 109.373 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -93.17 169.89 10.06 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.452 0.47 . . . . 0.81000000000000005 111.139 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -59.86 -20.96 60.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.044 -0.525 . . . . 3.0099999999999998 111.971 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.05 13.66 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.122 0.416 . . . . 1.03 112.122 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 61.9 25.22 15.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.635 0.255 . . . . 1.6299999999999999 111.271 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.02 142.89 17.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 109.475 -0.565 . . . . 1.04 109.475 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -104.42 121.08 42.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 3.0 110.619 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -113.6 139.8 48.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.018 -0.537 . . . . 0.81999999999999995 110.1 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -121.61 140.67 51.96 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.117 -0.327 . . . . 1.5900000000000001 110.117 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.0 -178.84 39.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.6 -1.0 . . . . 0.070000000000000007 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.78 139.1 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.067 -0.345 . . . . 1.05 110.067 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.95 109.06 2.39 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 1.0700000000000001 110.492 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -91.59 -52.15 4.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.255 -0.429 . . . . 0.92000000000000004 110.809 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 p -150.23 145.53 26.28 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.376 -0.375 . . . . 1.05 110.957 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.7 mt -118.45 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 1.0700000000000001 110.077 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -112.1 95.01 5.22 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.067 -0.345 . . . . 1.1000000000000001 110.067 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.7 m -67.87 -38.62 83.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.782 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.71 -32.15 68.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.311 -0.404 . . . . 1.97 111.615 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -112.64 13.94 20.01 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.163 0.431 . . . . 0.72999999999999998 112.163 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.6 p 49.99 42.15 24.16 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.936 0.398 . . . . 1.46 111.598 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -131.37 149.16 52.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.278 -0.419 . . . . 1.02 110.98 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.44 138.21 54.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.986 -0.552 . . . . 1.04 110.006 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.77 127.65 56.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.367 -0.379 . . . . 1.03 110.431 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.3 mt -116.93 139.48 50.6 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.112 -0.495 . . . . 1.1100000000000001 110.138 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.11 159.48 22.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.235 -0.439 . . . . 1.02 110.134 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 55.94 55.14 7.24 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.191 0.52 . . . . 2.7999999999999998 110.482 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.22 142.58 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.767 -0.651 . . . . 1.03 110.334 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -135.22 150.74 50.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 4.2699999999999996 110.493 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 p -96.47 128.01 43.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.83999999999999997 110.194 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.456 -0.338 . . . . 1.1699999999999999 110.828 -174.307 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.612 0.244 . . . . 0.51000000000000001 110.417 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.31 -40.5 89.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.164 -0.471 . . . . 2.54 111.251 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -146.85 121.94 10.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.728 0.299 . . . . 0.73999999999999999 111.041 -174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.17 143.77 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.199 -0.455 . . . . 1.05 110.045 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -112.45 138.22 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.256 -0.429 . . . . 1.04 110.369 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -130.08 141.28 50.72 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.17000000000000001 110.273 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -102.15 149.11 24.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.414 -0.357 . . . . 2.71 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.86 50.4 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 111.946 -0.462 . . . . 0.12 111.946 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -67.09 -42.15 85.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.456 0.169 . . . . 1.6299999999999999 111.15 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -32.05 30.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.56 -0.291 . . . . 1.0900000000000001 111.229 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.51 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.506 -0.315 . . . . 1.04 110.392 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -103.93 -45.99 4.6 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.648 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -148.25 149.13 31.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.3 -0.409 . . . . 1.1299999999999999 111.127 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.5 tt -131.39 129.2 41.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.982 -0.553 . . . . 1.21 110.17 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.463 0.199 0 CA-C-N 116.439 -0.346 . . . . 1.0600000000000001 110.571 178.284 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.016 0.436 . . . . 15.0 110.553 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -82.07 128.46 34.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.853 -0.529 . . . . 15.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.01 149.5 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 15.0 109.913 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.63 135.95 53.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.551 -0.537 . . . . 15.0 109.551 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -127.07 137.0 52.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.717 -0.614 . . . . 15.0 110.258 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.63 123.4 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.014 -0.736 . . . . 15.0 109.014 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -93.55 172.83 8.02 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.305 0.574 . . . . 15.0 110.944 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.74 -19.8 52.46 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.63 -0.668 . . . . 15.0 111.444 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.76 16.14 8.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.803 . . . . 15.0 111.336 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.57 29.32 16.97 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.302 -0.874 . . . . 15.0 110.781 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.2 mt -105.09 147.59 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -105.78 118.93 37.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.785 -0.572 . . . . 15.0 110.509 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -111.52 140.71 45.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.812 -0.555 . . . . 15.0 109.765 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -125.83 140.8 52.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.475 -0.766 . . . . 15.0 109.839 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.86 -178.84 39.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.128 -1.589 . . . . 15.0 109.128 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -107.28 133.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.436 -1.038 . . . . 15.0 109.736 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.61 114.66 3.4 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.751 -0.593 . . . . 15.0 110.474 -176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -95.72 -52.04 4.26 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.408 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -145.16 145.15 31.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.623 -0.673 . . . . 15.0 110.664 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -118.31 127.31 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.747 -0.595 . . . . 15.0 109.676 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.11 97.96 7.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 15.0 109.846 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -70.6 -36.57 73.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.719 -0.613 . . . . 15.0 110.484 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.09 -29.16 67.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.55 -0.719 . . . . 15.0 111.136 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -116.14 14.07 15.87 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.704 . . . . 15.0 111.539 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t 49.94 47.53 23.11 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.143 -0.973 . . . . 15.0 111.22 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 p -131.27 149.99 52.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.517 -0.739 . . . . 15.0 110.558 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.56 141.75 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.671 -0.643 . . . . 15.0 109.72 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.17 129.67 56.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.681 -0.637 . . . . 15.0 110.058 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.1 mt -116.92 138.95 51.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.884 -0.51 . . . . 15.0 109.845 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.08 16.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.736 -0.603 . . . . 15.0 109.861 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.3 mttt 51.72 58.36 5.56 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.709 -0.619 . . . . 15.0 110.441 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 p -121.29 148.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.566 -0.709 . . . . 15.0 110.332 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -138.62 153.91 48.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.81 -0.556 . . . . 15.0 110.128 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.3 p -101.24 131.84 47.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.832 -0.543 . . . . 15.0 109.856 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.687 . . . . 15.0 110.541 -174.181 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.921 0.391 . . . . 15.0 110.104 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -68.3 -43.37 77.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.769 -0.582 . . . . 15.0 110.579 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.92 122.02 8.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.543 -0.723 . . . . 15.0 110.609 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 65' ' ' ILE . 30.4 mt -130.85 146.98 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.699 -0.626 . . . . 15.0 109.56 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.87 137.29 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.72 -0.612 . . . . 15.0 109.93 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.93 144.28 51.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.75 -0.594 . . . . 15.0 109.846 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.27 152.68 24.9 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 15.0 110.088 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.04 -26.0 54.83 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.9 m -65.98 -45.86 80.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.472 -1.017 . . . . 15.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.95 -31.02 31.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.693 -0.63 . . . . 15.0 110.807 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.99 141.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.538 -0.726 . . . . 15.0 109.89 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -104.56 -42.54 5.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.781 -0.574 . . . . 15.0 110.198 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -145.88 145.95 30.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.695 -0.628 . . . . 15.0 110.679 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.74 129.12 45.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.804 -0.56 . . . . 15.0 110.13 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.629 -0.669 . . . . 15.0 110.428 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.016 0.436 . . . . 15.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -84.89 128.2 34.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.768 -0.583 . . . . 15.0 110.197 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.0 mt -132.19 150.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 15.0 109.988 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 t -115.53 131.34 56.96 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.532 -0.544 . . . . 15.0 109.532 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.82 134.9 54.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 15.0 110.285 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.5 mt -107.34 122.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.109 -0.701 . . . . 15.0 109.109 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -93.76 171.93 8.57 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.314 0.578 . . . . 15.0 110.87 -173.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -60.09 -19.05 51.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.614 -0.679 . . . . 15.0 111.441 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.23 16.69 8.14 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.353 -0.842 . . . . 15.0 111.275 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 57.1 28.44 14.94 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.28 -0.888 . . . . 15.0 110.827 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.0 mt -105.08 145.66 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.062 -0.718 . . . . 15.0 109.062 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -104.56 121.5 43.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.847 -0.533 . . . . 15.0 110.34 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.14 132.77 54.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.559 . . . . 15.0 109.654 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -115.96 140.58 49.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.532 -0.73 . . . . 15.0 109.886 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.05 -178.81 39.68 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.93 -1.668 . . . . 15.0 108.93 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -106.68 138.95 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.455 -1.026 . . . . 15.0 109.64 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.3 112.13 3.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.746 -0.596 . . . . 15.0 110.356 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -95.58 -52.11 4.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 15.0 110.489 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -144.31 142.54 30.48 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.573 -0.705 . . . . 15.0 110.604 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 126.55 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.805 -0.56 . . . . 15.0 109.609 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.09 95.28 5.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.609 -0.682 . . . . 15.0 109.792 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -69.33 -39.47 78.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.746 -0.596 . . . . 15.0 110.344 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -59.83 -29.27 68.14 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.549 -0.719 . . . . 15.0 111.063 -172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.17 12.35 21.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.464 -0.773 . . . . 15.0 111.555 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m 49.98 44.64 25.53 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.195 -0.941 . . . . 15.0 111.288 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 p -132.77 150.09 52.2 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.481 -0.762 . . . . 15.0 110.623 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.3 139.95 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.73 -0.606 . . . . 15.0 109.595 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.73 128.69 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.646 -0.659 . . . . 15.0 110.04 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -116.84 138.85 51.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.895 -0.503 . . . . 15.0 109.726 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.76 162.36 16.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 15.0 109.89 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt 52.09 61.05 3.41 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.619 -0.675 . . . . 15.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.07 147.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 15.0 110.46 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -132.8 149.92 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.857 -0.527 . . . . 15.0 109.988 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 p -97.74 130.8 44.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.688 -0.633 . . . . 15.0 109.823 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.493 -0.754 . . . . 15.0 110.819 -174.072 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.71 -46.02 70.07 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.87 -0.519 . . . . 15.0 110.543 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -149.29 121.93 8.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.579 -0.701 . . . . 15.0 110.48 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 147.19 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.718 -0.613 . . . . 15.0 109.605 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.66 136.32 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.746 -0.596 . . . . 15.0 109.818 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -126.28 143.96 50.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 15.0 109.984 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -106.66 151.99 24.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 15.0 110.173 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.99 -25.93 54.54 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.751 -0.94 . . . . 15.0 110.751 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 m -65.57 -45.41 83.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.48 -1.012 . . . . 15.0 110.661 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.98 -31.28 31.23 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.543 -0.723 . . . . 15.0 110.677 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.17 144.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.563 -0.711 . . . . 15.0 109.902 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -106.71 -43.09 4.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.748 -0.595 . . . . 15.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.74 151.72 32.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.652 -0.655 . . . . 15.0 110.629 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.38 129.79 45.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.851 -0.531 . . . . 15.0 110.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.497 1.876 0 O-C-N 121.65 -0.656 . . . . 15.0 110.396 178.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.938 0.399 . . . . 15.0 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -92.12 133.74 35.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.75 -0.594 . . . . 15.0 110.287 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.43 147.72 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.531 -0.731 . . . . 15.0 109.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -115.08 131.45 56.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.499 -0.556 . . . . 15.0 109.499 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.16 135.97 54.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.713 -0.617 . . . . 15.0 110.35 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.9 mt -108.83 120.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -91.53 171.64 9.05 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.334 0.587 . . . . 15.0 110.886 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -59.69 -18.99 46.75 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.617 -0.677 . . . . 15.0 111.643 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.03 17.21 8.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 15.0 111.257 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 58.0 28.86 16.85 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.254 -0.904 . . . . 15.0 110.835 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.13 148.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -105.32 119.01 38.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.762 -0.586 . . . . 15.0 110.462 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.76 136.46 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.761 -0.587 . . . . 15.0 109.652 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.81 140.57 52.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 15.0 110.007 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.93 -178.88 39.67 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.901 -1.68 . . . . 15.0 108.901 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.9 mm -107.27 140.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -1.059 . . . . 15.0 109.858 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.44 109.98 2.13 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.599 . . . . 15.0 110.344 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -93.39 -52.08 4.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.792 -0.567 . . . . 15.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -143.24 143.33 31.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.683 -0.635 . . . . 15.0 110.523 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.83 125.62 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.775 -0.578 . . . . 15.0 109.656 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -112.03 98.21 7.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.603 -0.686 . . . . 15.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -71.32 -36.04 71.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.8 -0.563 . . . . 15.0 110.457 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.88 -29.88 67.33 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.544 -0.723 . . . . 15.0 111.078 -171.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -116.45 14.04 15.54 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.639 -0.663 . . . . 15.0 111.519 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t 49.88 48.69 21.44 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.246 -0.909 . . . . 15.0 111.229 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.3 p -131.39 149.58 52.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.571 -0.706 . . . . 15.0 110.514 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.0 t -131.49 139.68 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.663 -0.648 . . . . 15.0 109.687 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.74 128.47 56.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 15.0 109.957 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -116.82 137.78 51.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.979 -0.451 . . . . 15.0 109.798 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.33 163.68 14.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.741 -0.599 . . . . 15.0 109.894 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 51.48 64.24 1.92 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 121.376 0.608 . . . . 15.0 110.439 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -123.9 145.51 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 15.0 110.347 -172.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -127.98 149.34 50.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.864 -0.522 . . . . 15.0 109.801 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -99.32 125.18 44.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.663 -0.648 . . . . 15.0 109.602 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 N--CA 1.499 1.989 0 C-N-CA 120.055 -0.658 . . . . 15.0 110.643 -171.659 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.995 0.426 . . . . 15.0 110.18 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.35 -44.7 71.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.79 -0.569 . . . . 15.0 110.604 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -148.87 121.98 8.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.571 -0.706 . . . . 15.0 110.507 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.73 147.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.745 -0.597 . . . . 15.0 109.663 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -111.18 136.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.739 -0.601 . . . . 15.0 109.865 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.72 144.1 51.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 15.0 109.913 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -108.47 151.9 25.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 15.0 110.097 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.02 -25.94 54.65 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 110.746 -0.942 . . . . 15.0 110.746 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -66.09 -45.41 81.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.48 -1.012 . . . . 15.0 110.731 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -82.05 -31.58 30.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.584 -0.697 . . . . 15.0 110.626 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.16 140.53 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.545 -0.722 . . . . 15.0 109.816 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -108.16 -42.28 4.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 15.0 110.344 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.23 145.16 38.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 15.0 110.653 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.82 129.61 38.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.701 -0.625 . . . . 15.0 110.254 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.743 -0.598 . . . . 15.0 110.219 178.586 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 121.026 0.441 . . . . 15.0 110.33 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -86.87 129.89 34.69 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.681 -0.637 . . . . 15.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.7 mt -132.77 150.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.617 -0.677 . . . . 15.0 109.927 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.46 132.97 56.46 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.57 136.93 55.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.751 -0.593 . . . . 15.0 110.335 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.1 mt -109.47 121.68 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -93.22 171.49 8.9 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.279 0.561 . . . . 15.0 110.937 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -60.23 -19.12 53.14 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.594 -0.691 . . . . 15.0 111.396 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.12 16.83 7.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.342 -0.848 . . . . 15.0 111.271 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 57.6 28.39 15.58 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.295 -0.878 . . . . 15.0 110.818 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.3 mt -104.95 147.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -106.71 119.84 40.4 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.698 -0.626 . . . . 15.0 110.52 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.23 137.24 49.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.874 -0.516 . . . . 15.0 109.772 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -121.29 140.69 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.745 . . . . 15.0 109.942 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.88 39.4 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.973 -1.651 . . . . 15.0 108.973 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.35 138.02 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.382 -1.069 . . . . 15.0 109.696 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.2 tp -66.19 108.84 2.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.727 -0.608 . . . . 15.0 110.168 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -93.51 -52.16 4.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.882 -0.511 . . . . 15.0 110.509 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -141.69 141.34 33.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 15.0 110.492 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.6 mt -118.04 124.92 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.742 -0.599 . . . . 15.0 109.644 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -112.11 97.46 6.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.532 -0.73 . . . . 15.0 109.907 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.01 -36.19 74.92 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.767 -0.583 . . . . 15.0 110.434 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -59.22 -29.62 67.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.539 -0.726 . . . . 15.0 111.074 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -115.53 14.07 16.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.522 -0.737 . . . . 15.0 111.471 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 m 50.0 46.65 24.24 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.184 -0.948 . . . . 15.0 111.181 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -131.6 149.81 52.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.404 -0.81 . . . . 15.0 110.51 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.41 140.23 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 15.0 109.72 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.33 130.05 56.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.709 -0.619 . . . . 15.0 109.961 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.8 138.06 51.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.765 -0.458 . . . . 15.0 109.765 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 162.39 16.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.722 -0.611 . . . . 15.0 109.887 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.7 mttt 51.75 61.2 3.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.673 -0.642 . . . . 15.0 110.428 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.4 145.88 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.686 -0.634 . . . . 15.0 110.376 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.88 149.42 52.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.813 -0.554 . . . . 15.0 109.99 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -97.22 127.79 43.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.615 . . . . 15.0 109.649 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.554 -0.717 . . . . 15.0 110.615 -173.539 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.867 0.365 . . . . 15.0 110.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -68.46 -43.98 75.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.853 -0.53 . . . . 15.0 110.631 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.83 122.08 8.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.601 -0.687 . . . . 15.0 110.587 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 91.2 mt -130.71 147.83 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.618 -0.676 . . . . 15.0 109.564 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.22 137.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.776 -0.578 . . . . 15.0 109.885 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.87 145.65 51.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.771 -0.58 . . . . 15.0 109.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.85 152.35 25.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.637 -0.664 . . . . 15.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.15 55.91 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.722 -0.951 . . . . 15.0 110.722 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 m -65.74 -45.24 83.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -1.047 . . . . 15.0 110.646 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.99 -31.44 31.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.552 -0.717 . . . . 15.0 110.669 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.21 141.98 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.576 -0.702 . . . . 15.0 109.816 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -107.95 -43.4 4.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.761 -0.587 . . . . 15.0 110.287 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -141.81 147.41 37.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.666 -0.646 . . . . 15.0 110.674 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.37 129.48 39.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.606 . . . . 15.0 110.18 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.627 -0.67 . . . . 15.0 110.362 178.884 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.014 0.435 . . . . 15.0 110.328 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -83.73 130.25 34.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.685 -0.635 . . . . 15.0 110.483 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.2 mt -130.61 149.39 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.749 -0.594 . . . . 15.0 109.908 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -112.32 133.91 54.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tp -123.31 133.3 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.78 -0.575 . . . . 15.0 110.319 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.8 mt -107.58 122.9 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -94.48 172.8 7.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.309 0.576 . . . . 15.0 110.903 -172.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.89 -19.56 52.18 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.608 -0.683 . . . . 15.0 111.48 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.38 15.39 9.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.27 -0.894 . . . . 15.0 111.316 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 58.02 27.5 14.92 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.341 -0.849 . . . . 15.0 110.813 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.3 mt -104.2 148.33 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.998 -0.741 . . . . 15.0 108.998 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 -107.27 121.35 44.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 15.0 110.557 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -112.02 138.48 48.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.875 -0.516 . . . . 15.0 109.711 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 140.7 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 15.0 109.899 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.01 -178.88 38.63 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.165 -1.574 . . . . 15.0 109.165 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.62 134.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -1.021 . . . . 15.0 109.772 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.3 112.04 1.99 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.669 -0.644 . . . . 15.0 110.445 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -94.11 -52.0 4.58 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.347 -0.541 . . . . 15.0 110.378 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -143.77 143.63 31.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 15.0 110.531 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.2 mt -116.84 125.2 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.767 -0.583 . . . . 15.0 109.664 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -112.07 96.75 6.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 15.0 109.823 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.5 m -70.91 -36.26 72.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.756 -0.59 . . . . 15.0 110.438 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.87 -29.29 66.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.508 -0.745 . . . . 15.0 111.046 -171.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -116.08 14.03 15.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.58 -0.7 . . . . 15.0 111.571 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.0 m 49.97 48.0 22.49 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.207 -0.933 . . . . 15.0 111.248 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.1 p -131.95 148.54 52.53 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.459 -0.776 . . . . 15.0 110.489 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.09 139.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.595 -0.691 . . . . 15.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.62 128.85 56.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.681 -0.637 . . . . 15.0 109.971 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -116.86 138.14 51.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.944 -0.473 . . . . 15.0 109.918 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.59 164.03 14.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.737 -0.602 . . . . 15.0 109.855 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 51.51 58.54 5.39 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.407 0.622 . . . . 15.0 110.464 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.72 148.43 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.575 -0.703 . . . . 15.0 110.331 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -137.53 148.83 46.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.829 -0.544 . . . . 15.0 110.029 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.6 p -96.59 131.61 43.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.799 -0.563 . . . . 15.0 109.653 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.499 2.02 0 O-C-N 121.615 -0.678 . . . . 15.0 110.641 -172.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 120.891 0.377 . . . . 15.0 110.029 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -44.1 76.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.879 -0.513 . . . . 15.0 110.562 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -150.08 122.03 8.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 15.0 110.571 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.6 mt -130.01 146.37 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.669 -0.644 . . . . 15.0 109.627 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.54 136.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.717 -0.615 . . . . 15.0 109.988 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.99 140.95 51.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.698 -0.626 . . . . 15.0 109.862 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -106.68 152.39 23.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.747 -0.596 . . . . 15.0 110.022 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.65 -26.07 52.3 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.745 -0.942 . . . . 15.0 110.745 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -66.29 -45.99 78.52 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.526 -0.985 . . . . 15.0 110.752 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.2 -31.94 30.11 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.576 -0.702 . . . . 15.0 110.678 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.24 141.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.573 -0.704 . . . . 15.0 109.817 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -100.85 -42.51 6.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.729 -0.607 . . . . 15.0 110.229 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -147.93 144.3 27.94 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.624 -0.673 . . . . 15.0 110.768 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -127.23 128.27 45.79 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.712 -0.617 . . . . 15.0 109.968 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.497 1.908 0 O-C-N 121.557 -0.714 . . . . 15.0 110.502 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.037 0.446 . . . . 15.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -78.38 127.67 32.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.846 -0.534 . . . . 15.0 110.199 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.4 mt -130.97 144.73 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 15.0 109.867 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -113.03 132.34 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -121.25 136.01 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.803 -0.561 . . . . 15.0 110.231 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.96 121.42 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.92 172.69 8.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.352 0.596 . . . . 15.0 110.911 -171.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -59.97 -19.25 51.14 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.614 -0.679 . . . . 15.0 111.472 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.88 9.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.395 -0.815 . . . . 15.0 111.337 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.6 29.11 16.68 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.293 -0.879 . . . . 15.0 110.752 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.09 147.93 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.74 122.65 46.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.799 -0.563 . . . . 15.0 110.567 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.8 137.44 51.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 15.0 109.812 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -119.43 140.66 50.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.458 -0.776 . . . . 15.0 109.796 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.12 -178.95 38.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.21 -1.556 . . . . 15.0 109.21 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.82 134.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.485 -1.009 . . . . 15.0 109.72 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.45 114.61 3.32 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.694 -0.629 . . . . 15.0 110.546 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -95.62 -51.93 4.32 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.324 -0.55 . . . . 15.0 110.402 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -143.81 143.94 31.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.632 -0.668 . . . . 15.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -117.2 124.63 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.67 -0.644 . . . . 15.0 109.64 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.09 98.14 7.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.648 -0.657 . . . . 15.0 109.844 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.707 -0.62 . . . . 15.0 110.423 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.8 -29.59 66.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.545 -0.722 . . . . 15.0 111.054 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -116.14 14.07 15.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.49 -0.756 . . . . 15.0 111.434 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t 49.97 48.91 21.21 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.133 -0.979 . . . . 15.0 111.254 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -132.33 147.88 52.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.512 -0.743 . . . . 15.0 110.57 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.84 138.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.675 -0.64 . . . . 15.0 109.686 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.61 126.34 54.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.719 -0.613 . . . . 15.0 109.907 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.5 mt -116.78 136.92 52.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.19 164.34 14.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.721 -0.612 . . . . 15.0 109.935 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 51.75 58.05 5.88 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.644 -0.66 . . . . 15.0 110.48 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.96 147.36 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 15.0 110.347 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -133.63 149.86 51.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.787 -0.571 . . . . 15.0 109.993 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.6 p -98.69 131.19 45.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.635 -0.666 . . . . 15.0 109.754 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 . . . . . 0 N--CA 1.499 2.014 0 O-C-N 121.515 -0.741 . . . . 15.0 110.69 -173.484 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.941 0.4 . . . . 15.0 110.119 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -68.09 -41.75 81.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.821 -0.549 . . . . 15.0 110.657 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -150.3 122.06 8.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.615 -0.678 . . . . 15.0 110.423 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.9 mt -129.6 144.58 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.685 -0.634 . . . . 15.0 109.481 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.54 133.42 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 109.785 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -123.83 140.53 52.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.705 -0.622 . . . . 15.0 109.893 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -105.25 152.02 23.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.652 -0.655 . . . . 15.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.66 -25.96 52.12 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -66.41 -43.06 86.79 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.483 -1.01 . . . . 15.0 110.729 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.9 -31.61 23.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.541 -0.724 . . . . 15.0 110.664 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.37 141.46 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.582 -0.699 . . . . 15.0 109.887 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -105.26 -42.7 5.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.65 -0.656 . . . . 15.0 110.214 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.53 147.4 32.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.592 -0.692 . . . . 15.0 110.763 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -130.25 129.49 43.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.724 -0.61 . . . . 15.0 110.133 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.563 -0.711 . . . . 15.0 110.433 -179.854 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.9 m . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 121.109 0.481 . . . . 15.0 110.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -83.56 127.63 33.88 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.741 -0.599 . . . . 15.0 110.442 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.1 mt -131.21 151.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.629 -0.67 . . . . 15.0 109.892 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -115.79 133.26 56.21 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.6 136.15 54.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.733 -0.605 . . . . 15.0 110.197 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.23 123.44 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -95.78 169.76 9.78 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.343 0.592 . . . . 15.0 110.947 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -60.4 -18.35 50.04 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.616 -0.677 . . . . 15.0 111.513 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 17.58 7.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.245 -0.91 . . . . 15.0 111.276 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 58.12 27.63 15.26 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.309 -0.869 . . . . 15.0 110.844 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -105.0 146.23 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -106.18 120.64 42.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.786 -0.571 . . . . 15.0 110.323 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.83 132.91 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.851 -0.53 . . . . 15.0 109.791 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.77 140.71 49.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 15.0 109.812 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.98 -178.81 40.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.196 -1.562 . . . . 15.0 109.196 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -105.51 132.39 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.502 -0.999 . . . . 15.0 109.677 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.2 tp -62.15 110.9 1.75 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.712 -0.618 . . . . 15.0 110.422 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -91.32 -52.09 4.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.786 -0.571 . . . . 15.0 110.481 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 p -144.64 143.65 30.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.641 -0.662 . . . . 15.0 110.581 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.45 125.78 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.629 . . . . 15.0 109.556 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.09 95.99 5.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 15.0 109.791 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -70.22 -37.08 74.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.772 -0.58 . . . . 15.0 110.389 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -59.12 -29.51 67.44 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.628 -0.67 . . . . 15.0 111.084 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -115.22 14.03 16.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.623 -0.673 . . . . 15.0 111.57 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 m 49.93 46.88 23.93 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.174 -0.954 . . . . 15.0 111.256 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 p -131.81 150.08 52.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 15.0 110.561 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.24 139.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.678 -0.639 . . . . 15.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.86 128.16 56.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.687 -0.633 . . . . 15.0 109.956 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.81 138.85 51.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.991 -0.443 . . . . 15.0 109.818 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.76 161.71 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.625 . . . . 15.0 109.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 51.64 56.56 7.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.66 -0.65 . . . . 15.0 110.535 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.72 147.52 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.565 -0.71 . . . . 15.0 110.356 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -136.22 153.28 51.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.781 -0.574 . . . . 15.0 110.096 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.6 p -99.68 131.85 45.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.714 -0.616 . . . . 15.0 110.008 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.64 . . . . 15.0 110.438 -176.63 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.964 0.412 . . . . 15.0 109.924 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.0 -44.37 76.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.8 -0.563 . . . . 15.0 110.686 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -148.59 121.99 9.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 15.0 110.572 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.36 147.32 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.715 -0.616 . . . . 15.0 109.517 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.51 138.39 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.65 -0.656 . . . . 15.0 109.917 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -128.99 145.35 51.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 15.0 109.908 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -107.16 152.45 24.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.694 -0.629 . . . . 15.0 110.131 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.02 56.35 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -65.95 -42.5 89.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.465 -1.021 . . . . 15.0 110.738 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.25 -31.12 23.29 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.595 -0.69 . . . . 15.0 110.696 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.36 146.78 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.632 -0.668 . . . . 15.0 109.75 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.42 -44.65 4.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.734 -0.604 . . . . 15.0 110.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -148.43 149.8 32.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.668 -0.645 . . . . 15.0 110.769 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.48 129.38 46.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.804 -0.56 . . . . 15.0 110.149 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.573 -0.704 . . . . 15.0 110.479 179.387 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.041 0.448 . . . . 15.0 110.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.94 130.6 34.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.806 -0.559 . . . . 15.0 110.256 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.1 mt -130.98 145.04 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.526 -0.734 . . . . 15.0 109.953 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.4 t -116.09 129.33 56.29 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -120.53 135.7 55.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.666 -0.646 . . . . 15.0 110.406 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.08 120.02 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -91.66 172.03 8.76 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.24 0.543 . . . . 15.0 110.951 -171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -59.25 -19.71 48.04 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.634 -0.666 . . . . 15.0 111.655 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.14 17.12 8.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.301 -0.874 . . . . 15.0 111.224 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.89 28.3 15.9 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.273 -0.892 . . . . 15.0 110.875 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -105.05 147.13 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm105 -104.91 121.07 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 15.0 110.483 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.98 135.67 52.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.806 -0.559 . . . . 15.0 109.782 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -118.0 140.56 49.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 15.0 109.805 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.66 -178.9 39.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.075 -1.61 . . . . 15.0 109.075 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -108.9 142.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.456 -1.026 . . . . 15.0 109.742 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.7 114.47 4.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.739 -0.601 . . . . 15.0 110.269 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -98.06 -52.05 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.761 -0.587 . . . . 15.0 110.363 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -143.83 143.7 31.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.65 -0.656 . . . . 15.0 110.488 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.6 125.86 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.833 -0.542 . . . . 15.0 109.735 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -112.11 96.91 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 15.0 109.788 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.3 -37.54 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.766 -0.584 . . . . 15.0 110.53 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.79 -28.7 66.2 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.549 -0.719 . . . . 15.0 111.153 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -116.21 14.13 15.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.735 . . . . 15.0 111.556 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.9 48.07 22.31 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.41 -0.806 . . . . 15.0 111.289 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.2 p -131.83 147.24 52.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.522 -0.736 . . . . 15.0 110.44 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.71 139.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.592 -0.693 . . . . 15.0 109.695 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.53 128.81 56.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 15.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.1 mt -116.85 138.84 51.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.914 -0.491 . . . . 15.0 109.742 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.49 165.6 12.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 15.0 109.873 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 51.69 58.83 5.06 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.691 -0.63 . . . . 15.0 110.496 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.0 147.37 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.64 -0.663 . . . . 15.0 110.337 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -135.2 150.0 50.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.599 . . . . 15.0 110.0 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.6 p -96.86 129.33 44.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 15.0 109.715 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 15.0 110.564 -173.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.908 0.385 . . . . 15.0 110.06 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -68.62 -44.24 74.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.883 -0.511 . . . . 15.0 110.555 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -148.88 121.99 8.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 15.0 110.568 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.485 HG23 HD11 ' A' ' 65' ' ' ILE . 41.3 mt -131.4 147.57 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.624 . . . . 15.0 109.447 173.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.8 mt -110.65 138.66 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 15.0 110.014 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -129.69 141.08 50.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.758 -0.589 . . . . 15.0 109.916 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -109.89 152.08 26.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.699 -0.626 . . . . 15.0 110.071 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -26.01 49.38 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.803 -0.919 . . . . 15.0 110.803 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.4 m -66.92 -46.05 76.03 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.469 -1.018 . . . . 15.0 110.732 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.35 -31.82 29.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.52 -0.738 . . . . 15.0 110.711 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.6 mt -65.47 141.62 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.57 -0.706 . . . . 15.0 109.892 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -101.7 -43.39 5.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.809 -0.557 . . . . 15.0 110.271 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -146.03 147.25 31.44 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.698 -0.626 . . . . 15.0 110.71 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.47 129.76 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.689 -0.632 . . . . 15.0 110.217 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.624 -0.673 . . . . 15.0 110.344 179.342 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.039 0.447 . . . . 15.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.26 133.57 33.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.599 . . . . 15.0 110.123 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.09 147.69 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.443 -0.786 . . . . 15.0 110.086 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -116.69 130.39 56.7 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.548 -0.538 . . . . 15.0 109.548 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 tp -119.44 136.79 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.717 -0.614 . . . . 15.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -113.4 122.55 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.168 -0.679 . . . . 15.0 109.168 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -93.5 170.98 9.19 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.233 0.54 . . . . 15.0 110.755 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -61.17 -16.47 45.03 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.608 -0.682 . . . . 15.0 111.505 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.93 13.67 10.44 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.233 -0.917 . . . . 15.0 111.338 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 56.38 29.72 15.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.257 -0.902 . . . . 15.0 110.718 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.98 143.34 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.787 -0.82 . . . . 15.0 108.787 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -103.98 122.23 44.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.805 -0.559 . . . . 15.0 110.419 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -110.96 132.27 54.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.755 -0.591 . . . . 15.0 109.673 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -115.97 140.62 49.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 15.0 109.794 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.56 -178.87 38.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.883 -1.687 . . . . 15.0 108.883 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 mm -109.07 142.56 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.43 -1.041 . . . . 15.0 109.78 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 tp -66.24 109.21 2.57 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.736 -0.603 . . . . 15.0 110.258 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -91.9 -52.01 4.93 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.343 -0.543 . . . . 15.0 110.386 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -144.33 143.88 31.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.726 . . . . 15.0 110.517 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.24 125.11 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.744 -0.598 . . . . 15.0 109.702 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.1 97.48 6.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 15.0 109.776 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 -36.37 71.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 15.0 110.428 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -29.39 67.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.561 -0.712 . . . . 15.0 111.153 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -116.14 14.08 15.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.528 -0.732 . . . . 15.0 111.544 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t 50.03 49.32 20.56 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.162 -0.962 . . . . 15.0 111.175 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -132.63 147.77 52.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.473 -0.767 . . . . 15.0 110.504 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.21 138.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.556 -0.715 . . . . 15.0 109.526 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.33 128.36 55.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.665 -0.647 . . . . 15.0 109.844 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.3 mt -116.85 137.53 52.14 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.906 -0.496 . . . . 15.0 109.776 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.6 164.47 13.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.811 -0.556 . . . . 15.0 109.772 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 51.79 56.91 7.13 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.722 -0.611 . . . . 15.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -120.35 148.7 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.563 -0.711 . . . . 15.0 110.253 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -139.55 150.67 45.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.739 -0.6 . . . . 15.0 110.291 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.5 p -98.5 131.22 44.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.819 -0.55 . . . . 15.0 109.804 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.543 -0.723 . . . . 15.0 110.774 -173.26 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 120.915 0.388 . . . . 15.0 109.982 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -68.31 -41.99 80.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.871 -0.518 . . . . 15.0 110.674 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.47 122.01 7.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.491 -0.756 . . . . 15.0 110.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.4 mt -130.75 147.35 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.658 -0.651 . . . . 15.0 109.57 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -109.85 136.64 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.763 -0.586 . . . . 15.0 109.929 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -127.71 140.64 51.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.725 -0.61 . . . . 15.0 109.975 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -108.11 152.81 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 15.0 110.153 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.2 -25.99 48.86 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.731 -0.948 . . . . 15.0 110.731 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 m -66.56 -45.99 77.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.527 -0.984 . . . . 15.0 110.747 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.97 -30.33 31.71 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.606 -0.684 . . . . 15.0 110.726 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -68.71 139.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.586 -0.696 . . . . 15.0 109.71 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.83 -43.55 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.754 -0.591 . . . . 15.0 110.261 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.17 141.82 42.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.718 -0.614 . . . . 15.0 110.505 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.12 127.61 40.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.735 -0.603 . . . . 15.0 110.087 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 15.0 110.133 178.144 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 121.094 0.473 . . . . 15.0 110.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -84.58 131.82 34.58 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.786 -0.571 . . . . 15.0 110.346 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -133.86 147.33 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.523 -0.736 . . . . 15.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -117.18 130.27 56.49 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.505 -0.554 . . . . 15.0 109.505 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.2 tp -119.11 135.68 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.736 -0.603 . . . . 15.0 110.322 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.4 mt -108.07 119.78 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.953 -0.758 . . . . 15.0 108.953 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -90.83 172.61 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.287 0.565 . . . . 15.0 110.902 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.25 -19.13 53.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.605 -0.684 . . . . 15.0 111.416 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 15.79 9.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.855 . . . . 15.0 111.318 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 57.8 29.27 17.19 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.289 -0.882 . . . . 15.0 110.786 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.1 146.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.07 120.68 42.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.759 -0.588 . . . . 15.0 110.465 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -112.03 133.98 53.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.827 -0.546 . . . . 15.0 109.713 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -116.2 140.61 49.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.472 -0.767 . . . . 15.0 109.828 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.73 -178.82 38.98 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.962 -1.655 . . . . 15.0 108.962 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -107.39 141.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.466 -1.02 . . . . 15.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.23 108.93 2.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.748 -0.595 . . . . 15.0 110.201 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.83 -51.94 4.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.805 -0.559 . . . . 15.0 110.486 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -143.27 142.65 31.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.624 . . . . 15.0 110.481 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.75 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 15.0 109.682 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.06 97.98 7.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.635 -0.665 . . . . 15.0 109.86 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -71.97 -36.12 69.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.78 -0.575 . . . . 15.0 110.456 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -58.75 -29.5 66.79 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.493 -0.754 . . . . 15.0 111.108 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -116.44 14.14 15.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.617 -0.677 . . . . 15.0 111.495 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m 49.9 49.56 20.02 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.174 -0.954 . . . . 15.0 111.152 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 p -132.54 147.79 52.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 15.0 110.539 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.59 137.87 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.661 . . . . 15.0 109.554 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.25 127.98 55.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.647 . . . . 15.0 109.888 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.8 136.14 53.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.919 -0.488 . . . . 15.0 109.771 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.12 14.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.761 -0.587 . . . . 15.0 109.901 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 51.76 61.64 3.11 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.656 -0.653 . . . . 15.0 110.475 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.33 146.4 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.538 -0.727 . . . . 15.0 110.383 -173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -135.13 148.56 49.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.841 -0.537 . . . . 15.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.5 p -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 15.0 109.781 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 . . . . . 0 N--CA 1.499 2.017 0 C-N-CA 120.072 -0.651 . . . . 15.0 110.589 -174.138 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.011 0.434 . . . . 15.0 110.139 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.73 -39.78 84.25 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.832 -0.543 . . . . 15.0 110.78 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -151.71 122.37 7.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 15.0 110.832 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -129.4 147.24 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.628 -0.67 . . . . 15.0 109.59 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.5 mt -110.65 136.28 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.692 -0.63 . . . . 15.0 109.849 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -127.02 140.64 52.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.763 -0.586 . . . . 15.0 109.922 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -107.73 151.66 25.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.18 -26.01 48.77 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.753 -0.939 . . . . 15.0 110.753 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -66.45 -45.95 78.06 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.485 -1.009 . . . . 15.0 110.718 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.1 -31.88 30.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.644 -0.66 . . . . 15.0 110.738 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.89 141.25 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.675 -0.641 . . . . 15.0 109.859 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -104.71 -43.18 5.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.76 -0.587 . . . . 15.0 110.251 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.6 147.35 34.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.609 -0.682 . . . . 15.0 110.647 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -131.0 130.66 43.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.706 -0.621 . . . . 15.0 110.248 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 15.0 110.304 178.791 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 120.927 0.394 . . . . 15.0 110.216 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -87.0 133.5 33.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.69 -0.631 . . . . 15.0 110.437 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.89 147.45 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 15.0 109.991 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.7 t -110.83 130.17 55.65 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -119.83 130.65 55.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.845 -0.535 . . . . 15.0 110.325 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.71 119.33 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -92.26 170.61 9.67 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.307 0.575 . . . . 15.0 110.948 -171.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -60.6 -17.56 47.52 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.62 -0.675 . . . . 15.0 111.513 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.4 15.34 9.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.222 -0.923 . . . . 15.0 111.278 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 57.25 29.37 16.63 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 15.0 110.67 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.41 144.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -105.67 119.79 40.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.727 -0.608 . . . . 15.0 110.453 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -111.85 137.44 49.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.773 -0.58 . . . . 15.0 109.566 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -121.42 140.49 52.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 15.0 109.938 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.87 39.84 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.124 -1.59 . . . . 15.0 109.124 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.49 142.37 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.495 -1.003 . . . . 15.0 109.708 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.21 112.51 3.47 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.721 -0.612 . . . . 15.0 110.295 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -96.03 -52.07 4.19 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.373 -0.531 . . . . 15.0 110.35 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -143.92 143.28 31.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.637 -0.664 . . . . 15.0 110.489 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.97 126.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.733 -0.604 . . . . 15.0 109.77 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -112.1 96.18 5.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.598 -0.689 . . . . 15.0 109.79 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.3 -36.78 74.54 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 15.0 110.369 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -58.91 -28.96 66.69 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.556 -0.715 . . . . 15.0 111.075 -171.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.16 13.99 15.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.722 . . . . 15.0 111.484 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t 49.96 47.27 23.51 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.241 -0.912 . . . . 15.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.2 p -131.43 149.56 52.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.447 -0.783 . . . . 15.0 110.471 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.41 140.28 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 15.0 109.649 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.12 56.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.689 -0.632 . . . . 15.0 109.935 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.87 138.84 51.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.826 -0.435 . . . . 15.0 109.826 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.54 165.35 13.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.732 -0.605 . . . . 15.0 109.873 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 51.86 60.97 3.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.631 -0.668 . . . . 15.0 110.36 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.99 145.27 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 15.0 110.523 -173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -127.36 150.98 49.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 15.0 109.808 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.5 p -102.39 129.67 48.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.753 -0.592 . . . . 15.0 109.927 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 . . . . . 0 N--CA 1.499 2.001 0 C-N-CA 120.116 -0.633 . . . . 15.0 110.416 -176.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.883 -0.414 . . . . 15.0 109.883 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -67.56 -41.14 84.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.868 -0.52 . . . . 15.0 110.981 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -154.8 122.0 5.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.757 . . . . 15.0 110.676 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.6 mt -129.64 147.9 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.66 -0.65 . . . . 15.0 109.767 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.22 136.89 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.724 -0.61 . . . . 15.0 109.917 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.25 143.84 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.768 -0.583 . . . . 15.0 109.905 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -109.49 151.27 26.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.682 -0.637 . . . . 15.0 110.133 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.74 -26.02 56.83 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.697 -0.961 . . . . 15.0 110.697 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -66.76 -40.59 88.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.462 -1.022 . . . . 15.0 110.724 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -86.41 -31.78 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.617 -0.677 . . . . 15.0 110.712 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.69 138.78 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.592 -0.692 . . . . 15.0 109.956 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -99.88 -41.5 7.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.734 -0.604 . . . . 15.0 110.116 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -147.33 145.1 29.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.677 -0.639 . . . . 15.0 110.628 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.3 130.36 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.725 -0.609 . . . . 15.0 110.038 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.497 1.925 0 O-C-N 121.62 -0.675 . . . . 15.0 110.514 -179.35 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.057 0.456 . . . . 15.0 110.534 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -83.72 132.54 34.85 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.752 -0.593 . . . . 15.0 110.035 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.8 mt -132.66 145.99 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.52 -0.738 . . . . 15.0 110.114 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -115.07 129.93 56.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.9 136.3 54.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.675 -0.641 . . . . 15.0 110.355 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.11 121.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.021 -0.733 . . . . 15.0 109.021 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.69 172.43 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.309 0.576 . . . . 15.0 110.907 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -59.98 -19.26 51.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.629 -0.67 . . . . 15.0 111.405 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.02 16.76 7.75 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.257 -0.902 . . . . 15.0 111.215 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 57.48 28.42 15.47 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.237 -0.914 . . . . 15.0 110.867 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.5 mt -105.0 147.23 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -105.64 121.38 43.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 15.0 110.526 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -112.32 136.23 52.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.833 -0.542 . . . . 15.0 109.786 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.75 140.54 49.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 15.0 109.779 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.19 -178.89 39.27 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.029 -1.628 . . . . 15.0 109.029 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.18 143.03 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.386 -1.067 . . . . 15.0 109.793 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.95 114.97 5.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.763 -0.585 . . . . 15.0 110.19 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -97.62 -52.05 3.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.806 -0.559 . . . . 15.0 110.381 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -144.56 143.35 30.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.717 -0.614 . . . . 15.0 110.541 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -115.43 125.23 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.717 -0.614 . . . . 15.0 109.613 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.08 97.2 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.605 -0.684 . . . . 15.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -70.89 -36.56 72.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.707 -0.62 . . . . 15.0 110.383 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.87 -29.36 66.93 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.572 -0.705 . . . . 15.0 111.015 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -115.64 13.91 16.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 15.0 111.461 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t 50.06 47.21 23.76 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.195 -0.941 . . . . 15.0 111.174 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -131.86 148.72 52.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.501 -0.75 . . . . 15.0 110.606 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.61 138.22 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 15.0 109.535 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.51 128.52 55.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.646 -0.658 . . . . 15.0 109.905 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.79 138.65 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.889 -0.507 . . . . 15.0 109.791 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.73 164.68 13.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.76 -0.587 . . . . 15.0 109.791 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 51.81 56.91 7.12 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.644 -0.66 . . . . 15.0 110.375 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 p -120.66 148.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.593 -0.692 . . . . 15.0 110.303 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -139.71 150.07 44.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.804 -0.56 . . . . 15.0 110.211 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.4 p -97.59 132.06 43.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.77 -0.581 . . . . 15.0 109.771 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.552 -0.718 . . . . 15.0 110.569 -174.097 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.905 0.383 . . . . 15.0 110.078 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.09 -42.37 80.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.86 -0.525 . . . . 15.0 110.691 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -150.98 121.89 7.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.507 -0.746 . . . . 15.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.73 147.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.681 -0.637 . . . . 15.0 109.698 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.04 135.74 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.719 -0.613 . . . . 15.0 109.901 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -125.74 140.77 52.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 15.0 109.991 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -104.37 151.07 23.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.679 -0.638 . . . . 15.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.13 -25.97 55.03 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -65.33 -45.0 86.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.446 -1.032 . . . . 15.0 110.778 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.96 -31.47 31.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.549 -0.72 . . . . 15.0 110.696 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 136.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.5 -0.75 . . . . 15.0 109.858 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -104.88 -39.85 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 15.0 110.253 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.29 142.69 33.86 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.659 -0.65 . . . . 15.0 110.56 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.39 127.41 39.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.714 -0.616 . . . . 15.0 110.164 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 15.0 110.251 178.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.154 0.502 . . . . 15.0 110.67 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -78.54 130.02 35.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.874 -0.516 . . . . 15.0 110.1 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.6 mt -132.75 147.85 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.506 -0.746 . . . . 15.0 109.97 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 t -116.21 133.87 55.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.577 -0.527 . . . . 15.0 109.577 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -124.14 136.52 54.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.737 -0.602 . . . . 15.0 110.375 -175.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -108.81 122.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -94.3 172.93 7.9 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.277 0.56 . . . . 15.0 110.988 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.7 -20.01 53.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.624 -0.672 . . . . 15.0 111.466 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 16.91 8.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.35 -0.843 . . . . 15.0 111.271 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 58.03 28.23 16.0 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.301 -0.874 . . . . 15.0 110.86 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.6 mt -105.02 147.76 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -106.08 121.54 44.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.779 -0.576 . . . . 15.0 110.403 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -112.18 136.78 51.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.769 -0.582 . . . . 15.0 109.756 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.49 140.68 49.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.507 -0.745 . . . . 15.0 109.725 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.55 -178.9 38.94 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.11 -1.596 . . . . 15.0 109.11 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.6 139.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.568 -0.96 . . . . 15.0 109.54 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.03 115.4 6.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 15.0 110.253 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -97.94 -52.05 3.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.865 -0.522 . . . . 15.0 110.403 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -144.46 143.39 30.86 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.615 -0.678 . . . . 15.0 110.637 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.58 127.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.633 -0.667 . . . . 15.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -112.12 95.42 5.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 15.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -69.26 -38.04 78.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.79 -0.569 . . . . 15.0 110.419 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.53 -28.96 67.55 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.582 -0.699 . . . . 15.0 111.1 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.26 13.91 17.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.473 -0.767 . . . . 15.0 111.554 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 m 50.0 45.65 25.09 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.171 -0.956 . . . . 15.0 111.309 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.4 p -131.88 149.74 52.36 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.463 -0.773 . . . . 15.0 110.666 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.86 140.64 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.582 -0.699 . . . . 15.0 109.603 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.07 129.47 56.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.621 -0.675 . . . . 15.0 110.015 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -116.89 139.12 51.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.938 -0.477 . . . . 15.0 109.753 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.82 162.98 16.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.698 -0.626 . . . . 15.0 109.868 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 51.89 59.34 4.62 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.666 -0.647 . . . . 15.0 110.488 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.51 148.03 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.592 -0.693 . . . . 15.0 110.314 -173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -136.45 149.55 48.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.901 -0.499 . . . . 15.0 110.073 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -97.21 131.75 43.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.714 -0.616 . . . . 15.0 109.724 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.543 -0.723 . . . . 15.0 110.702 -173.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.898 0.38 . . . . 15.0 110.066 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.2 -42.88 79.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.79 -0.569 . . . . 15.0 110.667 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -150.48 121.93 7.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 15.0 110.606 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 65' ' ' ILE . 25.8 mt -130.87 147.75 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 15.0 109.554 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.6 mt -110.58 136.05 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.741 -0.599 . . . . 15.0 109.86 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -126.08 142.64 51.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.631 . . . . 15.0 109.949 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -107.34 152.2 24.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.646 -0.659 . . . . 15.0 110.143 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.01 55.02 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.7 m -65.56 -45.54 82.92 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.447 -1.031 . . . . 15.0 110.766 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.02 -31.59 30.94 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.63 -0.669 . . . . 15.0 110.637 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.66 138.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.545 -0.722 . . . . 15.0 109.814 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -105.29 -40.07 5.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.652 . . . . 15.0 110.17 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -143.19 142.83 31.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 15.0 110.665 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.41 127.11 41.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.796 -0.565 . . . . 15.0 110.049 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.638 -0.664 . . . . 15.0 110.394 179.705 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.028 0.442 . . . . 15.0 110.416 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -86.09 132.02 34.13 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.797 -0.564 . . . . 15.0 110.369 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.2 147.68 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 15.0 109.937 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -116.88 132.81 56.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.498 -0.556 . . . . 15.0 109.498 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -124.51 137.51 54.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.643 -0.661 . . . . 15.0 110.356 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.59 121.42 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.038 -0.727 . . . . 15.0 109.038 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -92.15 174.04 7.52 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.298 0.57 . . . . 15.0 110.94 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.54 -20.53 56.25 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.624 -0.673 . . . . 15.0 111.444 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.82 16.62 8.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.334 -0.854 . . . . 15.0 111.295 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 57.3 29.76 17.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.222 -0.924 . . . . 15.0 110.779 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.3 mt -105.1 146.71 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.996 -0.742 . . . . 15.0 108.996 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -104.12 119.91 39.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.823 -0.548 . . . . 15.0 110.428 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -111.44 136.32 50.75 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.756 -0.59 . . . . 15.0 109.791 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.09 140.7 49.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.559 -0.713 . . . . 15.0 109.769 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.47 -178.92 38.91 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.937 -1.665 . . . . 15.0 108.937 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.0 mm -108.46 142.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.349 -1.089 . . . . 15.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.55 109.0 2.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.744 -0.597 . . . . 15.0 110.203 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -92.66 -52.05 4.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.801 -0.562 . . . . 15.0 110.439 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -143.59 142.91 31.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.638 -0.664 . . . . 15.0 110.422 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.9 mt -116.72 125.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 15.0 109.661 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.17 97.3 6.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.573 -0.704 . . . . 15.0 109.781 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -71.45 -36.38 71.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.675 -0.641 . . . . 15.0 110.49 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.82 -29.79 67.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.461 -0.775 . . . . 15.0 111.043 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -115.8 13.98 16.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.575 -0.703 . . . . 15.0 111.555 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t 49.89 48.75 21.36 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.154 -0.966 . . . . 15.0 111.266 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -131.81 148.33 52.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.477 -0.764 . . . . 15.0 110.484 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.42 139.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.66 -0.65 . . . . 15.0 109.662 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.4 128.94 56.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.77 -0.582 . . . . 15.0 109.911 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.7 mt -116.79 138.08 51.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.89 -0.506 . . . . 15.0 109.867 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.12 165.43 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.784 -0.573 . . . . 15.0 109.793 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 51.68 57.32 6.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.672 -0.642 . . . . 15.0 110.425 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.16 148.59 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 15.0 110.279 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -140.7 152.31 45.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.724 -0.61 . . . . 15.0 110.196 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.4 p -97.42 131.26 44.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.771 -0.581 . . . . 15.0 109.795 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.59 -0.694 . . . . 15.0 110.464 -173.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.95 0.405 . . . . 15.0 110.108 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -68.14 -41.84 81.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.867 -0.521 . . . . 15.0 110.684 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -150.8 121.96 7.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 15.0 110.589 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 94.8 mt -131.02 147.09 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.678 -0.639 . . . . 15.0 109.487 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -110.14 139.19 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.655 -0.653 . . . . 15.0 109.993 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.85 142.86 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.712 -0.617 . . . . 15.0 109.941 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -110.73 152.68 26.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 15.0 110.086 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.06 55.12 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.673 -0.971 . . . . 15.0 110.673 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -67.26 -40.79 86.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.44 -1.035 . . . . 15.0 110.795 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -88.34 -30.97 19.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.599 -0.688 . . . . 15.0 110.801 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.73 142.31 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.588 -0.695 . . . . 15.0 109.915 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -99.88 -44.14 6.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 15.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -146.86 147.17 30.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.686 -0.634 . . . . 15.0 110.705 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.18 129.95 45.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.728 -0.608 . . . . 15.0 110.221 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.647 -0.658 . . . . 15.0 110.346 178.428 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.97 0.414 . . . . 15.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -85.59 133.56 34.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.861 -0.524 . . . . 15.0 110.239 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.98 147.09 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.514 -0.741 . . . . 15.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -115.54 133.81 55.67 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -125.69 137.17 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.712 -0.618 . . . . 15.0 110.424 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 87.5 mt -109.3 121.37 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.968 -0.753 . . . . 15.0 108.968 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.8 m -93.33 175.68 6.67 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.32 0.581 . . . . 15.0 111.01 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.15 -21.5 59.45 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.606 -0.684 . . . . 15.0 111.398 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 15.97 9.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.321 -0.862 . . . . 15.0 111.326 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.71 28.99 16.64 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.306 -0.871 . . . . 15.0 110.811 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.0 149.59 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.151 -0.685 . . . . 15.0 109.151 172.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -106.35 121.19 43.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.798 -0.563 . . . . 15.0 110.608 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.44 141.75 45.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.802 -0.561 . . . . 15.0 109.809 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.2 140.69 50.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.561 -0.712 . . . . 15.0 109.762 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.9 -178.94 37.88 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 108.866 -1.694 . . . . 15.0 108.866 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -109.37 143.02 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.421 -1.046 . . . . 15.0 109.742 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.06 108.89 2.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.791 -0.568 . . . . 15.0 110.213 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -91.7 -52.02 4.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.795 -0.566 . . . . 15.0 110.407 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -144.11 142.43 30.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 15.0 110.439 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.42 125.59 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.77 -0.581 . . . . 15.0 109.644 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -112.05 97.38 6.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.627 -0.671 . . . . 15.0 109.851 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.82 -36.25 70.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.702 -0.624 . . . . 15.0 110.546 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.79 -29.1 66.58 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.524 -0.735 . . . . 15.0 111.118 -171.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.93 14.1 15.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.436 -0.79 . . . . 15.0 111.522 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m 49.9 49.14 20.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.181 -0.95 . . . . 15.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.9 p -131.89 148.29 52.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.462 -0.774 . . . . 15.0 110.401 -178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.65 138.49 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.561 -0.712 . . . . 15.0 109.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.28 128.79 56.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 15.0 109.954 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.84 137.22 52.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 15.0 109.801 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.03 164.12 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.739 -0.601 . . . . 15.0 109.785 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt 51.84 59.58 4.45 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.56 -0.712 . . . . 15.0 110.524 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.73 148.66 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.55 -0.719 . . . . 15.0 110.224 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -140.02 150.41 44.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.754 -0.591 . . . . 15.0 110.256 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -97.8 129.53 44.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.706 -0.621 . . . . 15.0 109.653 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 119.846 -0.742 . . . . 15.0 110.738 -171.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.877 0.37 . . . . 15.0 110.111 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.21 -42.65 79.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.851 -0.531 . . . . 15.0 110.692 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -150.14 121.9 8.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 15.0 110.608 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 65' ' ' ILE . 28.5 mt -130.93 147.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.705 -0.622 . . . . 15.0 109.505 173.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.45 137.94 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.696 -0.627 . . . . 15.0 109.999 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.41 141.49 51.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.805 -0.559 . . . . 15.0 109.819 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -108.72 152.2 25.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.714 -0.616 . . . . 15.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.46 -26.0 50.82 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.725 -0.95 . . . . 15.0 110.725 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 -45.99 76.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.401 -1.058 . . . . 15.0 110.743 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.1 -32.07 30.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.583 -0.698 . . . . 15.0 110.714 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.84 140.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.587 -0.696 . . . . 15.0 109.911 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -100.7 -42.21 6.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 15.0 110.195 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.4 144.58 30.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.649 -0.657 . . . . 15.0 110.667 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.31 128.59 43.47 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.655 -0.653 . . . . 15.0 110.148 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.598 -0.689 . . . . 15.0 110.192 178.187 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 121.078 0.465 . . . . 15.0 110.514 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.52 131.48 34.17 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 15.0 110.228 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.7 mt -132.62 145.01 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 15.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -115.72 127.45 55.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.3 tp -116.18 133.37 56.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 15.0 110.165 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -107.39 119.08 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.975 -0.75 . . . . 15.0 108.975 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -90.37 172.36 8.8 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.348 0.594 . . . . 15.0 110.808 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.37 -18.43 50.31 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.613 -0.679 . . . . 15.0 111.447 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 15.77 9.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.284 -0.885 . . . . 15.0 111.351 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.42 29.88 16.02 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.292 -0.88 . . . . 15.0 110.673 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.4 mt -104.07 143.27 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 172.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -102.77 119.36 38.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.78 -0.575 . . . . 15.0 110.391 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.3 130.55 55.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.822 -0.549 . . . . 15.0 109.625 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -115.99 140.67 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 15.0 109.868 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.4 -178.87 39.38 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.035 -1.626 . . . . 15.0 109.035 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.3 mm -108.08 138.8 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.389 -1.065 . . . . 15.0 109.772 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.39 108.96 1.21 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.754 -0.592 . . . . 15.0 110.379 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -91.53 -52.09 4.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.767 -0.583 . . . . 15.0 110.379 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -143.79 143.51 31.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.632 -0.668 . . . . 15.0 110.453 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.57 125.59 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.765 -0.584 . . . . 15.0 109.661 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -112.05 96.16 5.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 15.0 109.825 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -71.19 -37.12 72.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.716 -0.615 . . . . 15.0 110.418 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.12 -29.04 67.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.456 -0.778 . . . . 15.0 111.053 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -116.25 13.99 15.75 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 15.0 111.56 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.79 48.19 22.0 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.362 -0.836 . . . . 15.0 111.464 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.4 p -132.39 149.4 52.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 15.0 110.404 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.08 138.76 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.576 -0.703 . . . . 15.0 109.55 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.59 128.45 56.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.612 -0.68 . . . . 15.0 109.905 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.83 137.72 52.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.94 -0.475 . . . . 15.0 109.892 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.35 164.05 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.742 -0.599 . . . . 15.0 109.833 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 51.81 56.0 8.47 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.605 -0.684 . . . . 15.0 110.482 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.79 146.62 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 15.0 110.386 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -134.92 150.34 50.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.75 -0.594 . . . . 15.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -98.96 132.45 44.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.725 -0.61 . . . . 15.0 109.973 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.597 -0.689 . . . . 15.0 110.583 -175.78 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 120.947 0.403 . . . . 15.0 109.937 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -67.63 -41.63 83.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.808 -0.558 . . . . 15.0 110.745 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -150.8 121.88 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.585 -0.697 . . . . 15.0 110.585 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 91.6 mt -132.0 147.99 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.731 -0.606 . . . . 15.0 109.534 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -110.93 138.1 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.701 -0.624 . . . . 15.0 109.984 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.86 143.05 50.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.665 -0.647 . . . . 15.0 109.854 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -109.61 152.32 25.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.709 . . . . 15.0 110.166 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -26.05 55.66 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.759 -0.936 . . . . 15.0 110.759 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.6 p -66.7 -44.15 82.46 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.467 -1.019 . . . . 15.0 110.752 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.31 -31.86 26.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 15.0 110.673 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.55 143.54 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.648 -0.658 . . . . 15.0 109.895 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -105.05 -45.2 4.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 15.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -144.03 148.26 34.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 15.0 110.578 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.65 131.0 46.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.186 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 15.0 110.28 178.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.079 0.466 . . . . 15.0 110.602 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -81.3 128.58 33.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.858 -0.526 . . . . 15.0 110.129 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.65 146.52 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.494 -0.754 . . . . 15.0 109.994 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.93 130.93 57.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.482 -0.562 . . . . 15.0 109.482 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 tp -119.43 135.01 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.795 -0.566 . . . . 15.0 110.259 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.58 120.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -93.44 170.6 9.48 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.352 0.596 . . . . 15.0 110.862 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -60.6 -18.04 50.43 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.519 -0.738 . . . . 15.0 111.475 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 16.83 7.82 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.361 -0.837 . . . . 15.0 111.326 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.09 28.17 14.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 15.0 110.824 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -105.01 145.47 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -106.03 121.55 44.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.743 -0.598 . . . . 15.0 110.398 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.12 136.87 49.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.772 -0.58 . . . . 15.0 109.752 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -120.1 140.66 50.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.804 . . . . 15.0 109.876 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 -178.96 39.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.171 -1.572 . . . . 15.0 109.171 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.52 133.48 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.46 -1.023 . . . . 15.0 109.544 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.49 114.51 3.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.577 -0.702 . . . . 15.0 110.53 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -93.81 -52.08 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 15.0 110.379 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -146.45 145.27 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.597 -0.689 . . . . 15.0 110.595 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.04 126.61 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.795 -0.566 . . . . 15.0 109.658 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.12 97.68 6.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.676 . . . . 15.0 109.825 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.91 -36.1 72.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.784 -0.572 . . . . 15.0 110.41 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -59.21 -29.28 67.38 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.584 -0.697 . . . . 15.0 111.102 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.17 14.02 15.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.638 -0.664 . . . . 15.0 111.516 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t 49.99 47.26 23.56 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.14 -0.975 . . . . 15.0 111.24 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.0 p -131.51 150.14 52.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.542 -0.724 . . . . 15.0 110.489 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.92 139.38 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.589 -0.694 . . . . 15.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.59 128.6 56.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.699 -0.625 . . . . 15.0 110.01 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 mt -116.79 139.04 51.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.846 -0.428 . . . . 15.0 109.846 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 162.03 17.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.717 -0.615 . . . . 15.0 109.816 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 51.61 61.22 3.33 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.555 -0.715 . . . . 15.0 110.311 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.77 145.19 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.594 -0.691 . . . . 15.0 110.592 -172.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -138.64 155.77 48.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.759 -0.588 . . . . 15.0 110.296 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.4 p -99.03 133.48 43.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.841 -0.537 . . . . 15.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.671 . . . . 15.0 110.468 -176.58 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 109.859 -0.423 . . . . 15.0 109.859 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -69.09 -46.03 68.78 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.438 -0.505 . . . . 15.0 110.641 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -147.9 121.87 9.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.582 -0.699 . . . . 15.0 110.514 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.478 HG23 HD11 ' A' ' 65' ' ' ILE . 19.5 mt -132.27 147.98 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.705 -0.622 . . . . 15.0 109.432 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -112.36 138.86 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.648 -0.658 . . . . 15.0 110.094 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.1 144.71 51.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 15.0 109.815 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -108.7 151.8 25.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.7 -0.625 . . . . 15.0 110.237 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.08 -26.0 54.92 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -65.59 -45.3 83.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.551 -0.97 . . . . 15.0 110.715 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.01 -31.34 31.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 15.0 110.683 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.5 140.72 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.592 -0.693 . . . . 15.0 109.842 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -104.02 -42.53 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 15.0 110.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -147.41 149.6 33.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.678 -0.639 . . . . 15.0 110.7 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 tt -129.71 131.23 46.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.742 -0.599 . . . . 15.0 110.097 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.584 -0.697 . . . . 15.0 110.343 179.374 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 120.937 0.399 . . . . 15.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -91.99 137.03 32.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.619 -0.676 . . . . 15.0 110.264 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.43 146.31 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 15.0 109.883 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -114.36 128.12 56.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.386 -0.598 . . . . 15.0 109.386 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -120.56 135.92 54.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 15.0 110.282 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.4 mt -109.32 118.9 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -87.92 172.94 9.22 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.212 0.53 . . . . 15.0 110.781 -172.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -59.79 -18.44 43.52 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.606 -0.684 . . . . 15.0 111.601 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.52 15.47 10.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 15.0 111.286 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 56.17 28.58 13.31 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.191 -0.943 . . . . 15.0 110.776 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -101.87 142.9 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.82 -0.807 . . . . 15.0 108.82 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -100.84 120.8 40.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.744 -0.598 . . . . 15.0 110.467 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -112.73 132.35 55.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.837 -0.539 . . . . 15.0 109.591 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -117.92 140.65 49.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 15.0 109.907 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.85 39.38 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.944 -1.663 . . . . 15.0 108.944 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.4 mm -108.03 144.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -1.039 . . . . 15.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -66.15 113.49 4.56 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.807 -0.558 . . . . 15.0 110.21 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -94.25 -52.03 4.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.827 -0.546 . . . . 15.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -147.5 143.33 27.77 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 110.591 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.22 127.73 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.698 -0.627 . . . . 15.0 109.584 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -112.09 97.42 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.634 -0.666 . . . . 15.0 109.751 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.89 -35.74 72.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.703 -0.623 . . . . 15.0 110.405 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.56 -28.9 65.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.525 -0.734 . . . . 15.0 111.149 -171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -117.7 14.05 14.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.539 -0.725 . . . . 15.0 111.531 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t 49.92 48.69 21.47 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.104 -0.998 . . . . 15.0 111.257 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.7 p -131.99 150.26 52.2 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.383 -0.823 . . . . 15.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.04 138.58 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 15.0 109.558 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.75 127.66 54.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.655 . . . . 15.0 109.918 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -116.9 138.92 51.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.946 -0.471 . . . . 15.0 109.737 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.84 164.94 13.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.722 -0.611 . . . . 15.0 109.907 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 51.89 56.5 7.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.656 -0.653 . . . . 15.0 110.461 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -118.0 148.53 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.587 -0.695 . . . . 15.0 110.342 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -137.43 153.29 50.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.791 -0.568 . . . . 15.0 110.229 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.9 p -101.87 133.87 45.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.731 -0.606 . . . . 15.0 110.006 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.699 -0.626 . . . . 15.0 110.689 -175.674 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 120.986 0.422 . . . . 15.0 110.037 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.77 -40.7 83.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.847 -0.533 . . . . 15.0 110.843 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -151.99 121.94 7.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.775 . . . . 15.0 110.814 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.7 mt -130.85 148.02 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.688 -0.632 . . . . 15.0 109.664 172.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.26 135.09 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.718 -0.614 . . . . 15.0 109.813 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -126.22 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.75 -0.594 . . . . 15.0 109.841 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -108.16 151.86 25.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 15.0 110.159 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -25.95 55.45 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.3 p -66.46 -45.06 81.03 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.501 -1.0 . . . . 15.0 110.685 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.94 -31.92 31.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.745 . . . . 15.0 110.682 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.88 140.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.599 -0.688 . . . . 15.0 109.869 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -106.35 -42.28 5.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.745 -0.597 . . . . 15.0 110.251 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -139.26 142.65 37.78 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.672 -0.642 . . . . 15.0 110.531 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -130.84 126.96 37.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.681 -0.637 . . . . 15.0 110.19 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.616 -0.678 . . . . 15.0 110.093 177.416 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.038 0.447 . . . . 15.0 110.29 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -85.99 133.22 33.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.662 -0.649 . . . . 15.0 110.468 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.2 mt -133.83 154.18 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.598 -0.689 . . . . 15.0 109.735 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.9 t -115.89 132.62 56.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.901 -0.499 . . . . 15.0 109.85 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -116.53 130.19 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.87 -0.519 . . . . 15.0 109.88 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.18 119.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.91 -0.774 . . . . 15.0 108.91 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m -92.64 170.85 9.41 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.331 0.586 . . . . 15.0 110.981 -170.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.6 -18.54 53.65 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.603 -0.685 . . . . 15.0 111.422 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.59 16.13 8.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 15.0 111.251 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 58.12 28.53 16.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.344 -0.848 . . . . 15.0 110.829 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.0 mt -105.07 148.37 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -107.63 118.92 38.0 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.801 -0.562 . . . . 15.0 110.422 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.43 137.37 48.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.784 -0.573 . . . . 15.0 109.888 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -119.28 140.75 49.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 15.0 109.88 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.6 -178.9 38.97 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.072 -1.611 . . . . 15.0 109.072 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.21 135.16 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.516 -0.99 . . . . 15.0 109.708 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.5 tp -62.37 109.02 1.22 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.693 -0.629 . . . . 15.0 110.486 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.31 -52.07 5.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.819 -0.55 . . . . 15.0 110.356 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 p -144.52 144.17 31.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.622 -0.674 . . . . 15.0 110.538 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -116.44 125.35 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.778 -0.576 . . . . 15.0 109.654 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -112.03 96.37 6.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.706 . . . . 15.0 109.896 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.0 m -70.65 -36.8 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.803 -0.561 . . . . 15.0 110.379 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.29 -29.28 67.48 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 15.0 111.131 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -115.43 14.05 16.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 15.0 111.547 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t 49.87 47.93 22.46 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.093 -1.005 . . . . 15.0 111.25 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.4 p -131.97 148.41 52.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.357 -0.839 . . . . 15.0 110.561 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.78 139.25 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.607 -0.683 . . . . 15.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.15 128.69 56.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.684 . . . . 15.0 110.005 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.77 136.6 52.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.901 -0.499 . . . . 15.0 109.879 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.97 162.35 16.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.698 -0.627 . . . . 15.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 51.86 59.62 4.42 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.608 -0.683 . . . . 15.0 110.384 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.58 147.14 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.601 -0.687 . . . . 15.0 110.333 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -137.38 150.86 47.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.776 -0.578 . . . . 15.0 110.033 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.9 p -95.98 130.23 43.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.771 -0.581 . . . . 15.0 109.741 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 N--CA 1.499 2.013 0 O-C-N 121.6 -0.687 . . . . 15.0 110.443 -174.549 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.943 0.401 . . . . 15.0 110.096 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -67.55 -38.92 84.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.872 -0.517 . . . . 15.0 110.864 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.21 122.04 7.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.46 -0.775 . . . . 15.0 110.824 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.61 147.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.708 -0.62 . . . . 15.0 109.566 172.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.6 mt -110.8 137.76 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.723 -0.611 . . . . 15.0 109.927 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -129.47 142.64 50.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.718 -0.614 . . . . 15.0 109.905 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -110.35 152.15 26.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.621 -0.675 . . . . 15.0 110.107 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.94 55.12 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.5 p -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.436 -1.037 . . . . 15.0 110.75 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.13 -30.15 15.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.503 -0.748 . . . . 15.0 110.841 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.9 mt -63.52 138.37 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.453 -0.779 . . . . 15.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -98.86 -40.56 8.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.818 -0.551 . . . . 15.0 110.027 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.54 149.61 29.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.692 -0.63 . . . . 15.0 110.749 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -132.3 135.27 46.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.712 -0.617 . . . . 15.0 109.881 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.675 -0.641 . . . . 15.0 110.17 178.251 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.587 0.232 . . . . 10.41 110.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.8 155.21 42.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.243 -0.435 . . . . 8.0600000000000005 110.583 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -74.91 150.1 85.83 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.186 -0.461 . . . . 6.0999999999999996 110.539 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.26 -38.96 50.98 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.697 1.598 . . . . 6.2199999999999998 112.131 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -67.53 -37.59 82.96 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.291 -0.413 . . . . 5.1299999999999999 110.581 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.83 77.76 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.301 -0.719 . . . . 4.3899999999999997 111.301 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.3 -35.67 91.29 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.397 -0.681 . . . . 3.9100000000000001 111.397 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -96.39 122.91 56.37 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.438 -0.208 . . . . 2.8999999999999999 110.438 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.15 134.91 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.594 1.53 . . . . 1.97 112.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -68.99 -36.96 78.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.414 . . . . 4.1399999999999997 110.545 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.9 mt -66.53 133.09 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.245 -0.434 . . . . 1.1699999999999999 109.995 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.14 -2.09 63.32 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 116.116 -0.493 . . . . 0.38 112.399 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -102.99 156.7 17.49 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.554 0.677 . . . . 0.91000000000000003 110.772 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -82.84 133.2 35.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.034 -0.53 . . . . 2.5800000000000001 110.402 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.0 mt -135.85 147.25 28.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 1.0800000000000001 110.434 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.0 t -114.68 132.57 56.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.754 -0.657 . . . . 0.81999999999999995 109.893 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.2 tp -124.45 137.4 54.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.414 . . . . 1.1100000000000001 110.519 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mt -111.96 122.02 65.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.373 -0.602 . . . . 1.01 109.373 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -93.17 169.89 10.06 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.452 0.47 . . . . 0.81000000000000005 111.139 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -59.86 -20.96 60.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.044 -0.525 . . . . 3.0099999999999998 111.971 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.05 13.66 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.122 0.416 . . . . 1.03 112.122 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 61.9 25.22 15.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.635 0.255 . . . . 1.6299999999999999 111.271 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.02 142.89 17.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 109.475 -0.565 . . . . 1.04 109.475 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -104.42 121.08 42.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 3.0 110.619 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -113.6 139.8 48.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.018 -0.537 . . . . 0.81999999999999995 110.1 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -121.61 140.67 51.96 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.117 -0.327 . . . . 1.5900000000000001 110.117 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.0 -178.84 39.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.6 -1.0 . . . . 0.070000000000000007 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.9 mm -106.78 139.1 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.067 -0.345 . . . . 1.05 110.067 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.3 tp -65.95 109.06 2.39 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 1.0700000000000001 110.492 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -91.59 -52.15 4.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.255 -0.429 . . . . 0.92000000000000004 110.809 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 p -150.23 145.53 26.28 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.376 -0.375 . . . . 1.05 110.957 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.7 mt -118.45 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 1.0700000000000001 110.077 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -112.1 95.01 5.22 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.067 -0.345 . . . . 1.1000000000000001 110.067 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.7 m -67.87 -38.62 83.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.782 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.71 -32.15 68.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.311 -0.404 . . . . 1.97 111.615 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -112.64 13.94 20.01 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.163 0.431 . . . . 0.72999999999999998 112.163 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.6 p 49.99 42.15 24.16 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.936 0.398 . . . . 1.46 111.598 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 p -131.37 149.16 52.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.278 -0.419 . . . . 1.02 110.98 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.44 138.21 54.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.986 -0.552 . . . . 1.04 110.006 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.77 127.65 56.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.367 -0.379 . . . . 1.03 110.431 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.3 mt -116.93 139.48 50.6 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.112 -0.495 . . . . 1.1100000000000001 110.138 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.11 159.48 22.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.235 -0.439 . . . . 1.02 110.134 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 55.94 55.14 7.24 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.191 0.52 . . . . 2.7999999999999998 110.482 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.22 142.58 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.767 -0.651 . . . . 1.03 110.334 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -135.22 150.74 50.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 4.2699999999999996 110.493 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 p -96.47 128.01 43.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.83999999999999997 110.194 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -69.45 -40.31 77.25 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.456 -0.338 . . . . 1.1699999999999999 110.828 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 167.96 29.23 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.204 -0.758 . . . . 0.31 111.204 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.9 p -115.63 -30.6 6.12 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.524 0.202 . . . . 1.24 110.998 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.51 -27.2 64.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.582 -0.281 . . . . 2.3100000000000001 111.557 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.84 -33.23 68.42 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.674 0.273 . . . . 3.0899999999999999 110.865 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -119.22 94.97 48.97 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.109 -0.496 . . . . 5.7800000000000002 110.173 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.51 130.36 29.39 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 121.982 1.788 . . . . 2.5699999999999998 112.845 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.0 p -129.8 165.01 22.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.085 -0.507 . . . . 2.7200000000000002 110.377 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -77.9 -4.07 44.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.235 -0.439 . . . . 3.8700000000000001 112.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -118.09 106.87 44.63 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 110.555 -0.165 . . . . 5.7599999999999998 110.555 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.83 131.94 44.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.595 1.53 . . . . 3.6699999999999999 112.221 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.2 mm -119.35 130.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.206 -0.452 . . . . 2.3199999999999998 110.102 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.61 82.53 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 3.3599999999999999 110.492 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.01 135.82 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.701 1.601 . . . . 3.3300000000000001 112.045 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -134.8 131.26 37.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.168 -0.469 . . . . 7.7800000000000002 110.511 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -112.79 31.81 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.24 -0.437 . . . . 3.2200000000000002 110.777 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.3 147.61 30.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.363 -0.38 . . . . 2.3199999999999998 110.489 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -102.93 142.63 33.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 1.2 110.438 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.08 132.41 47.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.225 -0.443 . . . . 0.51000000000000001 110.417 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.31 -40.5 89.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.164 -0.471 . . . . 2.54 111.251 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -146.85 121.94 10.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.728 0.299 . . . . 0.73999999999999999 111.041 -174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.17 143.77 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.199 -0.455 . . . . 1.05 110.045 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -112.45 138.22 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.256 -0.429 . . . . 1.04 110.369 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -130.08 141.28 50.72 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.17000000000000001 110.273 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -102.15 149.11 24.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.414 -0.357 . . . . 2.71 110.295 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.86 50.4 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 111.946 -0.462 . . . . 0.12 111.946 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -67.09 -42.15 85.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.456 0.169 . . . . 1.6299999999999999 111.15 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -32.05 30.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.56 -0.291 . . . . 1.0900000000000001 111.229 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.51 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.506 -0.315 . . . . 1.04 110.392 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -103.93 -45.99 4.6 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.038 -0.528 . . . . 1.98 110.648 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -148.25 149.13 31.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.3 -0.409 . . . . 1.1299999999999999 111.127 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.5 tt -131.39 129.2 41.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.982 -0.553 . . . . 1.21 110.17 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.1 m -132.45 136.01 46.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.439 -0.346 . . . . 1.0600000000000001 110.571 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 143.94 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.369 -0.378 . . . . 1.29 110.136 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 80.3 m -93.76 -37.09 11.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.291 -0.413 . . . . 1.6499999999999999 110.81 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -90.85 117.52 67.99 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.374 -0.376 . . . . 2.29 110.523 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.38 156.41 9.42 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.767 1.644 . . . . 2.5499999999999998 112.181 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.11 135.87 21.52 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.718 1.612 . . . . 4.6299999999999999 111.983 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -88.56 152.18 49.09 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.185 -0.462 . . . . 8.3900000000000006 110.617 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 140.52 93.95 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.896 1.73 . . . . 9.3399999999999999 112.153 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.93 153.74 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.208 -0.451 . . . . 10.880000000000001 110.644 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.924 -1.036 . . . . 13.83 110.527 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 120.992 0.425 . . . . 15.0 110.151 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.33 -50.16 3.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.695 -0.628 . . . . 15.0 110.224 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -104.98 150.07 38.3 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.578 -0.701 . . . . 15.0 110.379 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.43 -31.91 88.54 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.401 1.211 . . . . 15.0 110.757 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 t -65.24 -31.81 73.16 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.616 -0.678 . . . . 15.0 110.515 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.47 -32.43 81.72 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.95 -1.26 . . . . 15.0 109.95 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.49 85.82 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.944 -1.262 . . . . 15.0 109.944 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.0 m -89.9 123.02 67.27 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.932 . . . . 15.0 110.053 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.31 130.58 20.15 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.351 1.185 . . . . 15.0 110.41 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -69.08 -32.39 71.8 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.683 -0.636 . . . . 15.0 110.215 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.55 133.91 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.422 -0.799 . . . . 15.0 109.763 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.63 -2.12 66.89 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -101.36 148.41 25.18 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.768 1.284 . . . . 15.0 110.553 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -82.07 128.46 34.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.853 -0.529 . . . . 15.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.8 mt -131.01 149.5 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 15.0 109.913 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.63 135.95 53.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.551 -0.537 . . . . 15.0 109.551 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 tp -127.07 137.0 52.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.717 -0.614 . . . . 15.0 110.258 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.63 123.4 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.014 -0.736 . . . . 15.0 109.014 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -93.55 172.83 8.02 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.305 0.574 . . . . 15.0 110.944 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.74 -19.8 52.46 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.63 -0.668 . . . . 15.0 111.444 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.76 16.14 8.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.803 . . . . 15.0 111.336 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.57 29.32 16.97 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.302 -0.874 . . . . 15.0 110.781 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.2 mt -105.09 147.59 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -105.78 118.93 37.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.785 -0.572 . . . . 15.0 110.509 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -111.52 140.71 45.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.812 -0.555 . . . . 15.0 109.765 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -125.83 140.8 52.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.475 -0.766 . . . . 15.0 109.839 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.86 -178.84 39.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.128 -1.589 . . . . 15.0 109.128 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -107.28 133.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.436 -1.038 . . . . 15.0 109.736 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 tp -61.61 114.66 3.4 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.751 -0.593 . . . . 15.0 110.474 -176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -95.72 -52.04 4.26 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.408 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -145.16 145.15 31.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.623 -0.673 . . . . 15.0 110.664 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -118.31 127.31 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.747 -0.595 . . . . 15.0 109.676 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.11 97.96 7.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 15.0 109.846 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -70.6 -36.57 73.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.719 -0.613 . . . . 15.0 110.484 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.09 -29.16 67.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.55 -0.719 . . . . 15.0 111.136 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -116.14 14.07 15.87 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.704 . . . . 15.0 111.539 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t 49.94 47.53 23.11 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.143 -0.973 . . . . 15.0 111.22 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.3 p -131.27 149.99 52.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.517 -0.739 . . . . 15.0 110.558 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.56 141.75 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.671 -0.643 . . . . 15.0 109.72 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.17 129.67 56.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.681 -0.637 . . . . 15.0 110.058 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 22.1 mt -116.92 138.95 51.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.884 -0.51 . . . . 15.0 109.845 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.08 16.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.736 -0.603 . . . . 15.0 109.861 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.3 mttt 51.72 58.36 5.56 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.709 -0.619 . . . . 15.0 110.441 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.8 p -121.29 148.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.566 -0.709 . . . . 15.0 110.332 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -138.62 153.91 48.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.81 -0.556 . . . . 15.0 110.128 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.3 p -101.24 131.84 47.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.832 -0.543 . . . . 15.0 109.856 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.84 -40.19 72.52 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.687 . . . . 15.0 110.541 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.78 169.9 31.88 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.809 -1.316 . . . . 15.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.8 p -117.98 -28.28 5.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.787 -0.831 . . . . 15.0 110.618 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -62.98 -29.9 71.17 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.446 -0.784 . . . . 15.0 110.892 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.42 -32.52 71.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.552 -0.717 . . . . 15.0 110.325 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -120.38 95.09 49.03 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.792 -0.567 . . . . 15.0 109.779 176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.19 132.34 46.33 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.423 1.223 . . . . 15.0 111.024 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.9 p -127.69 165.11 20.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.897 -0.502 . . . . 15.0 110.044 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.85 -1.6 32.42 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.71 -0.619 . . . . 15.0 111.487 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -114.88 115.0 43.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.183 -0.948 . . . . 15.0 109.853 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -65.72 132.04 29.45 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.385 1.202 . . . . 15.0 110.622 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.6 mm -121.28 146.02 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.672 -0.642 . . . . 15.0 109.665 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.42 150.68 43.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.687 -0.633 . . . . 15.0 110.081 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.11 145.91 62.49 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.611 1.322 . . . . 15.0 110.35 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -155.2 151.85 28.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 15.0 110.336 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -133.93 33.19 3.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.691 -0.631 . . . . 15.0 110.258 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -99.96 158.55 15.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.654 -0.654 . . . . 15.0 110.156 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.4 m -102.91 141.93 34.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.724 -0.61 . . . . 15.0 110.176 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -102.02 128.27 48.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.648 -0.658 . . . . 15.0 110.104 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -68.3 -43.37 77.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.769 -0.582 . . . . 15.0 110.579 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -149.92 122.02 8.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.543 -0.723 . . . . 15.0 110.609 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 65' ' ' ILE . 30.4 mt -130.85 146.98 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.699 -0.626 . . . . 15.0 109.56 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.87 137.29 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.72 -0.612 . . . . 15.0 109.93 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.93 144.28 51.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.75 -0.594 . . . . 15.0 109.846 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -109.27 152.68 24.9 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 15.0 110.088 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.04 -26.0 54.83 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.9 m -65.98 -45.86 80.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.472 -1.017 . . . . 15.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.95 -31.02 31.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.693 -0.63 . . . . 15.0 110.807 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.0 mt -65.99 141.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.538 -0.726 . . . . 15.0 109.89 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -104.56 -42.54 5.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.781 -0.574 . . . . 15.0 110.198 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -145.88 145.95 30.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.695 -0.628 . . . . 15.0 110.679 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.74 129.12 45.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.804 -0.56 . . . . 15.0 110.13 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -135.42 142.74 45.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.629 -0.669 . . . . 15.0 110.428 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.19 144.05 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.658 -0.651 . . . . 15.0 109.684 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.46 -37.05 7.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.525 -0.734 . . . . 15.0 110.358 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -155.57 139.17 11.12 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 15.0 110.206 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.6 175.86 2.59 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 123.315 1.166 . . . . 15.0 110.503 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.94 156.71 52.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.659 1.347 . . . . 15.0 110.547 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.32 157.59 72.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.68 -0.637 . . . . 15.0 110.178 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -67.2 148.54 80.82 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.663 1.349 . . . . 15.0 110.423 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.91 -35.0 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.772 -0.58 . . . . 15.0 109.699 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.018 -0.992 . . . . 15.0 110.247 179.776 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 68.65 166.24 0.26 Allowed 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.13 149.55 38.27 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.211 -1.033 . . . . 15.0 108.211 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.03 -33.17 42.32 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.618 1.325 . . . . 15.0 110.529 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -67.11 -35.8 80.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.68 -0.638 . . . . 15.0 110.222 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.11 -34.38 75.84 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.78 -1.328 . . . . 15.0 109.78 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.74 -36.86 88.17 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 15.0 109.825 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -99.46 141.38 22.72 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.914 . . . . 15.0 110.195 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -73.75 144.13 34.67 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 123.47 1.247 . . . . 15.0 110.36 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.04 -33.31 73.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.674 -0.641 . . . . 15.0 110.123 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.82 134.23 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.399 -0.813 . . . . 15.0 109.733 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 -2.06 64.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m -98.62 152.29 19.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.256 . . . . 15.0 110.599 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -84.89 128.2 34.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.768 -0.583 . . . . 15.0 110.197 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.0 mt -132.19 150.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 15.0 109.988 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 t -115.53 131.34 56.96 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.532 -0.544 . . . . 15.0 109.532 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.8 tp -118.82 134.9 54.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 15.0 110.285 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.5 mt -107.34 122.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.109 -0.701 . . . . 15.0 109.109 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -93.76 171.93 8.57 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.314 0.578 . . . . 15.0 110.87 -173.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -60.09 -19.05 51.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.614 -0.679 . . . . 15.0 111.441 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.23 16.69 8.14 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.353 -0.842 . . . . 15.0 111.275 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 57.1 28.44 14.94 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.28 -0.888 . . . . 15.0 110.827 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.0 mt -105.08 145.66 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.062 -0.718 . . . . 15.0 109.062 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -104.56 121.5 43.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.847 -0.533 . . . . 15.0 110.34 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.14 132.77 54.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.559 . . . . 15.0 109.654 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -115.96 140.58 49.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.532 -0.73 . . . . 15.0 109.886 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.05 -178.81 39.68 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.93 -1.668 . . . . 15.0 108.93 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -106.68 138.95 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.455 -1.026 . . . . 15.0 109.64 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.3 112.13 3.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.746 -0.596 . . . . 15.0 110.356 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -95.58 -52.11 4.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 15.0 110.489 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -144.31 142.54 30.48 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.573 -0.705 . . . . 15.0 110.604 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.27 126.55 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.805 -0.56 . . . . 15.0 109.609 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.09 95.28 5.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.609 -0.682 . . . . 15.0 109.792 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -69.33 -39.47 78.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.746 -0.596 . . . . 15.0 110.344 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -59.83 -29.27 68.14 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.549 -0.719 . . . . 15.0 111.063 -172.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -111.17 12.35 21.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.464 -0.773 . . . . 15.0 111.555 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m 49.98 44.64 25.53 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.195 -0.941 . . . . 15.0 111.288 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.1 p -132.77 150.09 52.2 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.481 -0.762 . . . . 15.0 110.623 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.3 139.95 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.73 -0.606 . . . . 15.0 109.595 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.73 128.69 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.646 -0.659 . . . . 15.0 110.04 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.9 mt -116.84 138.85 51.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.895 -0.503 . . . . 15.0 109.726 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.76 162.36 16.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 15.0 109.89 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt 52.09 61.05 3.41 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.619 -0.675 . . . . 15.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.07 147.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 15.0 110.46 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -132.8 149.92 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.857 -0.527 . . . . 15.0 109.988 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 p -97.74 130.8 44.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.688 -0.633 . . . . 15.0 109.823 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.96 -40.33 63.1 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.493 -0.754 . . . . 15.0 110.819 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.83 175.28 37.5 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.985 -1.246 . . . . 15.0 109.985 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.5 p -118.1 6.23 12.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.706 -0.879 . . . . 15.0 111.073 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.53 -23.21 49.06 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.251 -0.906 . . . . 15.0 111.419 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -60.51 -33.22 72.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.43 -0.794 . . . . 15.0 110.45 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -144.06 95.13 5.69 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.789 -0.57 . . . . 15.0 109.949 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.6 137.1 66.94 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.371 1.195 . . . . 15.0 110.74 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 p -123.79 165.19 17.73 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.815 -0.553 . . . . 15.0 110.134 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.77 -1.62 32.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.689 -0.632 . . . . 15.0 111.298 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -108.6 106.95 59.66 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.125 -0.984 . . . . 15.0 109.827 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.22 141.65 83.26 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.426 1.224 . . . . 15.0 110.811 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.0 mm -104.06 142.4 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.762 -0.586 . . . . 15.0 109.592 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.64 155.67 92.46 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.637 -0.664 . . . . 15.0 110.214 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.34 165.04 15.97 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.612 1.322 . . . . 15.0 110.601 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -66.96 136.84 55.96 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.752 -0.593 . . . . 15.0 110.129 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -150.25 -62.2 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.684 -0.635 . . . . 15.0 110.361 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -118.39 167.6 11.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.71 -0.619 . . . . 15.0 110.457 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.5 m -103.03 162.68 12.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.814 -0.554 . . . . 15.0 110.01 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -98.05 125.52 43.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.639 -0.663 . . . . 15.0 109.962 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.71 -46.02 70.07 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.87 -0.519 . . . . 15.0 110.543 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -149.29 121.93 8.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.579 -0.701 . . . . 15.0 110.48 -177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 147.19 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.718 -0.613 . . . . 15.0 109.605 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.66 136.32 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.746 -0.596 . . . . 15.0 109.818 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -126.28 143.96 50.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 15.0 109.984 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -106.66 151.99 24.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 15.0 110.173 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.99 -25.93 54.54 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.751 -0.94 . . . . 15.0 110.751 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 m -65.57 -45.41 83.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.48 -1.012 . . . . 15.0 110.661 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.98 -31.28 31.23 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.543 -0.723 . . . . 15.0 110.677 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.17 144.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.563 -0.711 . . . . 15.0 109.902 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -106.71 -43.09 4.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.748 -0.595 . . . . 15.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.74 151.72 32.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.652 -0.655 . . . . 15.0 110.629 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.38 129.79 45.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.851 -0.531 . . . . 15.0 110.176 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m -131.79 143.17 50.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.65 -0.656 . . . . 15.0 110.396 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.44 144.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.68 -0.637 . . . . 15.0 109.738 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 94.2 m -98.51 -37.14 9.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.603 -0.686 . . . . 15.0 110.343 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.15 117.48 63.13 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.656 -0.652 . . . . 15.0 110.115 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.67 151.31 32.09 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.397 1.209 . . . . 15.0 110.301 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -69.77 151.99 69.15 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.554 1.291 . . . . 15.0 110.229 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -101.45 161.76 22.59 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.682 . . . . 15.0 110.228 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -62.92 141.63 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.643 1.338 . . . . 15.0 110.591 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.5 mt -120.64 134.43 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.678 -0.638 . . . . 15.0 109.658 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.983 -1.008 . . . . 15.0 110.217 179.9 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.0 0.429 . . . . 15.0 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -116.45 167.31 11.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.683 -0.635 . . . . 15.0 110.106 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -89.5 150.1 43.78 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.67 -0.644 . . . . 15.0 110.121 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.72 -33.28 86.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.454 1.239 . . . . 15.0 110.729 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.3 p -67.74 -36.23 80.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.655 -0.653 . . . . 15.0 110.369 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.39 -36.91 54.5 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.557 -1.417 . . . . 15.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.3 76.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.847 -1.301 . . . . 15.0 109.847 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -71.43 144.79 89.58 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.925 . . . . 15.0 110.196 -177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -63.87 149.12 91.38 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.348 1.183 . . . . 15.0 110.562 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.84 -30.43 71.49 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.722 -0.611 . . . . 15.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.6 mt -64.32 135.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.373 -0.829 . . . . 15.0 109.595 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.18 -2.22 61.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.86 -0.896 . . . . 15.0 110.86 -174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 m -93.15 159.46 15.28 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.31 . . . . 15.0 110.347 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -92.12 133.74 35.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.75 -0.594 . . . . 15.0 110.287 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.43 147.72 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.531 -0.731 . . . . 15.0 109.923 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -115.08 131.45 56.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.499 -0.556 . . . . 15.0 109.499 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.16 135.97 54.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.713 -0.617 . . . . 15.0 110.35 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 79.9 mt -108.83 120.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -91.53 171.64 9.05 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.334 0.587 . . . . 15.0 110.886 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -59.69 -18.99 46.75 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.617 -0.677 . . . . 15.0 111.643 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.03 17.21 8.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 15.0 111.257 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 58.0 28.86 16.85 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.254 -0.904 . . . . 15.0 110.835 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.13 148.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -105.32 119.01 38.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.762 -0.586 . . . . 15.0 110.462 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.76 136.46 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.761 -0.587 . . . . 15.0 109.652 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.81 140.57 52.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 15.0 110.007 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.93 -178.88 39.67 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.901 -1.68 . . . . 15.0 108.901 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.9 mm -107.27 140.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -1.059 . . . . 15.0 109.858 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 tp -64.44 109.98 2.13 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.599 . . . . 15.0 110.344 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -93.39 -52.08 4.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.792 -0.567 . . . . 15.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -143.24 143.33 31.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.683 -0.635 . . . . 15.0 110.523 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.4 mt -116.83 125.62 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.775 -0.578 . . . . 15.0 109.656 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -112.03 98.21 7.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.603 -0.686 . . . . 15.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -71.32 -36.04 71.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.8 -0.563 . . . . 15.0 110.457 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.88 -29.88 67.33 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.544 -0.723 . . . . 15.0 111.078 -171.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -116.45 14.04 15.54 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.639 -0.663 . . . . 15.0 111.519 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t 49.88 48.69 21.44 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.246 -0.909 . . . . 15.0 111.229 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.3 p -131.39 149.58 52.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.571 -0.706 . . . . 15.0 110.514 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.0 t -131.49 139.68 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.663 -0.648 . . . . 15.0 109.687 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.74 128.47 56.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 15.0 109.957 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -116.82 137.78 51.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.979 -0.451 . . . . 15.0 109.798 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.33 163.68 14.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.741 -0.599 . . . . 15.0 109.894 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 51.48 64.24 1.92 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 121.376 0.608 . . . . 15.0 110.439 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -123.9 145.51 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 15.0 110.347 -172.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -127.98 149.34 50.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.864 -0.522 . . . . 15.0 109.801 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -99.32 125.18 44.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.663 -0.648 . . . . 15.0 109.602 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -70.35 -40.27 74.16 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.055 -0.658 . . . . 15.0 110.643 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 169.13 30.79 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.918 -1.273 . . . . 15.0 109.918 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.2 p -118.06 -19.46 9.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.911 -0.758 . . . . 15.0 110.946 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.5 -29.28 70.58 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.319 -0.863 . . . . 15.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -60.01 -32.9 71.31 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.445 -0.784 . . . . 15.0 110.252 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -125.21 94.97 42.42 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.825 -0.547 . . . . 15.0 109.766 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.48 132.63 47.17 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.388 1.204 . . . . 15.0 111.1 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.1 p -128.97 165.17 21.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.803 -0.56 . . . . 15.0 110.035 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.83 -1.85 33.6 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.664 -0.648 . . . . 15.0 111.352 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -109.54 106.91 59.09 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.14 -0.975 . . . . 15.0 109.976 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.8 138.77 54.66 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.389 1.205 . . . . 15.0 110.516 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.4 mm -122.4 145.96 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.653 -0.654 . . . . 15.0 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.59 158.04 38.99 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.71 -0.619 . . . . 15.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.54 161.12 36.55 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.586 1.309 . . . . 15.0 110.543 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -128.71 145.68 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 15.0 110.471 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.08 -31.86 5.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.75 -0.593 . . . . 15.0 110.485 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.93 166.38 11.31 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.593 -0.692 . . . . 15.0 110.348 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -102.96 169.31 8.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.761 -0.587 . . . . 15.0 109.884 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -101.92 125.46 48.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.495 -0.753 . . . . 15.0 110.18 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.35 -44.7 71.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.79 -0.569 . . . . 15.0 110.604 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -148.87 121.98 8.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.571 -0.706 . . . . 15.0 110.507 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.73 147.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.745 -0.597 . . . . 15.0 109.663 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -111.18 136.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.739 -0.601 . . . . 15.0 109.865 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.72 144.1 51.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 15.0 109.913 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -108.47 151.9 25.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 15.0 110.097 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.02 -25.94 54.65 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 110.746 -0.942 . . . . 15.0 110.746 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -66.09 -45.41 81.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.48 -1.012 . . . . 15.0 110.731 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -82.05 -31.58 30.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.584 -0.697 . . . . 15.0 110.626 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.9 mt -66.16 140.53 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.545 -0.722 . . . . 15.0 109.816 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -108.16 -42.28 4.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 15.0 110.344 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.23 145.16 38.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 15.0 110.653 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -132.82 129.61 38.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.701 -0.625 . . . . 15.0 110.254 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -130.48 142.59 50.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.743 -0.598 . . . . 15.0 110.219 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -102.26 144.08 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.626 -0.671 . . . . 15.0 109.893 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -88.21 -34.6 17.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.716 -0.615 . . . . 15.0 110.177 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -84.18 154.92 63.76 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.622 -0.674 . . . . 15.0 109.879 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.24 111.01 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.638 1.336 . . . . 15.0 111.048 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -75.63 152.68 38.17 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 O-C-N 123.448 1.236 . . . . 15.0 110.129 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -102.16 158.64 31.37 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.733 . . . . 15.0 110.15 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -62.62 141.1 84.61 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 O-C-N 123.548 1.289 . . . . 15.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.5 tt -66.45 -31.27 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.67 -0.644 . . . . 15.0 110.386 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.983 -1.008 . . . . 15.0 110.241 179.513 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.9 tt . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.959 0.409 . . . . 15.0 110.202 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.03 -58.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.761 -0.587 . . . . 15.0 110.188 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -105.0 138.73 19.59 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.709 -0.619 . . . . 15.0 110.009 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.1 -41.01 14.11 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.489 1.258 . . . . 15.0 110.517 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.1 p -69.53 -33.81 73.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.642 -0.661 . . . . 15.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.61 -34.29 67.29 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.699 -1.361 . . . . 15.0 109.699 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.58 -38.32 90.27 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.749 -1.341 . . . . 15.0 109.749 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.5 m -117.84 122.97 30.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.635 -0.921 . . . . 15.0 110.166 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.69 149.01 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.377 1.198 . . . . 15.0 110.23 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -62.6 -24.97 67.85 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.599 -0.688 . . . . 15.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.7 mt -64.82 139.87 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 15.0 109.17 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -2.1 66.72 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.799 -0.92 . . . . 15.0 110.799 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -76.55 159.94 29.9 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.046 -1.267 . . . . 15.0 110.33 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -86.87 129.89 34.69 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.681 -0.637 . . . . 15.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.7 mt -132.77 150.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.617 -0.677 . . . . 15.0 109.927 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.46 132.97 56.46 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.57 136.93 55.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.751 -0.593 . . . . 15.0 110.335 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.1 mt -109.47 121.68 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -93.22 171.49 8.9 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.279 0.561 . . . . 15.0 110.937 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -60.23 -19.12 53.14 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.594 -0.691 . . . . 15.0 111.396 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.12 16.83 7.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.342 -0.848 . . . . 15.0 111.271 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 57.6 28.39 15.58 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.295 -0.878 . . . . 15.0 110.818 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.3 mt -104.95 147.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -106.71 119.84 40.4 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.698 -0.626 . . . . 15.0 110.52 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.23 137.24 49.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.874 -0.516 . . . . 15.0 109.772 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -121.29 140.69 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.745 . . . . 15.0 109.942 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.88 39.4 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.973 -1.651 . . . . 15.0 108.973 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.35 138.02 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.382 -1.069 . . . . 15.0 109.696 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.2 tp -66.19 108.84 2.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.727 -0.608 . . . . 15.0 110.168 -177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -93.51 -52.16 4.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.882 -0.511 . . . . 15.0 110.509 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -141.69 141.34 33.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 15.0 110.492 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.6 mt -118.04 124.92 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.742 -0.599 . . . . 15.0 109.644 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -112.11 97.46 6.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.532 -0.73 . . . . 15.0 109.907 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.01 -36.19 74.92 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.767 -0.583 . . . . 15.0 110.434 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -59.22 -29.62 67.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.539 -0.726 . . . . 15.0 111.074 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -115.53 14.07 16.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.522 -0.737 . . . . 15.0 111.471 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 m 50.0 46.65 24.24 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.184 -0.948 . . . . 15.0 111.181 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.7 p -131.6 149.81 52.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.404 -0.81 . . . . 15.0 110.51 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.41 140.23 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 15.0 109.72 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.33 130.05 56.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.709 -0.619 . . . . 15.0 109.961 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.8 138.06 51.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.765 -0.458 . . . . 15.0 109.765 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 162.39 16.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.722 -0.611 . . . . 15.0 109.887 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.7 mttt 51.75 61.2 3.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.673 -0.642 . . . . 15.0 110.428 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.4 145.88 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.686 -0.634 . . . . 15.0 110.376 -173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.88 149.42 52.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.813 -0.554 . . . . 15.0 109.99 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -97.22 127.79 43.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.615 . . . . 15.0 109.649 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -68.9 -40.24 79.25 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.554 -0.717 . . . . 15.0 110.615 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.72 170.24 32.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.758 -1.337 . . . . 15.0 109.758 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.8 p -118.03 -30.8 5.24 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.796 -0.826 . . . . 15.0 110.485 176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.64 -28.53 69.97 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.507 -0.746 . . . . 15.0 110.901 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -60.25 -32.34 71.06 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.44 -0.788 . . . . 15.0 110.314 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -118.97 95.15 49.1 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 15.0 109.704 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.09 134.7 65.24 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 O-C-N 123.426 1.224 . . . . 15.0 111.374 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.1 p -132.82 165.14 25.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.874 -0.516 . . . . 15.0 110.03 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.8 -2.14 34.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.666 -0.646 . . . . 15.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -116.84 106.85 47.17 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 15.0 109.99 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -62.66 134.06 45.47 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.324 1.171 . . . . 15.0 110.798 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.8 mm -121.86 146.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.679 -0.638 . . . . 15.0 109.655 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.46 157.78 36.71 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.641 -0.662 . . . . 15.0 110.292 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.8 152.33 79.18 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.505 1.266 . . . . 15.0 110.624 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -138.74 -50.06 0.54 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.733 -0.605 . . . . 15.0 110.268 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 52.43 39.3 27.36 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.681 -0.637 . . . . 15.0 110.984 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.54 154.63 31.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 15.0 110.131 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.9 m -102.97 135.54 44.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.643 -0.66 . . . . 15.0 110.086 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.12 133.05 47.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 15.0 110.153 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -68.46 -43.98 75.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.853 -0.53 . . . . 15.0 110.631 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.83 122.08 8.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.601 -0.687 . . . . 15.0 110.587 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 91.2 mt -130.71 147.83 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.618 -0.676 . . . . 15.0 109.564 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.22 137.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.776 -0.578 . . . . 15.0 109.885 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.87 145.65 51.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.771 -0.58 . . . . 15.0 109.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.85 152.35 25.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.637 -0.664 . . . . 15.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.15 55.91 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.722 -0.951 . . . . 15.0 110.722 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 m -65.74 -45.24 83.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -1.047 . . . . 15.0 110.646 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.99 -31.44 31.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.552 -0.717 . . . . 15.0 110.669 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.1 mt -66.21 141.98 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.576 -0.702 . . . . 15.0 109.816 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -107.95 -43.4 4.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.761 -0.587 . . . . 15.0 110.287 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -141.81 147.41 37.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.666 -0.646 . . . . 15.0 110.674 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -132.37 129.48 39.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.606 . . . . 15.0 110.18 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.5 m -131.62 141.46 49.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.627 -0.67 . . . . 15.0 110.362 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.21 144.06 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 15.0 109.774 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.1 m -94.18 -37.01 11.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 15.0 110.267 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -84.19 117.48 68.8 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.621 -0.675 . . . . 15.0 110.006 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.53 156.01 65.11 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.395 1.208 . . . . 15.0 110.383 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.51 152.2 75.1 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.654 1.344 . . . . 15.0 110.268 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -97.09 164.34 18.05 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.643 -0.66 . . . . 15.0 110.189 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.79 148.55 82.79 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.758 1.399 . . . . 15.0 110.418 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -111.85 135.44 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.752 -0.592 . . . . 15.0 109.67 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.026 -0.988 . . . . 15.0 110.3 179.76 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.682 0.623 . . . . 15.0 112.682 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.03 92.07 2.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.692 -0.63 . . . . 15.0 111.966 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -105.06 150.07 38.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.69 -0.631 . . . . 15.0 110.109 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.03 -41.07 14.24 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.536 1.282 . . . . 15.0 110.36 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -72.58 -37.41 68.17 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.653 -0.655 . . . . 15.0 109.834 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.63 -27.55 73.24 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.998 -1.241 . . . . 15.0 109.998 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.23 -34.34 87.76 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.17 -1.172 . . . . 15.0 110.17 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -108.39 122.83 39.2 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.923 . . . . 15.0 110.042 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.12 134.68 19.76 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.409 1.215 . . . . 15.0 110.375 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -69.01 -36.29 77.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 15.0 109.922 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.85 135.42 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.524 -0.735 . . . . 15.0 109.495 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.49 -2.08 60.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -95.97 150.16 20.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.276 . . . . 15.0 110.328 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -83.73 130.25 34.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.685 -0.635 . . . . 15.0 110.483 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 89.2 mt -130.61 149.39 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.749 -0.594 . . . . 15.0 109.908 -177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -112.32 133.91 54.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 tp -123.31 133.3 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.78 -0.575 . . . . 15.0 110.319 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.8 mt -107.58 122.9 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -94.48 172.8 7.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.309 0.576 . . . . 15.0 110.903 -172.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.89 -19.56 52.18 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.608 -0.683 . . . . 15.0 111.48 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.38 15.39 9.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.27 -0.894 . . . . 15.0 111.316 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 58.02 27.5 14.92 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.341 -0.849 . . . . 15.0 110.813 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.3 mt -104.2 148.33 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.998 -0.741 . . . . 15.0 108.998 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 -107.27 121.35 44.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 15.0 110.557 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -112.02 138.48 48.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.875 -0.516 . . . . 15.0 109.711 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -120.44 140.7 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 15.0 109.899 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.01 -178.88 38.63 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.165 -1.574 . . . . 15.0 109.165 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.62 134.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -1.021 . . . . 15.0 109.772 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 tp -61.3 112.04 1.99 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.669 -0.644 . . . . 15.0 110.445 -177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -94.11 -52.0 4.58 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.347 -0.541 . . . . 15.0 110.378 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.3 p -143.77 143.63 31.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 15.0 110.531 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.2 mt -116.84 125.2 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.767 -0.583 . . . . 15.0 109.664 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -112.07 96.75 6.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 15.0 109.823 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.5 m -70.91 -36.26 72.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.756 -0.59 . . . . 15.0 110.438 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.87 -29.29 66.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.508 -0.745 . . . . 15.0 111.046 -171.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -116.08 14.03 15.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.58 -0.7 . . . . 15.0 111.571 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.0 m 49.97 48.0 22.49 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.207 -0.933 . . . . 15.0 111.248 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.1 p -131.95 148.54 52.53 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.459 -0.776 . . . . 15.0 110.489 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.09 139.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.595 -0.691 . . . . 15.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.62 128.85 56.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.681 -0.637 . . . . 15.0 109.971 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 mt -116.86 138.14 51.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.944 -0.473 . . . . 15.0 109.918 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.59 164.03 14.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.737 -0.602 . . . . 15.0 109.855 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 51.51 58.54 5.39 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.407 0.622 . . . . 15.0 110.464 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.72 148.43 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.575 -0.703 . . . . 15.0 110.331 -173.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -137.53 148.83 46.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.829 -0.544 . . . . 15.0 110.029 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.6 p -96.59 131.61 43.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.799 -0.563 . . . . 15.0 109.653 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.92 -40.37 63.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.615 -0.678 . . . . 15.0 110.641 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.68 173.06 35.43 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.941 -1.264 . . . . 15.0 109.941 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.3 p -114.4 -20.06 10.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.701 -0.882 . . . . 15.0 110.741 173.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -61.53 -30.14 70.45 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.375 -0.828 . . . . 15.0 110.832 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -60.17 -32.35 70.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.484 -0.76 . . . . 15.0 110.168 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.97 95.08 49.02 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.796 -0.565 . . . . 15.0 109.739 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.08 132.84 54.42 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.501 1.264 . . . . 15.0 111.252 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.8 p -118.13 165.01 14.29 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.827 -0.546 . . . . 15.0 109.996 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.66 -13.49 59.89 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.694 -0.629 . . . . 15.0 111.212 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.5 ptt85 -118.22 139.04 26.22 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.219 -0.926 . . . . 15.0 110.082 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -67.64 149.6 79.31 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.182 1.096 . . . . 15.0 110.408 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.2 mm -113.64 139.99 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.674 -0.641 . . . . 15.0 109.551 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.35 96.81 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.544 -0.722 . . . . 15.0 110.152 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.68 143.17 86.2 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.544 1.286 . . . . 15.0 110.601 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -158.26 132.86 8.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.732 -0.605 . . . . 15.0 110.308 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -142.66 32.94 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.709 -0.619 . . . . 15.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -109.68 170.25 8.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 15.0 110.197 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.2 m -102.98 143.13 32.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.629 -0.669 . . . . 15.0 110.12 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -102.04 127.85 48.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.689 -0.632 . . . . 15.0 110.029 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -44.1 76.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.879 -0.513 . . . . 15.0 110.562 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -150.08 122.03 8.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 15.0 110.571 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.6 mt -130.01 146.37 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.669 -0.644 . . . . 15.0 109.627 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.54 136.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.717 -0.615 . . . . 15.0 109.988 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.99 140.95 51.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.698 -0.626 . . . . 15.0 109.862 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -106.68 152.39 23.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.747 -0.596 . . . . 15.0 110.022 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.65 -26.07 52.3 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.745 -0.942 . . . . 15.0 110.745 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -66.29 -45.99 78.52 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.526 -0.985 . . . . 15.0 110.752 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.2 -31.94 30.11 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.576 -0.702 . . . . 15.0 110.678 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 84.9 mt -67.24 141.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.573 -0.704 . . . . 15.0 109.817 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -100.85 -42.51 6.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.729 -0.607 . . . . 15.0 110.229 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -147.93 144.3 27.94 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.624 -0.673 . . . . 15.0 110.768 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -127.23 128.27 45.79 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.712 -0.617 . . . . 15.0 109.968 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -135.9 142.24 44.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.557 -0.714 . . . . 15.0 110.502 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.37 144.05 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.665 -0.647 . . . . 15.0 109.492 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 28.7 p -114.66 -29.64 6.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.532 -0.73 . . . . 15.0 110.983 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -84.26 117.45 68.74 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.582 -0.698 . . . . 15.0 110.119 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.65 161.99 33.35 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 O-C-N 123.406 1.214 . . . . 15.0 110.428 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -68.05 152.97 76.13 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.705 1.371 . . . . 15.0 110.173 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -86.25 154.08 56.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.652 -0.655 . . . . 15.0 110.221 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.24 145.65 66.91 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.651 1.342 . . . . 15.0 110.371 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 pt -123.68 152.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 15.0 110.236 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 117.965 -1.016 . . . . 15.0 110.132 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.95 0.405 . . . . 15.0 110.334 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -109.75 147.97 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.73 -0.606 . . . . 15.0 110.248 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -104.39 148.64 36.3 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.667 -0.646 . . . . 15.0 110.127 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.61 -32.46 69.36 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.467 1.246 . . . . 15.0 110.552 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -66.73 -30.98 71.35 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.724 -0.61 . . . . 15.0 110.497 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.5 -35.46 81.53 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.733 -1.347 . . . . 15.0 109.733 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.55 -35.33 74.77 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.739 -1.344 . . . . 15.0 109.739 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 m -96.68 142.44 24.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.938 . . . . 15.0 110.063 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.99 131.43 22.32 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 123.432 1.227 . . . . 15.0 110.338 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -68.98 -33.91 74.45 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.667 -0.646 . . . . 15.0 110.118 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.4 mt -65.08 133.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.42 -0.8 . . . . 15.0 109.833 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.06 68.35 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.029 -0.828 . . . . 15.0 111.029 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -101.66 151.26 22.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.248 . . . . 15.0 110.657 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -78.38 127.67 32.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.846 -0.534 . . . . 15.0 110.199 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 96.4 mt -130.97 144.73 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 15.0 109.867 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -113.03 132.34 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -121.25 136.01 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.803 -0.561 . . . . 15.0 110.231 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.96 121.42 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.92 172.69 8.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.352 0.596 . . . . 15.0 110.911 -171.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -59.97 -19.25 51.14 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.614 -0.679 . . . . 15.0 111.472 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.88 9.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.395 -0.815 . . . . 15.0 111.337 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.6 29.11 16.68 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.293 -0.879 . . . . 15.0 110.752 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.09 147.93 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.74 122.65 46.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.799 -0.563 . . . . 15.0 110.567 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.8 137.44 51.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 15.0 109.812 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -119.43 140.66 50.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.458 -0.776 . . . . 15.0 109.796 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.12 -178.95 38.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.21 -1.556 . . . . 15.0 109.21 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.82 134.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.485 -1.009 . . . . 15.0 109.72 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.6 tp -61.45 114.61 3.32 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.694 -0.629 . . . . 15.0 110.546 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -95.62 -51.93 4.32 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.324 -0.55 . . . . 15.0 110.402 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.3 p -143.81 143.94 31.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.632 -0.668 . . . . 15.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -117.2 124.63 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.67 -0.644 . . . . 15.0 109.64 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.09 98.14 7.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.648 -0.657 . . . . 15.0 109.844 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.707 -0.62 . . . . 15.0 110.423 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.8 -29.59 66.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.545 -0.722 . . . . 15.0 111.054 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -116.14 14.07 15.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.49 -0.756 . . . . 15.0 111.434 -177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t 49.97 48.91 21.21 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.133 -0.979 . . . . 15.0 111.254 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -132.33 147.88 52.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.512 -0.743 . . . . 15.0 110.57 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.84 138.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.675 -0.64 . . . . 15.0 109.686 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.61 126.34 54.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.719 -0.613 . . . . 15.0 109.907 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 26.5 mt -116.78 136.92 52.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.19 164.34 14.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.721 -0.612 . . . . 15.0 109.935 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 51.75 58.05 5.88 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.644 -0.66 . . . . 15.0 110.48 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -119.96 147.36 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 15.0 110.347 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -133.63 149.86 51.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.787 -0.571 . . . . 15.0 109.993 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.6 p -98.69 131.19 45.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.635 -0.666 . . . . 15.0 109.754 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -73.27 -40.32 64.68 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.515 -0.741 . . . . 15.0 110.69 -173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.92 34.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.804 -1.318 . . . . 15.0 109.804 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.4 p -118.06 -17.01 9.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.772 -0.84 . . . . 15.0 110.901 175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -63.57 -26.67 68.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.275 -0.891 . . . . 15.0 111.13 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -59.41 -31.79 69.59 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.487 -0.758 . . . . 15.0 110.411 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -128.3 95.03 34.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 15.0 109.848 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.33 135.32 69.44 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.472 1.248 . . . . 15.0 111.113 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.0 p -131.21 165.11 24.06 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.545 . . . . 15.0 109.99 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.84 -1.43 31.58 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.55 -0.719 . . . . 15.0 111.411 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -110.35 106.91 58.34 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.234 -0.916 . . . . 15.0 109.827 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.06 136.49 48.4 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.356 1.187 . . . . 15.0 110.747 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.8 mm -118.25 143.63 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.711 -0.618 . . . . 15.0 109.638 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.89 155.08 47.8 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.667 -0.646 . . . . 15.0 110.17 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -62.65 137.19 62.43 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.537 1.283 . . . . 15.0 110.649 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -139.22 127.61 22.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.69 -0.631 . . . . 15.0 110.216 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -117.56 32.15 6.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.631 -0.668 . . . . 15.0 110.357 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 158.11 18.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 15.0 110.195 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -103.03 146.79 27.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.694 -0.629 . . . . 15.0 110.021 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.95 126.37 48.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 15.0 110.119 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -68.09 -41.75 81.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.821 -0.549 . . . . 15.0 110.657 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -150.3 122.06 8.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.615 -0.678 . . . . 15.0 110.423 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 92.9 mt -129.6 144.58 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.685 -0.634 . . . . 15.0 109.481 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.54 133.42 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 109.785 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -123.83 140.53 52.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.705 -0.622 . . . . 15.0 109.893 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -105.25 152.02 23.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.652 -0.655 . . . . 15.0 110.074 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.66 -25.96 52.12 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -66.41 -43.06 86.79 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.483 -1.01 . . . . 15.0 110.729 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.9 -31.61 23.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.541 -0.724 . . . . 15.0 110.664 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.37 141.46 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.582 -0.699 . . . . 15.0 109.887 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -105.26 -42.7 5.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.65 -0.656 . . . . 15.0 110.214 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.53 147.4 32.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.592 -0.692 . . . . 15.0 110.763 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -130.25 129.49 43.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.724 -0.61 . . . . 15.0 110.133 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -133.81 145.38 49.69 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.563 -0.711 . . . . 15.0 110.433 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.15 144.06 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.701 -0.625 . . . . 15.0 109.676 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 93.1 m -101.67 -37.06 8.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 15.0 110.656 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -100.07 148.89 35.47 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.672 -0.643 . . . . 15.0 110.417 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.24 163.7 34.32 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.501 1.264 . . . . 15.0 110.278 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.74 134.6 44.59 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.556 1.292 . . . . 15.0 110.432 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -102.13 164.63 15.39 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.668 -0.645 . . . . 15.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.71 143.38 92.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.583 1.307 . . . . 15.0 110.52 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -94.92 -34.72 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 15.0 109.723 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.98 -1.01 . . . . 15.0 110.144 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 121.02 0.438 . . . . 15.0 110.207 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.29 -32.77 74.38 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.661 -0.65 . . . . 15.0 110.432 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.66 150.0 58.52 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.692 -0.63 . . . . 15.0 110.184 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.0 -35.72 33.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.54 1.284 . . . . 15.0 110.497 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -67.74 -34.13 76.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.668 . . . . 15.0 110.236 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.65 76.13 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.796 -1.321 . . . . 15.0 109.796 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.17 -35.42 90.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.814 -1.315 . . . . 15.0 109.814 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -133.62 122.89 17.04 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.899 . . . . 15.0 110.121 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.75 149.01 53.69 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.334 1.176 . . . . 15.0 110.351 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.42 -33.6 76.34 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.655 . . . . 15.0 110.17 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.7 137.24 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 15.0 109.546 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.17 -2.16 63.3 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.9 m -91.4 153.06 20.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.131 -1.217 . . . . 15.0 110.43 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -83.56 127.63 33.88 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.741 -0.599 . . . . 15.0 110.442 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.1 mt -131.21 151.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.629 -0.67 . . . . 15.0 109.892 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -115.79 133.26 56.21 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.4 tp -121.6 136.15 54.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.733 -0.605 . . . . 15.0 110.197 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.23 123.44 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -95.78 169.76 9.78 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.343 0.592 . . . . 15.0 110.947 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -60.4 -18.35 50.04 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.616 -0.677 . . . . 15.0 111.513 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 17.58 7.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.245 -0.91 . . . . 15.0 111.276 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 58.12 27.63 15.26 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.309 -0.869 . . . . 15.0 110.844 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -105.0 146.23 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -106.18 120.64 42.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.786 -0.571 . . . . 15.0 110.323 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.83 132.91 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.851 -0.53 . . . . 15.0 109.791 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.77 140.71 49.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 15.0 109.812 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.98 -178.81 40.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.196 -1.562 . . . . 15.0 109.196 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -105.51 132.39 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.502 -0.999 . . . . 15.0 109.677 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.2 tp -62.15 110.9 1.75 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.712 -0.618 . . . . 15.0 110.422 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -91.32 -52.09 4.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.786 -0.571 . . . . 15.0 110.481 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 p -144.64 143.65 30.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.641 -0.662 . . . . 15.0 110.581 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.45 125.78 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.629 . . . . 15.0 109.556 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.09 95.99 5.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 15.0 109.791 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -70.22 -37.08 74.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.772 -0.58 . . . . 15.0 110.389 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -59.12 -29.51 67.44 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.628 -0.67 . . . . 15.0 111.084 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -115.22 14.03 16.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.623 -0.673 . . . . 15.0 111.57 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 m 49.93 46.88 23.93 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.174 -0.954 . . . . 15.0 111.256 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 p -131.81 150.08 52.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 15.0 110.561 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.24 139.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.678 -0.639 . . . . 15.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.86 128.16 56.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.687 -0.633 . . . . 15.0 109.956 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.81 138.85 51.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.991 -0.443 . . . . 15.0 109.818 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.76 161.71 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.625 . . . . 15.0 109.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 51.64 56.56 7.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.66 -0.65 . . . . 15.0 110.535 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.72 147.52 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.565 -0.71 . . . . 15.0 110.356 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -136.22 153.28 51.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.781 -0.574 . . . . 15.0 110.096 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.6 p -99.68 131.85 45.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.714 -0.616 . . . . 15.0 110.008 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -68.85 -40.09 79.57 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.64 . . . . 15.0 110.438 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.87 169.74 31.75 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.884 -1.287 . . . . 15.0 109.884 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -118.04 6.33 12.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.841 -0.799 . . . . 15.0 111.155 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -53.95 -25.42 20.55 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.296 -0.877 . . . . 15.0 111.286 -174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -63.47 -33.74 76.23 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.47 -0.769 . . . . 15.0 110.054 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp85 -144.53 92.5 5.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.737 -0.602 . . . . 15.0 109.829 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.4 138.62 61.2 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.473 1.249 . . . . 15.0 110.659 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.0 p -127.78 165.05 20.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.695 -0.628 . . . . 15.0 110.082 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.89 -3.08 39.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.689 -0.632 . . . . 15.0 111.375 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -100.36 124.85 41.44 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 15.0 110.051 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.0 139.97 48.63 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.337 1.177 . . . . 15.0 110.43 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.5 mm -111.74 145.99 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 15.0 109.687 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.71 156.73 88.38 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.75 -0.594 . . . . 15.0 110.213 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 157.97 42.26 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.578 1.304 . . . . 15.0 110.742 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -62.02 -27.71 69.07 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.709 -0.619 . . . . 15.0 110.942 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.46 -34.41 76.76 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.585 -0.697 . . . . 15.0 110.586 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -80.45 141.76 34.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.69 -0.631 . . . . 15.0 110.028 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -125.69 153.73 43.45 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.727 -0.608 . . . . 15.0 110.394 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -102.01 136.37 41.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.747 -0.595 . . . . 15.0 109.924 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.0 -44.37 76.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.8 -0.563 . . . . 15.0 110.686 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -148.59 121.99 9.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 15.0 110.572 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.36 147.32 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.715 -0.616 . . . . 15.0 109.517 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.51 138.39 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.65 -0.656 . . . . 15.0 109.917 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -128.99 145.35 51.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 15.0 109.908 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -107.16 152.45 24.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.694 -0.629 . . . . 15.0 110.131 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.02 56.35 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -65.95 -42.5 89.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.465 -1.021 . . . . 15.0 110.738 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.25 -31.12 23.29 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.595 -0.69 . . . . 15.0 110.696 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.7 mt -66.36 146.78 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.632 -0.668 . . . . 15.0 109.75 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.42 -44.65 4.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.734 -0.604 . . . . 15.0 110.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -148.43 149.8 32.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.668 -0.645 . . . . 15.0 110.769 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.48 129.38 46.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.804 -0.56 . . . . 15.0 110.149 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -134.47 143.92 47.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.573 -0.704 . . . . 15.0 110.479 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.54 144.13 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.669 -0.644 . . . . 15.0 109.629 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.7 t -114.98 -37.04 4.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 15.0 110.57 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -96.61 117.47 65.98 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.68 . . . . 15.0 110.287 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.72 176.99 9.07 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.358 1.188 . . . . 15.0 110.267 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.8 153.79 70.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.577 1.304 . . . . 15.0 110.48 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -90.11 161.14 38.71 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.69 -0.631 . . . . 15.0 110.212 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.5 147.09 95.38 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.687 1.362 . . . . 15.0 110.596 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 pt -124.78 160.37 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.743 -0.598 . . . . 15.0 110.198 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.977 -1.011 . . . . 15.0 110.204 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.993 0.425 . . . . 15.0 110.192 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -116.31 155.67 28.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 15.0 110.267 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.59 150.08 36.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.726 -0.609 . . . . 15.0 110.104 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.08 -39.37 24.14 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.46 1.242 . . . . 15.0 110.539 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -68.87 -36.98 78.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.596 -0.69 . . . . 15.0 110.125 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.15 75.13 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.676 -0.97 . . . . 15.0 110.676 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.39 -32.26 82.32 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.178 -1.19 . . . . 15.0 110.226 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.5 m -87.42 122.91 70.47 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.533 -0.981 . . . . 15.0 110.011 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.1 148.12 39.2 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.389 1.205 . . . . 15.0 110.44 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -68.96 -30.46 68.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.66 . . . . 15.0 110.137 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.6 mt -63.1 138.14 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.344 -0.847 . . . . 15.0 109.707 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.03 -2.21 61.45 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.1 m -95.32 151.96 18.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.085 -1.244 . . . . 15.0 110.472 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.94 130.6 34.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.806 -0.559 . . . . 15.0 110.256 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.1 mt -130.98 145.04 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.526 -0.734 . . . . 15.0 109.953 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.4 t -116.09 129.33 56.29 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 tp -120.53 135.7 55.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.666 -0.646 . . . . 15.0 110.406 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.08 120.02 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -91.66 172.03 8.76 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.24 0.543 . . . . 15.0 110.951 -171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -59.25 -19.71 48.04 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.634 -0.666 . . . . 15.0 111.655 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.14 17.12 8.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.301 -0.874 . . . . 15.0 111.224 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.89 28.3 15.9 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.273 -0.892 . . . . 15.0 110.875 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -105.05 147.13 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm105 -104.91 121.07 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 15.0 110.483 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.98 135.67 52.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.806 -0.559 . . . . 15.0 109.782 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -118.0 140.56 49.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 15.0 109.805 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.66 -178.9 39.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.075 -1.61 . . . . 15.0 109.075 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -108.9 142.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.456 -1.026 . . . . 15.0 109.742 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.1 tp -64.7 114.47 4.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.739 -0.601 . . . . 15.0 110.269 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -98.06 -52.05 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.761 -0.587 . . . . 15.0 110.363 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.2 p -143.83 143.7 31.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.65 -0.656 . . . . 15.0 110.488 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -117.6 125.86 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.833 -0.542 . . . . 15.0 109.735 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -112.11 96.91 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 15.0 109.788 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.3 -37.54 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.766 -0.584 . . . . 15.0 110.53 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.79 -28.7 66.2 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.549 -0.719 . . . . 15.0 111.153 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -116.21 14.13 15.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.735 . . . . 15.0 111.556 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.9 48.07 22.31 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.41 -0.806 . . . . 15.0 111.289 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.2 p -131.83 147.24 52.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.522 -0.736 . . . . 15.0 110.44 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.71 139.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.592 -0.693 . . . . 15.0 109.695 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.53 128.81 56.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 15.0 109.916 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.1 mt -116.85 138.84 51.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.914 -0.491 . . . . 15.0 109.742 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.49 165.6 12.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 15.0 109.873 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 51.69 58.83 5.06 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.691 -0.63 . . . . 15.0 110.496 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.0 147.37 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.64 -0.663 . . . . 15.0 110.337 -173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -135.2 150.0 50.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.599 . . . . 15.0 110.0 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.6 p -96.86 129.33 44.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 15.0 109.715 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -70.55 -40.28 73.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 15.0 110.564 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.82 172.04 34.43 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.844 -1.303 . . . . 15.0 109.844 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.0 p -118.09 -21.08 8.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.855 -0.791 . . . . 15.0 110.829 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.18 -25.14 68.2 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.399 -0.813 . . . . 15.0 111.056 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.33 -31.75 69.45 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.372 -0.83 . . . . 15.0 110.362 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -123.23 95.06 46.17 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.778 -0.576 . . . . 15.0 109.751 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.28 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 O-C-N 123.443 1.233 . . . . 15.0 111.384 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 p -129.4 165.13 22.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.834 -0.541 . . . . 15.0 110.062 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.74 -2.25 35.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.674 -0.642 . . . . 15.0 111.371 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -115.22 106.97 50.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 15.0 109.923 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -62.34 132.25 37.72 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.395 1.208 . . . . 15.0 110.772 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.0 mm -120.43 141.35 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.627 -0.671 . . . . 15.0 109.667 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.87 152.26 50.93 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.642 -0.661 . . . . 15.0 110.185 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.01 144.7 58.98 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.603 1.318 . . . . 15.0 110.342 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -132.21 133.43 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.707 -0.62 . . . . 15.0 110.198 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -110.7 31.62 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 15.0 110.368 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.63 154.6 25.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 15.0 110.167 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.5 m -102.97 147.93 26.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.713 -0.617 . . . . 15.0 110.032 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -102.02 127.43 48.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.65 . . . . 15.0 110.06 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -68.62 -44.24 74.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.883 -0.511 . . . . 15.0 110.555 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -148.88 121.99 8.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 15.0 110.568 -176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.485 HG23 HD11 ' A' ' 65' ' ' ILE . 41.3 mt -131.4 147.57 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.624 . . . . 15.0 109.447 173.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.8 mt -110.65 138.66 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 15.0 110.014 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -129.69 141.08 50.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.758 -0.589 . . . . 15.0 109.916 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -109.89 152.08 26.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.699 -0.626 . . . . 15.0 110.071 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -26.01 49.38 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.803 -0.919 . . . . 15.0 110.803 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.4 m -66.92 -46.05 76.03 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.469 -1.018 . . . . 15.0 110.732 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.35 -31.82 29.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.52 -0.738 . . . . 15.0 110.711 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.6 mt -65.47 141.62 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.57 -0.706 . . . . 15.0 109.892 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -101.7 -43.39 5.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.809 -0.557 . . . . 15.0 110.271 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -146.03 147.25 31.44 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.698 -0.626 . . . . 15.0 110.71 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.47 129.76 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.689 -0.632 . . . . 15.0 110.217 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -131.52 145.18 51.62 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.624 -0.673 . . . . 15.0 110.344 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.19 144.09 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.64 -0.663 . . . . 15.0 109.783 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.8 m -93.54 -35.78 12.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 15.0 110.256 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.18 152.08 61.03 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 120.175 -0.61 . . . . 15.0 110.256 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.51 148.52 73.06 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.629 1.331 . . . . 15.0 110.31 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.5 156.64 57.81 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.515 1.271 . . . . 15.0 110.26 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -95.47 156.79 37.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.607 -0.683 . . . . 15.0 110.083 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.81 137.67 46.09 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 O-C-N 123.665 1.35 . . . . 15.0 110.416 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -113.01 -27.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.711 -0.618 . . . . 15.0 110.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 83.2 mtp . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.986 -1.006 . . . . 15.0 110.239 178.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.917 0.389 . . . . 15.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -103.89 33.78 3.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 15.0 110.467 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -97.2 143.23 25.78 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.772 . . . . 15.0 110.124 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.13 -41.03 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.455 1.239 . . . . 15.0 110.534 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -71.92 -35.18 69.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 15.0 109.954 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.23 -29.54 70.24 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.93 -1.268 . . . . 15.0 109.93 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.01 -42.23 98.29 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.862 -1.295 . . . . 15.0 109.862 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -143.02 122.91 7.81 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.674 -0.898 . . . . 15.0 110.263 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -68.9 149.05 71.89 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.276 1.145 . . . . 15.0 110.218 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -64.21 -33.82 76.68 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.618 -0.676 . . . . 15.0 110.156 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.66 137.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.456 -0.777 . . . . 15.0 109.417 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.98 -2.21 59.81 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.805 -0.918 . . . . 15.0 110.805 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m -86.68 158.43 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.665 1.232 . . . . 15.0 110.405 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -87.26 133.57 33.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.599 . . . . 15.0 110.123 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.9 mt -134.09 147.69 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.443 -0.786 . . . . 15.0 110.086 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -116.69 130.39 56.7 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.548 -0.538 . . . . 15.0 109.548 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 tp -119.44 136.79 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.717 -0.614 . . . . 15.0 110.18 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -113.4 122.55 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.168 -0.679 . . . . 15.0 109.168 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -93.5 170.98 9.19 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.233 0.54 . . . . 15.0 110.755 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -61.17 -16.47 45.03 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.608 -0.682 . . . . 15.0 111.505 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.93 13.67 10.44 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.233 -0.917 . . . . 15.0 111.338 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 56.38 29.72 15.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.257 -0.902 . . . . 15.0 110.718 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.98 143.34 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.787 -0.82 . . . . 15.0 108.787 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -103.98 122.23 44.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.805 -0.559 . . . . 15.0 110.419 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -110.96 132.27 54.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.755 -0.591 . . . . 15.0 109.673 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -115.97 140.62 49.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 15.0 109.794 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.56 -178.87 38.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.883 -1.687 . . . . 15.0 108.883 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.6 mm -109.07 142.56 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.43 -1.041 . . . . 15.0 109.78 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 tp -66.24 109.21 2.57 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.736 -0.603 . . . . 15.0 110.258 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -91.9 -52.01 4.93 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.343 -0.543 . . . . 15.0 110.386 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -144.33 143.88 31.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.726 . . . . 15.0 110.517 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.24 125.11 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.744 -0.598 . . . . 15.0 109.702 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.1 97.48 6.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 15.0 109.776 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 -36.37 71.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 15.0 110.428 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -29.39 67.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.561 -0.712 . . . . 15.0 111.153 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -116.14 14.08 15.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.528 -0.732 . . . . 15.0 111.544 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t 50.03 49.32 20.56 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.162 -0.962 . . . . 15.0 111.175 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -132.63 147.77 52.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.473 -0.767 . . . . 15.0 110.504 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.21 138.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.556 -0.715 . . . . 15.0 109.526 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.33 128.36 55.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.665 -0.647 . . . . 15.0 109.844 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.3 mt -116.85 137.53 52.14 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.906 -0.496 . . . . 15.0 109.776 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.6 164.47 13.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.811 -0.556 . . . . 15.0 109.772 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 51.79 56.91 7.13 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.722 -0.611 . . . . 15.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -120.35 148.7 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.563 -0.711 . . . . 15.0 110.253 -174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -139.55 150.67 45.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.739 -0.6 . . . . 15.0 110.291 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.5 p -98.5 131.22 44.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.819 -0.55 . . . . 15.0 109.804 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -71.66 -40.37 69.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.543 -0.723 . . . . 15.0 110.774 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 -179.18 41.26 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.041 -1.224 . . . . 15.0 110.041 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.2 p -116.63 6.2 13.36 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.811 -0.817 . . . . 15.0 110.965 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.09 -19.34 61.34 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.245 -0.909 . . . . 15.0 111.514 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.07 -32.11 69.49 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.284 -0.885 . . . . 15.0 110.467 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.15 95.08 7.57 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.708 -0.62 . . . . 15.0 110.039 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.7 140.76 91.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.536 1.282 . . . . 15.0 110.945 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.5 p -129.51 165.16 22.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.71 -0.619 . . . . 15.0 110.141 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.69 -1.73 32.56 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.683 -0.635 . . . . 15.0 111.242 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -112.19 106.91 55.98 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.159 -0.963 . . . . 15.0 109.722 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -66.43 133.85 33.84 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.429 1.226 . . . . 15.0 110.691 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -97.77 129.96 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.596 . . . . 15.0 109.545 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.09 154.65 94.8 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.637 -0.664 . . . . 15.0 110.252 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -62.15 141.35 88.04 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.578 1.304 . . . . 15.0 110.568 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -126.78 121.23 31.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.654 -0.654 . . . . 15.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -117.26 31.23 6.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.723 -0.611 . . . . 15.0 110.269 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -127.27 163.05 24.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.576 -0.703 . . . . 15.0 110.138 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.1 m -110.24 154.92 22.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.694 -0.629 . . . . 15.0 110.198 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -100.37 128.13 46.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.67 -0.644 . . . . 15.0 109.982 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -68.31 -41.99 80.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.871 -0.518 . . . . 15.0 110.674 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.47 122.01 7.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.491 -0.756 . . . . 15.0 110.536 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.4 mt -130.75 147.35 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.658 -0.651 . . . . 15.0 109.57 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -109.85 136.64 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.763 -0.586 . . . . 15.0 109.929 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -127.71 140.64 51.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.725 -0.61 . . . . 15.0 109.975 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -108.11 152.81 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 15.0 110.153 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.2 -25.99 48.86 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.731 -0.948 . . . . 15.0 110.731 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 m -66.56 -45.99 77.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.527 -0.984 . . . . 15.0 110.747 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.97 -30.33 31.71 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.606 -0.684 . . . . 15.0 110.726 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -68.71 139.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.586 -0.696 . . . . 15.0 109.71 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.83 -43.55 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.754 -0.591 . . . . 15.0 110.261 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.17 141.82 42.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.718 -0.614 . . . . 15.0 110.505 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.12 127.61 40.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.735 -0.603 . . . . 15.0 110.087 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -129.15 136.34 50.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 15.0 110.133 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.58 144.01 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.625 -0.672 . . . . 15.0 109.834 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 97.0 m -83.44 -37.09 23.65 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.67 -0.644 . . . . 15.0 110.039 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.2 117.51 68.88 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.721 -0.612 . . . . 15.0 109.872 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.91 150.93 84.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.299 1.157 . . . . 15.0 110.698 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -70.37 156.68 61.22 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.664 1.35 . . . . 15.0 110.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -97.05 157.85 34.3 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.743 -0.598 . . . . 15.0 110.136 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.08 139.01 49.39 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.621 1.327 . . . . 15.0 110.392 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -126.47 158.69 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.69 -0.631 . . . . 15.0 110.274 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.6 ttp . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.98 -1.01 . . . . 15.0 110.253 179.615 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.041 0.448 . . . . 15.0 110.135 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -162.04 178.04 9.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.694 -0.629 . . . . 15.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.19 150.03 38.44 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.715 -0.616 . . . . 15.0 109.994 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -60.67 -40.28 56.63 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.42 1.221 . . . . 15.0 110.735 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.9 m -69.25 -38.92 78.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.669 . . . . 15.0 110.077 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.31 -33.52 56.42 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.68 -1.368 . . . . 15.0 109.68 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.07 -34.61 87.15 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.965 -1.254 . . . . 15.0 109.965 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -108.28 122.88 39.14 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.697 -0.884 . . . . 15.0 110.346 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.07 149.09 40.84 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.375 1.198 . . . . 15.0 110.346 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -62.23 -33.6 74.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.642 -0.661 . . . . 15.0 110.276 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -65.29 138.5 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.388 -0.82 . . . . 15.0 109.351 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.33 -2.24 60.95 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.699 -0.961 . . . . 15.0 110.699 -173.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.5 m -82.92 159.62 22.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.294 . . . . 15.0 110.44 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -84.58 131.82 34.58 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.786 -0.571 . . . . 15.0 110.346 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.8 mt -133.86 147.33 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.523 -0.736 . . . . 15.0 109.93 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -117.18 130.27 56.49 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.505 -0.554 . . . . 15.0 109.505 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.2 tp -119.11 135.68 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.736 -0.603 . . . . 15.0 110.322 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.4 mt -108.07 119.78 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.953 -0.758 . . . . 15.0 108.953 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -90.83 172.61 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.287 0.565 . . . . 15.0 110.902 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.25 -19.13 53.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.605 -0.684 . . . . 15.0 111.416 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 15.79 9.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.855 . . . . 15.0 111.318 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 57.8 29.27 17.19 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.289 -0.882 . . . . 15.0 110.786 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.1 146.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.07 120.68 42.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.759 -0.588 . . . . 15.0 110.465 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -112.03 133.98 53.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.827 -0.546 . . . . 15.0 109.713 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -116.2 140.61 49.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.472 -0.767 . . . . 15.0 109.828 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.73 -178.82 38.98 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.962 -1.655 . . . . 15.0 108.962 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -107.39 141.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.466 -1.02 . . . . 15.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.23 108.93 2.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.748 -0.595 . . . . 15.0 110.201 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.83 -51.94 4.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.805 -0.559 . . . . 15.0 110.486 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -143.27 142.65 31.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.624 . . . . 15.0 110.481 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.3 mt -115.75 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 15.0 109.682 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.06 97.98 7.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.635 -0.665 . . . . 15.0 109.86 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -71.97 -36.12 69.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.78 -0.575 . . . . 15.0 110.456 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -58.75 -29.5 66.79 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.493 -0.754 . . . . 15.0 111.108 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -116.44 14.14 15.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.617 -0.677 . . . . 15.0 111.495 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m 49.9 49.56 20.02 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.174 -0.954 . . . . 15.0 111.152 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 p -132.54 147.79 52.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 15.0 110.539 -178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.59 137.87 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.661 . . . . 15.0 109.554 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.25 127.98 55.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.647 . . . . 15.0 109.888 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.8 136.14 53.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.919 -0.488 . . . . 15.0 109.771 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.12 14.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.761 -0.587 . . . . 15.0 109.901 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 51.76 61.64 3.11 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.656 -0.653 . . . . 15.0 110.475 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.9 p -122.33 146.4 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.538 -0.727 . . . . 15.0 110.383 -173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -135.13 148.56 49.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.841 -0.537 . . . . 15.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.5 p -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 15.0 109.781 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -70.97 -40.35 72.0 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.072 -0.651 . . . . 15.0 110.589 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 170.94 33.2 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.789 -1.325 . . . . 15.0 109.789 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -118.04 -19.65 9.02 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.775 -0.838 . . . . 15.0 110.938 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.23 -26.92 69.02 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.323 -0.861 . . . . 15.0 111.016 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.74 -31.8 69.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.381 -0.824 . . . . 15.0 110.458 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -120.53 95.07 49.03 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.719 -0.613 . . . . 15.0 109.877 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.92 131.6 35.79 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 O-C-N 123.401 1.211 . . . . 15.0 110.858 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 p -131.02 165.1 23.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.565 . . . . 15.0 110.023 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -77.83 -1.38 31.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.712 -0.618 . . . . 15.0 111.461 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -117.87 106.93 44.96 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.229 -0.919 . . . . 15.0 109.824 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.48 139.22 85.16 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.318 1.167 . . . . 15.0 110.933 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.8 mm -120.63 146.0 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.669 -0.645 . . . . 15.0 109.693 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.92 109.86 48.75 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.728 -0.607 . . . . 15.0 110.118 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.77 141.42 54.3 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.356 1.187 . . . . 15.0 110.401 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -130.9 151.26 51.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.742 -0.599 . . . . 15.0 110.182 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -99.95 31.75 3.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.744 -0.597 . . . . 15.0 110.323 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -111.73 151.98 28.3 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.606 -0.684 . . . . 15.0 110.214 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.4 m -103.05 146.87 27.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.654 -0.654 . . . . 15.0 110.111 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.11 133.57 46.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.637 -0.664 . . . . 15.0 110.139 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.73 -39.78 84.25 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.832 -0.543 . . . . 15.0 110.78 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -151.71 122.37 7.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 15.0 110.832 -175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -129.4 147.24 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.628 -0.67 . . . . 15.0 109.59 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.5 mt -110.65 136.28 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.692 -0.63 . . . . 15.0 109.849 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -127.02 140.64 52.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.763 -0.586 . . . . 15.0 109.922 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -107.73 151.66 25.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.18 -26.01 48.77 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.753 -0.939 . . . . 15.0 110.753 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -66.45 -45.95 78.06 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.485 -1.009 . . . . 15.0 110.718 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.1 -31.88 30.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.644 -0.66 . . . . 15.0 110.738 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.89 141.25 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.675 -0.641 . . . . 15.0 109.859 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -104.71 -43.18 5.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.76 -0.587 . . . . 15.0 110.251 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.6 147.35 34.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.609 -0.682 . . . . 15.0 110.647 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -131.0 130.66 43.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.706 -0.621 . . . . 15.0 110.248 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -129.78 140.43 51.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 15.0 110.304 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.23 144.0 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.654 -0.654 . . . . 15.0 109.844 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 99.7 m -91.21 -37.11 13.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.693 -0.629 . . . . 15.0 110.259 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.18 150.62 58.34 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 15.0 109.975 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.18 136.3 34.17 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.592 1.311 . . . . 15.0 110.291 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.87 151.09 86.73 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.371 1.195 . . . . 15.0 110.491 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -102.05 157.14 34.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.725 -0.61 . . . . 15.0 110.213 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.88 141.16 83.46 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.579 1.305 . . . . 15.0 110.598 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -127.22 150.43 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 15.0 110.238 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 117.966 -1.016 . . . . 15.0 110.35 179.862 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.03 0.443 . . . . 15.0 110.202 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.42 -30.52 70.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.652 -0.655 . . . . 15.0 110.553 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.89 150.09 85.86 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 15.0 110.145 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.08 -41.01 14.18 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.547 1.288 . . . . 15.0 110.449 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.0 p -69.23 -34.09 74.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.67 -0.644 . . . . 15.0 110.067 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.99 -31.06 44.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.839 -1.304 . . . . 15.0 109.839 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.51 96.57 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.085 -1.206 . . . . 15.0 110.085 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -111.26 122.81 36.69 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.648 -0.913 . . . . 15.0 110.124 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.05 149.03 40.86 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.346 1.182 . . . . 15.0 110.388 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -66.19 -31.94 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.637 -0.664 . . . . 15.0 110.171 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.6 mt -64.16 137.54 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.365 -0.834 . . . . 15.0 109.622 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.15 -2.2 61.25 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.906 -0.877 . . . . 15.0 110.906 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m -95.85 153.88 17.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.079 -1.248 . . . . 15.0 110.216 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -87.0 133.5 33.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.69 -0.631 . . . . 15.0 110.437 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.89 147.45 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 15.0 109.991 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.7 t -110.83 130.17 55.65 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -119.83 130.65 55.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.845 -0.535 . . . . 15.0 110.325 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.71 119.33 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -92.26 170.61 9.67 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.307 0.575 . . . . 15.0 110.948 -171.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -60.6 -17.56 47.52 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.62 -0.675 . . . . 15.0 111.513 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.4 15.34 9.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.222 -0.923 . . . . 15.0 111.278 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 57.25 29.37 16.63 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 15.0 110.67 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.41 144.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -105.67 119.79 40.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.727 -0.608 . . . . 15.0 110.453 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -111.85 137.44 49.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.773 -0.58 . . . . 15.0 109.566 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -121.42 140.49 52.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 15.0 109.938 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.87 39.84 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.124 -1.59 . . . . 15.0 109.124 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.49 142.37 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.495 -1.003 . . . . 15.0 109.708 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.21 112.51 3.47 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.721 -0.612 . . . . 15.0 110.295 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -96.03 -52.07 4.19 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.373 -0.531 . . . . 15.0 110.35 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -143.92 143.28 31.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.637 -0.664 . . . . 15.0 110.489 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -116.97 126.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.733 -0.604 . . . . 15.0 109.77 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -112.1 96.18 5.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.598 -0.689 . . . . 15.0 109.79 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.3 -36.78 74.54 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 15.0 110.369 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -58.91 -28.96 66.69 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.556 -0.715 . . . . 15.0 111.075 -171.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.16 13.99 15.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.722 . . . . 15.0 111.484 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t 49.96 47.27 23.51 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.241 -0.912 . . . . 15.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.2 p -131.43 149.56 52.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.447 -0.783 . . . . 15.0 110.471 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.41 140.28 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 15.0 109.649 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.12 56.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.689 -0.632 . . . . 15.0 109.935 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.4 mt -116.87 138.84 51.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.826 -0.435 . . . . 15.0 109.826 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.54 165.35 13.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.732 -0.605 . . . . 15.0 109.873 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 51.86 60.97 3.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.631 -0.668 . . . . 15.0 110.36 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.99 145.27 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 15.0 110.523 -173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -127.36 150.98 49.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 15.0 109.808 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.5 p -102.39 129.67 48.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.753 -0.592 . . . . 15.0 109.927 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -71.6 -40.01 70.12 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.116 -0.633 . . . . 15.0 110.416 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.81 166.36 26.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.774 -1.33 . . . . 15.0 109.774 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.4 p -118.1 6.26 12.05 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.734 -0.862 . . . . 15.0 111.27 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -55.19 -24.22 25.93 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.24 -0.913 . . . . 15.0 111.31 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -62.52 -32.89 73.9 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.511 -0.743 . . . . 15.0 110.378 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -135.99 94.2 14.66 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 15.0 110.038 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.09 134.99 55.92 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.421 1.222 . . . . 15.0 110.641 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.0 p -129.77 165.02 22.77 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.635 . . . . 15.0 110.202 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.9 -2.91 39.08 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.724 -0.61 . . . . 15.0 111.442 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -109.1 107.02 59.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.095 -1.003 . . . . 15.0 110.058 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.71 139.42 80.63 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.321 1.169 . . . . 15.0 110.647 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -95.5 143.45 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.675 -0.641 . . . . 15.0 109.783 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 158.09 86.38 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.722 -0.611 . . . . 15.0 110.216 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.66 165.11 6.63 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.587 1.309 . . . . 15.0 110.785 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -92.55 20.03 6.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.624 -0.673 . . . . 15.0 111.155 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.92 -34.55 73.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.227 -0.921 . . . . 15.0 109.96 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -103.37 149.58 24.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.707 -0.621 . . . . 15.0 110.095 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.9 m -105.94 163.3 12.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.792 -0.568 . . . . 15.0 110.295 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -96.48 125.24 40.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.671 -0.643 . . . . 15.0 109.883 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -67.56 -41.14 84.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.868 -0.52 . . . . 15.0 110.981 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -154.8 122.0 5.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.757 . . . . 15.0 110.676 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.6 mt -129.64 147.9 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.66 -0.65 . . . . 15.0 109.767 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.22 136.89 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.724 -0.61 . . . . 15.0 109.917 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.25 143.84 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.768 -0.583 . . . . 15.0 109.905 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -109.49 151.27 26.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.682 -0.637 . . . . 15.0 110.133 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.74 -26.02 56.83 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.697 -0.961 . . . . 15.0 110.697 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -66.76 -40.59 88.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.462 -1.022 . . . . 15.0 110.724 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -86.41 -31.78 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.617 -0.677 . . . . 15.0 110.712 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.69 138.78 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.592 -0.692 . . . . 15.0 109.956 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -99.88 -41.5 7.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.734 -0.604 . . . . 15.0 110.116 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -147.33 145.1 29.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.677 -0.639 . . . . 15.0 110.628 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -133.3 130.36 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.725 -0.609 . . . . 15.0 110.038 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 m -132.21 144.6 50.76 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.62 -0.675 . . . . 15.0 110.514 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.62 144.02 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.594 -0.691 . . . . 15.0 109.688 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.5 m -95.48 -36.53 11.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.66 . . . . 15.0 110.373 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -84.26 117.58 69.06 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.741 -0.599 . . . . 15.0 110.048 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.21 159.7 51.21 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.332 1.174 . . . . 15.0 110.331 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.84 155.86 68.19 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.677 1.356 . . . . 15.0 110.301 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -89.64 157.43 46.73 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.701 -0.625 . . . . 15.0 110.191 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.07 145.68 74.24 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.708 1.373 . . . . 15.0 110.456 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.39 -35.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.752 -0.593 . . . . 15.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 118.015 -0.993 . . . . 15.0 110.185 179.784 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.01 0.433 . . . . 15.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -150.81 -46.89 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.7 -0.625 . . . . 15.0 110.261 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -75.0 150.06 85.6 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.744 -0.598 . . . . 15.0 110.071 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.2 -32.13 52.59 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.569 1.3 . . . . 15.0 110.534 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -66.69 -32.65 74.09 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.609 -0.682 . . . . 15.0 110.21 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.43 -30.25 76.24 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.09 -1.204 . . . . 15.0 110.09 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.58 93.52 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.954 -1.259 . . . . 15.0 109.954 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 m -142.92 122.94 7.89 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.618 -0.931 . . . . 15.0 110.077 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.02 144.08 33.55 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.405 1.213 . . . . 15.0 110.384 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.13 -31.97 71.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.665 -0.647 . . . . 15.0 110.095 176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.45 135.54 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.447 -0.783 . . . . 15.0 109.692 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.64 -2.15 62.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.977 -0.849 . . . . 15.0 110.977 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.2 m -99.47 153.98 18.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.035 -1.273 . . . . 15.0 110.534 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -83.72 132.54 34.85 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.752 -0.593 . . . . 15.0 110.035 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.8 mt -132.66 145.99 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.52 -0.738 . . . . 15.0 110.114 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -115.07 129.93 56.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.9 136.3 54.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.675 -0.641 . . . . 15.0 110.355 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.11 121.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.021 -0.733 . . . . 15.0 109.021 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.69 172.43 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.309 0.576 . . . . 15.0 110.907 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -59.98 -19.26 51.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.629 -0.67 . . . . 15.0 111.405 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.02 16.76 7.75 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.257 -0.902 . . . . 15.0 111.215 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 57.48 28.42 15.47 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.237 -0.914 . . . . 15.0 110.867 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.5 mt -105.0 147.23 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -105.64 121.38 43.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 15.0 110.526 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -112.32 136.23 52.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.833 -0.542 . . . . 15.0 109.786 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.75 140.54 49.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 15.0 109.779 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.19 -178.89 39.27 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.029 -1.628 . . . . 15.0 109.029 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.18 143.03 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.386 -1.067 . . . . 15.0 109.793 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.95 114.97 5.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.763 -0.585 . . . . 15.0 110.19 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -97.62 -52.05 3.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.806 -0.559 . . . . 15.0 110.381 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.5 p -144.56 143.35 30.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.717 -0.614 . . . . 15.0 110.541 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -115.43 125.23 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.717 -0.614 . . . . 15.0 109.613 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.08 97.2 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.605 -0.684 . . . . 15.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -70.89 -36.56 72.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.707 -0.62 . . . . 15.0 110.383 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.87 -29.36 66.93 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.572 -0.705 . . . . 15.0 111.015 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -115.64 13.91 16.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 15.0 111.461 -176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t 50.06 47.21 23.76 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.195 -0.941 . . . . 15.0 111.174 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -131.86 148.72 52.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.501 -0.75 . . . . 15.0 110.606 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.61 138.22 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 15.0 109.535 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -110.51 128.52 55.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.646 -0.658 . . . . 15.0 109.905 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.79 138.65 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.889 -0.507 . . . . 15.0 109.791 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.73 164.68 13.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.76 -0.587 . . . . 15.0 109.791 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 51.81 56.91 7.12 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.644 -0.66 . . . . 15.0 110.375 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.0 p -120.66 148.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.593 -0.692 . . . . 15.0 110.303 -173.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -139.71 150.07 44.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.804 -0.56 . . . . 15.0 110.211 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.4 p -97.59 132.06 43.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.77 -0.581 . . . . 15.0 109.771 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -72.82 -40.2 66.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.552 -0.718 . . . . 15.0 110.569 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 171.16 33.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.856 -1.298 . . . . 15.0 109.856 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.8 p -118.01 3.44 12.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.744 -0.856 . . . . 15.0 111.066 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.77 -30.42 71.07 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.287 -0.883 . . . . 15.0 111.031 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.77 -33.69 73.34 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.329 -0.857 . . . . 15.0 110.52 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -141.24 95.05 7.51 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.753 -0.592 . . . . 15.0 110.038 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.06 139.29 89.9 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.385 1.203 . . . . 15.0 110.997 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.4 p -128.02 165.13 20.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.847 -0.533 . . . . 15.0 110.077 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.82 -1.88 33.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.664 -0.648 . . . . 15.0 111.315 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -107.94 106.97 59.7 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.222 -0.924 . . . . 15.0 109.939 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.84 140.68 74.8 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.403 1.212 . . . . 15.0 110.684 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -113.58 141.64 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.693 -0.629 . . . . 15.0 109.731 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.67 158.01 86.8 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.701 -0.624 . . . . 15.0 110.143 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.14 164.66 14.08 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 123.586 1.308 . . . . 15.0 110.713 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -89.22 144.67 25.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.698 -0.626 . . . . 15.0 110.112 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -157.62 -46.09 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.64 -0.663 . . . . 15.0 110.31 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.92 176.64 8.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.625 -0.672 . . . . 15.0 110.376 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 m -103.04 166.0 10.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.78 -0.575 . . . . 15.0 110.161 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -102.02 128.11 48.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.604 -0.685 . . . . 15.0 110.078 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.09 -42.37 80.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.86 -0.525 . . . . 15.0 110.691 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -150.98 121.89 7.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.507 -0.746 . . . . 15.0 110.631 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 95.3 mt -130.73 147.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.681 -0.637 . . . . 15.0 109.698 173.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.04 135.74 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.719 -0.613 . . . . 15.0 109.901 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -125.74 140.77 52.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 15.0 109.991 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -104.37 151.07 23.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.679 -0.638 . . . . 15.0 110.087 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.13 -25.97 55.03 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -65.33 -45.0 86.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.446 -1.032 . . . . 15.0 110.778 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.96 -31.47 31.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.549 -0.72 . . . . 15.0 110.696 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -65.88 136.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.5 -0.75 . . . . 15.0 109.858 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -104.88 -39.85 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 15.0 110.253 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.29 142.69 33.86 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.659 -0.65 . . . . 15.0 110.56 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -130.39 127.41 39.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.714 -0.616 . . . . 15.0 110.164 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -129.5 139.06 51.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 15.0 110.251 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.99 144.03 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 15.0 109.782 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.05 -37.14 16.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.661 -0.649 . . . . 15.0 110.184 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -84.31 117.51 68.9 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.597 -0.69 . . . . 15.0 109.868 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.07 154.39 62.49 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.318 1.167 . . . . 15.0 110.348 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -63.87 156.68 56.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.573 1.302 . . . . 15.0 110.454 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -86.65 142.56 34.87 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.697 -0.627 . . . . 15.0 109.964 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.75 133.17 28.72 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.405 1.213 . . . . 15.0 110.407 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.9 tp -129.56 139.21 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.739 -0.601 . . . . 15.0 110.082 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.2 mmm . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.94 -1.028 . . . . 15.0 110.22 179.773 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 20.4 tp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.906 0.384 . . . . 15.0 110.152 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.44 137.05 55.6 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.752 -0.593 . . . . 15.0 110.255 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -105.02 150.1 38.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 15.0 110.216 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.64 -29.3 60.53 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.497 1.261 . . . . 15.0 110.638 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -63.95 -30.54 71.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.561 -0.712 . . . . 15.0 110.422 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.1 69.92 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.367 -1.093 . . . . 15.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.41 -30.6 71.82 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.235 -1.146 . . . . 15.0 110.235 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -66.94 139.76 95.77 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.591 -0.946 . . . . 15.0 109.936 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.22 124.94 13.23 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.375 1.197 . . . . 15.0 110.672 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.25 -19.87 63.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.833 -0.542 . . . . 15.0 110.854 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.68 138.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.087 -1.008 . . . . 15.0 110.028 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.31 -2.11 74.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m -103.43 151.81 22.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.712 1.256 . . . . 15.0 110.67 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -78.54 130.02 35.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.874 -0.516 . . . . 15.0 110.1 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 93.6 mt -132.75 147.85 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.506 -0.746 . . . . 15.0 109.97 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 t -116.21 133.87 55.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.577 -0.527 . . . . 15.0 109.577 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -124.14 136.52 54.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.737 -0.602 . . . . 15.0 110.375 -175.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 81.4 mt -108.81 122.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -94.3 172.93 7.9 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.277 0.56 . . . . 15.0 110.988 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.7 -20.01 53.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.624 -0.672 . . . . 15.0 111.466 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 16.91 8.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.35 -0.843 . . . . 15.0 111.271 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 58.03 28.23 16.0 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.301 -0.874 . . . . 15.0 110.86 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.6 mt -105.02 147.76 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -106.08 121.54 44.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.779 -0.576 . . . . 15.0 110.403 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -112.18 136.78 51.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.769 -0.582 . . . . 15.0 109.756 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.49 140.68 49.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.507 -0.745 . . . . 15.0 109.725 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.55 -178.9 38.94 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.11 -1.596 . . . . 15.0 109.11 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.6 139.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.568 -0.96 . . . . 15.0 109.54 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.03 115.4 6.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 15.0 110.253 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -97.94 -52.05 3.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.865 -0.522 . . . . 15.0 110.403 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -144.46 143.39 30.86 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.615 -0.678 . . . . 15.0 110.637 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -116.58 127.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.633 -0.667 . . . . 15.0 109.679 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -112.12 95.42 5.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 15.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -69.26 -38.04 78.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.79 -0.569 . . . . 15.0 110.419 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.53 -28.96 67.55 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.582 -0.699 . . . . 15.0 111.1 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -114.26 13.91 17.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.473 -0.767 . . . . 15.0 111.554 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 m 50.0 45.65 25.09 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.171 -0.956 . . . . 15.0 111.309 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.4 p -131.88 149.74 52.36 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.463 -0.773 . . . . 15.0 110.666 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.86 140.64 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.582 -0.699 . . . . 15.0 109.603 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.07 129.47 56.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.621 -0.675 . . . . 15.0 110.015 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -116.89 139.12 51.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.938 -0.477 . . . . 15.0 109.753 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.82 162.98 16.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.698 -0.626 . . . . 15.0 109.868 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 51.89 59.34 4.62 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.666 -0.647 . . . . 15.0 110.488 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.51 148.03 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.592 -0.693 . . . . 15.0 110.314 -173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -136.45 149.55 48.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.901 -0.499 . . . . 15.0 110.073 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -97.21 131.75 43.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.714 -0.616 . . . . 15.0 109.724 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -73.88 -40.37 63.24 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.543 -0.723 . . . . 15.0 110.702 -173.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 174.49 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.894 -1.283 . . . . 15.0 109.894 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.4 p -115.9 6.05 14.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.774 -0.839 . . . . 15.0 110.961 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -63.99 -27.01 68.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.236 -0.915 . . . . 15.0 111.123 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.62 -35.66 76.7 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.385 -0.822 . . . . 15.0 110.311 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -142.74 95.09 6.43 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.821 -0.55 . . . . 15.0 109.82 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.36 142.83 87.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.471 1.248 . . . . 15.0 110.702 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.1 p -122.13 165.1 16.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.827 -0.546 . . . . 15.0 110.094 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.82 -2.22 35.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.674 -0.641 . . . . 15.0 111.351 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -113.28 136.45 21.84 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.994 . . . . 15.0 109.972 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.39 142.98 51.11 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.442 1.233 . . . . 15.0 110.41 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.8 mm -114.12 145.99 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.638 -0.664 . . . . 15.0 109.689 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.41 158.12 59.95 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.639 -0.663 . . . . 15.0 110.461 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.41 165.05 9.9 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 O-C-N 123.519 1.273 . . . . 15.0 110.764 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 -107.36 32.4 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.682 -0.636 . . . . 15.0 110.533 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.66 31.17 4.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 15.0 110.35 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.71 152.0 41.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.655 -0.653 . . . . 15.0 110.154 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 m -110.46 141.64 43.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.656 -0.653 . . . . 15.0 110.173 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -102.06 128.04 48.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 15.0 110.066 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.2 -42.88 79.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.79 -0.569 . . . . 15.0 110.667 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -150.48 121.93 7.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 15.0 110.606 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 65' ' ' ILE . 25.8 mt -130.87 147.75 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 15.0 109.554 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.6 mt -110.58 136.05 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.741 -0.599 . . . . 15.0 109.86 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -126.08 142.64 51.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.631 . . . . 15.0 109.949 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -107.34 152.2 24.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.646 -0.659 . . . . 15.0 110.143 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.01 55.02 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.7 m -65.56 -45.54 82.92 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.447 -1.031 . . . . 15.0 110.766 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.02 -31.59 30.94 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.63 -0.669 . . . . 15.0 110.637 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.66 138.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.545 -0.722 . . . . 15.0 109.814 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -105.29 -40.07 5.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.652 . . . . 15.0 110.17 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -143.19 142.83 31.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 15.0 110.665 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.41 127.11 41.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.796 -0.565 . . . . 15.0 110.049 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -131.81 139.91 49.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.638 -0.664 . . . . 15.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.8 144.08 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.588 -0.695 . . . . 15.0 109.636 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -95.28 -37.11 11.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.604 -0.685 . . . . 15.0 110.272 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.49 117.48 49.03 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.639 -0.663 . . . . 15.0 110.17 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 145.73 35.08 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.294 1.155 . . . . 15.0 110.189 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.19 153.78 62.1 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.494 1.26 . . . . 15.0 110.262 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -98.2 154.7 37.56 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.796 -0.565 . . . . 15.0 110.137 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.31 149.51 75.57 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.632 1.333 . . . . 15.0 110.36 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 mp -114.58 135.12 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.595 -0.69 . . . . 15.0 109.67 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.999 -1.0 . . . . 15.0 110.193 -179.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.992 0.425 . . . . 15.0 110.011 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -128.81 -57.32 1.18 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.628 -0.67 . . . . 15.0 110.448 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -90.48 144.74 31.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.625 -0.672 . . . . 15.0 110.426 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -64.47 -34.33 53.91 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.417 1.22 . . . . 15.0 110.745 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -65.6 -38.38 89.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.637 -0.664 . . . . 15.0 110.488 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.03 -37.62 60.16 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.424 -1.47 . . . . 15.0 109.424 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.96 -38.74 64.39 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.66 -1.376 . . . . 15.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -109.86 122.95 37.59 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.875 . . . . 15.0 110.387 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.96 149.16 52.68 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.355 1.187 . . . . 15.0 110.252 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -59.46 -29.79 68.06 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.605 -0.684 . . . . 15.0 110.458 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.97 138.64 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.385 -0.822 . . . . 15.0 109.445 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.9 -2.15 59.91 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.791 -0.924 . . . . 15.0 110.791 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -83.22 159.16 22.04 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.962 -1.317 . . . . 15.0 110.416 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -86.09 132.02 34.13 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.797 -0.564 . . . . 15.0 110.369 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.2 147.68 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 15.0 109.937 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -116.88 132.81 56.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.498 -0.556 . . . . 15.0 109.498 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.9 tp -124.51 137.51 54.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.643 -0.661 . . . . 15.0 110.356 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.59 121.42 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.038 -0.727 . . . . 15.0 109.038 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -92.15 174.04 7.52 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.298 0.57 . . . . 15.0 110.94 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.54 -20.53 56.25 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.624 -0.673 . . . . 15.0 111.444 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.82 16.62 8.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.334 -0.854 . . . . 15.0 111.295 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 57.3 29.76 17.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.222 -0.924 . . . . 15.0 110.779 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.3 mt -105.1 146.71 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.996 -0.742 . . . . 15.0 108.996 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -104.12 119.91 39.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.823 -0.548 . . . . 15.0 110.428 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -111.44 136.32 50.75 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.756 -0.59 . . . . 15.0 109.791 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.09 140.7 49.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.559 -0.713 . . . . 15.0 109.769 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.47 -178.92 38.91 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.937 -1.665 . . . . 15.0 108.937 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.0 mm -108.46 142.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.349 -1.089 . . . . 15.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.5 tp -65.55 109.0 2.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.744 -0.597 . . . . 15.0 110.203 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -92.66 -52.05 4.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.801 -0.562 . . . . 15.0 110.439 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -143.59 142.91 31.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.638 -0.664 . . . . 15.0 110.422 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.9 mt -116.72 125.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 15.0 109.661 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.17 97.3 6.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.573 -0.704 . . . . 15.0 109.781 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -71.45 -36.38 71.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.675 -0.641 . . . . 15.0 110.49 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.82 -29.79 67.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.461 -0.775 . . . . 15.0 111.043 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -115.8 13.98 16.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.575 -0.703 . . . . 15.0 111.555 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t 49.89 48.75 21.36 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.154 -0.966 . . . . 15.0 111.266 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -131.81 148.33 52.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.477 -0.764 . . . . 15.0 110.484 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.42 139.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.66 -0.65 . . . . 15.0 109.662 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.4 128.94 56.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.77 -0.582 . . . . 15.0 109.911 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.7 mt -116.79 138.08 51.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.89 -0.506 . . . . 15.0 109.867 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.12 165.43 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.784 -0.573 . . . . 15.0 109.793 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 51.68 57.32 6.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.672 -0.642 . . . . 15.0 110.425 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.16 148.59 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 15.0 110.279 -173.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -140.7 152.31 45.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.724 -0.61 . . . . 15.0 110.196 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.4 p -97.42 131.26 44.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.771 -0.581 . . . . 15.0 109.795 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -70.89 -40.3 72.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.59 -0.694 . . . . 15.0 110.464 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.75 170.7 32.86 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.816 -1.314 . . . . 15.0 109.816 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -118.01 -19.68 9.03 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.814 -0.815 . . . . 15.0 110.898 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.14 -29.53 70.87 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.282 -0.886 . . . . 15.0 110.864 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.32 -32.73 71.52 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.468 -0.77 . . . . 15.0 110.262 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -127.26 95.04 37.18 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.745 -0.597 . . . . 15.0 109.632 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -53.35 134.53 57.48 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 O-C-N 123.418 1.22 . . . . 15.0 111.482 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.3 p -127.44 165.14 20.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.813 -0.554 . . . . 15.0 109.98 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.76 -1.66 32.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.664 -0.647 . . . . 15.0 111.319 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -113.98 106.9 52.89 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.093 -1.005 . . . . 15.0 109.929 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -66.69 131.98 27.47 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.413 1.217 . . . . 15.0 110.631 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.7 mm -124.22 144.84 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.724 -0.61 . . . . 15.0 109.618 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.07 155.97 40.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.681 -0.637 . . . . 15.0 110.279 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -62.23 143.69 94.53 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.506 1.266 . . . . 15.0 110.652 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -153.88 154.44 33.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.69 -0.631 . . . . 15.0 110.348 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -126.09 33.62 5.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.629 -0.669 . . . . 15.0 110.261 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.68 143.88 26.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.679 -0.638 . . . . 15.0 110.217 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 m -102.96 146.08 28.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.75 -0.593 . . . . 15.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -102.08 128.66 48.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.744 -0.597 . . . . 15.0 110.108 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -68.14 -41.84 81.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.867 -0.521 . . . . 15.0 110.684 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -150.8 121.96 7.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 15.0 110.589 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 94.8 mt -131.02 147.09 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.678 -0.639 . . . . 15.0 109.487 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -110.14 139.19 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.655 -0.653 . . . . 15.0 109.993 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.85 142.86 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.712 -0.617 . . . . 15.0 109.941 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -110.73 152.68 26.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 15.0 110.086 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.06 55.12 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.673 -0.971 . . . . 15.0 110.673 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -67.26 -40.79 86.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.44 -1.035 . . . . 15.0 110.795 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -88.34 -30.97 19.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.599 -0.688 . . . . 15.0 110.801 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.73 142.31 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.588 -0.695 . . . . 15.0 109.915 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -99.88 -44.14 6.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 15.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -146.86 147.17 30.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.686 -0.634 . . . . 15.0 110.705 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.18 129.95 45.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.728 -0.608 . . . . 15.0 110.221 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -131.46 138.89 49.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.647 -0.658 . . . . 15.0 110.346 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.75 144.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.691 -0.631 . . . . 15.0 109.792 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.3 t -90.86 -37.02 13.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.653 -0.654 . . . . 15.0 110.193 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -87.02 117.5 68.72 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 15.0 109.975 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.14 152.7 56.72 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.379 1.199 . . . . 15.0 110.343 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -64.16 156.59 58.41 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.527 1.277 . . . . 15.0 110.526 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -94.02 139.09 22.49 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.717 -0.614 . . . . 15.0 109.938 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.73 134.29 34.55 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.436 1.229 . . . . 15.0 110.488 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.5 139.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.709 -0.619 . . . . 15.0 110.15 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.026 -0.988 . . . . 15.0 110.171 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.023 0.439 . . . . 15.0 110.139 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.85 -33.44 75.86 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.696 -0.628 . . . . 15.0 110.433 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.17 119.92 59.47 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.696 -0.628 . . . . 15.0 110.146 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.35 -33.67 47.02 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.348 1.183 . . . . 15.0 110.563 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 t -66.94 -39.0 87.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.613 -0.679 . . . . 15.0 110.407 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.89 -36.28 42.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.577 -1.409 . . . . 15.0 109.577 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.16 -35.31 77.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.299 . . . . 15.0 109.851 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -108.05 142.25 24.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.894 . . . . 15.0 110.304 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 149.09 42.73 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 O-C-N 123.375 1.198 . . . . 15.0 110.403 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.67 -44.59 90.23 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.621 -0.674 . . . . 15.0 110.404 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.29 137.28 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.376 -0.828 . . . . 15.0 109.26 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.48 -2.19 62.63 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.815 -0.914 . . . . 15.0 110.815 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m -82.6 160.12 22.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.031 -1.276 . . . . 15.0 110.417 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -85.59 133.56 34.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.861 -0.524 . . . . 15.0 110.239 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 92.2 mt -133.98 147.09 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.514 -0.741 . . . . 15.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -115.54 133.81 55.67 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tp -125.69 137.17 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.712 -0.618 . . . . 15.0 110.424 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 87.5 mt -109.3 121.37 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.968 -0.753 . . . . 15.0 108.968 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.8 m -93.33 175.68 6.67 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.32 0.581 . . . . 15.0 111.01 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.15 -21.5 59.45 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.606 -0.684 . . . . 15.0 111.398 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 15.97 9.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.321 -0.862 . . . . 15.0 111.326 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.71 28.99 16.64 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.306 -0.871 . . . . 15.0 110.811 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.0 149.59 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.151 -0.685 . . . . 15.0 109.151 172.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -106.35 121.19 43.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.798 -0.563 . . . . 15.0 110.608 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.44 141.75 45.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.802 -0.561 . . . . 15.0 109.809 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -120.2 140.69 50.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.561 -0.712 . . . . 15.0 109.762 173.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.9 -178.94 37.88 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 108.866 -1.694 . . . . 15.0 108.866 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -109.37 143.02 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.421 -1.046 . . . . 15.0 109.742 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.6 tp -66.06 108.89 2.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.791 -0.568 . . . . 15.0 110.213 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -91.7 -52.02 4.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.795 -0.566 . . . . 15.0 110.407 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -144.11 142.43 30.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 15.0 110.439 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.6 mt -114.42 125.59 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.77 -0.581 . . . . 15.0 109.644 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -112.05 97.38 6.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.627 -0.671 . . . . 15.0 109.851 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.82 -36.25 70.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.702 -0.624 . . . . 15.0 110.546 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.79 -29.1 66.58 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.524 -0.735 . . . . 15.0 111.118 -171.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -116.93 14.1 15.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.436 -0.79 . . . . 15.0 111.522 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m 49.9 49.14 20.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.181 -0.95 . . . . 15.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.9 p -131.89 148.29 52.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.462 -0.774 . . . . 15.0 110.401 -178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.65 138.49 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.561 -0.712 . . . . 15.0 109.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.28 128.79 56.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 15.0 109.954 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.84 137.22 52.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 15.0 109.801 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.03 164.12 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.739 -0.601 . . . . 15.0 109.785 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt 51.84 59.58 4.45 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.56 -0.712 . . . . 15.0 110.524 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.73 148.66 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.55 -0.719 . . . . 15.0 110.224 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -140.02 150.41 44.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.754 -0.591 . . . . 15.0 110.256 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -97.8 129.53 44.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.706 -0.621 . . . . 15.0 109.653 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -74.04 -40.52 62.79 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.846 -0.742 . . . . 15.0 110.738 -171.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.51 -173.78 42.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.847 -1.301 . . . . 15.0 109.847 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -117.95 5.36 12.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.822 -0.811 . . . . 15.0 110.909 172.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -66.23 -32.7 74.29 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.283 -0.885 . . . . 15.0 110.936 -175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -60.75 -33.7 73.32 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.413 -0.804 . . . . 15.0 110.429 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -139.11 95.1 9.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.718 -0.614 . . . . 15.0 109.994 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -57.32 148.2 72.54 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.482 1.254 . . . . 15.0 111.027 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.6 p -128.2 165.05 21.2 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 15.0 110.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -77.81 -1.76 33.1 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.649 -0.657 . . . . 15.0 111.516 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -112.45 133.43 21.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.167 -0.958 . . . . 15.0 109.937 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.96 131.87 21.84 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.34 1.179 . . . . 15.0 110.488 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mm -122.09 136.58 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.64 -0.662 . . . . 15.0 109.658 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.54 150.56 38.27 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.666 -0.646 . . . . 15.0 110.206 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.97 148.13 69.45 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.625 1.329 . . . . 15.0 110.398 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -152.24 146.61 25.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.759 -0.588 . . . . 15.0 110.327 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -120.48 33.1 5.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.735 -0.603 . . . . 15.0 110.31 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -96.58 145.86 25.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 15.0 110.161 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.6 m -103.04 144.9 30.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.673 -0.642 . . . . 15.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -102.01 127.94 48.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.625 -0.672 . . . . 15.0 110.111 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.21 -42.65 79.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.851 -0.531 . . . . 15.0 110.692 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -150.14 121.9 8.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 15.0 110.608 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 65' ' ' ILE . 28.5 mt -130.93 147.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.705 -0.622 . . . . 15.0 109.505 173.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.45 137.94 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.696 -0.627 . . . . 15.0 109.999 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.41 141.49 51.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.805 -0.559 . . . . 15.0 109.819 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -108.72 152.2 25.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.714 -0.616 . . . . 15.0 110.046 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.46 -26.0 50.82 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.725 -0.95 . . . . 15.0 110.725 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 -45.99 76.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.401 -1.058 . . . . 15.0 110.743 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.1 -32.07 30.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.583 -0.698 . . . . 15.0 110.714 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.4 mt -65.84 140.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.587 -0.696 . . . . 15.0 109.911 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -100.7 -42.21 6.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 15.0 110.195 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.4 144.58 30.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.649 -0.657 . . . . 15.0 110.667 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.31 128.59 43.47 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.655 -0.653 . . . . 15.0 110.148 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -129.5 136.5 49.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.598 -0.689 . . . . 15.0 110.192 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.51 144.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.631 -0.668 . . . . 15.0 109.938 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 97.8 m -85.86 -36.97 19.65 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.671 -0.643 . . . . 15.0 110.055 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -84.28 151.67 60.02 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.71 -0.619 . . . . 15.0 109.958 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -67.96 154.74 72.01 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.614 1.323 . . . . 15.0 110.435 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.27 156.77 53.73 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.509 1.268 . . . . 15.0 110.522 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -81.47 150.24 66.61 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.69 -0.631 . . . . 15.0 109.956 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.23 153.62 63.81 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 O-C-N 123.517 1.272 . . . . 15.0 110.742 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -111.48 -26.64 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.657 -0.652 . . . . 15.0 110.602 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 117.968 -1.015 . . . . 15.0 110.198 178.352 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 120.987 0.422 . . . . 15.0 110.191 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -99.18 145.39 27.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 15.0 110.268 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.14 150.08 39.74 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.619 . . . . 15.0 110.049 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -66.05 -36.33 30.3 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.544 1.287 . . . . 15.0 110.455 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -70.54 -35.75 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 15.0 110.086 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.18 60.31 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.605 -1.398 . . . . 15.0 109.605 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.61 -33.18 83.7 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.967 -1.253 . . . . 15.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.5 m -68.92 147.04 97.77 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.603 -0.939 . . . . 15.0 110.134 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -63.08 149.18 92.25 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.484 1.255 . . . . 15.0 110.642 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -62.54 -36.53 82.91 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.708 -0.62 . . . . 15.0 110.237 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.85 137.81 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.483 -0.761 . . . . 15.0 109.401 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.85 -2.22 61.84 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 m -85.79 160.04 19.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.084 -1.245 . . . . 15.0 110.514 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.52 131.48 34.17 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 15.0 110.228 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.7 mt -132.62 145.01 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 15.0 109.928 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -115.72 127.45 55.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.3 tp -116.18 133.37 56.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 15.0 110.165 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -107.39 119.08 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.975 -0.75 . . . . 15.0 108.975 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -90.37 172.36 8.8 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.348 0.594 . . . . 15.0 110.808 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.37 -18.43 50.31 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.613 -0.679 . . . . 15.0 111.447 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 15.77 9.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.284 -0.885 . . . . 15.0 111.351 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.42 29.88 16.02 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.292 -0.88 . . . . 15.0 110.673 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.4 mt -104.07 143.27 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 172.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -102.77 119.36 38.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.78 -0.575 . . . . 15.0 110.391 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.3 130.55 55.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.822 -0.549 . . . . 15.0 109.625 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -115.99 140.67 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 15.0 109.868 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.4 -178.87 39.38 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.035 -1.626 . . . . 15.0 109.035 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.3 mm -108.08 138.8 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.389 -1.065 . . . . 15.0 109.772 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.39 108.96 1.21 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.754 -0.592 . . . . 15.0 110.379 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -91.53 -52.09 4.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.767 -0.583 . . . . 15.0 110.379 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -143.79 143.51 31.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.632 -0.668 . . . . 15.0 110.453 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.6 mt -115.57 125.59 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.765 -0.584 . . . . 15.0 109.661 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -112.05 96.16 5.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 15.0 109.825 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -71.19 -37.12 72.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.716 -0.615 . . . . 15.0 110.418 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.12 -29.04 67.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.456 -0.778 . . . . 15.0 111.053 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -116.25 13.99 15.75 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 15.0 111.56 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.79 48.19 22.0 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.362 -0.836 . . . . 15.0 111.464 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 42.4 p -132.39 149.4 52.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 15.0 110.404 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.08 138.76 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.576 -0.703 . . . . 15.0 109.55 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.59 128.45 56.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.612 -0.68 . . . . 15.0 109.905 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.83 137.72 52.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.94 -0.475 . . . . 15.0 109.892 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.35 164.05 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.742 -0.599 . . . . 15.0 109.833 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 51.81 56.0 8.47 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.605 -0.684 . . . . 15.0 110.482 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.79 146.62 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 15.0 110.386 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -134.92 150.34 50.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.75 -0.594 . . . . 15.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -98.96 132.45 44.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.725 -0.61 . . . . 15.0 109.973 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -71.72 -40.18 69.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.597 -0.689 . . . . 15.0 110.583 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.91 171.84 34.28 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.888 -1.285 . . . . 15.0 109.888 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -118.03 6.26 12.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.79 -0.829 . . . . 15.0 111.198 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.83 -23.86 46.95 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.202 -0.936 . . . . 15.0 111.313 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.49 -35.15 76.86 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.408 -0.807 . . . . 15.0 110.445 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -144.35 95.03 5.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.687 -0.633 . . . . 15.0 110.008 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.13 139.51 90.21 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 O-C-N 123.478 1.252 . . . . 15.0 110.969 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.5 p -122.36 165.11 16.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.725 -0.609 . . . . 15.0 110.195 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.85 -2.06 34.73 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.749 -0.594 . . . . 15.0 111.312 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -109.6 106.92 59.04 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.168 -0.958 . . . . 15.0 109.877 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.1 132.8 46.37 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.377 1.198 . . . . 15.0 110.874 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.72 138.4 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.743 -0.598 . . . . 15.0 109.599 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 158.06 87.84 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.767 -0.583 . . . . 15.0 110.16 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.92 161.74 41.05 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.633 1.333 . . . . 15.0 110.345 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -64.48 127.01 29.67 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.668 -0.645 . . . . 15.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -155.78 -51.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.219 -1.03 . . . . 15.0 108.219 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -106.86 163.03 13.29 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.372 0.878 . . . . 15.0 113.372 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.1 m -112.35 158.77 19.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.691 -0.631 . . . . 15.0 110.189 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -98.59 129.65 45.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.696 -0.628 . . . . 15.0 109.937 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -67.63 -41.63 83.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.808 -0.558 . . . . 15.0 110.745 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -150.8 121.88 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.585 -0.697 . . . . 15.0 110.585 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 91.6 mt -132.0 147.99 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.731 -0.606 . . . . 15.0 109.534 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -110.93 138.1 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.701 -0.624 . . . . 15.0 109.984 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.86 143.05 50.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.665 -0.647 . . . . 15.0 109.854 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -109.61 152.32 25.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.709 . . . . 15.0 110.166 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -26.05 55.66 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.759 -0.936 . . . . 15.0 110.759 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.6 p -66.7 -44.15 82.46 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.467 -1.019 . . . . 15.0 110.752 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.31 -31.86 26.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 15.0 110.673 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.55 143.54 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.648 -0.658 . . . . 15.0 109.895 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -105.05 -45.2 4.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 15.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -144.03 148.26 34.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 15.0 110.578 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.5 tt -129.65 131.0 46.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.186 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -128.29 143.26 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 15.0 110.28 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.27 144.11 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.58 -0.7 . . . . 15.0 109.872 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 31.2 m -88.02 -35.89 17.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.668 -0.645 . . . . 15.0 110.147 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.18 146.95 49.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.657 -0.652 . . . . 15.0 109.816 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.66 147.13 69.19 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.526 1.277 . . . . 15.0 110.468 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.72 156.76 52.98 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.614 1.323 . . . . 15.0 110.241 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.31 154.58 66.47 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.631 . . . . 15.0 110.016 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.48 138.85 47.3 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.653 1.344 . . . . 15.0 110.432 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.1 133.1 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.749 -0.594 . . . . 15.0 109.628 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.007 -0.997 . . . . 15.0 110.145 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 120.949 0.404 . . . . 15.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.51 -52.93 2.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.581 -0.699 . . . . 15.0 110.103 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -98.02 150.1 36.4 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.689 -0.632 . . . . 15.0 110.121 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -65.57 -33.2 46.69 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.539 1.284 . . . . 15.0 110.459 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 t -68.74 -33.94 74.76 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.709 -0.619 . . . . 15.0 110.176 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.58 71.63 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.343 . . . . 15.0 109.744 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.78 -42.94 85.77 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.839 -1.304 . . . . 15.0 109.839 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -104.21 124.11 38.47 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.667 -0.902 . . . . 15.0 110.099 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.15 133.85 32.1 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.382 1.201 . . . . 15.0 110.511 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.68 -32.04 71.57 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.699 -0.626 . . . . 15.0 110.151 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.75 136.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.353 -0.842 . . . . 15.0 109.675 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.13 -2.11 68.33 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.4 m -96.01 154.0 17.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.101 -1.235 . . . . 15.0 110.602 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -81.3 128.58 33.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.858 -0.526 . . . . 15.0 110.129 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 95.9 mt -131.65 146.52 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.494 -0.754 . . . . 15.0 109.994 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.93 130.93 57.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.482 -0.562 . . . . 15.0 109.482 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 tp -119.43 135.01 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.795 -0.566 . . . . 15.0 110.259 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.58 120.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -93.44 170.6 9.48 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.352 0.596 . . . . 15.0 110.862 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -60.6 -18.04 50.43 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.519 -0.738 . . . . 15.0 111.475 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 16.83 7.82 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.361 -0.837 . . . . 15.0 111.326 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.09 28.17 14.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 15.0 110.824 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -105.01 145.47 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -106.03 121.55 44.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.743 -0.598 . . . . 15.0 110.398 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.12 136.87 49.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.772 -0.58 . . . . 15.0 109.752 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -120.1 140.66 50.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.804 . . . . 15.0 109.876 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 -178.96 39.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.171 -1.572 . . . . 15.0 109.171 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 mm -108.52 133.48 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.46 -1.023 . . . . 15.0 109.544 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.49 114.51 3.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.577 -0.702 . . . . 15.0 110.53 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -93.81 -52.08 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 15.0 110.379 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.5 p -146.45 145.27 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.597 -0.689 . . . . 15.0 110.595 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.7 mt -116.04 126.61 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.795 -0.566 . . . . 15.0 109.658 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.12 97.68 6.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.676 . . . . 15.0 109.825 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.91 -36.1 72.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.784 -0.572 . . . . 15.0 110.41 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -59.21 -29.28 67.38 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.584 -0.697 . . . . 15.0 111.102 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.17 14.02 15.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.638 -0.664 . . . . 15.0 111.516 -177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t 49.99 47.26 23.56 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.14 -0.975 . . . . 15.0 111.24 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.0 p -131.51 150.14 52.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.542 -0.724 . . . . 15.0 110.489 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.92 139.38 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.589 -0.694 . . . . 15.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.59 128.6 56.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.699 -0.625 . . . . 15.0 110.01 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 mt -116.79 139.04 51.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.846 -0.428 . . . . 15.0 109.846 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 162.03 17.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.717 -0.615 . . . . 15.0 109.816 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 51.61 61.22 3.33 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.555 -0.715 . . . . 15.0 110.311 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.77 145.19 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.594 -0.691 . . . . 15.0 110.592 -172.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -138.64 155.77 48.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.759 -0.588 . . . . 15.0 110.296 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.4 p -99.03 133.48 43.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.841 -0.537 . . . . 15.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -69.36 -40.07 77.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.671 . . . . 15.0 110.468 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.95 171.43 33.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.806 -1.317 . . . . 15.0 109.806 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.0 p -118.0 6.37 12.14 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.755 -0.85 . . . . 15.0 111.161 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -54.68 -22.84 14.98 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.247 -0.908 . . . . 15.0 111.488 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -60.44 -32.03 70.98 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.382 -0.824 . . . . 15.0 110.391 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -120.89 95.01 49.04 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.734 -0.604 . . . . 15.0 109.881 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.03 130.02 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.5 1.263 . . . . 15.0 110.571 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -132.72 165.13 25.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 15.0 110.106 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -77.95 -2.17 35.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.645 -0.66 . . . . 15.0 111.427 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -118.05 106.94 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.11 -0.994 . . . . 15.0 109.985 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.03 145.11 72.47 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.456 1.24 . . . . 15.0 110.465 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.3 mm -105.36 136.01 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.732 -0.605 . . . . 15.0 109.651 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.28 109.96 61.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.644 -0.66 . . . . 15.0 110.231 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -66.96 152.36 80.47 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.431 1.227 . . . . 15.0 110.342 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -118.59 153.62 33.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.734 -0.604 . . . . 15.0 110.274 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.02 -32.55 73.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.72 -0.613 . . . . 15.0 110.315 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -83.15 -171.2 3.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.61 -0.681 . . . . 15.0 110.18 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.5 t -134.81 172.09 13.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.691 -0.631 . . . . 15.0 110.368 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -86.79 133.16 33.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.705 -0.622 . . . . 15.0 109.859 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -69.09 -46.03 68.78 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.438 -0.505 . . . . 15.0 110.641 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -147.9 121.87 9.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.582 -0.699 . . . . 15.0 110.514 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.478 HG23 HD11 ' A' ' 65' ' ' ILE . 19.5 mt -132.27 147.98 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.705 -0.622 . . . . 15.0 109.432 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -112.36 138.86 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.648 -0.658 . . . . 15.0 110.094 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.1 144.71 51.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 15.0 109.815 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -108.7 151.8 25.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.7 -0.625 . . . . 15.0 110.237 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.08 -26.0 54.92 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -65.59 -45.3 83.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.551 -0.97 . . . . 15.0 110.715 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.01 -31.34 31.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 15.0 110.683 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.5 140.72 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.592 -0.693 . . . . 15.0 109.842 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -104.02 -42.53 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 15.0 110.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -147.41 149.6 33.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.678 -0.639 . . . . 15.0 110.7 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 tt -129.71 131.23 46.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.742 -0.599 . . . . 15.0 110.097 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m -131.62 142.71 49.94 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.584 -0.697 . . . . 15.0 110.343 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 144.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.636 . . . . 15.0 109.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 93.0 m -97.83 -37.08 9.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.685 . . . . 15.0 110.318 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -97.59 117.48 65.32 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.705 -0.622 . . . . 15.0 110.158 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.63 157.95 58.29 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.279 1.147 . . . . 15.0 110.283 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.08 145.78 94.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.558 1.294 . . . . 15.0 110.489 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -96.89 142.57 24.73 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.68 -0.638 . . . . 15.0 110.04 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.8 138.64 41.53 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.488 1.257 . . . . 15.0 110.433 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 tt -129.52 137.81 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 15.0 110.057 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.001 -0.999 . . . . 15.0 110.228 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 120.936 0.398 . . . . 15.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.56 -62.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 15.0 110.224 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.99 149.97 38.19 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.681 -0.637 . . . . 15.0 110.192 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.97 -32.23 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.603 1.317 . . . . 15.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -65.99 -34.92 79.2 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.584 -0.697 . . . . 15.0 110.362 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.69 -35.31 80.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.738 -1.345 . . . . 15.0 109.738 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.24 77.95 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.87 -1.292 . . . . 15.0 109.87 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -68.19 135.23 91.39 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.578 -0.954 . . . . 15.0 110.134 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.18 149.02 92.58 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.26 1.137 . . . . 15.0 110.668 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -65.0 -29.11 70.01 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.694 -0.629 . . . . 15.0 110.374 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 86.4 mt -63.1 137.79 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.363 -0.836 . . . . 15.0 109.615 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.65 -2.32 58.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.8 -0.92 . . . . 15.0 110.8 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.1 m -94.86 160.07 14.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.106 -1.232 . . . . 15.0 110.277 174.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -91.99 137.03 32.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.619 -0.676 . . . . 15.0 110.264 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.43 146.31 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 15.0 109.883 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -114.36 128.12 56.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.386 -0.598 . . . . 15.0 109.386 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 tp -120.56 135.92 54.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 15.0 110.282 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.4 mt -109.32 118.9 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -87.92 172.94 9.22 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.212 0.53 . . . . 15.0 110.781 -172.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -59.79 -18.44 43.52 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.606 -0.684 . . . . 15.0 111.601 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.52 15.47 10.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 15.0 111.286 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 56.17 28.58 13.31 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.191 -0.943 . . . . 15.0 110.776 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -101.87 142.9 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.82 -0.807 . . . . 15.0 108.82 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -100.84 120.8 40.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.744 -0.598 . . . . 15.0 110.467 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -112.73 132.35 55.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.837 -0.539 . . . . 15.0 109.591 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -117.92 140.65 49.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 15.0 109.907 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.85 39.38 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.944 -1.663 . . . . 15.0 108.944 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.4 mm -108.03 144.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -1.039 . . . . 15.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.0 tp -66.15 113.49 4.56 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.807 -0.558 . . . . 15.0 110.21 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -94.25 -52.03 4.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.827 -0.546 . . . . 15.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -147.5 143.33 27.77 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 110.591 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.2 mt -112.22 127.73 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.698 -0.627 . . . . 15.0 109.584 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -112.09 97.42 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.634 -0.666 . . . . 15.0 109.751 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.89 -35.74 72.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.703 -0.623 . . . . 15.0 110.405 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.56 -28.9 65.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.525 -0.734 . . . . 15.0 111.149 -171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -117.7 14.05 14.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.539 -0.725 . . . . 15.0 111.531 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t 49.92 48.69 21.47 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.104 -0.998 . . . . 15.0 111.257 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.7 p -131.99 150.26 52.2 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.383 -0.823 . . . . 15.0 110.513 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.04 138.58 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 15.0 109.558 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.75 127.66 54.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.655 . . . . 15.0 109.918 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -116.9 138.92 51.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.946 -0.471 . . . . 15.0 109.737 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.84 164.94 13.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.722 -0.611 . . . . 15.0 109.907 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 51.89 56.5 7.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.656 -0.653 . . . . 15.0 110.461 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -118.0 148.53 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.587 -0.695 . . . . 15.0 110.342 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -137.43 153.29 50.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.791 -0.568 . . . . 15.0 110.229 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.9 p -101.87 133.87 45.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.731 -0.606 . . . . 15.0 110.006 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.06 -40.13 63.0 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.699 -0.626 . . . . 15.0 110.689 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 171.21 33.51 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.984 -1.246 . . . . 15.0 109.984 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.8 p -118.15 6.27 12.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.798 -0.824 . . . . 15.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.13 -23.56 35.33 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.128 -0.983 . . . . 15.0 111.472 -173.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.25 -31.68 71.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.467 -0.771 . . . . 15.0 110.573 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -123.29 95.02 46.11 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.571 -0.706 . . . . 15.0 110.095 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.79 129.95 34.58 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 O-C-N 123.463 1.244 . . . . 15.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.8 p -132.27 165.2 24.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.759 -0.588 . . . . 15.0 110.197 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 -1.12 29.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.698 -0.626 . . . . 15.0 111.437 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -113.59 106.87 53.67 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 15.0 109.724 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.49 131.89 24.17 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.356 1.187 . . . . 15.0 110.648 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.9 mm -122.73 119.01 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.654 -0.654 . . . . 15.0 109.472 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.37 156.05 36.19 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 15.0 110.346 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.85 145.65 94.73 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.596 1.314 . . . . 15.0 110.576 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -125.2 159.66 31.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.731 -0.606 . . . . 15.0 110.188 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -98.91 29.13 3.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.671 -0.643 . . . . 15.0 110.576 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.0 141.53 51.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 15.0 110.131 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.4 m -103.15 159.77 15.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.689 -0.632 . . . . 15.0 110.132 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.14 130.39 44.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.747 -0.596 . . . . 15.0 110.037 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.77 -40.7 83.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.847 -0.533 . . . . 15.0 110.843 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -151.99 121.94 7.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.775 . . . . 15.0 110.814 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.7 mt -130.85 148.02 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.688 -0.632 . . . . 15.0 109.664 172.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.26 135.09 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.718 -0.614 . . . . 15.0 109.813 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -126.22 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.75 -0.594 . . . . 15.0 109.841 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -108.16 151.86 25.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 15.0 110.159 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -25.95 55.45 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.3 p -66.46 -45.06 81.03 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.501 -1.0 . . . . 15.0 110.685 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.94 -31.92 31.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.745 . . . . 15.0 110.682 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.5 mt -65.88 140.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.599 -0.688 . . . . 15.0 109.869 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -106.35 -42.28 5.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.745 -0.597 . . . . 15.0 110.251 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -139.26 142.65 37.78 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.672 -0.642 . . . . 15.0 110.531 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 tt -130.84 126.96 37.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.681 -0.637 . . . . 15.0 110.19 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -129.2 136.39 50.08 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.616 -0.678 . . . . 15.0 110.093 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.08 144.04 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.646 -0.659 . . . . 15.0 109.94 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.11 -37.05 34.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.68 -0.637 . . . . 15.0 109.956 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.27 117.6 69.11 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.664 -0.648 . . . . 15.0 109.785 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.87 110.12 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.295 1.155 . . . . 15.0 110.981 -175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.82 156.65 65.1 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.443 1.233 . . . . 15.0 110.245 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -97.86 160.06 29.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.719 -0.613 . . . . 15.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -62.41 147.19 95.3 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.608 1.32 . . . . 15.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 tt -154.74 51.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 15.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 ttp . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.052 -0.975 . . . . 15.0 110.181 179.892 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.947 0.403 . . . . 15.0 110.298 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -95.38 152.57 18.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.707 -0.621 . . . . 15.0 110.163 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.0 150.03 85.58 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.705 -0.622 . . . . 15.0 109.991 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.58 -34.69 92.17 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.455 1.239 . . . . 15.0 110.731 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p -69.53 -36.45 76.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.659 -0.65 . . . . 15.0 110.18 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.34 -35.16 34.28 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.598 -1.401 . . . . 15.0 109.598 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.53 83.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.985 -1.246 . . . . 15.0 109.985 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.2 m -86.03 122.87 72.54 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.536 -0.979 . . . . 15.0 110.12 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.37 149.08 90.75 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.277 1.146 . . . . 15.0 110.462 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -63.19 -35.22 79.57 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.67 -0.644 . . . . 15.0 110.268 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.0 mt -64.88 137.7 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.444 -0.785 . . . . 15.0 109.53 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 -2.31 63.25 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.835 -0.906 . . . . 15.0 110.835 -174.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.6 m -90.46 156.29 18.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.063 -1.257 . . . . 15.0 110.29 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -85.99 133.22 33.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.662 -0.649 . . . . 15.0 110.468 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.2 mt -133.83 154.18 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.598 -0.689 . . . . 15.0 109.735 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.9 t -115.89 132.62 56.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.901 -0.499 . . . . 15.0 109.85 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -116.53 130.19 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.87 -0.519 . . . . 15.0 109.88 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.18 119.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.91 -0.774 . . . . 15.0 108.91 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m -92.64 170.85 9.41 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.331 0.586 . . . . 15.0 110.981 -170.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.6 -18.54 53.65 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.603 -0.685 . . . . 15.0 111.422 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.59 16.13 8.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 15.0 111.251 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 58.12 28.53 16.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.344 -0.848 . . . . 15.0 110.829 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.0 mt -105.07 148.37 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -107.63 118.92 38.0 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.801 -0.562 . . . . 15.0 110.422 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.43 137.37 48.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.784 -0.573 . . . . 15.0 109.888 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -119.28 140.75 49.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 15.0 109.88 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.6 -178.9 38.97 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.072 -1.611 . . . . 15.0 109.072 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.21 135.16 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.516 -0.99 . . . . 15.0 109.708 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.5 tp -62.37 109.02 1.22 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.693 -0.629 . . . . 15.0 110.486 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.31 -52.07 5.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.819 -0.55 . . . . 15.0 110.356 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.5 p -144.52 144.17 31.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.622 -0.674 . . . . 15.0 110.538 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -116.44 125.35 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.778 -0.576 . . . . 15.0 109.654 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -112.03 96.37 6.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.706 . . . . 15.0 109.896 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.0 m -70.65 -36.8 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.803 -0.561 . . . . 15.0 110.379 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.29 -29.28 67.48 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 15.0 111.131 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -115.43 14.05 16.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 15.0 111.547 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t 49.87 47.93 22.46 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.093 -1.005 . . . . 15.0 111.25 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.4 p -131.97 148.41 52.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.357 -0.839 . . . . 15.0 110.561 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.78 139.25 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.607 -0.683 . . . . 15.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.15 128.69 56.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.684 . . . . 15.0 110.005 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.77 136.6 52.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.901 -0.499 . . . . 15.0 109.879 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.97 162.35 16.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.698 -0.627 . . . . 15.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 51.86 59.62 4.42 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.608 -0.683 . . . . 15.0 110.384 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.58 147.14 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.601 -0.687 . . . . 15.0 110.333 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -137.38 150.86 47.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.776 -0.578 . . . . 15.0 110.033 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.9 p -95.98 130.23 43.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.771 -0.581 . . . . 15.0 109.741 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.19 -40.27 74.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.6 -0.687 . . . . 15.0 110.443 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.45 32.54 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.787 -1.325 . . . . 15.0 109.787 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.5 p -118.06 -13.4 9.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.828 -0.807 . . . . 15.0 111.05 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -63.7 -28.95 70.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.903 . . . . 15.0 110.945 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.98 -32.16 70.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.442 -0.786 . . . . 15.0 110.399 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -123.46 95.14 45.61 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 15.0 109.837 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.08 134.58 50.1 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.38 1.2 . . . . 15.0 110.903 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 p -132.54 165.12 25.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.847 -0.533 . . . . 15.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.89 -1.47 31.94 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.62 -0.675 . . . . 15.0 111.453 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -116.93 106.99 46.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.192 -0.943 . . . . 15.0 109.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.69 134.45 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.316 1.167 . . . . 15.0 110.801 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.3 mm -119.6 141.62 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.704 -0.622 . . . . 15.0 109.677 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.75 109.92 60.71 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 15.0 110.178 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -63.18 146.52 94.14 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.35 1.184 . . . . 15.0 110.566 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -123.45 133.62 54.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.709 -0.619 . . . . 15.0 110.249 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.95 -33.36 73.6 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 15.0 110.252 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.06 155.38 39.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.623 -0.673 . . . . 15.0 110.238 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -102.95 161.04 14.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.721 -0.612 . . . . 15.0 110.2 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.97 133.27 47.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.671 -0.643 . . . . 15.0 110.096 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -67.55 -38.92 84.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.872 -0.517 . . . . 15.0 110.864 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.21 122.04 7.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.46 -0.775 . . . . 15.0 110.824 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.61 147.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.708 -0.62 . . . . 15.0 109.566 172.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.6 mt -110.8 137.76 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.723 -0.611 . . . . 15.0 109.927 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -129.47 142.64 50.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.718 -0.614 . . . . 15.0 109.905 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -110.35 152.15 26.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.621 -0.675 . . . . 15.0 110.107 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.94 55.12 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.5 p -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.436 -1.037 . . . . 15.0 110.75 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.13 -30.15 15.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.503 -0.748 . . . . 15.0 110.841 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.9 mt -63.52 138.37 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.453 -0.779 . . . . 15.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -98.86 -40.56 8.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.818 -0.551 . . . . 15.0 110.027 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.54 149.61 29.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.692 -0.63 . . . . 15.0 110.749 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -132.3 135.27 46.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.712 -0.617 . . . . 15.0 109.881 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -133.16 143.07 48.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.675 -0.641 . . . . 15.0 110.17 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.1 143.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.691 -0.63 . . . . 15.0 109.779 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.1 m -94.9 -37.02 11.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 15.0 110.345 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -84.31 160.88 56.14 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.725 -0.61 . . . . 15.0 110.192 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.5 112.71 2.68 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.716 1.377 . . . . 15.0 110.351 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.06 154.14 73.31 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.372 1.196 . . . . 15.0 110.316 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -102.11 164.1 16.44 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 15.0 110.377 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -62.72 147.08 95.18 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.718 1.378 . . . . 15.0 110.623 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 tp -143.38 65.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.603 . . . . 15.0 110.006 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 118.0 -1.0 . . . . 15.0 110.317 -179.839 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.753 0.311 . . . . 0.19 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' HD12 ' A' ' 25' ' ' ILE . 60.9 mttm -82.84 133.2 35.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.034 -0.53 . . . . 2.07 110.402 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.0 mt -135.85 147.25 28.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 0.22 110.434 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.0 t -114.68 132.57 56.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.754 -0.657 . . . . 0.15 109.893 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -124.45 137.4 54.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.414 . . . . 0.34 110.519 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mt -111.96 122.02 65.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.373 -0.602 . . . . 0.17 109.373 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -93.17 169.89 10.06 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.452 0.47 . . . . 0.17 111.139 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -59.86 -20.96 60.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.044 -0.525 . . . . 2.62 111.971 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.05 13.66 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.122 0.416 . . . . 0.19 112.122 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 61.9 25.22 15.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.635 0.255 . . . . 1.63 111.271 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.02 142.89 17.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 109.475 -0.565 . . . . 0.21 109.475 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -104.42 121.08 42.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 2.39 110.619 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -113.6 139.8 48.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.018 -0.537 . . . . 0.16 110.1 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -121.61 140.67 51.96 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.0 -178.84 39.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.6 -1.0 . . . . 0.07 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 11' ' ' LYS . 10.9 mm -106.78 139.1 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.067 -0.345 . . . . 0.2 110.067 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.878 HD21 HD11 ' A' ' 29' ' ' ILE . 17.3 tp -65.95 109.06 2.39 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.25 110.492 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -91.59 -52.15 4.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.255 -0.429 . . . . 0.23 110.809 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 p -150.23 145.53 26.28 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.376 -0.375 . . . . 0.17 110.957 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.878 HD11 HD21 ' A' ' 26' ' ' LEU . 44.7 mt -118.45 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.25 110.077 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -112.1 95.01 5.22 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.067 -0.345 . . . . 1.1 110.067 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.7 m -67.87 -38.62 83.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.782 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.71 -32.15 68.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.311 -0.404 . . . . 1.97 111.615 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -112.64 13.94 20.01 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.163 0.431 . . . . 0.47 112.163 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.6 p 49.99 42.15 24.16 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.936 0.398 . . . . 1.14 111.598 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 68' ' ' ARG . 4.2 p -131.37 149.16 52.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.278 -0.419 . . . . 0.13 110.98 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.44 138.21 54.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.12 110.006 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.77 127.65 56.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.367 -0.379 . . . . 0.07 110.431 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.3 mt -116.93 139.48 50.6 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.112 -0.495 . . . . 0.42 110.138 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.11 159.48 22.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.06 110.134 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 55.94 55.14 7.24 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.191 0.52 . . . . 2.43 110.482 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -119.22 142.58 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.767 -0.651 . . . . 0.11 110.334 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -135.22 150.74 50.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 3.55 110.493 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 p -96.47 128.01 43.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.2 110.194 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.456 -0.338 . . . . 0.79 110.828 -174.307 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.612 0.244 . . . . 0.38 110.417 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.31 -40.5 89.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.164 -0.471 . . . . 2.54 111.251 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.8 t80 -146.85 121.94 10.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.728 0.299 . . . . 0.13 111.041 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.17 143.77 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.16 110.045 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -112.45 138.22 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.256 -0.429 . . . . 0.13 110.369 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -130.08 141.28 50.72 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.14 110.273 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' HG22 ' A' ' 35' ' ' THR . 75.7 mtm180 -102.15 149.11 24.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.414 -0.357 . . . . 2.11 110.295 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.86 50.4 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 111.946 -0.462 . . . . 0.11 111.946 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -67.09 -42.15 85.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.456 0.169 . . . . 1.24 111.15 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -32.05 30.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.56 -0.291 . . . . 1.09 111.229 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 14' ' ' LEU . 50.8 mt -65.51 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.13 110.392 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -103.93 -45.99 4.6 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.038 -0.528 . . . . 1.35 110.648 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -148.25 149.13 31.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.3 -0.409 . . . . 1.13 111.127 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt -131.39 129.2 41.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.982 -0.553 . . . . 0.51 110.17 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.463 0.199 0 CA-C-N 116.439 -0.346 . . . . 0.23 110.571 178.284 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.016 0.436 . . . . 15.0 110.553 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -82.07 128.46 34.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.853 -0.529 . . . . 15.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' HB2' ' A' ' 26' ' ' LEU . 89.8 mt -131.01 149.5 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 15.0 109.913 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.63 135.95 53.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.551 -0.537 . . . . 15.0 109.551 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 HG12 ' A' ' 72' ' ' ILE . 10.5 tp -127.07 137.0 52.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.717 -0.614 . . . . 15.0 110.258 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.63 123.4 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.014 -0.736 . . . . 15.0 109.014 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -93.55 172.83 8.02 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.305 0.574 . . . . 15.0 110.944 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.74 -19.8 52.46 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.63 -0.668 . . . . 15.0 111.444 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.76 16.14 8.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.803 . . . . 15.0 111.336 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.57 29.32 16.97 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.302 -0.874 . . . . 15.0 110.781 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.2 mt -105.09 147.59 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -105.78 118.93 37.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.785 -0.572 . . . . 15.0 110.509 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -111.52 140.71 45.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.812 -0.555 . . . . 15.0 109.765 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.1 tt0 -125.83 140.8 52.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.475 -0.766 . . . . 15.0 109.839 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.86 -178.84 39.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.128 -1.589 . . . . 15.0 109.128 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -107.28 133.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.436 -1.038 . . . . 15.0 109.736 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -61.61 114.66 3.4 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.751 -0.593 . . . . 15.0 110.474 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -95.72 -52.04 4.26 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.408 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -145.16 145.15 31.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.623 -0.673 . . . . 15.0 110.664 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.822 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -118.31 127.31 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.747 -0.595 . . . . 15.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.11 97.96 7.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 15.0 109.846 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -70.6 -36.57 73.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.719 -0.613 . . . . 15.0 110.484 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.09 -29.16 67.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.55 -0.719 . . . . 15.0 111.136 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.14 14.07 15.87 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.704 . . . . 15.0 111.539 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t 49.94 47.53 23.11 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.143 -0.973 . . . . 15.0 111.22 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 21.3 p -131.27 149.99 52.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.517 -0.739 . . . . 15.0 110.558 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.56 141.75 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.671 -0.643 . . . . 15.0 109.72 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.17 129.67 56.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.681 -0.637 . . . . 15.0 110.058 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 26' ' ' LEU . 22.1 mt -116.92 138.95 51.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.884 -0.51 . . . . 15.0 109.845 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.08 16.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.736 -0.603 . . . . 15.0 109.861 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.3 mttt 51.72 58.36 5.56 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.709 -0.619 . . . . 15.0 110.441 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.8 p -121.29 148.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.566 -0.709 . . . . 15.0 110.332 -173.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -138.62 153.91 48.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.81 -0.556 . . . . 15.0 110.128 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.3 p -101.24 131.84 47.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.832 -0.543 . . . . 15.0 109.856 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.687 . . . . 15.0 110.541 -174.181 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.0 m-85 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.921 0.391 . . . . 15.0 110.104 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -68.3 -43.37 77.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.769 -0.582 . . . . 15.0 110.579 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -149.92 122.02 8.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.543 -0.723 . . . . 15.0 110.609 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.636 HD11 ' CG ' ' A' ' 62' ' ' PHE . 30.4 mt -130.85 146.98 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.699 -0.626 . . . . 15.0 109.56 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.87 137.29 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.72 -0.612 . . . . 15.0 109.93 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.93 144.28 51.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.75 -0.594 . . . . 15.0 109.846 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 82.8 mtm180 -109.27 152.68 24.9 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 15.0 110.088 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.04 -26.0 54.83 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.9 m -65.98 -45.86 80.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.472 -1.017 . . . . 15.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.95 -31.02 31.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.693 -0.63 . . . . 15.0 110.807 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.579 HG12 HD21 ' A' ' 14' ' ' LEU . 73.0 mt -65.99 141.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.538 -0.726 . . . . 15.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -104.56 -42.54 5.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.781 -0.574 . . . . 15.0 110.198 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -145.88 145.95 30.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.695 -0.628 . . . . 15.0 110.679 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.74 129.12 45.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.804 -0.56 . . . . 15.0 110.13 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.629 -0.669 . . . . 15.0 110.428 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.016 0.436 . . . . 15.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -84.89 128.2 34.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.768 -0.583 . . . . 15.0 110.197 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.0 mt -132.19 150.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 15.0 109.988 -175.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 t -115.53 131.34 56.96 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.532 -0.544 . . . . 15.0 109.532 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.562 HD21 HG12 ' A' ' 72' ' ' ILE . 11.8 tp -118.82 134.9 54.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 15.0 110.285 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.5 mt -107.34 122.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.109 -0.701 . . . . 15.0 109.109 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -93.76 171.93 8.57 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.314 0.578 . . . . 15.0 110.87 -173.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -60.09 -19.05 51.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.614 -0.679 . . . . 15.0 111.441 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.23 16.69 8.14 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.353 -0.842 . . . . 15.0 111.275 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 57.1 28.44 14.94 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.28 -0.888 . . . . 15.0 110.827 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.0 mt -105.08 145.66 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.062 -0.718 . . . . 15.0 109.062 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -104.56 121.5 43.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.847 -0.533 . . . . 15.0 110.34 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.14 132.77 54.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.559 . . . . 15.0 109.654 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 9.3 tm-20 -115.96 140.58 49.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.532 -0.73 . . . . 15.0 109.886 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.05 -178.81 39.68 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.93 -1.668 . . . . 15.0 108.93 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -106.68 138.95 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.455 -1.026 . . . . 15.0 109.64 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 29' ' ' ILE . 19.0 tp -65.3 112.13 3.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.746 -0.596 . . . . 15.0 110.356 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -95.58 -52.11 4.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 15.0 110.489 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 18.1 p -144.31 142.54 30.48 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.573 -0.705 . . . . 15.0 110.604 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 26' ' ' LEU . 75.5 mt -116.27 126.55 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.805 -0.56 . . . . 15.0 109.609 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.09 95.28 5.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.609 -0.682 . . . . 15.0 109.792 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -69.33 -39.47 78.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.746 -0.596 . . . . 15.0 110.344 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -59.83 -29.27 68.14 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.549 -0.719 . . . . 15.0 111.063 -172.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' THR . 94.5 m-20 -111.17 12.35 21.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.464 -0.773 . . . . 15.0 111.555 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m 49.98 44.64 25.53 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.195 -0.941 . . . . 15.0 111.288 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.704 HG22 ' HG2' ' A' ' 68' ' ' ARG . 15.1 p -132.77 150.09 52.2 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.481 -0.762 . . . . 15.0 110.623 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.3 139.95 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.73 -0.606 . . . . 15.0 109.595 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.73 128.69 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.646 -0.659 . . . . 15.0 110.04 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.9 mt -116.84 138.85 51.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.895 -0.503 . . . . 15.0 109.726 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.76 162.36 16.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 15.0 109.89 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt 52.09 61.05 3.41 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.619 -0.675 . . . . 15.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.07 147.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 15.0 110.46 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -132.8 149.92 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.857 -0.527 . . . . 15.0 109.988 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 p -97.74 130.8 44.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.688 -0.633 . . . . 15.0 109.823 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.493 -0.754 . . . . 15.0 110.819 -174.072 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.71 -46.02 70.07 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.87 -0.519 . . . . 15.0 110.543 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.5 t80 -149.29 121.93 8.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.579 -0.701 . . . . 15.0 110.48 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 147.19 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.718 -0.613 . . . . 15.0 109.605 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.66 136.32 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.746 -0.596 . . . . 15.0 109.818 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -126.28 143.96 50.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 15.0 109.984 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.704 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -106.66 151.99 24.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 15.0 110.173 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.99 -25.93 54.54 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.751 -0.94 . . . . 15.0 110.751 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 m -65.57 -45.41 83.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.48 -1.012 . . . . 15.0 110.661 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.98 -31.28 31.23 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.543 -0.723 . . . . 15.0 110.677 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 14' ' ' LEU . 72.7 mt -66.17 144.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.563 -0.711 . . . . 15.0 109.902 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -106.71 -43.09 4.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.748 -0.595 . . . . 15.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.74 151.72 32.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.652 -0.655 . . . . 15.0 110.629 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.38 129.79 45.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.851 -0.531 . . . . 15.0 110.176 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.497 1.876 0 O-C-N 121.65 -0.656 . . . . 15.0 110.396 178.978 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.938 0.399 . . . . 15.0 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -92.12 133.74 35.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.75 -0.594 . . . . 15.0 110.287 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.6 mt -132.43 147.72 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.531 -0.731 . . . . 15.0 109.923 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -115.08 131.45 56.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.499 -0.556 . . . . 15.0 109.499 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -123.16 135.97 54.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.713 -0.617 . . . . 15.0 110.35 -175.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 74' ' ' ASP . 79.9 mt -108.83 120.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -91.53 171.64 9.05 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.334 0.587 . . . . 15.0 110.886 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -59.69 -18.99 46.75 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.617 -0.677 . . . . 15.0 111.643 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.03 17.21 8.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 15.0 111.257 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 58.0 28.86 16.85 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.254 -0.904 . . . . 15.0 110.835 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.13 148.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -105.32 119.01 38.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.762 -0.586 . . . . 15.0 110.462 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.76 136.46 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.761 -0.587 . . . . 15.0 109.652 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.0 tt0 -122.81 140.57 52.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 15.0 110.007 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.93 -178.88 39.67 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.901 -1.68 . . . . 15.0 108.901 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.9 mm -107.27 140.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -1.059 . . . . 15.0 109.858 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 29' ' ' ILE . 21.0 tp -64.44 109.98 2.13 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.599 . . . . 15.0 110.344 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -93.39 -52.08 4.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.792 -0.567 . . . . 15.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -143.24 143.33 31.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.683 -0.635 . . . . 15.0 110.523 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 HD21 ' A' ' 26' ' ' LEU . 74.4 mt -116.83 125.62 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.775 -0.578 . . . . 15.0 109.656 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -112.03 98.21 7.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.603 -0.686 . . . . 15.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -71.32 -36.04 71.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.8 -0.563 . . . . 15.0 110.457 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.88 -29.88 67.33 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.544 -0.723 . . . . 15.0 111.078 -171.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.45 14.04 15.54 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.639 -0.663 . . . . 15.0 111.519 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t 49.88 48.69 21.44 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.246 -0.909 . . . . 15.0 111.229 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.3 p -131.39 149.58 52.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.571 -0.706 . . . . 15.0 110.514 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.0 t -131.49 139.68 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.663 -0.648 . . . . 15.0 109.687 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.74 128.47 56.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 15.0 109.957 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 59.7 mt -116.82 137.78 51.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.979 -0.451 . . . . 15.0 109.798 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.33 163.68 14.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.741 -0.599 . . . . 15.0 109.894 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 51.48 64.24 1.92 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 121.376 0.608 . . . . 15.0 110.439 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -123.9 145.51 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 15.0 110.347 -172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -127.98 149.34 50.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.864 -0.522 . . . . 15.0 109.801 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -99.32 125.18 44.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.663 -0.648 . . . . 15.0 109.602 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 N--CA 1.499 1.989 0 C-N-CA 120.055 -0.658 . . . . 15.0 110.643 -171.659 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.995 0.426 . . . . 15.0 110.18 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.35 -44.7 71.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.79 -0.569 . . . . 15.0 110.604 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.87 121.98 8.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.571 -0.706 . . . . 15.0 110.507 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.73 147.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.745 -0.597 . . . . 15.0 109.663 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -111.18 136.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.739 -0.601 . . . . 15.0 109.865 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.72 144.1 51.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 15.0 109.913 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 67.7 mtm180 -108.47 151.9 25.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 15.0 110.097 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.02 -25.94 54.65 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 110.746 -0.942 . . . . 15.0 110.746 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -66.09 -45.41 81.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.48 -1.012 . . . . 15.0 110.731 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -82.05 -31.58 30.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.584 -0.697 . . . . 15.0 110.626 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.602 HG12 HD21 ' A' ' 14' ' ' LEU . 66.9 mt -66.16 140.53 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.545 -0.722 . . . . 15.0 109.816 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -108.16 -42.28 4.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 15.0 110.344 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 15' ' ' ILE . 26.7 t70 -139.23 145.16 38.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 15.0 110.653 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -132.82 129.61 38.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.701 -0.625 . . . . 15.0 110.254 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.743 -0.598 . . . . 15.0 110.219 178.586 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 121.026 0.441 . . . . 15.0 110.33 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -86.87 129.89 34.69 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.681 -0.637 . . . . 15.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 HD12 HD13 ' A' ' 26' ' ' LEU . 92.7 mt -132.77 150.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.617 -0.677 . . . . 15.0 109.927 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.46 132.97 56.46 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -122.57 136.93 55.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.751 -0.593 . . . . 15.0 110.335 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.1 mt -109.47 121.68 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -93.22 171.49 8.9 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.279 0.561 . . . . 15.0 110.937 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -60.23 -19.12 53.14 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.594 -0.691 . . . . 15.0 111.396 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.12 16.83 7.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.342 -0.848 . . . . 15.0 111.271 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 57.6 28.39 15.58 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.295 -0.878 . . . . 15.0 110.818 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.3 mt -104.95 147.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -106.71 119.84 40.4 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.698 -0.626 . . . . 15.0 110.52 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.23 137.24 49.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.874 -0.516 . . . . 15.0 109.772 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.8 tt0 -121.29 140.69 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.745 . . . . 15.0 109.942 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.88 39.4 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.973 -1.651 . . . . 15.0 108.973 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.35 138.02 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.382 -1.069 . . . . 15.0 109.696 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.694 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -66.19 108.84 2.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.727 -0.608 . . . . 15.0 110.168 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -93.51 -52.16 4.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.882 -0.511 . . . . 15.0 110.509 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -141.69 141.34 33.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 15.0 110.492 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 HD21 ' A' ' 26' ' ' LEU . 78.6 mt -118.04 124.92 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.742 -0.599 . . . . 15.0 109.644 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -112.11 97.46 6.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.532 -0.73 . . . . 15.0 109.907 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.01 -36.19 74.92 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.767 -0.583 . . . . 15.0 110.434 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -59.22 -29.62 67.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.539 -0.726 . . . . 15.0 111.074 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -115.53 14.07 16.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.522 -0.737 . . . . 15.0 111.471 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 m 50.0 46.65 24.24 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.184 -0.948 . . . . 15.0 111.181 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.7 p -131.6 149.81 52.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.404 -0.81 . . . . 15.0 110.51 -177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.41 140.23 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 15.0 109.72 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.33 130.05 56.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.709 -0.619 . . . . 15.0 109.961 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 26' ' ' LEU . 92.4 mt -116.8 138.06 51.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.765 -0.458 . . . . 15.0 109.765 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 162.39 16.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.722 -0.611 . . . . 15.0 109.887 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.7 mttt 51.75 61.2 3.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.673 -0.642 . . . . 15.0 110.428 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -122.4 145.88 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.686 -0.634 . . . . 15.0 110.376 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.88 149.42 52.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.813 -0.554 . . . . 15.0 109.99 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -97.22 127.79 43.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.615 . . . . 15.0 109.649 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.554 -0.717 . . . . 15.0 110.615 -173.539 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.3 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.867 0.365 . . . . 15.0 110.153 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -68.46 -43.98 75.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.853 -0.53 . . . . 15.0 110.631 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -149.83 122.08 8.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.601 -0.687 . . . . 15.0 110.587 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.2 mt -130.71 147.83 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.618 -0.676 . . . . 15.0 109.564 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.22 137.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.776 -0.578 . . . . 15.0 109.885 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.87 145.65 51.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.771 -0.58 . . . . 15.0 109.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.745 ' HG2' HG22 ' A' ' 35' ' ' THR . 96.5 mtt180 -108.85 152.35 25.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.637 -0.664 . . . . 15.0 110.172 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.15 55.91 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.722 -0.951 . . . . 15.0 110.722 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 m -65.74 -45.24 83.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -1.047 . . . . 15.0 110.646 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.99 -31.44 31.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.552 -0.717 . . . . 15.0 110.669 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.614 HG12 HD21 ' A' ' 14' ' ' LEU . 71.1 mt -66.21 141.98 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.576 -0.702 . . . . 15.0 109.816 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -107.95 -43.4 4.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.761 -0.587 . . . . 15.0 110.287 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' HD12 ' A' ' 15' ' ' ILE . 19.5 t70 -141.81 147.41 37.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.666 -0.646 . . . . 15.0 110.674 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -132.37 129.48 39.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.606 . . . . 15.0 110.18 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.627 -0.67 . . . . 15.0 110.362 178.884 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.014 0.435 . . . . 15.0 110.328 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -83.73 130.25 34.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.685 -0.635 . . . . 15.0 110.483 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.2 mt -130.61 149.39 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.749 -0.594 . . . . 15.0 109.908 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -112.32 133.91 54.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 72' ' ' ILE . 8.0 tp -123.31 133.3 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.78 -0.575 . . . . 15.0 110.319 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.8 mt -107.58 122.9 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -94.48 172.8 7.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.309 0.576 . . . . 15.0 110.903 -172.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.89 -19.56 52.18 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.608 -0.683 . . . . 15.0 111.48 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.38 15.39 9.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.27 -0.894 . . . . 15.0 111.316 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 58.02 27.5 14.92 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.341 -0.849 . . . . 15.0 110.813 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.3 mt -104.2 148.33 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.998 -0.741 . . . . 15.0 108.998 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 -107.27 121.35 44.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 15.0 110.557 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -112.02 138.48 48.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.875 -0.516 . . . . 15.0 109.711 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 35.6 mt-10 -120.44 140.7 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 15.0 109.899 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.01 -178.88 38.63 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.165 -1.574 . . . . 15.0 109.165 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.62 134.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -1.021 . . . . 15.0 109.772 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.814 HD21 HD11 ' A' ' 29' ' ' ILE . 12.0 tp -61.3 112.04 1.99 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.669 -0.644 . . . . 15.0 110.445 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -94.11 -52.0 4.58 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.347 -0.541 . . . . 15.0 110.378 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.3 p -143.77 143.63 31.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 15.0 110.531 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.814 HD11 HD21 ' A' ' 26' ' ' LEU . 74.2 mt -116.84 125.2 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.767 -0.583 . . . . 15.0 109.664 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -112.07 96.75 6.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 15.0 109.823 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.5 m -70.91 -36.26 72.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.756 -0.59 . . . . 15.0 110.438 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.87 -29.29 66.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.508 -0.745 . . . . 15.0 111.046 -171.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.08 14.03 15.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.58 -0.7 . . . . 15.0 111.571 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.0 m 49.97 48.0 22.49 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.207 -0.933 . . . . 15.0 111.248 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.1 p -131.95 148.54 52.53 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.459 -0.776 . . . . 15.0 110.489 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.09 139.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.595 -0.691 . . . . 15.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.62 128.85 56.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.681 -0.637 . . . . 15.0 109.971 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 26' ' ' LEU . 33.4 mt -116.86 138.14 51.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.944 -0.473 . . . . 15.0 109.918 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.59 164.03 14.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.737 -0.602 . . . . 15.0 109.855 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 51.51 58.54 5.39 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.407 0.622 . . . . 15.0 110.464 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.72 148.43 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.575 -0.703 . . . . 15.0 110.331 -173.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -137.53 148.83 46.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.829 -0.544 . . . . 15.0 110.029 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.6 p -96.59 131.61 43.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.799 -0.563 . . . . 15.0 109.653 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.499 2.02 0 O-C-N 121.615 -0.678 . . . . 15.0 110.641 -172.756 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.71 ' CG ' HD11 ' A' ' 65' ' ' ILE . 94.4 m-85 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 120.891 0.377 . . . . 15.0 110.029 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -44.1 76.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.879 -0.513 . . . . 15.0 110.562 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -150.08 122.03 8.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 15.0 110.571 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.71 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.6 mt -130.01 146.37 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.669 -0.644 . . . . 15.0 109.627 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.54 136.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.717 -0.615 . . . . 15.0 109.988 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.99 140.95 51.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.698 -0.626 . . . . 15.0 109.862 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 35' ' ' THR . 74.7 mtt85 -106.68 152.39 23.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.747 -0.596 . . . . 15.0 110.022 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.65 -26.07 52.3 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.745 -0.942 . . . . 15.0 110.745 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -66.29 -45.99 78.52 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.526 -0.985 . . . . 15.0 110.752 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.2 -31.94 30.11 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.576 -0.702 . . . . 15.0 110.678 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 14' ' ' LEU . 84.9 mt -67.24 141.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.573 -0.704 . . . . 15.0 109.817 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -100.85 -42.51 6.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.729 -0.607 . . . . 15.0 110.229 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -147.93 144.3 27.94 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.624 -0.673 . . . . 15.0 110.768 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -127.23 128.27 45.79 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.712 -0.617 . . . . 15.0 109.968 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.497 1.908 0 O-C-N 121.557 -0.714 . . . . 15.0 110.502 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.037 0.446 . . . . 15.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -78.38 127.67 32.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.846 -0.534 . . . . 15.0 110.199 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 26' ' ' LEU . 96.4 mt -130.97 144.73 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 15.0 109.867 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -113.03 132.34 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.617 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -121.25 136.01 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.803 -0.561 . . . . 15.0 110.231 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.96 121.42 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.92 172.69 8.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.352 0.596 . . . . 15.0 110.911 -171.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -59.97 -19.25 51.14 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.614 -0.679 . . . . 15.0 111.472 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.88 9.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.395 -0.815 . . . . 15.0 111.337 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.6 29.11 16.68 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.293 -0.879 . . . . 15.0 110.752 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.09 147.93 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.74 122.65 46.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.799 -0.563 . . . . 15.0 110.567 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.8 137.44 51.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 15.0 109.812 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.661 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.4 mm-40 -119.43 140.66 50.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.458 -0.776 . . . . 15.0 109.796 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.12 -178.95 38.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.21 -1.556 . . . . 15.0 109.21 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.82 134.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.485 -1.009 . . . . 15.0 109.72 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 29' ' ' ILE . 11.6 tp -61.45 114.61 3.32 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.694 -0.629 . . . . 15.0 110.546 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -95.62 -51.93 4.32 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.324 -0.55 . . . . 15.0 110.402 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 20.3 p -143.81 143.94 31.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.632 -0.668 . . . . 15.0 110.649 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.809 HD11 HD21 ' A' ' 26' ' ' LEU . 75.1 mt -117.2 124.63 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.67 -0.644 . . . . 15.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.09 98.14 7.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.648 -0.657 . . . . 15.0 109.844 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.707 -0.62 . . . . 15.0 110.423 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.8 -29.59 66.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.545 -0.722 . . . . 15.0 111.054 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.2 m-20 -116.14 14.07 15.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.49 -0.756 . . . . 15.0 111.434 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t 49.97 48.91 21.21 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.133 -0.979 . . . . 15.0 111.254 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.4 p -132.33 147.88 52.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.512 -0.743 . . . . 15.0 110.57 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.84 138.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.675 -0.64 . . . . 15.0 109.686 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -110.61 126.34 54.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.719 -0.613 . . . . 15.0 109.907 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 26' ' ' LEU . 26.5 mt -116.78 136.92 52.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.19 164.34 14.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.721 -0.612 . . . . 15.0 109.935 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 51.75 58.05 5.88 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.644 -0.66 . . . . 15.0 110.48 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -119.96 147.36 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 15.0 110.347 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -133.63 149.86 51.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.787 -0.571 . . . . 15.0 109.993 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.6 p -98.69 131.19 45.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.635 -0.666 . . . . 15.0 109.754 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 . . . . . 0 N--CA 1.499 2.014 0 O-C-N 121.515 -0.741 . . . . 15.0 110.69 -173.484 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.755 ' CG ' HD11 ' A' ' 65' ' ' ILE . 97.4 m-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.941 0.4 . . . . 15.0 110.119 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -68.09 -41.75 81.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.821 -0.549 . . . . 15.0 110.657 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.559 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 2.2 t80 -150.3 122.06 8.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.615 -0.678 . . . . 15.0 110.423 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.755 HD11 ' CG ' ' A' ' 62' ' ' PHE . 92.9 mt -129.6 144.58 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.685 -0.634 . . . . 15.0 109.481 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.54 133.42 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 109.785 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -123.83 140.53 52.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.705 -0.622 . . . . 15.0 109.893 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.8 mtt180 -105.25 152.02 23.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.652 -0.655 . . . . 15.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.66 -25.96 52.12 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -66.41 -43.06 86.79 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.483 -1.01 . . . . 15.0 110.729 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.9 -31.61 23.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.541 -0.724 . . . . 15.0 110.664 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.617 HG12 HD21 ' A' ' 14' ' ' LEU . 75.4 mt -66.37 141.46 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.582 -0.699 . . . . 15.0 109.887 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -105.26 -42.7 5.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.65 -0.656 . . . . 15.0 110.214 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.53 147.4 32.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.592 -0.692 . . . . 15.0 110.763 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -130.25 129.49 43.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.724 -0.61 . . . . 15.0 110.133 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.563 -0.711 . . . . 15.0 110.433 -179.854 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.9 m . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 121.109 0.481 . . . . 15.0 110.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -83.56 127.63 33.88 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.741 -0.599 . . . . 15.0 110.442 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.1 mt -131.21 151.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.629 -0.67 . . . . 15.0 109.892 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -115.79 133.26 56.21 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 72' ' ' ILE . 11.4 tp -121.6 136.15 54.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.733 -0.605 . . . . 15.0 110.197 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.23 123.44 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -95.78 169.76 9.78 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.343 0.592 . . . . 15.0 110.947 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -60.4 -18.35 50.04 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.616 -0.677 . . . . 15.0 111.513 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 17.58 7.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.245 -0.91 . . . . 15.0 111.276 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 58.12 27.63 15.26 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.309 -0.869 . . . . 15.0 110.844 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -105.0 146.23 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -106.18 120.64 42.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.786 -0.571 . . . . 15.0 110.323 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.83 132.91 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.851 -0.53 . . . . 15.0 109.791 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -118.77 140.71 49.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 15.0 109.812 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.98 -178.81 40.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.196 -1.562 . . . . 15.0 109.196 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -105.51 132.39 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.502 -0.999 . . . . 15.0 109.677 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 29' ' ' ILE . 18.2 tp -62.15 110.9 1.75 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.712 -0.618 . . . . 15.0 110.422 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -91.32 -52.09 4.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.786 -0.571 . . . . 15.0 110.481 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 23.0 p -144.64 143.65 30.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.641 -0.662 . . . . 15.0 110.581 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 26' ' ' LEU . 74.0 mt -116.45 125.78 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.629 . . . . 15.0 109.556 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.09 95.99 5.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 15.0 109.791 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -70.22 -37.08 74.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.772 -0.58 . . . . 15.0 110.389 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -59.12 -29.51 67.44 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.628 -0.67 . . . . 15.0 111.084 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -115.22 14.03 16.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.623 -0.673 . . . . 15.0 111.57 -177.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 m 49.93 46.88 23.93 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.174 -0.954 . . . . 15.0 111.256 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.662 HG22 ' HG2' ' A' ' 68' ' ' ARG . 14.7 p -131.81 150.08 52.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 15.0 110.561 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.24 139.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.678 -0.639 . . . . 15.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.86 128.16 56.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.687 -0.633 . . . . 15.0 109.956 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 26' ' ' LEU . 19.2 mt -116.81 138.85 51.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.991 -0.443 . . . . 15.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.76 161.71 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.625 . . . . 15.0 109.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 51.64 56.56 7.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.66 -0.65 . . . . 15.0 110.535 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -118.72 147.52 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.565 -0.71 . . . . 15.0 110.356 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -136.22 153.28 51.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.781 -0.574 . . . . 15.0 110.096 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.6 p -99.68 131.85 45.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.714 -0.616 . . . . 15.0 110.008 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.64 . . . . 15.0 110.438 -176.63 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CG ' HD11 ' A' ' 65' ' ' ILE . 26.5 m-85 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.964 0.412 . . . . 15.0 109.924 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.0 -44.37 76.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.8 -0.563 . . . . 15.0 110.686 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.9 t80 -148.59 121.99 9.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 15.0 110.572 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 62' ' ' PHE . 90.7 mt -131.36 147.32 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.715 -0.616 . . . . 15.0 109.517 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.51 138.39 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.65 -0.656 . . . . 15.0 109.917 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -128.99 145.35 51.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 15.0 109.908 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.2 mtp85 -107.16 152.45 24.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.694 -0.629 . . . . 15.0 110.131 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.02 56.35 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -65.95 -42.5 89.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.465 -1.021 . . . . 15.0 110.738 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.25 -31.12 23.29 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.595 -0.69 . . . . 15.0 110.696 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.528 HG12 HD21 ' A' ' 14' ' ' LEU . 65.7 mt -66.36 146.78 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.632 -0.668 . . . . 15.0 109.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.42 -44.65 4.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.734 -0.604 . . . . 15.0 110.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -148.43 149.8 32.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.668 -0.645 . . . . 15.0 110.769 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.48 129.38 46.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.804 -0.56 . . . . 15.0 110.149 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.573 -0.704 . . . . 15.0 110.479 179.387 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.041 0.448 . . . . 15.0 110.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 25' ' ' ILE . 98.7 mttt -83.94 130.6 34.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.806 -0.559 . . . . 15.0 110.256 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.643 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.1 mt -130.98 145.04 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.526 -0.734 . . . . 15.0 109.953 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.4 t -116.09 129.33 56.29 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 72' ' ' ILE . 10.7 tp -120.53 135.7 55.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.666 -0.646 . . . . 15.0 110.406 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.08 120.02 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -91.66 172.03 8.76 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.24 0.543 . . . . 15.0 110.951 -171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -59.25 -19.71 48.04 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.634 -0.666 . . . . 15.0 111.655 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.14 17.12 8.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.301 -0.874 . . . . 15.0 111.224 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.89 28.3 15.9 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.273 -0.892 . . . . 15.0 110.875 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -105.05 147.13 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm105 -104.91 121.07 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 15.0 110.483 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.98 135.67 52.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.806 -0.559 . . . . 15.0 109.782 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.4 tt0 -118.0 140.56 49.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 15.0 109.805 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.66 -178.9 39.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.075 -1.61 . . . . 15.0 109.075 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.0 mm -108.9 142.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.456 -1.026 . . . . 15.0 109.742 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -64.7 114.47 4.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.739 -0.601 . . . . 15.0 110.269 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -98.06 -52.05 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.761 -0.587 . . . . 15.0 110.363 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.2 p -143.83 143.7 31.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.65 -0.656 . . . . 15.0 110.488 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 26' ' ' LEU . 70.2 mt -117.6 125.86 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.833 -0.542 . . . . 15.0 109.735 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -112.11 96.91 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 15.0 109.788 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.3 -37.54 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.766 -0.584 . . . . 15.0 110.53 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.79 -28.7 66.2 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.549 -0.719 . . . . 15.0 111.153 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -116.21 14.13 15.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.735 . . . . 15.0 111.556 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.9 48.07 22.31 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.41 -0.806 . . . . 15.0 111.289 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.2 p -131.83 147.24 52.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.522 -0.736 . . . . 15.0 110.44 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.71 139.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.592 -0.693 . . . . 15.0 109.695 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.53 128.81 56.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 15.0 109.916 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.1 mt -116.85 138.84 51.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.914 -0.491 . . . . 15.0 109.742 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.49 165.6 12.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 15.0 109.873 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 51.69 58.83 5.06 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.691 -0.63 . . . . 15.0 110.496 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 23' ' ' GLU . 15.0 p -121.0 147.37 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.64 -0.663 . . . . 15.0 110.337 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -135.2 150.0 50.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.599 . . . . 15.0 110.0 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.6 p -96.86 129.33 44.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 15.0 109.715 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 15.0 110.564 -173.881 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.677 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.908 0.385 . . . . 15.0 110.06 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -68.62 -44.24 74.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.883 -0.511 . . . . 15.0 110.555 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.88 121.99 8.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 15.0 110.568 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.677 HD11 ' CG ' ' A' ' 62' ' ' PHE . 41.3 mt -131.4 147.57 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.624 . . . . 15.0 109.447 173.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.8 mt -110.65 138.66 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 15.0 110.014 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -129.69 141.08 50.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.758 -0.589 . . . . 15.0 109.916 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.717 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.3 mtt85 -109.89 152.08 26.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.699 -0.626 . . . . 15.0 110.071 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -26.01 49.38 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.803 -0.919 . . . . 15.0 110.803 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.4 m -66.92 -46.05 76.03 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.469 -1.018 . . . . 15.0 110.732 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.35 -31.82 29.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.52 -0.738 . . . . 15.0 110.711 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD21 ' A' ' 14' ' ' LEU . 72.6 mt -65.47 141.62 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.57 -0.706 . . . . 15.0 109.892 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -101.7 -43.39 5.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.809 -0.557 . . . . 15.0 110.271 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -146.03 147.25 31.44 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.698 -0.626 . . . . 15.0 110.71 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.47 129.76 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.689 -0.632 . . . . 15.0 110.217 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.624 -0.673 . . . . 15.0 110.344 179.342 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.039 0.447 . . . . 15.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' HD12 ' A' ' 25' ' ' ILE . 30.2 mtmm -87.26 133.57 33.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.599 . . . . 15.0 110.123 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.9 mt -134.09 147.69 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.443 -0.786 . . . . 15.0 110.086 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -116.69 130.39 56.7 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.548 -0.538 . . . . 15.0 109.548 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.652 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -119.44 136.79 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.717 -0.614 . . . . 15.0 110.18 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -113.4 122.55 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.168 -0.679 . . . . 15.0 109.168 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -93.5 170.98 9.19 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.233 0.54 . . . . 15.0 110.755 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -61.17 -16.47 45.03 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.608 -0.682 . . . . 15.0 111.505 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.93 13.67 10.44 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.233 -0.917 . . . . 15.0 111.338 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 56.38 29.72 15.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.257 -0.902 . . . . 15.0 110.718 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.98 143.34 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.787 -0.82 . . . . 15.0 108.787 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -103.98 122.23 44.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.805 -0.559 . . . . 15.0 110.419 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -110.96 132.27 54.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.755 -0.591 . . . . 15.0 109.673 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.0 tt0 -115.97 140.62 49.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 15.0 109.794 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.56 -178.87 38.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.883 -1.687 . . . . 15.0 108.883 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.6 mm -109.07 142.56 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.43 -1.041 . . . . 15.0 109.78 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 29' ' ' ILE . 13.0 tp -66.24 109.21 2.57 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.736 -0.603 . . . . 15.0 110.258 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -91.9 -52.01 4.93 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.343 -0.543 . . . . 15.0 110.386 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -144.33 143.88 31.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.726 . . . . 15.0 110.517 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.834 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.24 125.11 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.744 -0.598 . . . . 15.0 109.702 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.1 97.48 6.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 15.0 109.776 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 -36.37 71.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 15.0 110.428 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -29.39 67.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.561 -0.712 . . . . 15.0 111.153 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 93.8 m-20 -116.14 14.08 15.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.528 -0.732 . . . . 15.0 111.544 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t 50.03 49.32 20.56 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.162 -0.962 . . . . 15.0 111.175 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.723 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -132.63 147.77 52.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.473 -0.767 . . . . 15.0 110.504 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.21 138.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.556 -0.715 . . . . 15.0 109.526 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.33 128.36 55.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.665 -0.647 . . . . 15.0 109.844 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 26' ' ' LEU . 95.3 mt -116.85 137.53 52.14 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.906 -0.496 . . . . 15.0 109.776 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.6 164.47 13.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.811 -0.556 . . . . 15.0 109.772 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 51.79 56.91 7.13 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.722 -0.611 . . . . 15.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -120.35 148.7 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.563 -0.711 . . . . 15.0 110.253 -174.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -139.55 150.67 45.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.739 -0.6 . . . . 15.0 110.291 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.5 p -98.5 131.22 44.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.819 -0.55 . . . . 15.0 109.804 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.543 -0.723 . . . . 15.0 110.774 -173.26 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.689 ' CG ' HD11 ' A' ' 65' ' ' ILE . 89.9 m-85 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 120.915 0.388 . . . . 15.0 109.982 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -68.31 -41.99 80.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.871 -0.518 . . . . 15.0 110.674 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -150.47 122.01 7.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.491 -0.756 . . . . 15.0 110.536 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.689 HD11 ' CG ' ' A' ' 62' ' ' PHE . 96.4 mt -130.75 147.35 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.658 -0.651 . . . . 15.0 109.57 172.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -109.85 136.64 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.763 -0.586 . . . . 15.0 109.929 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -127.71 140.64 51.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.725 -0.61 . . . . 15.0 109.975 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.723 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.4 mtt85 -108.11 152.81 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 15.0 110.153 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.2 -25.99 48.86 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.731 -0.948 . . . . 15.0 110.731 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 m -66.56 -45.99 77.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.527 -0.984 . . . . 15.0 110.747 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.97 -30.33 31.71 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.606 -0.684 . . . . 15.0 110.726 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 14' ' ' LEU . 73.2 mt -68.71 139.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.586 -0.696 . . . . 15.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.83 -43.55 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.754 -0.591 . . . . 15.0 110.261 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.17 141.82 42.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.718 -0.614 . . . . 15.0 110.505 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.12 127.61 40.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.735 -0.603 . . . . 15.0 110.087 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 15.0 110.133 178.144 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 121.094 0.473 . . . . 15.0 110.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -84.58 131.82 34.58 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.786 -0.571 . . . . 15.0 110.346 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.8 mt -133.86 147.33 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.523 -0.736 . . . . 15.0 109.93 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -117.18 130.27 56.49 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.505 -0.554 . . . . 15.0 109.505 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -119.11 135.68 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.736 -0.603 . . . . 15.0 110.322 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.4 mt -108.07 119.78 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.953 -0.758 . . . . 15.0 108.953 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -90.83 172.61 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.287 0.565 . . . . 15.0 110.902 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.25 -19.13 53.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.605 -0.684 . . . . 15.0 111.416 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 15.79 9.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.855 . . . . 15.0 111.318 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 57.8 29.27 17.19 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.289 -0.882 . . . . 15.0 110.786 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.1 146.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.07 120.68 42.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.759 -0.588 . . . . 15.0 110.465 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -112.03 133.98 53.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.827 -0.546 . . . . 15.0 109.713 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.1 tt0 -116.2 140.61 49.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.472 -0.767 . . . . 15.0 109.828 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.73 -178.82 38.98 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.962 -1.655 . . . . 15.0 108.962 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -107.39 141.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.466 -1.02 . . . . 15.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.82 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -66.23 108.93 2.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.748 -0.595 . . . . 15.0 110.201 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.83 -51.94 4.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.805 -0.559 . . . . 15.0 110.486 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.4 p -143.27 142.65 31.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.624 . . . . 15.0 110.481 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 HD21 ' A' ' 26' ' ' LEU . 73.3 mt -115.75 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 15.0 109.682 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.06 97.98 7.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.635 -0.665 . . . . 15.0 109.86 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -71.97 -36.12 69.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.78 -0.575 . . . . 15.0 110.456 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -58.75 -29.5 66.79 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.493 -0.754 . . . . 15.0 111.108 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -116.44 14.14 15.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.617 -0.677 . . . . 15.0 111.495 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m 49.9 49.56 20.02 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.174 -0.954 . . . . 15.0 111.152 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.725 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.4 p -132.54 147.79 52.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 15.0 110.539 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.59 137.87 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.661 . . . . 15.0 109.554 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.558 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.25 127.98 55.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.647 . . . . 15.0 109.888 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.3 mt -116.8 136.14 53.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.919 -0.488 . . . . 15.0 109.771 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.12 14.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.761 -0.587 . . . . 15.0 109.901 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 51.76 61.64 3.11 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.656 -0.653 . . . . 15.0 110.475 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -122.33 146.4 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.538 -0.727 . . . . 15.0 110.383 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -135.13 148.56 49.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.841 -0.537 . . . . 15.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.5 p -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 15.0 109.781 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 . . . . . 0 N--CA 1.499 2.017 0 C-N-CA 120.072 -0.651 . . . . 15.0 110.589 -174.138 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.011 0.434 . . . . 15.0 110.139 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.73 -39.78 84.25 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.832 -0.543 . . . . 15.0 110.78 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.522 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.5 t80 -151.71 122.37 7.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 15.0 110.832 -175.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -129.4 147.24 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.628 -0.67 . . . . 15.0 109.59 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.5 mt -110.65 136.28 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.692 -0.63 . . . . 15.0 109.849 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -127.02 140.64 52.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.763 -0.586 . . . . 15.0 109.922 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HG2' HG22 ' A' ' 35' ' ' THR . 83.2 mtp180 -107.73 151.66 25.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.18 -26.01 48.77 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.753 -0.939 . . . . 15.0 110.753 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -66.45 -45.95 78.06 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.485 -1.009 . . . . 15.0 110.718 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.1 -31.88 30.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.644 -0.66 . . . . 15.0 110.738 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.64 HG12 HD21 ' A' ' 14' ' ' LEU . 71.4 mt -65.89 141.25 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.675 -0.641 . . . . 15.0 109.859 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -104.71 -43.18 5.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.76 -0.587 . . . . 15.0 110.251 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.6 147.35 34.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.609 -0.682 . . . . 15.0 110.647 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -131.0 130.66 43.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.706 -0.621 . . . . 15.0 110.248 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 15.0 110.304 178.791 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 120.927 0.394 . . . . 15.0 110.216 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -87.0 133.5 33.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.69 -0.631 . . . . 15.0 110.437 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.89 147.45 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 15.0 109.991 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.7 t -110.83 130.17 55.65 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -119.83 130.65 55.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.845 -0.535 . . . . 15.0 110.325 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.71 119.33 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -92.26 170.61 9.67 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.307 0.575 . . . . 15.0 110.948 -171.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -60.6 -17.56 47.52 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.62 -0.675 . . . . 15.0 111.513 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.4 15.34 9.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.222 -0.923 . . . . 15.0 111.278 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 57.25 29.37 16.63 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 15.0 110.67 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.41 144.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -105.67 119.79 40.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.727 -0.608 . . . . 15.0 110.453 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -111.85 137.44 49.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.773 -0.58 . . . . 15.0 109.566 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.8 tt0 -121.42 140.49 52.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 15.0 109.938 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.87 39.84 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.124 -1.59 . . . . 15.0 109.124 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.49 142.37 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.495 -1.003 . . . . 15.0 109.708 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 29' ' ' ILE . 20.4 tp -65.21 112.51 3.47 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.721 -0.612 . . . . 15.0 110.295 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -96.03 -52.07 4.19 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.373 -0.531 . . . . 15.0 110.35 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -143.92 143.28 31.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.637 -0.664 . . . . 15.0 110.489 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.97 126.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.733 -0.604 . . . . 15.0 109.77 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -112.1 96.18 5.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.598 -0.689 . . . . 15.0 109.79 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.3 -36.78 74.54 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 15.0 110.369 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -58.91 -28.96 66.69 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.556 -0.715 . . . . 15.0 111.075 -171.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.16 13.99 15.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.722 . . . . 15.0 111.484 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t 49.96 47.27 23.51 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.241 -0.912 . . . . 15.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.2 p -131.43 149.56 52.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.447 -0.783 . . . . 15.0 110.471 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.41 140.28 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 15.0 109.649 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.05 129.12 56.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.689 -0.632 . . . . 15.0 109.935 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.4 mt -116.87 138.84 51.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.826 -0.435 . . . . 15.0 109.826 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.54 165.35 13.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.732 -0.605 . . . . 15.0 109.873 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 51.86 60.97 3.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.631 -0.668 . . . . 15.0 110.36 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -119.99 145.27 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 15.0 110.523 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -127.36 150.98 49.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 15.0 109.808 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.5 p -102.39 129.67 48.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.753 -0.592 . . . . 15.0 109.927 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 . . . . . 0 N--CA 1.499 2.001 0 C-N-CA 120.116 -0.633 . . . . 15.0 110.416 -176.732 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.883 -0.414 . . . . 15.0 109.883 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -67.56 -41.14 84.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.868 -0.52 . . . . 15.0 110.981 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -154.8 122.0 5.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.757 . . . . 15.0 110.676 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.6 mt -129.64 147.9 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.66 -0.65 . . . . 15.0 109.767 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.22 136.89 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.724 -0.61 . . . . 15.0 109.917 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.25 143.84 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.768 -0.583 . . . . 15.0 109.905 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.9 mtt85 -109.49 151.27 26.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.682 -0.637 . . . . 15.0 110.133 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.74 -26.02 56.83 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.697 -0.961 . . . . 15.0 110.697 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -66.76 -40.59 88.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.462 -1.022 . . . . 15.0 110.724 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -86.41 -31.78 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.617 -0.677 . . . . 15.0 110.712 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.69 138.78 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.592 -0.692 . . . . 15.0 109.956 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -99.88 -41.5 7.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.734 -0.604 . . . . 15.0 110.116 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -147.33 145.1 29.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.677 -0.639 . . . . 15.0 110.628 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -133.3 130.36 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.725 -0.609 . . . . 15.0 110.038 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 22.0 m . . . . . 0 N--CA 1.497 1.925 0 O-C-N 121.62 -0.675 . . . . 15.0 110.514 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.057 0.456 . . . . 15.0 110.534 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -83.72 132.54 34.85 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.752 -0.593 . . . . 15.0 110.035 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -132.66 145.99 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.52 -0.738 . . . . 15.0 110.114 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -115.07 129.93 56.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HG12 ' A' ' 72' ' ' ILE . 10.8 tp -121.9 136.3 54.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.675 -0.641 . . . . 15.0 110.355 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.11 121.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.021 -0.733 . . . . 15.0 109.021 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.69 172.43 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.309 0.576 . . . . 15.0 110.907 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -59.98 -19.26 51.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.629 -0.67 . . . . 15.0 111.405 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.02 16.76 7.75 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.257 -0.902 . . . . 15.0 111.215 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 57.48 28.42 15.47 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.237 -0.914 . . . . 15.0 110.867 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.5 mt -105.0 147.23 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -105.64 121.38 43.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 15.0 110.526 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -112.32 136.23 52.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.833 -0.542 . . . . 15.0 109.786 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.4 tt0 -117.75 140.54 49.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 15.0 109.779 173.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.19 -178.89 39.27 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.029 -1.628 . . . . 15.0 109.029 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.18 143.03 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.386 -1.067 . . . . 15.0 109.793 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 29' ' ' ILE . 12.1 tp -65.95 114.97 5.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.763 -0.585 . . . . 15.0 110.19 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -97.62 -52.05 3.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.806 -0.559 . . . . 15.0 110.381 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -144.56 143.35 30.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.717 -0.614 . . . . 15.0 110.541 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -115.43 125.23 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.717 -0.614 . . . . 15.0 109.613 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.08 97.2 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.605 -0.684 . . . . 15.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -70.89 -36.56 72.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.707 -0.62 . . . . 15.0 110.383 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.87 -29.36 66.93 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.572 -0.705 . . . . 15.0 111.015 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.64 13.91 16.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 15.0 111.461 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t 50.06 47.21 23.76 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.195 -0.941 . . . . 15.0 111.174 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.68 HG22 ' HG2' ' A' ' 68' ' ' ARG . 16.8 p -131.86 148.72 52.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.501 -0.75 . . . . 15.0 110.606 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.61 138.22 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 15.0 109.535 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -110.51 128.52 55.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.646 -0.658 . . . . 15.0 109.905 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.9 mt -116.79 138.65 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.889 -0.507 . . . . 15.0 109.791 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.73 164.68 13.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.76 -0.587 . . . . 15.0 109.791 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 51.81 56.91 7.12 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.644 -0.66 . . . . 15.0 110.375 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.0 p -120.66 148.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.593 -0.692 . . . . 15.0 110.303 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -139.71 150.07 44.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.804 -0.56 . . . . 15.0 110.211 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.4 p -97.59 132.06 43.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.77 -0.581 . . . . 15.0 109.771 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.552 -0.718 . . . . 15.0 110.569 -174.097 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.711 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.905 0.383 . . . . 15.0 110.078 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.09 -42.37 80.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.86 -0.525 . . . . 15.0 110.691 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -150.98 121.89 7.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.507 -0.746 . . . . 15.0 110.631 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.711 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.3 mt -130.73 147.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.681 -0.637 . . . . 15.0 109.698 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.04 135.74 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.719 -0.613 . . . . 15.0 109.901 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -125.74 140.77 52.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 15.0 109.991 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.68 ' HG2' HG22 ' A' ' 35' ' ' THR . 92.6 mtt-85 -104.37 151.07 23.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.679 -0.638 . . . . 15.0 110.087 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.13 -25.97 55.03 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -65.33 -45.0 86.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.446 -1.032 . . . . 15.0 110.778 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.96 -31.47 31.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.549 -0.72 . . . . 15.0 110.696 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.634 HG12 HD21 ' A' ' 14' ' ' LEU . 74.8 mt -65.88 136.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.5 -0.75 . . . . 15.0 109.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -104.88 -39.85 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 15.0 110.253 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.29 142.69 33.86 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.659 -0.65 . . . . 15.0 110.56 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.39 127.41 39.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.714 -0.616 . . . . 15.0 110.164 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 15.0 110.251 178.969 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.154 0.502 . . . . 15.0 110.67 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -78.54 130.02 35.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.874 -0.516 . . . . 15.0 110.1 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' CD1' HD13 ' A' ' 26' ' ' LEU . 93.6 mt -132.75 147.85 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.506 -0.746 . . . . 15.0 109.97 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 t -116.21 133.87 55.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.577 -0.527 . . . . 15.0 109.577 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 72' ' ' ILE . 11.1 tp -124.14 136.52 54.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.737 -0.602 . . . . 15.0 110.375 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.4 mt -108.81 122.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -94.3 172.93 7.9 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.277 0.56 . . . . 15.0 110.988 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.7 -20.01 53.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.624 -0.672 . . . . 15.0 111.466 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 16.91 8.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.35 -0.843 . . . . 15.0 111.271 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 58.03 28.23 16.0 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.301 -0.874 . . . . 15.0 110.86 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.6 mt -105.02 147.76 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -106.08 121.54 44.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.779 -0.576 . . . . 15.0 110.403 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -112.18 136.78 51.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.769 -0.582 . . . . 15.0 109.756 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.9 tt0 -118.49 140.68 49.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.507 -0.745 . . . . 15.0 109.725 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.55 -178.9 38.94 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.11 -1.596 . . . . 15.0 109.11 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.6 139.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.568 -0.96 . . . . 15.0 109.54 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.821 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -66.03 115.4 6.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 15.0 110.253 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -97.94 -52.05 3.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.865 -0.522 . . . . 15.0 110.403 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.6 p -144.46 143.39 30.86 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.615 -0.678 . . . . 15.0 110.637 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.821 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -116.58 127.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.633 -0.667 . . . . 15.0 109.679 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -112.12 95.42 5.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 15.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -69.26 -38.04 78.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.79 -0.569 . . . . 15.0 110.419 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.53 -28.96 67.55 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.582 -0.699 . . . . 15.0 111.1 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' THR . 94.8 m-20 -114.26 13.91 17.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.473 -0.767 . . . . 15.0 111.554 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 m 50.0 45.65 25.09 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.171 -0.956 . . . . 15.0 111.309 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.742 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.4 p -131.88 149.74 52.36 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.463 -0.773 . . . . 15.0 110.666 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.86 140.64 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.582 -0.699 . . . . 15.0 109.603 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.07 129.47 56.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.621 -0.675 . . . . 15.0 110.015 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.9 mt -116.89 139.12 51.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.938 -0.477 . . . . 15.0 109.753 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.82 162.98 16.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.698 -0.626 . . . . 15.0 109.868 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 51.89 59.34 4.62 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.666 -0.647 . . . . 15.0 110.488 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.51 148.03 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.592 -0.693 . . . . 15.0 110.314 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -136.45 149.55 48.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.901 -0.499 . . . . 15.0 110.073 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -97.21 131.75 43.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.714 -0.616 . . . . 15.0 109.724 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.543 -0.723 . . . . 15.0 110.702 -173.278 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 65' ' ' ILE . 85.1 m-85 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.898 0.38 . . . . 15.0 110.066 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.2 -42.88 79.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.79 -0.569 . . . . 15.0 110.667 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.4 t80 -150.48 121.93 7.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 15.0 110.606 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' CG ' ' A' ' 62' ' ' PHE . 25.8 mt -130.87 147.75 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 15.0 109.554 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.6 mt -110.58 136.05 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.741 -0.599 . . . . 15.0 109.86 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -126.08 142.64 51.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.631 . . . . 15.0 109.949 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.8 mtt180 -107.34 152.2 24.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.646 -0.659 . . . . 15.0 110.143 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.01 55.02 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.7 m -65.56 -45.54 82.92 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.447 -1.031 . . . . 15.0 110.766 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.02 -31.59 30.94 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.63 -0.669 . . . . 15.0 110.637 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 14' ' ' LEU . 69.7 mt -66.66 138.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.545 -0.722 . . . . 15.0 109.814 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -105.29 -40.07 5.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.652 . . . . 15.0 110.17 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 15' ' ' ILE . 18.4 t0 -143.19 142.83 31.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 15.0 110.665 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -128.41 127.11 41.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.796 -0.565 . . . . 15.0 110.049 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.638 -0.664 . . . . 15.0 110.394 179.705 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.028 0.442 . . . . 15.0 110.416 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -86.09 132.02 34.13 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.797 -0.564 . . . . 15.0 110.369 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 26' ' ' LEU . 94.5 mt -133.2 147.68 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 15.0 109.937 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -116.88 132.81 56.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.498 -0.556 . . . . 15.0 109.498 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 72' ' ' ILE . 10.9 tp -124.51 137.51 54.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.643 -0.661 . . . . 15.0 110.356 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.59 121.42 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.038 -0.727 . . . . 15.0 109.038 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -92.15 174.04 7.52 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.298 0.57 . . . . 15.0 110.94 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.54 -20.53 56.25 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.624 -0.673 . . . . 15.0 111.444 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.82 16.62 8.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.334 -0.854 . . . . 15.0 111.295 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 57.3 29.76 17.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.222 -0.924 . . . . 15.0 110.779 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.3 mt -105.1 146.71 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.996 -0.742 . . . . 15.0 108.996 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -104.12 119.91 39.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.823 -0.548 . . . . 15.0 110.428 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -111.44 136.32 50.75 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.756 -0.59 . . . . 15.0 109.791 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.643 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 tt0 -118.09 140.7 49.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.559 -0.713 . . . . 15.0 109.769 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.47 -178.92 38.91 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.937 -1.665 . . . . 15.0 108.937 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.0 mm -108.46 142.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.349 -1.089 . . . . 15.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 29' ' ' ILE . 20.5 tp -65.55 109.0 2.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.744 -0.597 . . . . 15.0 110.203 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -92.66 -52.05 4.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.801 -0.562 . . . . 15.0 110.439 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.59 142.91 31.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.638 -0.664 . . . . 15.0 110.422 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 26' ' ' LEU . 68.9 mt -116.72 125.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 15.0 109.661 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.17 97.3 6.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.573 -0.704 . . . . 15.0 109.781 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -71.45 -36.38 71.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.675 -0.641 . . . . 15.0 110.49 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.82 -29.79 67.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.461 -0.775 . . . . 15.0 111.043 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 93.4 m-20 -115.8 13.98 16.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.575 -0.703 . . . . 15.0 111.555 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t 49.89 48.75 21.36 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.154 -0.966 . . . . 15.0 111.266 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.711 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -131.81 148.33 52.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.477 -0.764 . . . . 15.0 110.484 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.42 139.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.66 -0.65 . . . . 15.0 109.662 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.4 128.94 56.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.77 -0.582 . . . . 15.0 109.911 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.7 mt -116.79 138.08 51.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.89 -0.506 . . . . 15.0 109.867 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.12 165.43 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.784 -0.573 . . . . 15.0 109.793 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 51.68 57.32 6.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.672 -0.642 . . . . 15.0 110.425 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -121.16 148.59 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 15.0 110.279 -173.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -140.7 152.31 45.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.724 -0.61 . . . . 15.0 110.196 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.4 p -97.42 131.26 44.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.771 -0.581 . . . . 15.0 109.795 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.59 -0.694 . . . . 15.0 110.464 -173.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.714 ' CG ' HD11 ' A' ' 65' ' ' ILE . 90.4 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.95 0.405 . . . . 15.0 110.108 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -68.14 -41.84 81.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.867 -0.521 . . . . 15.0 110.684 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -150.8 121.96 7.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 15.0 110.589 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.714 HD11 ' CG ' ' A' ' 62' ' ' PHE . 94.8 mt -131.02 147.09 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.678 -0.639 . . . . 15.0 109.487 173.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -110.14 139.19 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.655 -0.653 . . . . 15.0 109.993 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.85 142.86 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.712 -0.617 . . . . 15.0 109.941 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.711 ' HG2' HG22 ' A' ' 35' ' ' THR . 90.7 mtt180 -110.73 152.68 26.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 15.0 110.086 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.06 55.12 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.673 -0.971 . . . . 15.0 110.673 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -67.26 -40.79 86.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.44 -1.035 . . . . 15.0 110.795 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -88.34 -30.97 19.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.599 -0.688 . . . . 15.0 110.801 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 14' ' ' LEU . 70.6 mt -64.73 142.31 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.588 -0.695 . . . . 15.0 109.915 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -99.88 -44.14 6.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 15.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -146.86 147.17 30.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.686 -0.634 . . . . 15.0 110.705 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -129.18 129.95 45.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.728 -0.608 . . . . 15.0 110.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.647 -0.658 . . . . 15.0 110.346 178.428 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.97 0.414 . . . . 15.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -85.59 133.56 34.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.861 -0.524 . . . . 15.0 110.239 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.614 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.2 mt -133.98 147.09 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.514 -0.741 . . . . 15.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -115.54 133.81 55.67 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HG12 ' A' ' 72' ' ' ILE . 9.4 tp -125.69 137.17 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.712 -0.618 . . . . 15.0 110.424 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 87.5 mt -109.3 121.37 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.968 -0.753 . . . . 15.0 108.968 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.8 m -93.33 175.68 6.67 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.32 0.581 . . . . 15.0 111.01 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.15 -21.5 59.45 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.606 -0.684 . . . . 15.0 111.398 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 15.97 9.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.321 -0.862 . . . . 15.0 111.326 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.71 28.99 16.64 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.306 -0.871 . . . . 15.0 110.811 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.0 149.59 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.151 -0.685 . . . . 15.0 109.151 172.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -106.35 121.19 43.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.798 -0.563 . . . . 15.0 110.608 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.44 141.75 45.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.802 -0.561 . . . . 15.0 109.809 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.2 tt0 -120.2 140.69 50.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.561 -0.712 . . . . 15.0 109.762 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.9 -178.94 37.88 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 108.866 -1.694 . . . . 15.0 108.866 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -109.37 143.02 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.421 -1.046 . . . . 15.0 109.742 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.813 HD21 HD11 ' A' ' 29' ' ' ILE . 12.6 tp -66.06 108.89 2.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.791 -0.568 . . . . 15.0 110.213 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -91.7 -52.02 4.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.795 -0.566 . . . . 15.0 110.407 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -144.11 142.43 30.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 15.0 110.439 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.813 HD11 HD21 ' A' ' 26' ' ' LEU . 74.6 mt -114.42 125.59 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.77 -0.581 . . . . 15.0 109.644 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -112.05 97.38 6.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.627 -0.671 . . . . 15.0 109.851 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.82 -36.25 70.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.702 -0.624 . . . . 15.0 110.546 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.79 -29.1 66.58 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.524 -0.735 . . . . 15.0 111.118 -171.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.535 ' O ' HG23 ' A' ' 35' ' ' THR . 94.6 m-20 -116.93 14.1 15.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.436 -0.79 . . . . 15.0 111.522 -176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m 49.9 49.14 20.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.181 -0.95 . . . . 15.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.701 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.9 p -131.89 148.29 52.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.462 -0.774 . . . . 15.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.65 138.49 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.561 -0.712 . . . . 15.0 109.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.28 128.79 56.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 15.0 109.954 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.5 mt -116.84 137.22 52.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 15.0 109.801 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.03 164.12 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.739 -0.601 . . . . 15.0 109.785 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt 51.84 59.58 4.45 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.56 -0.712 . . . . 15.0 110.524 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -122.73 148.66 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.55 -0.719 . . . . 15.0 110.224 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -140.02 150.41 44.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.754 -0.591 . . . . 15.0 110.256 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -97.8 129.53 44.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.706 -0.621 . . . . 15.0 109.653 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 119.846 -0.742 . . . . 15.0 110.738 -171.917 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.5 m-85 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.877 0.37 . . . . 15.0 110.111 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.21 -42.65 79.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.851 -0.531 . . . . 15.0 110.692 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -150.14 121.9 8.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 15.0 110.608 -176.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.63 HD11 ' CG ' ' A' ' 62' ' ' PHE . 28.5 mt -130.93 147.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.705 -0.622 . . . . 15.0 109.505 173.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.45 137.94 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.696 -0.627 . . . . 15.0 109.999 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.41 141.49 51.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.805 -0.559 . . . . 15.0 109.819 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.701 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.7 mtt180 -108.72 152.2 25.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.714 -0.616 . . . . 15.0 110.046 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.46 -26.0 50.82 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.725 -0.95 . . . . 15.0 110.725 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 -45.99 76.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.401 -1.058 . . . . 15.0 110.743 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.1 -32.07 30.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.583 -0.698 . . . . 15.0 110.714 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.613 HG12 HD21 ' A' ' 14' ' ' LEU . 83.4 mt -65.84 140.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.587 -0.696 . . . . 15.0 109.911 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -100.7 -42.21 6.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 15.0 110.195 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.4 144.58 30.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.649 -0.657 . . . . 15.0 110.667 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.31 128.59 43.47 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.655 -0.653 . . . . 15.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.598 -0.689 . . . . 15.0 110.192 178.187 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 121.078 0.465 . . . . 15.0 110.514 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.52 131.48 34.17 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 15.0 110.228 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.608 ' CD1' HD13 ' A' ' 26' ' ' LEU . 95.7 mt -132.62 145.01 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 15.0 109.928 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -115.72 127.45 55.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 11.3 tp -116.18 133.37 56.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 15.0 110.165 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -107.39 119.08 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.975 -0.75 . . . . 15.0 108.975 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -90.37 172.36 8.8 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.348 0.594 . . . . 15.0 110.808 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.37 -18.43 50.31 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.613 -0.679 . . . . 15.0 111.447 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 15.77 9.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.284 -0.885 . . . . 15.0 111.351 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.42 29.88 16.02 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.292 -0.88 . . . . 15.0 110.673 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.4 mt -104.07 143.27 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 172.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -102.77 119.36 38.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.78 -0.575 . . . . 15.0 110.391 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.3 130.55 55.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.822 -0.549 . . . . 15.0 109.625 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.0 tt0 -115.99 140.67 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 15.0 109.868 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.4 -178.87 39.38 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.035 -1.626 . . . . 15.0 109.035 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.3 mm -108.08 138.8 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.389 -1.065 . . . . 15.0 109.772 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 29' ' ' ILE . 12.9 tp -62.39 108.96 1.21 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.754 -0.592 . . . . 15.0 110.379 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -91.53 -52.09 4.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.767 -0.583 . . . . 15.0 110.379 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.79 143.51 31.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.632 -0.668 . . . . 15.0 110.453 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.828 HD11 HD21 ' A' ' 26' ' ' LEU . 73.6 mt -115.57 125.59 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.765 -0.584 . . . . 15.0 109.661 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -112.05 96.16 5.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 15.0 109.825 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -71.19 -37.12 72.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.716 -0.615 . . . . 15.0 110.418 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.12 -29.04 67.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.456 -0.778 . . . . 15.0 111.053 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 35' ' ' THR . 94.9 m-20 -116.25 13.99 15.75 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 15.0 111.56 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.79 48.19 22.0 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.362 -0.836 . . . . 15.0 111.464 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 33' ' ' ASN . 42.4 p -132.39 149.4 52.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 15.0 110.404 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.08 138.76 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.576 -0.703 . . . . 15.0 109.55 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.45 56.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.612 -0.68 . . . . 15.0 109.905 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.9 mt -116.83 137.72 52.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.94 -0.475 . . . . 15.0 109.892 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.35 164.05 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.742 -0.599 . . . . 15.0 109.833 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 51.81 56.0 8.47 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.605 -0.684 . . . . 15.0 110.482 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.5 p -116.79 146.62 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 15.0 110.386 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -134.92 150.34 50.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.75 -0.594 . . . . 15.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -98.96 132.45 44.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.725 -0.61 . . . . 15.0 109.973 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.597 -0.689 . . . . 15.0 110.583 -175.78 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.687 ' CG ' HD11 ' A' ' 65' ' ' ILE . 91.7 m-85 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 120.947 0.403 . . . . 15.0 109.937 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -67.63 -41.63 83.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.808 -0.558 . . . . 15.0 110.745 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -150.8 121.88 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.585 -0.697 . . . . 15.0 110.585 -176.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.6 mt -132.0 147.99 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.731 -0.606 . . . . 15.0 109.534 172.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -110.93 138.1 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.701 -0.624 . . . . 15.0 109.984 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.86 143.05 50.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.665 -0.647 . . . . 15.0 109.854 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 35' ' ' THR . 89.9 mtt180 -109.61 152.32 25.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.709 . . . . 15.0 110.166 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -26.05 55.66 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.759 -0.936 . . . . 15.0 110.759 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.6 p -66.7 -44.15 82.46 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.467 -1.019 . . . . 15.0 110.752 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.31 -31.86 26.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 15.0 110.673 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 64.9 mt -65.55 143.54 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.648 -0.658 . . . . 15.0 109.895 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -105.05 -45.2 4.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 15.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -144.03 148.26 34.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 15.0 110.578 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.65 131.0 46.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.186 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 15.0 110.28 178.593 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.079 0.466 . . . . 15.0 110.602 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 25' ' ' ILE . 77.3 mttt -81.3 128.58 33.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.858 -0.526 . . . . 15.0 110.129 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 26' ' ' LEU . 95.9 mt -131.65 146.52 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.494 -0.754 . . . . 15.0 109.994 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.93 130.93 57.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.482 -0.562 . . . . 15.0 109.482 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 9.1 tp -119.43 135.01 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.795 -0.566 . . . . 15.0 110.259 -175.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.58 120.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -93.44 170.6 9.48 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.352 0.596 . . . . 15.0 110.862 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -60.6 -18.04 50.43 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.519 -0.738 . . . . 15.0 111.475 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 16.83 7.82 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.361 -0.837 . . . . 15.0 111.326 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.09 28.17 14.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 15.0 110.824 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -105.01 145.47 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -106.03 121.55 44.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.743 -0.598 . . . . 15.0 110.398 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.12 136.87 49.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.772 -0.58 . . . . 15.0 109.752 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.0 tt0 -120.1 140.66 50.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.804 . . . . 15.0 109.876 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 -178.96 39.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.171 -1.572 . . . . 15.0 109.171 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.473 HD12 ' HG2' ' A' ' 11' ' ' LYS . 15.8 mm -108.52 133.48 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.46 -1.023 . . . . 15.0 109.544 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.777 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -61.49 114.51 3.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.577 -0.702 . . . . 15.0 110.53 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -93.81 -52.08 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 15.0 110.379 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 22.5 p -146.45 145.27 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.597 -0.689 . . . . 15.0 110.595 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.777 HD11 HD21 ' A' ' 26' ' ' LEU . 75.7 mt -116.04 126.61 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.795 -0.566 . . . . 15.0 109.658 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.12 97.68 6.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.676 . . . . 15.0 109.825 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.91 -36.1 72.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.784 -0.572 . . . . 15.0 110.41 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -59.21 -29.28 67.38 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.584 -0.697 . . . . 15.0 111.102 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.17 14.02 15.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.638 -0.664 . . . . 15.0 111.516 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t 49.99 47.26 23.56 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.14 -0.975 . . . . 15.0 111.24 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.0 p -131.51 150.14 52.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.542 -0.724 . . . . 15.0 110.489 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.92 139.38 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.589 -0.694 . . . . 15.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.6 56.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.699 -0.625 . . . . 15.0 110.01 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 26' ' ' LEU . 21.7 mt -116.79 139.04 51.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.846 -0.428 . . . . 15.0 109.846 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 162.03 17.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.717 -0.615 . . . . 15.0 109.816 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 51.61 61.22 3.33 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.555 -0.715 . . . . 15.0 110.311 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 11.2 p -126.77 145.19 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.594 -0.691 . . . . 15.0 110.592 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -138.64 155.77 48.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.759 -0.588 . . . . 15.0 110.296 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.4 p -99.03 133.48 43.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.841 -0.537 . . . . 15.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.671 . . . . 15.0 110.468 -176.58 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CG ' HD11 ' A' ' 65' ' ' ILE . 78.5 m-85 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 109.859 -0.423 . . . . 15.0 109.859 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -69.09 -46.03 68.78 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.438 -0.505 . . . . 15.0 110.641 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -147.9 121.87 9.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.582 -0.699 . . . . 15.0 110.514 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.532 HD11 ' CG ' ' A' ' 62' ' ' PHE . 19.5 mt -132.27 147.98 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.705 -0.622 . . . . 15.0 109.432 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -112.36 138.86 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.648 -0.658 . . . . 15.0 110.094 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.1 144.71 51.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 15.0 109.815 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -108.7 151.8 25.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.7 -0.625 . . . . 15.0 110.237 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.08 -26.0 54.92 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -65.59 -45.3 83.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.551 -0.97 . . . . 15.0 110.715 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.01 -31.34 31.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 15.0 110.683 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 75.9 mt -66.5 140.72 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.592 -0.693 . . . . 15.0 109.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -104.02 -42.53 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 15.0 110.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -147.41 149.6 33.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.678 -0.639 . . . . 15.0 110.7 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -129.71 131.23 46.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.742 -0.599 . . . . 15.0 110.097 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.584 -0.697 . . . . 15.0 110.343 179.374 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 120.937 0.399 . . . . 15.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -91.99 137.03 32.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.619 -0.676 . . . . 15.0 110.264 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.43 146.31 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 15.0 109.883 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -114.36 128.12 56.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.386 -0.598 . . . . 15.0 109.386 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 72' ' ' ILE . 11.0 tp -120.56 135.92 54.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 15.0 110.282 -175.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.4 mt -109.32 118.9 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -87.92 172.94 9.22 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.212 0.53 . . . . 15.0 110.781 -172.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -59.79 -18.44 43.52 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.606 -0.684 . . . . 15.0 111.601 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.52 15.47 10.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 15.0 111.286 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 56.17 28.58 13.31 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.191 -0.943 . . . . 15.0 110.776 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -101.87 142.9 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.82 -0.807 . . . . 15.0 108.82 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -100.84 120.8 40.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.744 -0.598 . . . . 15.0 110.467 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -112.73 132.35 55.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.837 -0.539 . . . . 15.0 109.591 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.7 mt-10 -117.92 140.65 49.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 15.0 109.907 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.85 39.38 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.944 -1.663 . . . . 15.0 108.944 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.4 mm -108.03 144.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -1.039 . . . . 15.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 29' ' ' ILE . 24.0 tp -66.15 113.49 4.56 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.807 -0.558 . . . . 15.0 110.21 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -94.25 -52.03 4.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.827 -0.546 . . . . 15.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 21.1 p -147.5 143.33 27.77 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 110.591 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 26' ' ' LEU . 78.2 mt -112.22 127.73 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.698 -0.627 . . . . 15.0 109.584 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -112.09 97.42 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.634 -0.666 . . . . 15.0 109.751 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.89 -35.74 72.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.703 -0.623 . . . . 15.0 110.405 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.56 -28.9 65.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.525 -0.734 . . . . 15.0 111.149 -171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -117.7 14.05 14.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.539 -0.725 . . . . 15.0 111.531 -176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t 49.92 48.69 21.47 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.104 -0.998 . . . . 15.0 111.257 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 33' ' ' ASN . 45.7 p -131.99 150.26 52.2 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.383 -0.823 . . . . 15.0 110.513 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.04 138.58 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 15.0 109.558 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -109.75 127.66 54.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.655 . . . . 15.0 109.918 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.8 mt -116.9 138.92 51.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.946 -0.471 . . . . 15.0 109.737 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.84 164.94 13.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.722 -0.611 . . . . 15.0 109.907 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 51.89 56.5 7.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.656 -0.653 . . . . 15.0 110.461 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.7 p -118.0 148.53 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.587 -0.695 . . . . 15.0 110.342 -174.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -137.43 153.29 50.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.791 -0.568 . . . . 15.0 110.229 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.9 p -101.87 133.87 45.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.731 -0.606 . . . . 15.0 110.006 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.699 -0.626 . . . . 15.0 110.689 -175.674 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 120.986 0.422 . . . . 15.0 110.037 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.77 -40.7 83.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.847 -0.533 . . . . 15.0 110.843 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.468 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -151.99 121.94 7.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.775 . . . . 15.0 110.814 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.7 mt -130.85 148.02 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.688 -0.632 . . . . 15.0 109.664 172.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.26 135.09 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.718 -0.614 . . . . 15.0 109.813 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -126.22 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.75 -0.594 . . . . 15.0 109.841 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.7 mtt180 -108.16 151.86 25.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 15.0 110.159 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -25.95 55.45 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.3 p -66.46 -45.06 81.03 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.501 -1.0 . . . . 15.0 110.685 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.94 -31.92 31.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.745 . . . . 15.0 110.682 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HD21 ' A' ' 14' ' ' LEU . 67.5 mt -65.88 140.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.599 -0.688 . . . . 15.0 109.869 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -106.35 -42.28 5.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.745 -0.597 . . . . 15.0 110.251 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -139.26 142.65 37.78 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.672 -0.642 . . . . 15.0 110.531 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -130.84 126.96 37.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.681 -0.637 . . . . 15.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.616 -0.678 . . . . 15.0 110.093 177.416 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.038 0.447 . . . . 15.0 110.29 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -85.99 133.22 33.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.662 -0.649 . . . . 15.0 110.468 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 26' ' ' LEU . 91.2 mt -133.83 154.18 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.598 -0.689 . . . . 15.0 109.735 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.9 t -115.89 132.62 56.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.901 -0.499 . . . . 15.0 109.85 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 75' ' ' LEU . 6.0 tp -116.53 130.19 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.87 -0.519 . . . . 15.0 109.88 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.18 119.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.91 -0.774 . . . . 15.0 108.91 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m -92.64 170.85 9.41 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.331 0.586 . . . . 15.0 110.981 -170.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.6 -18.54 53.65 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.603 -0.685 . . . . 15.0 111.422 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.59 16.13 8.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 15.0 111.251 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 58.12 28.53 16.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.344 -0.848 . . . . 15.0 110.829 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.0 mt -105.07 148.37 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -107.63 118.92 38.0 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.801 -0.562 . . . . 15.0 110.422 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.43 137.37 48.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.784 -0.573 . . . . 15.0 109.888 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.7 tm-20 -119.28 140.75 49.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 15.0 109.88 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.6 -178.9 38.97 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.072 -1.611 . . . . 15.0 109.072 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.21 135.16 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.516 -0.99 . . . . 15.0 109.708 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.799 HD21 HD11 ' A' ' 29' ' ' ILE . 12.5 tp -62.37 109.02 1.22 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.693 -0.629 . . . . 15.0 110.486 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.31 -52.07 5.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.819 -0.55 . . . . 15.0 110.356 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.5 p -144.52 144.17 31.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.622 -0.674 . . . . 15.0 110.538 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.799 HD11 HD21 ' A' ' 26' ' ' LEU . 74.1 mt -116.44 125.35 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.778 -0.576 . . . . 15.0 109.654 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -112.03 96.37 6.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.706 . . . . 15.0 109.896 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.0 m -70.65 -36.8 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.803 -0.561 . . . . 15.0 110.379 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.29 -29.28 67.48 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 15.0 111.131 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.43 14.05 16.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 15.0 111.547 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t 49.87 47.93 22.46 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.093 -1.005 . . . . 15.0 111.25 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.4 p -131.97 148.41 52.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.357 -0.839 . . . . 15.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.78 139.25 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.607 -0.683 . . . . 15.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -113.15 128.69 56.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.684 . . . . 15.0 110.005 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 26' ' ' LEU . 30.3 mt -116.77 136.6 52.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.901 -0.499 . . . . 15.0 109.879 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.97 162.35 16.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.698 -0.627 . . . . 15.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 51.86 59.62 4.42 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.608 -0.683 . . . . 15.0 110.384 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.58 147.14 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.601 -0.687 . . . . 15.0 110.333 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -137.38 150.86 47.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.776 -0.578 . . . . 15.0 110.033 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.9 p -95.98 130.23 43.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.771 -0.581 . . . . 15.0 109.741 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 N--CA 1.499 2.013 0 O-C-N 121.6 -0.687 . . . . 15.0 110.443 -174.549 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.943 0.401 . . . . 15.0 110.096 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -67.55 -38.92 84.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.872 -0.517 . . . . 15.0 110.864 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.4 t80 -152.21 122.04 7.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.46 -0.775 . . . . 15.0 110.824 -175.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.61 147.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.708 -0.62 . . . . 15.0 109.566 172.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.6 mt -110.8 137.76 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.723 -0.611 . . . . 15.0 109.927 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -129.47 142.64 50.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.718 -0.614 . . . . 15.0 109.905 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 35' ' ' THR . 91.3 mtt180 -110.35 152.15 26.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.621 -0.675 . . . . 15.0 110.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.94 55.12 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.5 p -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.436 -1.037 . . . . 15.0 110.75 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.13 -30.15 15.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.503 -0.748 . . . . 15.0 110.841 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.9 mt -63.52 138.37 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.453 -0.779 . . . . 15.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -98.86 -40.56 8.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.818 -0.551 . . . . 15.0 110.027 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.54 149.61 29.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.692 -0.63 . . . . 15.0 110.749 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 14' ' ' LEU . 40.8 tp -132.3 135.27 46.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.712 -0.617 . . . . 15.0 109.881 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.675 -0.641 . . . . 15.0 110.17 178.251 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.587 0.232 . . . . 10.09 110.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.8 155.21 42.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.243 -0.435 . . . . 7.65 110.583 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -74.91 150.1 85.83 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.186 -0.461 . . . . 6.09 110.539 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.26 -38.96 50.98 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.697 1.598 . . . . 5.77 112.131 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -67.53 -37.59 82.96 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.291 -0.413 . . . . 4.71 110.581 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.83 77.76 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.301 -0.719 . . . . 3.93 111.301 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.3 -35.67 91.29 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.397 -0.681 . . . . 3.59 111.397 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -96.39 122.91 56.37 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.438 -0.208 . . . . 2.87 110.438 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.15 134.91 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.594 1.53 . . . . 1.74 112.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' C ' HD23 ' A' ' 26' ' ' LEU . 97.6 m-85 -68.99 -36.96 78.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.414 . . . . 3.81 110.545 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.449 ' N ' HD23 ' A' ' 26' ' ' LEU . 61.9 mt -66.53 133.09 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.245 -0.434 . . . . 0.5 109.995 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.14 -2.09 63.32 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 116.116 -0.493 . . . . 0.35 112.399 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -102.99 156.7 17.49 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.554 0.677 . . . . 0.19 110.772 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' HD12 ' A' ' 25' ' ' ILE . 60.9 mttm -82.84 133.2 35.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.034 -0.53 . . . . 2.07 110.402 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.0 mt -135.85 147.25 28.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 0.22 110.434 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.0 t -114.68 132.57 56.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.754 -0.657 . . . . 0.15 109.893 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -124.45 137.4 54.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.414 . . . . 0.34 110.519 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mt -111.96 122.02 65.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.373 -0.602 . . . . 0.17 109.373 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -93.17 169.89 10.06 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.452 0.47 . . . . 0.17 111.139 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -59.86 -20.96 60.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.044 -0.525 . . . . 2.62 111.971 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.05 13.66 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.122 0.416 . . . . 0.19 112.122 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 61.9 25.22 15.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.635 0.255 . . . . 1.63 111.271 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.02 142.89 17.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 109.475 -0.565 . . . . 0.21 109.475 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -104.42 121.08 42.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 2.39 110.619 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -113.6 139.8 48.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.018 -0.537 . . . . 0.16 110.1 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -121.61 140.67 51.96 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.0 -178.84 39.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.6 -1.0 . . . . 0.07 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 11' ' ' LYS . 10.9 mm -106.78 139.1 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.067 -0.345 . . . . 0.2 110.067 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.878 HD21 HD11 ' A' ' 29' ' ' ILE . 17.3 tp -65.95 109.06 2.39 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.25 110.492 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -91.59 -52.15 4.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.255 -0.429 . . . . 0.23 110.809 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 p -150.23 145.53 26.28 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.376 -0.375 . . . . 0.17 110.957 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.878 HD11 HD21 ' A' ' 26' ' ' LEU . 44.7 mt -118.45 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.25 110.077 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -112.1 95.01 5.22 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.067 -0.345 . . . . 1.1 110.067 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.7 m -67.87 -38.62 83.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.782 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.71 -32.15 68.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.311 -0.404 . . . . 1.97 111.615 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -112.64 13.94 20.01 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.163 0.431 . . . . 0.47 112.163 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.6 p 49.99 42.15 24.16 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.936 0.398 . . . . 1.14 111.598 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 68' ' ' ARG . 4.2 p -131.37 149.16 52.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.278 -0.419 . . . . 0.13 110.98 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.44 138.21 54.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.12 110.006 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.77 127.65 56.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.367 -0.379 . . . . 0.07 110.431 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.3 mt -116.93 139.48 50.6 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.112 -0.495 . . . . 0.42 110.138 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.11 159.48 22.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.06 110.134 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 55.94 55.14 7.24 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.191 0.52 . . . . 2.43 110.482 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -119.22 142.58 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.767 -0.651 . . . . 0.11 110.334 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -135.22 150.74 50.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 3.55 110.493 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 p -96.47 128.01 43.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.2 110.194 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -69.45 -40.31 77.25 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.456 -0.338 . . . . 0.79 110.828 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 167.96 29.23 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.204 -0.758 . . . . 0.31 111.204 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.9 p -115.63 -30.6 6.12 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.524 0.202 . . . . 0.76 110.998 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.51 -27.2 64.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.582 -0.281 . . . . 2.31 111.557 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.84 -33.23 68.42 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.674 0.273 . . . . 3.09 110.865 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' THR . 20.4 mmt180 -119.22 94.97 48.97 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.109 -0.496 . . . . 5.19 110.173 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.51 130.36 29.39 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 121.982 1.788 . . . . 2.46 112.845 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ARG . 75.0 p -129.8 165.01 22.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.085 -0.507 . . . . 2.72 110.377 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -77.9 -4.07 44.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.235 -0.439 . . . . 3.83 112.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -118.09 106.87 44.63 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 110.555 -0.165 . . . . 5.15 110.555 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.83 131.94 44.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.595 1.53 . . . . 3.39 112.221 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.2 mm -119.35 130.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.206 -0.452 . . . . 2.26 110.102 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.61 82.53 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 3.04 110.492 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.01 135.82 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.701 1.601 . . . . 3.02 112.045 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -134.8 131.26 37.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.168 -0.469 . . . . 6.95 110.511 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -112.79 31.81 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.24 -0.437 . . . . 3.22 110.777 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.3 147.61 30.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.363 -0.38 . . . . 2.32 110.489 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -102.93 142.63 33.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 0.76 110.438 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.08 132.41 47.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.225 -0.443 . . . . 0.38 110.417 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.31 -40.5 89.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.164 -0.471 . . . . 2.54 111.251 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.8 t80 -146.85 121.94 10.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.728 0.299 . . . . 0.13 111.041 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.17 143.77 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.16 110.045 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -112.45 138.22 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.256 -0.429 . . . . 0.13 110.369 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -130.08 141.28 50.72 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.14 110.273 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' HG22 ' A' ' 35' ' ' THR . 75.7 mtm180 -102.15 149.11 24.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.414 -0.357 . . . . 2.11 110.295 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.86 50.4 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 111.946 -0.462 . . . . 0.11 111.946 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -67.09 -42.15 85.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.456 0.169 . . . . 1.24 111.15 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -32.05 30.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.56 -0.291 . . . . 1.09 111.229 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 14' ' ' LEU . 50.8 mt -65.51 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.13 110.392 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -103.93 -45.99 4.6 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.038 -0.528 . . . . 1.35 110.648 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -148.25 149.13 31.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.3 -0.409 . . . . 1.13 111.127 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt -131.39 129.2 41.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.982 -0.553 . . . . 0.51 110.17 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.1 m -132.45 136.01 46.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.439 -0.346 . . . . 0.23 110.571 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 143.94 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.369 -0.378 . . . . 0.53 110.136 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 80.3 m -93.76 -37.09 11.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.291 -0.413 . . . . 1.22 110.81 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -90.85 117.52 67.99 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.374 -0.376 . . . . 2.29 110.523 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.38 156.41 9.42 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.767 1.644 . . . . 2.55 112.181 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.11 135.87 21.52 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.718 1.612 . . . . 4.24 111.983 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -88.56 152.18 49.09 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.185 -0.462 . . . . 7.85 110.617 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 140.52 93.95 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.896 1.73 . . . . 8.72 112.153 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.93 153.74 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.208 -0.451 . . . . 10.88 110.644 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.924 -1.036 . . . . 13.63 110.527 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.566 HD11 ' CA ' ' A' ' 4' ' ' GLY . 7.5 tt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 120.992 0.425 . . . . 15.0 110.151 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.33 -50.16 3.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.695 -0.628 . . . . 15.0 110.224 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ASP . . . . . 0.533 ' O ' HD21 ' A' ' -2' ' ' LEU . 9.1 p-10 -104.98 150.07 38.3 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.578 -0.701 . . . . 15.0 110.379 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.43 -31.91 88.54 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.401 1.211 . . . . 15.0 110.757 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 t -65.24 -31.81 73.16 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.616 -0.678 . . . . 15.0 110.515 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.47 -32.43 81.72 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.95 -1.26 . . . . 15.0 109.95 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.566 ' CA ' HD11 ' A' ' -2' ' ' LEU . . . -65.93 -33.49 85.82 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.944 -1.262 . . . . 15.0 109.944 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.0 m -89.9 123.02 67.27 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.932 . . . . 15.0 110.053 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.31 130.58 20.15 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.351 1.185 . . . . 15.0 110.41 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' C ' HD23 ' A' ' 26' ' ' LEU . 97.4 m-85 -69.08 -32.39 71.8 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.683 -0.636 . . . . 15.0 110.215 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.55 133.91 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.422 -0.799 . . . . 15.0 109.763 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.63 -2.12 66.89 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -101.36 148.41 25.18 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.768 1.284 . . . . 15.0 110.553 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -82.07 128.46 34.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.853 -0.529 . . . . 15.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' HB2' ' A' ' 26' ' ' LEU . 89.8 mt -131.01 149.5 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 15.0 109.913 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.63 135.95 53.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.551 -0.537 . . . . 15.0 109.551 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 HG12 ' A' ' 72' ' ' ILE . 10.5 tp -127.07 137.0 52.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.717 -0.614 . . . . 15.0 110.258 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.63 123.4 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.014 -0.736 . . . . 15.0 109.014 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -93.55 172.83 8.02 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.305 0.574 . . . . 15.0 110.944 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.74 -19.8 52.46 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.63 -0.668 . . . . 15.0 111.444 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 51' ' ' THR . . . -89.76 16.14 8.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.803 . . . . 15.0 111.336 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.57 29.32 16.97 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.302 -0.874 . . . . 15.0 110.781 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 46' ' ' THR . 70.2 mt -105.09 147.59 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 172.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -105.78 118.93 37.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.785 -0.572 . . . . 15.0 110.509 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -111.52 140.71 45.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.812 -0.555 . . . . 15.0 109.765 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.1 tt0 -125.83 140.8 52.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.475 -0.766 . . . . 15.0 109.839 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.86 -178.84 39.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.128 -1.589 . . . . 15.0 109.128 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -107.28 133.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.436 -1.038 . . . . 15.0 109.736 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -61.61 114.66 3.4 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.751 -0.593 . . . . 15.0 110.474 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -95.72 -52.04 4.26 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.408 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -145.16 145.15 31.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.623 -0.673 . . . . 15.0 110.664 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.822 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -118.31 127.31 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.747 -0.595 . . . . 15.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.11 97.96 7.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 15.0 109.846 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -70.6 -36.57 73.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.719 -0.613 . . . . 15.0 110.484 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.09 -29.16 67.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.55 -0.719 . . . . 15.0 111.136 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.14 14.07 15.87 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.704 . . . . 15.0 111.539 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t 49.94 47.53 23.11 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.143 -0.973 . . . . 15.0 111.22 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 21.3 p -131.27 149.99 52.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.517 -0.739 . . . . 15.0 110.558 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.56 141.75 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.671 -0.643 . . . . 15.0 109.72 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.17 129.67 56.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.681 -0.637 . . . . 15.0 110.058 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 26' ' ' LEU . 22.1 mt -116.92 138.95 51.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.884 -0.51 . . . . 15.0 109.845 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.08 16.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.736 -0.603 . . . . 15.0 109.861 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.3 mttt 51.72 58.36 5.56 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.709 -0.619 . . . . 15.0 110.441 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.8 p -121.29 148.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.566 -0.709 . . . . 15.0 110.332 -173.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -138.62 153.91 48.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.81 -0.556 . . . . 15.0 110.128 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.3 p -101.24 131.84 47.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.832 -0.543 . . . . 15.0 109.856 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.84 -40.19 72.52 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.687 . . . . 15.0 110.541 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.78 169.9 31.88 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.809 -1.316 . . . . 15.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.705 HG21 HG21 ' A' ' 55' ' ' ILE . 45.8 p -117.98 -28.28 5.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.787 -0.831 . . . . 15.0 110.618 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -62.98 -29.9 71.17 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.446 -0.784 . . . . 15.0 110.892 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.42 -32.52 71.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.552 -0.717 . . . . 15.0 110.325 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 51' ' ' THR . 32.3 mtt180 -120.38 95.09 49.03 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.792 -0.567 . . . . 15.0 109.779 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.19 132.34 46.33 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.423 1.223 . . . . 15.0 111.024 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.548 HG21 ' O ' ' A' ' 18' ' ' ALA . 33.9 p -127.69 165.11 20.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.897 -0.502 . . . . 15.0 110.044 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.85 -1.6 32.42 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.71 -0.619 . . . . 15.0 111.487 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -114.88 115.0 43.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.183 -0.948 . . . . 15.0 109.853 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -65.72 132.04 29.45 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.385 1.202 . . . . 15.0 110.622 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG21 HG21 ' A' ' 46' ' ' THR . 51.6 mm -121.28 146.02 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.672 -0.642 . . . . 15.0 109.665 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.42 150.68 43.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.687 -0.633 . . . . 15.0 110.081 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.11 145.91 62.49 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.611 1.322 . . . . 15.0 110.35 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -155.2 151.85 28.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 15.0 110.336 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -133.93 33.19 3.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.691 -0.631 . . . . 15.0 110.258 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -99.96 158.55 15.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.654 -0.654 . . . . 15.0 110.156 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.4 m -102.91 141.93 34.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.724 -0.61 . . . . 15.0 110.176 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.0 m-85 -102.02 128.27 48.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.648 -0.658 . . . . 15.0 110.104 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -68.3 -43.37 77.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.769 -0.582 . . . . 15.0 110.579 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -149.92 122.02 8.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.543 -0.723 . . . . 15.0 110.609 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.636 HD11 ' CG ' ' A' ' 62' ' ' PHE . 30.4 mt -130.85 146.98 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.699 -0.626 . . . . 15.0 109.56 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.87 137.29 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.72 -0.612 . . . . 15.0 109.93 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.93 144.28 51.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.75 -0.594 . . . . 15.0 109.846 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 82.8 mtm180 -109.27 152.68 24.9 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 15.0 110.088 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.04 -26.0 54.83 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.9 m -65.98 -45.86 80.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.472 -1.017 . . . . 15.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.95 -31.02 31.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.693 -0.63 . . . . 15.0 110.807 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.579 HG12 HD21 ' A' ' 14' ' ' LEU . 73.0 mt -65.99 141.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.538 -0.726 . . . . 15.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -104.56 -42.54 5.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.781 -0.574 . . . . 15.0 110.198 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -145.88 145.95 30.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.695 -0.628 . . . . 15.0 110.679 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.74 129.12 45.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.804 -0.56 . . . . 15.0 110.13 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -135.42 142.74 45.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.629 -0.669 . . . . 15.0 110.428 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.19 144.05 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.658 -0.651 . . . . 15.0 109.684 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.46 -37.05 7.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.525 -0.734 . . . . 15.0 110.358 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -155.57 139.17 11.12 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 15.0 110.206 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.6 175.86 2.59 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 123.315 1.166 . . . . 15.0 110.503 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.94 156.71 52.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.659 1.347 . . . . 15.0 110.547 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.32 157.59 72.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.68 -0.637 . . . . 15.0 110.178 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -67.2 148.54 80.82 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.663 1.349 . . . . 15.0 110.423 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.91 -35.0 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.772 -0.58 . . . . 15.0 109.699 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.018 -0.992 . . . . 15.0 110.247 179.776 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 68.65 166.24 0.26 Allowed 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.13 149.55 38.27 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.211 -1.033 . . . . 15.0 108.211 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.03 -33.17 42.32 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.618 1.325 . . . . 15.0 110.529 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -67.11 -35.8 80.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.68 -0.638 . . . . 15.0 110.222 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.11 -34.38 75.84 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.78 -1.328 . . . . 15.0 109.78 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.74 -36.86 88.17 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 15.0 109.825 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -99.46 141.38 22.72 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.914 . . . . 15.0 110.195 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -73.75 144.13 34.67 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 123.47 1.247 . . . . 15.0 110.36 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.404 ' C ' HD23 ' A' ' 26' ' ' LEU . 98.5 m-85 -69.04 -33.31 73.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.674 -0.641 . . . . 15.0 110.123 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.82 134.23 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.399 -0.813 . . . . 15.0 109.733 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 -2.06 64.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m -98.62 152.29 19.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.256 . . . . 15.0 110.599 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -84.89 128.2 34.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.768 -0.583 . . . . 15.0 110.197 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.0 mt -132.19 150.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 15.0 109.988 -175.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 t -115.53 131.34 56.96 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.532 -0.544 . . . . 15.0 109.532 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.562 HD21 HG12 ' A' ' 72' ' ' ILE . 11.8 tp -118.82 134.9 54.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 15.0 110.285 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.5 mt -107.34 122.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.109 -0.701 . . . . 15.0 109.109 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -93.76 171.93 8.57 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.314 0.578 . . . . 15.0 110.87 -173.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -60.09 -19.05 51.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.614 -0.679 . . . . 15.0 111.441 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.23 16.69 8.14 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.353 -0.842 . . . . 15.0 111.275 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 57.1 28.44 14.94 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.28 -0.888 . . . . 15.0 110.827 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 45' ' ' GLY . 90.0 mt -105.08 145.66 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.062 -0.718 . . . . 15.0 109.062 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -104.56 121.5 43.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.847 -0.533 . . . . 15.0 110.34 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.14 132.77 54.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.559 . . . . 15.0 109.654 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 9.3 tm-20 -115.96 140.58 49.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.532 -0.73 . . . . 15.0 109.886 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.05 -178.81 39.68 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.93 -1.668 . . . . 15.0 108.93 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -106.68 138.95 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.455 -1.026 . . . . 15.0 109.64 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 29' ' ' ILE . 19.0 tp -65.3 112.13 3.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.746 -0.596 . . . . 15.0 110.356 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -95.58 -52.11 4.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 15.0 110.489 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 18.1 p -144.31 142.54 30.48 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.573 -0.705 . . . . 15.0 110.604 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 26' ' ' LEU . 75.5 mt -116.27 126.55 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.805 -0.56 . . . . 15.0 109.609 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.09 95.28 5.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.609 -0.682 . . . . 15.0 109.792 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -69.33 -39.47 78.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.746 -0.596 . . . . 15.0 110.344 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -59.83 -29.27 68.14 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.549 -0.719 . . . . 15.0 111.063 -172.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' THR . 94.5 m-20 -111.17 12.35 21.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.464 -0.773 . . . . 15.0 111.555 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m 49.98 44.64 25.53 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.195 -0.941 . . . . 15.0 111.288 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.704 HG22 ' HG2' ' A' ' 68' ' ' ARG . 15.1 p -132.77 150.09 52.2 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.481 -0.762 . . . . 15.0 110.623 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.3 139.95 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.73 -0.606 . . . . 15.0 109.595 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.73 128.69 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.646 -0.659 . . . . 15.0 110.04 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.9 mt -116.84 138.85 51.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.895 -0.503 . . . . 15.0 109.726 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.76 162.36 16.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 15.0 109.89 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt 52.09 61.05 3.41 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.619 -0.675 . . . . 15.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.07 147.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 15.0 110.46 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.673 ' CG ' HG23 ' A' ' 61' ' ' THR . 81.7 mtp180 -132.8 149.92 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.857 -0.527 . . . . 15.0 109.988 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 p -97.74 130.8 44.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.688 -0.633 . . . . 15.0 109.823 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.96 -40.33 63.1 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.493 -0.754 . . . . 15.0 110.819 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 20' ' ' ILE . . . 167.83 175.28 37.5 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.985 -1.246 . . . . 15.0 109.985 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.642 HG21 HG13 ' A' ' 55' ' ' ILE . 38.5 p -118.1 6.23 12.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.706 -0.879 . . . . 15.0 111.073 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.53 -23.21 49.06 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.251 -0.906 . . . . 15.0 111.419 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -60.51 -33.22 72.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.43 -0.794 . . . . 15.0 110.45 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -144.06 95.13 5.69 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.789 -0.57 . . . . 15.0 109.949 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.6 137.1 66.94 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.371 1.195 . . . . 15.0 110.74 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 p -123.79 165.19 17.73 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.815 -0.553 . . . . 15.0 110.134 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.77 -1.62 32.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.689 -0.632 . . . . 15.0 111.298 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -108.6 106.95 59.66 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.125 -0.984 . . . . 15.0 109.827 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.22 141.65 83.26 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.426 1.224 . . . . 15.0 110.811 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.642 HG13 HG21 ' A' ' 46' ' ' THR . 51.0 mm -104.06 142.4 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.762 -0.586 . . . . 15.0 109.592 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.64 155.67 92.46 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.637 -0.664 . . . . 15.0 110.214 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.34 165.04 15.97 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.612 1.322 . . . . 15.0 110.601 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -66.96 136.84 55.96 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.752 -0.593 . . . . 15.0 110.129 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -150.25 -62.2 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.684 -0.635 . . . . 15.0 110.361 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -118.39 167.6 11.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.71 -0.619 . . . . 15.0 110.457 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.673 HG23 ' CG ' ' A' ' 42' ' ' ARG . 34.5 m -103.03 162.68 12.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.814 -0.554 . . . . 15.0 110.01 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -98.05 125.52 43.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.639 -0.663 . . . . 15.0 109.962 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.71 -46.02 70.07 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.87 -0.519 . . . . 15.0 110.543 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.5 t80 -149.29 121.93 8.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.579 -0.701 . . . . 15.0 110.48 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 147.19 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.718 -0.613 . . . . 15.0 109.605 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.66 136.32 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.746 -0.596 . . . . 15.0 109.818 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -126.28 143.96 50.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 15.0 109.984 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.704 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -106.66 151.99 24.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 15.0 110.173 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.99 -25.93 54.54 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.751 -0.94 . . . . 15.0 110.751 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 m -65.57 -45.41 83.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.48 -1.012 . . . . 15.0 110.661 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.98 -31.28 31.23 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.543 -0.723 . . . . 15.0 110.677 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 14' ' ' LEU . 72.7 mt -66.17 144.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.563 -0.711 . . . . 15.0 109.902 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -106.71 -43.09 4.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.748 -0.595 . . . . 15.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.74 151.72 32.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.652 -0.655 . . . . 15.0 110.629 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.38 129.79 45.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.851 -0.531 . . . . 15.0 110.176 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m -131.79 143.17 50.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.65 -0.656 . . . . 15.0 110.396 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.44 144.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.68 -0.637 . . . . 15.0 109.738 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 94.2 m -98.51 -37.14 9.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.603 -0.686 . . . . 15.0 110.343 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.15 117.48 63.13 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.656 -0.652 . . . . 15.0 110.115 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.67 151.31 32.09 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.397 1.209 . . . . 15.0 110.301 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -69.77 151.99 69.15 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.554 1.291 . . . . 15.0 110.229 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -101.45 161.76 22.59 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.682 . . . . 15.0 110.228 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -62.92 141.63 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.643 1.338 . . . . 15.0 110.591 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.5 mt -120.64 134.43 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.678 -0.638 . . . . 15.0 109.658 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.983 -1.008 . . . . 15.0 110.217 179.9 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.0 0.429 . . . . 15.0 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -116.45 167.31 11.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.683 -0.635 . . . . 15.0 110.106 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -89.5 150.1 43.78 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.67 -0.644 . . . . 15.0 110.121 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.72 -33.28 86.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.454 1.239 . . . . 15.0 110.729 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.3 p -67.74 -36.23 80.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.655 -0.653 . . . . 15.0 110.369 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.39 -36.91 54.5 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.557 -1.417 . . . . 15.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.3 76.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.847 -1.301 . . . . 15.0 109.847 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.5 m -71.43 144.79 89.58 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.925 . . . . 15.0 110.196 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 16.5 Cg_exo -63.87 149.12 91.38 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.348 1.183 . . . . 15.0 110.562 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.84 -30.43 71.49 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.722 -0.611 . . . . 15.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.6 mt -64.32 135.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.373 -0.829 . . . . 15.0 109.595 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.18 -2.22 61.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.86 -0.896 . . . . 15.0 110.86 -174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 m -93.15 159.46 15.28 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.31 . . . . 15.0 110.347 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -92.12 133.74 35.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.75 -0.594 . . . . 15.0 110.287 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.6 mt -132.43 147.72 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.531 -0.731 . . . . 15.0 109.923 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -115.08 131.45 56.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.499 -0.556 . . . . 15.0 109.499 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -123.16 135.97 54.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.713 -0.617 . . . . 15.0 110.35 -175.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 74' ' ' ASP . 79.9 mt -108.83 120.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -91.53 171.64 9.05 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.334 0.587 . . . . 15.0 110.886 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -59.69 -18.99 46.75 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.617 -0.677 . . . . 15.0 111.643 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.03 17.21 8.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 15.0 111.257 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 58.0 28.86 16.85 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.254 -0.904 . . . . 15.0 110.835 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 46' ' ' THR . 88.8 mt -105.13 148.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 172.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -105.32 119.01 38.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.762 -0.586 . . . . 15.0 110.462 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.76 136.46 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.761 -0.587 . . . . 15.0 109.652 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.0 tt0 -122.81 140.57 52.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 15.0 110.007 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.93 -178.88 39.67 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.901 -1.68 . . . . 15.0 108.901 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.9 mm -107.27 140.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -1.059 . . . . 15.0 109.858 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 29' ' ' ILE . 21.0 tp -64.44 109.98 2.13 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.599 . . . . 15.0 110.344 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -93.39 -52.08 4.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.792 -0.567 . . . . 15.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -143.24 143.33 31.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.683 -0.635 . . . . 15.0 110.523 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 HD21 ' A' ' 26' ' ' LEU . 74.4 mt -116.83 125.62 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.775 -0.578 . . . . 15.0 109.656 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -112.03 98.21 7.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.603 -0.686 . . . . 15.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -71.32 -36.04 71.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.8 -0.563 . . . . 15.0 110.457 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.88 -29.88 67.33 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.544 -0.723 . . . . 15.0 111.078 -171.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.45 14.04 15.54 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.639 -0.663 . . . . 15.0 111.519 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t 49.88 48.69 21.44 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.246 -0.909 . . . . 15.0 111.229 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.3 p -131.39 149.58 52.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.571 -0.706 . . . . 15.0 110.514 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.0 t -131.49 139.68 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.663 -0.648 . . . . 15.0 109.687 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.74 128.47 56.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 15.0 109.957 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 59.7 mt -116.82 137.78 51.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.979 -0.451 . . . . 15.0 109.798 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.33 163.68 14.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.741 -0.599 . . . . 15.0 109.894 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 51.48 64.24 1.92 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 121.376 0.608 . . . . 15.0 110.439 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -123.9 145.51 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 15.0 110.347 -172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -127.98 149.34 50.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.864 -0.522 . . . . 15.0 109.801 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -99.32 125.18 44.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.663 -0.648 . . . . 15.0 109.602 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -70.35 -40.27 74.16 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.055 -0.658 . . . . 15.0 110.643 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 169.13 30.79 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.918 -1.273 . . . . 15.0 109.918 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 20' ' ' ILE . 70.2 p -118.06 -19.46 9.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.911 -0.758 . . . . 15.0 110.946 175.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.5 -29.28 70.58 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.319 -0.863 . . . . 15.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -60.01 -32.9 71.31 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.445 -0.784 . . . . 15.0 110.252 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' THR . 62.2 mtt180 -125.21 94.97 42.42 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.825 -0.547 . . . . 15.0 109.766 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.48 132.63 47.17 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.388 1.204 . . . . 15.0 111.1 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 49' ' ' ARG . 33.1 p -128.97 165.17 21.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.803 -0.56 . . . . 15.0 110.035 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.83 -1.85 33.6 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.664 -0.648 . . . . 15.0 111.352 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -109.54 106.91 59.09 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.14 -0.975 . . . . 15.0 109.976 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.8 138.77 54.66 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.389 1.205 . . . . 15.0 110.516 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.4 mm -122.4 145.96 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.653 -0.654 . . . . 15.0 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.59 158.04 38.99 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.71 -0.619 . . . . 15.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.54 161.12 36.55 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.586 1.309 . . . . 15.0 110.543 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -128.71 145.68 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 15.0 110.471 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.08 -31.86 5.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.75 -0.593 . . . . 15.0 110.485 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.93 166.38 11.31 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.593 -0.692 . . . . 15.0 110.348 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -102.96 169.31 8.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.761 -0.587 . . . . 15.0 109.884 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -101.92 125.46 48.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.495 -0.753 . . . . 15.0 110.18 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.35 -44.7 71.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.79 -0.569 . . . . 15.0 110.604 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.87 121.98 8.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.571 -0.706 . . . . 15.0 110.507 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.73 147.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.745 -0.597 . . . . 15.0 109.663 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -111.18 136.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.739 -0.601 . . . . 15.0 109.865 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.72 144.1 51.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 15.0 109.913 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 67.7 mtm180 -108.47 151.9 25.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 15.0 110.097 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.02 -25.94 54.65 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 110.746 -0.942 . . . . 15.0 110.746 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -66.09 -45.41 81.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.48 -1.012 . . . . 15.0 110.731 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -82.05 -31.58 30.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.584 -0.697 . . . . 15.0 110.626 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.602 HG12 HD21 ' A' ' 14' ' ' LEU . 66.9 mt -66.16 140.53 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.545 -0.722 . . . . 15.0 109.816 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -108.16 -42.28 4.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 15.0 110.344 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 15' ' ' ILE . 26.7 t70 -139.23 145.16 38.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 15.0 110.653 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -132.82 129.61 38.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.701 -0.625 . . . . 15.0 110.254 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -130.48 142.59 50.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.743 -0.598 . . . . 15.0 110.219 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -102.26 144.08 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.626 -0.671 . . . . 15.0 109.893 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -88.21 -34.6 17.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.716 -0.615 . . . . 15.0 110.177 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -84.18 154.92 63.76 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.622 -0.674 . . . . 15.0 109.879 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.24 111.01 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.638 1.336 . . . . 15.0 111.048 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -75.63 152.68 38.17 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 O-C-N 123.448 1.236 . . . . 15.0 110.129 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -102.16 158.64 31.37 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.733 . . . . 15.0 110.15 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -62.62 141.1 84.61 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 O-C-N 123.548 1.289 . . . . 15.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.5 tt -66.45 -31.27 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.67 -0.644 . . . . 15.0 110.386 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.983 -1.008 . . . . 15.0 110.241 179.513 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.601 HD11 ' HA3' ' A' ' 4' ' ' GLY . 7.9 tt . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.959 0.409 . . . . 15.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.03 -58.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.761 -0.587 . . . . 15.0 110.188 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ASP . . . . . 0.59 ' O ' HD21 ' A' ' -2' ' ' LEU . 6.3 t70 -105.0 138.73 19.59 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.709 -0.619 . . . . 15.0 110.009 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.1 -41.01 14.11 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.489 1.258 . . . . 15.0 110.517 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.1 p -69.53 -33.81 73.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.642 -0.661 . . . . 15.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.61 -34.29 67.29 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.699 -1.361 . . . . 15.0 109.699 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.601 ' HA3' HD11 ' A' ' -2' ' ' LEU . . . -67.58 -38.32 90.27 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.749 -1.341 . . . . 15.0 109.749 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.5 m -117.84 122.97 30.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.635 -0.921 . . . . 15.0 110.166 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.69 149.01 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.377 1.198 . . . . 15.0 110.23 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -62.6 -24.97 67.85 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.599 -0.688 . . . . 15.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.7 mt -64.82 139.87 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 15.0 109.17 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -2.1 66.72 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.799 -0.92 . . . . 15.0 110.799 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -76.55 159.94 29.9 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.046 -1.267 . . . . 15.0 110.33 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -86.87 129.89 34.69 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.681 -0.637 . . . . 15.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 HD12 HD13 ' A' ' 26' ' ' LEU . 92.7 mt -132.77 150.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.617 -0.677 . . . . 15.0 109.927 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.46 132.97 56.46 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -122.57 136.93 55.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.751 -0.593 . . . . 15.0 110.335 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.1 mt -109.47 121.68 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -93.22 171.49 8.9 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.279 0.561 . . . . 15.0 110.937 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -60.23 -19.12 53.14 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.594 -0.691 . . . . 15.0 111.396 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.12 16.83 7.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.342 -0.848 . . . . 15.0 111.271 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 57.6 28.39 15.58 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.295 -0.878 . . . . 15.0 110.818 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 46' ' ' THR . 87.3 mt -104.95 147.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -106.71 119.84 40.4 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.698 -0.626 . . . . 15.0 110.52 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.23 137.24 49.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.874 -0.516 . . . . 15.0 109.772 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.8 tt0 -121.29 140.69 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.745 . . . . 15.0 109.942 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.88 39.4 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.973 -1.651 . . . . 15.0 108.973 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.35 138.02 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.382 -1.069 . . . . 15.0 109.696 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.694 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -66.19 108.84 2.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.727 -0.608 . . . . 15.0 110.168 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -93.51 -52.16 4.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.882 -0.511 . . . . 15.0 110.509 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -141.69 141.34 33.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 15.0 110.492 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 HD21 ' A' ' 26' ' ' LEU . 78.6 mt -118.04 124.92 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.742 -0.599 . . . . 15.0 109.644 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -112.11 97.46 6.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.532 -0.73 . . . . 15.0 109.907 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.01 -36.19 74.92 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.767 -0.583 . . . . 15.0 110.434 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -59.22 -29.62 67.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.539 -0.726 . . . . 15.0 111.074 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -115.53 14.07 16.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.522 -0.737 . . . . 15.0 111.471 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 m 50.0 46.65 24.24 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.184 -0.948 . . . . 15.0 111.181 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.7 p -131.6 149.81 52.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.404 -0.81 . . . . 15.0 110.51 -177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.41 140.23 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 15.0 109.72 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.33 130.05 56.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.709 -0.619 . . . . 15.0 109.961 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 26' ' ' LEU . 92.4 mt -116.8 138.06 51.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.765 -0.458 . . . . 15.0 109.765 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 162.39 16.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.722 -0.611 . . . . 15.0 109.887 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.7 mttt 51.75 61.2 3.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.673 -0.642 . . . . 15.0 110.428 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -122.4 145.88 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.686 -0.634 . . . . 15.0 110.376 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' CG ' HG23 ' A' ' 61' ' ' THR . 81.0 mtp180 -132.88 149.42 52.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.813 -0.554 . . . . 15.0 109.99 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -97.22 127.79 43.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.615 . . . . 15.0 109.649 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -68.9 -40.24 79.25 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.554 -0.717 . . . . 15.0 110.615 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.72 170.24 32.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.758 -1.337 . . . . 15.0 109.758 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.454 HG21 HG21 ' A' ' 55' ' ' ILE . 39.8 p -118.03 -30.8 5.24 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.796 -0.826 . . . . 15.0 110.485 176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.64 -28.53 69.97 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.507 -0.746 . . . . 15.0 110.901 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -60.25 -32.34 71.06 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.44 -0.788 . . . . 15.0 110.314 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' THR . 31.5 mtt180 -118.97 95.15 49.1 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 15.0 109.704 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.09 134.7 65.24 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 O-C-N 123.426 1.224 . . . . 15.0 111.374 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 49' ' ' ARG . 19.1 p -132.82 165.14 25.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.874 -0.516 . . . . 15.0 110.03 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.8 -2.14 34.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.666 -0.646 . . . . 15.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -116.84 106.85 47.17 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 15.0 109.99 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -62.66 134.06 45.47 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.324 1.171 . . . . 15.0 110.798 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.454 HG21 HG21 ' A' ' 46' ' ' THR . 50.8 mm -121.86 146.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.679 -0.638 . . . . 15.0 109.655 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.46 157.78 36.71 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.641 -0.662 . . . . 15.0 110.292 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.8 152.33 79.18 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.505 1.266 . . . . 15.0 110.624 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -138.74 -50.06 0.54 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.733 -0.605 . . . . 15.0 110.268 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 52.43 39.3 27.36 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.681 -0.637 . . . . 15.0 110.984 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.54 154.63 31.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 15.0 110.131 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.404 HG23 ' CG ' ' A' ' 42' ' ' ARG . 23.9 m -102.97 135.54 44.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.643 -0.66 . . . . 15.0 110.086 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.3 m-85 -102.12 133.05 47.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 15.0 110.153 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -68.46 -43.98 75.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.853 -0.53 . . . . 15.0 110.631 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -149.83 122.08 8.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.601 -0.687 . . . . 15.0 110.587 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.2 mt -130.71 147.83 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.618 -0.676 . . . . 15.0 109.564 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.22 137.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.776 -0.578 . . . . 15.0 109.885 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.87 145.65 51.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.771 -0.58 . . . . 15.0 109.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.745 ' HG2' HG22 ' A' ' 35' ' ' THR . 96.5 mtt180 -108.85 152.35 25.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.637 -0.664 . . . . 15.0 110.172 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.15 55.91 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.722 -0.951 . . . . 15.0 110.722 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 m -65.74 -45.24 83.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -1.047 . . . . 15.0 110.646 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.99 -31.44 31.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.552 -0.717 . . . . 15.0 110.669 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.614 HG12 HD21 ' A' ' 14' ' ' LEU . 71.1 mt -66.21 141.98 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.576 -0.702 . . . . 15.0 109.816 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -107.95 -43.4 4.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.761 -0.587 . . . . 15.0 110.287 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' HD12 ' A' ' 15' ' ' ILE . 19.5 t70 -141.81 147.41 37.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.666 -0.646 . . . . 15.0 110.674 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -132.37 129.48 39.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.606 . . . . 15.0 110.18 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.5 m -131.62 141.46 49.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.627 -0.67 . . . . 15.0 110.362 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.21 144.06 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 15.0 109.774 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.1 m -94.18 -37.01 11.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 15.0 110.267 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -84.19 117.48 68.8 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.621 -0.675 . . . . 15.0 110.006 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.53 156.01 65.11 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.395 1.208 . . . . 15.0 110.383 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.51 152.2 75.1 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.654 1.344 . . . . 15.0 110.268 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -97.09 164.34 18.05 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.643 -0.66 . . . . 15.0 110.189 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.79 148.55 82.79 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.758 1.399 . . . . 15.0 110.418 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.54 HD12 ' N ' ' A' ' 84' ' ' ILE . 5.3 mp -111.85 135.44 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.752 -0.592 . . . . 15.0 109.67 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.026 -0.988 . . . . 15.0 110.3 179.76 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' -2' ' ' LEU . 6.3 mp . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.682 0.623 . . . . 15.0 112.682 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.03 92.07 2.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.692 -0.63 . . . . 15.0 111.966 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -105.06 150.07 38.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.69 -0.631 . . . . 15.0 110.109 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.03 -41.07 14.24 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.536 1.282 . . . . 15.0 110.36 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -72.58 -37.41 68.17 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.653 -0.655 . . . . 15.0 109.834 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.63 -27.55 73.24 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.998 -1.241 . . . . 15.0 109.998 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.23 -34.34 87.76 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.17 -1.172 . . . . 15.0 110.17 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -108.39 122.83 39.2 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.923 . . . . 15.0 110.042 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.12 134.68 19.76 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.409 1.215 . . . . 15.0 110.375 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -69.01 -36.29 77.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 15.0 109.922 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.85 135.42 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.524 -0.735 . . . . 15.0 109.495 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.49 -2.08 60.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -95.97 150.16 20.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.276 . . . . 15.0 110.328 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -83.73 130.25 34.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.685 -0.635 . . . . 15.0 110.483 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.2 mt -130.61 149.39 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.749 -0.594 . . . . 15.0 109.908 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -112.32 133.91 54.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 72' ' ' ILE . 8.0 tp -123.31 133.3 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.78 -0.575 . . . . 15.0 110.319 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.8 mt -107.58 122.9 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -94.48 172.8 7.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.309 0.576 . . . . 15.0 110.903 -172.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.89 -19.56 52.18 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.608 -0.683 . . . . 15.0 111.48 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.38 15.39 9.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.27 -0.894 . . . . 15.0 111.316 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 58.02 27.5 14.92 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.341 -0.849 . . . . 15.0 110.813 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 46' ' ' THR . 84.3 mt -104.2 148.33 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.998 -0.741 . . . . 15.0 108.998 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 -107.27 121.35 44.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 15.0 110.557 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -112.02 138.48 48.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.875 -0.516 . . . . 15.0 109.711 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 35.6 mt-10 -120.44 140.7 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 15.0 109.899 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.01 -178.88 38.63 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.165 -1.574 . . . . 15.0 109.165 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.62 134.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -1.021 . . . . 15.0 109.772 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.814 HD21 HD11 ' A' ' 29' ' ' ILE . 12.0 tp -61.3 112.04 1.99 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.669 -0.644 . . . . 15.0 110.445 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -94.11 -52.0 4.58 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.347 -0.541 . . . . 15.0 110.378 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.3 p -143.77 143.63 31.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 15.0 110.531 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.814 HD11 HD21 ' A' ' 26' ' ' LEU . 74.2 mt -116.84 125.2 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.767 -0.583 . . . . 15.0 109.664 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -112.07 96.75 6.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 15.0 109.823 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.5 m -70.91 -36.26 72.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.756 -0.59 . . . . 15.0 110.438 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.87 -29.29 66.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.508 -0.745 . . . . 15.0 111.046 -171.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.08 14.03 15.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.58 -0.7 . . . . 15.0 111.571 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.0 m 49.97 48.0 22.49 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.207 -0.933 . . . . 15.0 111.248 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.1 p -131.95 148.54 52.53 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.459 -0.776 . . . . 15.0 110.489 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.09 139.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.595 -0.691 . . . . 15.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.62 128.85 56.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.681 -0.637 . . . . 15.0 109.971 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 26' ' ' LEU . 33.4 mt -116.86 138.14 51.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.944 -0.473 . . . . 15.0 109.918 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.59 164.03 14.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.737 -0.602 . . . . 15.0 109.855 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 51.51 58.54 5.39 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.407 0.622 . . . . 15.0 110.464 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.72 148.43 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.575 -0.703 . . . . 15.0 110.331 -173.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -137.53 148.83 46.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.829 -0.544 . . . . 15.0 110.029 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.6 p -96.59 131.61 43.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.799 -0.563 . . . . 15.0 109.653 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.92 -40.37 63.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.615 -0.678 . . . . 15.0 110.641 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.68 173.06 35.43 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.941 -1.264 . . . . 15.0 109.941 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.566 HG22 HG12 ' A' ' 20' ' ' ILE . 41.3 p -114.4 -20.06 10.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.701 -0.882 . . . . 15.0 110.741 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -61.53 -30.14 70.45 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.375 -0.828 . . . . 15.0 110.832 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -60.17 -32.35 70.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.484 -0.76 . . . . 15.0 110.168 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.97 95.08 49.02 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.796 -0.565 . . . . 15.0 109.739 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.08 132.84 54.42 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.501 1.264 . . . . 15.0 111.252 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.8 p -118.13 165.01 14.29 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.827 -0.546 . . . . 15.0 109.996 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.66 -13.49 59.89 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.694 -0.629 . . . . 15.0 111.212 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.564 HH11 HD11 ' A' ' 55' ' ' ILE . 10.5 ptt85 -118.22 139.04 26.22 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.219 -0.926 . . . . 15.0 110.082 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 53' ' ' ARG . 9.5 Cg_exo -67.64 149.6 79.31 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.182 1.096 . . . . 15.0 110.408 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.564 HD11 HH11 ' A' ' 53' ' ' ARG . 51.2 mm -113.64 139.99 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.674 -0.641 . . . . 15.0 109.551 175.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.35 96.81 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.544 -0.722 . . . . 15.0 110.152 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.68 143.17 86.2 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.544 1.286 . . . . 15.0 110.601 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -158.26 132.86 8.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.732 -0.605 . . . . 15.0 110.308 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -142.66 32.94 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.709 -0.619 . . . . 15.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -109.68 170.25 8.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 15.0 110.197 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.2 m -102.98 143.13 32.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.629 -0.669 . . . . 15.0 110.12 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.71 ' CG ' HD11 ' A' ' 65' ' ' ILE . 94.4 m-85 -102.04 127.85 48.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.689 -0.632 . . . . 15.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -44.1 76.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.879 -0.513 . . . . 15.0 110.562 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -150.08 122.03 8.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 15.0 110.571 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.71 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.6 mt -130.01 146.37 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.669 -0.644 . . . . 15.0 109.627 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.54 136.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.717 -0.615 . . . . 15.0 109.988 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.99 140.95 51.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.698 -0.626 . . . . 15.0 109.862 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 35' ' ' THR . 74.7 mtt85 -106.68 152.39 23.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.747 -0.596 . . . . 15.0 110.022 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.65 -26.07 52.3 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.745 -0.942 . . . . 15.0 110.745 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -66.29 -45.99 78.52 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.526 -0.985 . . . . 15.0 110.752 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.2 -31.94 30.11 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.576 -0.702 . . . . 15.0 110.678 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 14' ' ' LEU . 84.9 mt -67.24 141.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.573 -0.704 . . . . 15.0 109.817 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -100.85 -42.51 6.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.729 -0.607 . . . . 15.0 110.229 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -147.93 144.3 27.94 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.624 -0.673 . . . . 15.0 110.768 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -127.23 128.27 45.79 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.712 -0.617 . . . . 15.0 109.968 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -135.9 142.24 44.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.557 -0.714 . . . . 15.0 110.502 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.37 144.05 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.665 -0.647 . . . . 15.0 109.492 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 28.7 p -114.66 -29.64 6.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.532 -0.73 . . . . 15.0 110.983 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -84.26 117.45 68.74 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.582 -0.698 . . . . 15.0 110.119 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.65 161.99 33.35 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 O-C-N 123.406 1.214 . . . . 15.0 110.428 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -68.05 152.97 76.13 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.705 1.371 . . . . 15.0 110.173 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -86.25 154.08 56.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.652 -0.655 . . . . 15.0 110.221 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.24 145.65 66.91 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.651 1.342 . . . . 15.0 110.371 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 pt -123.68 152.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 15.0 110.236 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 117.965 -1.016 . . . . 15.0 110.132 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' -2' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.95 0.405 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -109.75 147.97 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.73 -0.606 . . . . 15.0 110.248 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -104.39 148.64 36.3 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.667 -0.646 . . . . 15.0 110.127 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.61 -32.46 69.36 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.467 1.246 . . . . 15.0 110.552 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -66.73 -30.98 71.35 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.724 -0.61 . . . . 15.0 110.497 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.5 -35.46 81.53 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.733 -1.347 . . . . 15.0 109.733 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.55 -35.33 74.77 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.739 -1.344 . . . . 15.0 109.739 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 m -96.68 142.44 24.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.938 . . . . 15.0 110.063 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.99 131.43 22.32 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 123.432 1.227 . . . . 15.0 110.338 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' HB3' HD22 ' A' ' 26' ' ' LEU . 97.7 m-85 -68.98 -33.91 74.45 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.667 -0.646 . . . . 15.0 110.118 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.4 ' N ' HD23 ' A' ' 26' ' ' LEU . 85.4 mt -65.08 133.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.42 -0.8 . . . . 15.0 109.833 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.06 68.35 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.029 -0.828 . . . . 15.0 111.029 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -101.66 151.26 22.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.248 . . . . 15.0 110.657 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -78.38 127.67 32.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.846 -0.534 . . . . 15.0 110.199 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 26' ' ' LEU . 96.4 mt -130.97 144.73 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 15.0 109.867 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -113.03 132.34 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.617 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -121.25 136.01 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.803 -0.561 . . . . 15.0 110.231 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.96 121.42 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.92 172.69 8.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.352 0.596 . . . . 15.0 110.911 -171.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -59.97 -19.25 51.14 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.614 -0.679 . . . . 15.0 111.472 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.88 9.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.395 -0.815 . . . . 15.0 111.337 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.6 29.11 16.68 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.293 -0.879 . . . . 15.0 110.752 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 46' ' ' THR . 81.9 mt -105.09 147.93 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.74 122.65 46.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.799 -0.563 . . . . 15.0 110.567 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.8 137.44 51.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 15.0 109.812 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.4 mm-40 -119.43 140.66 50.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.458 -0.776 . . . . 15.0 109.796 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.12 -178.95 38.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.21 -1.556 . . . . 15.0 109.21 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.82 134.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.485 -1.009 . . . . 15.0 109.72 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 29' ' ' ILE . 11.6 tp -61.45 114.61 3.32 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.694 -0.629 . . . . 15.0 110.546 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -95.62 -51.93 4.32 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.324 -0.55 . . . . 15.0 110.402 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 20.3 p -143.81 143.94 31.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.632 -0.668 . . . . 15.0 110.649 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.809 HD11 HD21 ' A' ' 26' ' ' LEU . 75.1 mt -117.2 124.63 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.67 -0.644 . . . . 15.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.09 98.14 7.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.648 -0.657 . . . . 15.0 109.844 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.707 -0.62 . . . . 15.0 110.423 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.8 -29.59 66.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.545 -0.722 . . . . 15.0 111.054 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.2 m-20 -116.14 14.07 15.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.49 -0.756 . . . . 15.0 111.434 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t 49.97 48.91 21.21 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.133 -0.979 . . . . 15.0 111.254 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.4 p -132.33 147.88 52.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.512 -0.743 . . . . 15.0 110.57 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.84 138.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.675 -0.64 . . . . 15.0 109.686 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -110.61 126.34 54.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.719 -0.613 . . . . 15.0 109.907 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 26' ' ' LEU . 26.5 mt -116.78 136.92 52.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.19 164.34 14.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.721 -0.612 . . . . 15.0 109.935 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 51.75 58.05 5.88 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.644 -0.66 . . . . 15.0 110.48 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -119.96 147.36 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 15.0 110.347 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -133.63 149.86 51.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.787 -0.571 . . . . 15.0 109.993 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.6 p -98.69 131.19 45.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.635 -0.666 . . . . 15.0 109.754 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -73.27 -40.32 64.68 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.515 -0.741 . . . . 15.0 110.69 -173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.92 34.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.804 -1.318 . . . . 15.0 109.804 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.422 HG22 HG12 ' A' ' 20' ' ' ILE . 48.4 p -118.06 -17.01 9.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.772 -0.84 . . . . 15.0 110.901 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -63.57 -26.67 68.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.275 -0.891 . . . . 15.0 111.13 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -59.41 -31.79 69.59 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.487 -0.758 . . . . 15.0 110.411 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 51' ' ' THR . 7.3 mmt180 -128.3 95.03 34.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 15.0 109.848 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.33 135.32 69.44 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.472 1.248 . . . . 15.0 111.113 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 49' ' ' ARG . 47.0 p -131.21 165.11 24.06 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.545 . . . . 15.0 109.99 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.84 -1.43 31.58 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.55 -0.719 . . . . 15.0 111.411 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HE ' HD11 ' A' ' 55' ' ' ILE . 1.4 tmm_? -110.35 106.91 58.34 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.234 -0.916 . . . . 15.0 109.827 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.06 136.49 48.4 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.356 1.187 . . . . 15.0 110.747 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.483 HD11 ' HE ' ' A' ' 53' ' ' ARG . 51.8 mm -118.25 143.63 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.711 -0.618 . . . . 15.0 109.638 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.89 155.08 47.8 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.667 -0.646 . . . . 15.0 110.17 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -62.65 137.19 62.43 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.537 1.283 . . . . 15.0 110.649 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -139.22 127.61 22.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.69 -0.631 . . . . 15.0 110.216 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -117.56 32.15 6.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.631 -0.668 . . . . 15.0 110.357 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 158.11 18.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 15.0 110.195 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -103.03 146.79 27.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.694 -0.629 . . . . 15.0 110.021 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.755 ' CG ' HD11 ' A' ' 65' ' ' ILE . 97.4 m-85 -101.95 126.37 48.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 15.0 110.119 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -68.09 -41.75 81.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.821 -0.549 . . . . 15.0 110.657 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.559 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 2.2 t80 -150.3 122.06 8.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.615 -0.678 . . . . 15.0 110.423 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.755 HD11 ' CG ' ' A' ' 62' ' ' PHE . 92.9 mt -129.6 144.58 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.685 -0.634 . . . . 15.0 109.481 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.54 133.42 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 109.785 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -123.83 140.53 52.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.705 -0.622 . . . . 15.0 109.893 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.8 mtt180 -105.25 152.02 23.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.652 -0.655 . . . . 15.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.66 -25.96 52.12 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -66.41 -43.06 86.79 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.483 -1.01 . . . . 15.0 110.729 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.9 -31.61 23.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.541 -0.724 . . . . 15.0 110.664 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.617 HG12 HD21 ' A' ' 14' ' ' LEU . 75.4 mt -66.37 141.46 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.582 -0.699 . . . . 15.0 109.887 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -105.26 -42.7 5.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.65 -0.656 . . . . 15.0 110.214 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.53 147.4 32.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.592 -0.692 . . . . 15.0 110.763 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -130.25 129.49 43.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.724 -0.61 . . . . 15.0 110.133 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -133.81 145.38 49.69 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.563 -0.711 . . . . 15.0 110.433 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.15 144.06 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.701 -0.625 . . . . 15.0 109.676 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 93.1 m -101.67 -37.06 8.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 15.0 110.656 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -100.07 148.89 35.47 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.672 -0.643 . . . . 15.0 110.417 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.24 163.7 34.32 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.501 1.264 . . . . 15.0 110.278 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.74 134.6 44.59 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.556 1.292 . . . . 15.0 110.432 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -102.13 164.63 15.39 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.668 -0.645 . . . . 15.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.71 143.38 92.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.583 1.307 . . . . 15.0 110.52 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 84' ' ' ILE . 5.3 mp -94.92 -34.72 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 15.0 109.723 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.98 -1.01 . . . . 15.0 110.144 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.584 HD12 ' CA ' ' A' ' 3' ' ' GLY . 85.6 mt . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 121.02 0.438 . . . . 15.0 110.207 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.29 -32.77 74.38 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.661 -0.65 . . . . 15.0 110.432 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.66 150.0 58.52 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.692 -0.63 . . . . 15.0 110.184 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.0 -35.72 33.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.54 1.284 . . . . 15.0 110.497 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -67.74 -34.13 76.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.668 . . . . 15.0 110.236 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.584 ' CA ' HD12 ' A' ' -2' ' ' LEU . . . -68.76 -33.65 76.13 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.796 -1.321 . . . . 15.0 109.796 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.17 -35.42 90.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.814 -1.315 . . . . 15.0 109.814 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -133.62 122.89 17.04 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.899 . . . . 15.0 110.121 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.75 149.01 53.69 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.334 1.176 . . . . 15.0 110.351 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.42 -33.6 76.34 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.655 . . . . 15.0 110.17 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.7 137.24 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 15.0 109.546 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.17 -2.16 63.3 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.9 m -91.4 153.06 20.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.131 -1.217 . . . . 15.0 110.43 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -83.56 127.63 33.88 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.741 -0.599 . . . . 15.0 110.442 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.1 mt -131.21 151.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.629 -0.67 . . . . 15.0 109.892 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -115.79 133.26 56.21 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 72' ' ' ILE . 11.4 tp -121.6 136.15 54.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.733 -0.605 . . . . 15.0 110.197 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.23 123.44 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -95.78 169.76 9.78 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.343 0.592 . . . . 15.0 110.947 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -60.4 -18.35 50.04 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.616 -0.677 . . . . 15.0 111.513 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 17.58 7.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.245 -0.91 . . . . 15.0 111.276 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 58.12 27.63 15.26 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.309 -0.869 . . . . 15.0 110.844 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -105.0 146.23 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -106.18 120.64 42.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.786 -0.571 . . . . 15.0 110.323 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.83 132.91 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.851 -0.53 . . . . 15.0 109.791 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -118.77 140.71 49.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 15.0 109.812 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.98 -178.81 40.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.196 -1.562 . . . . 15.0 109.196 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -105.51 132.39 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.502 -0.999 . . . . 15.0 109.677 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 29' ' ' ILE . 18.2 tp -62.15 110.9 1.75 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.712 -0.618 . . . . 15.0 110.422 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -91.32 -52.09 4.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.786 -0.571 . . . . 15.0 110.481 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 23.0 p -144.64 143.65 30.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.641 -0.662 . . . . 15.0 110.581 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 26' ' ' LEU . 74.0 mt -116.45 125.78 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.629 . . . . 15.0 109.556 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.09 95.99 5.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 15.0 109.791 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -70.22 -37.08 74.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.772 -0.58 . . . . 15.0 110.389 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -59.12 -29.51 67.44 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.628 -0.67 . . . . 15.0 111.084 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -115.22 14.03 16.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.623 -0.673 . . . . 15.0 111.57 -177.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 m 49.93 46.88 23.93 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.174 -0.954 . . . . 15.0 111.256 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.662 HG22 ' HG2' ' A' ' 68' ' ' ARG . 14.7 p -131.81 150.08 52.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 15.0 110.561 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.24 139.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.678 -0.639 . . . . 15.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.86 128.16 56.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.687 -0.633 . . . . 15.0 109.956 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 26' ' ' LEU . 19.2 mt -116.81 138.85 51.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.991 -0.443 . . . . 15.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.76 161.71 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.625 . . . . 15.0 109.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 51.64 56.56 7.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.66 -0.65 . . . . 15.0 110.535 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -118.72 147.52 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.565 -0.71 . . . . 15.0 110.356 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -136.22 153.28 51.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.781 -0.574 . . . . 15.0 110.096 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.6 p -99.68 131.85 45.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.714 -0.616 . . . . 15.0 110.008 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -68.85 -40.09 79.57 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.64 . . . . 15.0 110.438 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.87 169.74 31.75 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.884 -1.287 . . . . 15.0 109.884 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.715 HG21 HG13 ' A' ' 55' ' ' ILE . 37.0 p -118.04 6.33 12.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.841 -0.799 . . . . 15.0 111.155 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -53.95 -25.42 20.55 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.296 -0.877 . . . . 15.0 111.286 -174.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -63.47 -33.74 76.23 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.47 -0.769 . . . . 15.0 110.054 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp85 -144.53 92.5 5.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.737 -0.602 . . . . 15.0 109.829 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.4 138.62 61.2 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.473 1.249 . . . . 15.0 110.659 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.0 p -127.78 165.05 20.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.695 -0.628 . . . . 15.0 110.082 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.89 -3.08 39.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.689 -0.632 . . . . 15.0 111.375 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -100.36 124.85 41.44 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 15.0 110.051 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.0 139.97 48.63 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.337 1.177 . . . . 15.0 110.43 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.715 HG13 HG21 ' A' ' 46' ' ' THR . 51.5 mm -111.74 145.99 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 15.0 109.687 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.71 156.73 88.38 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.75 -0.594 . . . . 15.0 110.213 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 157.97 42.26 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.578 1.304 . . . . 15.0 110.742 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -62.02 -27.71 69.07 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.709 -0.619 . . . . 15.0 110.942 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.46 -34.41 76.76 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.585 -0.697 . . . . 15.0 110.586 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -80.45 141.76 34.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.69 -0.631 . . . . 15.0 110.028 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -125.69 153.73 43.45 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.727 -0.608 . . . . 15.0 110.394 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CG ' HD11 ' A' ' 65' ' ' ILE . 26.5 m-85 -102.01 136.37 41.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.747 -0.595 . . . . 15.0 109.924 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.0 -44.37 76.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.8 -0.563 . . . . 15.0 110.686 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.9 t80 -148.59 121.99 9.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 15.0 110.572 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 62' ' ' PHE . 90.7 mt -131.36 147.32 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.715 -0.616 . . . . 15.0 109.517 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.51 138.39 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.65 -0.656 . . . . 15.0 109.917 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -128.99 145.35 51.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 15.0 109.908 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.2 mtp85 -107.16 152.45 24.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.694 -0.629 . . . . 15.0 110.131 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.02 56.35 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -65.95 -42.5 89.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.465 -1.021 . . . . 15.0 110.738 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.25 -31.12 23.29 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.595 -0.69 . . . . 15.0 110.696 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.528 HG12 HD21 ' A' ' 14' ' ' LEU . 65.7 mt -66.36 146.78 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.632 -0.668 . . . . 15.0 109.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.42 -44.65 4.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.734 -0.604 . . . . 15.0 110.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -148.43 149.8 32.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.668 -0.645 . . . . 15.0 110.769 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.48 129.38 46.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.804 -0.56 . . . . 15.0 110.149 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -134.47 143.92 47.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.573 -0.704 . . . . 15.0 110.479 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.54 144.13 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.669 -0.644 . . . . 15.0 109.629 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.7 t -114.98 -37.04 4.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 15.0 110.57 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -96.61 117.47 65.98 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.68 . . . . 15.0 110.287 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.72 176.99 9.07 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.358 1.188 . . . . 15.0 110.267 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.8 153.79 70.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.577 1.304 . . . . 15.0 110.48 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -90.11 161.14 38.71 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.69 -0.631 . . . . 15.0 110.212 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.5 147.09 95.38 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.687 1.362 . . . . 15.0 110.596 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 pt -124.78 160.37 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.743 -0.598 . . . . 15.0 110.198 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.977 -1.011 . . . . 15.0 110.204 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' -2' ' ' LEU . 6.3 mp . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.993 0.425 . . . . 15.0 110.192 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -116.31 155.67 28.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 15.0 110.267 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.59 150.08 36.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.726 -0.609 . . . . 15.0 110.104 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.08 -39.37 24.14 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.46 1.242 . . . . 15.0 110.539 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -68.87 -36.98 78.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.596 -0.69 . . . . 15.0 110.125 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.15 75.13 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.676 -0.97 . . . . 15.0 110.676 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.39 -32.26 82.32 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.178 -1.19 . . . . 15.0 110.226 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.595 HG21 ' HE3' ' A' ' 82' ' ' LYS . 22.5 m -87.42 122.91 70.47 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.533 -0.981 . . . . 15.0 110.011 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.1 148.12 39.2 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.389 1.205 . . . . 15.0 110.44 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' C ' HD23 ' A' ' 26' ' ' LEU . 97.4 m-85 -68.96 -30.46 68.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.66 . . . . 15.0 110.137 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 26' ' ' LEU . 85.6 mt -63.1 138.14 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.344 -0.847 . . . . 15.0 109.707 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.03 -2.21 61.45 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.1 m -95.32 151.96 18.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.085 -1.244 . . . . 15.0 110.472 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 25' ' ' ILE . 98.7 mttt -83.94 130.6 34.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.806 -0.559 . . . . 15.0 110.256 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.643 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.1 mt -130.98 145.04 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.526 -0.734 . . . . 15.0 109.953 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.4 t -116.09 129.33 56.29 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 72' ' ' ILE . 10.7 tp -120.53 135.7 55.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.666 -0.646 . . . . 15.0 110.406 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.08 120.02 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -91.66 172.03 8.76 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.24 0.543 . . . . 15.0 110.951 -171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -59.25 -19.71 48.04 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.634 -0.666 . . . . 15.0 111.655 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.14 17.12 8.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.301 -0.874 . . . . 15.0 111.224 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.89 28.3 15.9 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.273 -0.892 . . . . 15.0 110.875 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 HG22 ' A' ' 46' ' ' THR . 88.7 mt -105.05 147.13 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm105 -104.91 121.07 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 15.0 110.483 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.98 135.67 52.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.806 -0.559 . . . . 15.0 109.782 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.4 tt0 -118.0 140.56 49.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 15.0 109.805 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.66 -178.9 39.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.075 -1.61 . . . . 15.0 109.075 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.0 mm -108.9 142.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.456 -1.026 . . . . 15.0 109.742 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -64.7 114.47 4.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.739 -0.601 . . . . 15.0 110.269 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -98.06 -52.05 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.761 -0.587 . . . . 15.0 110.363 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.2 p -143.83 143.7 31.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.65 -0.656 . . . . 15.0 110.488 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 26' ' ' LEU . 70.2 mt -117.6 125.86 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.833 -0.542 . . . . 15.0 109.735 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -112.11 96.91 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 15.0 109.788 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.3 -37.54 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.766 -0.584 . . . . 15.0 110.53 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.79 -28.7 66.2 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.549 -0.719 . . . . 15.0 111.153 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -116.21 14.13 15.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.735 . . . . 15.0 111.556 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.9 48.07 22.31 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.41 -0.806 . . . . 15.0 111.289 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.2 p -131.83 147.24 52.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.522 -0.736 . . . . 15.0 110.44 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.71 139.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.592 -0.693 . . . . 15.0 109.695 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.53 128.81 56.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 15.0 109.916 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.1 mt -116.85 138.84 51.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.914 -0.491 . . . . 15.0 109.742 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.49 165.6 12.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 15.0 109.873 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 51.69 58.83 5.06 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.691 -0.63 . . . . 15.0 110.496 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 23' ' ' GLU . 15.0 p -121.0 147.37 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.64 -0.663 . . . . 15.0 110.337 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.472 ' CG ' HG23 ' A' ' 61' ' ' THR . 62.2 mtt85 -135.2 150.0 50.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.599 . . . . 15.0 110.0 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.6 p -96.86 129.33 44.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 15.0 109.715 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -70.55 -40.28 73.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 15.0 110.564 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.82 172.04 34.43 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.844 -1.303 . . . . 15.0 109.844 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 HG12 ' A' ' 20' ' ' ILE . 63.0 p -118.09 -21.08 8.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.855 -0.791 . . . . 15.0 110.829 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.18 -25.14 68.2 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.399 -0.813 . . . . 15.0 111.056 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.33 -31.75 69.45 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.372 -0.83 . . . . 15.0 110.362 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' THR . 13.4 mmm180 -123.23 95.06 46.17 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.778 -0.576 . . . . 15.0 109.751 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.28 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 O-C-N 123.443 1.233 . . . . 15.0 111.384 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 49' ' ' ARG . 21.0 p -129.4 165.13 22.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.834 -0.541 . . . . 15.0 110.062 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.74 -2.25 35.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.674 -0.642 . . . . 15.0 111.371 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -115.22 106.97 50.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 15.0 109.923 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -62.34 132.25 37.72 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.395 1.208 . . . . 15.0 110.772 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.0 mm -120.43 141.35 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.627 -0.671 . . . . 15.0 109.667 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.87 152.26 50.93 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.642 -0.661 . . . . 15.0 110.185 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.01 144.7 58.98 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.603 1.318 . . . . 15.0 110.342 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -132.21 133.43 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.707 -0.62 . . . . 15.0 110.198 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -110.7 31.62 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 15.0 110.368 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.63 154.6 25.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 15.0 110.167 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.472 HG23 ' CG ' ' A' ' 42' ' ' ARG . 24.5 m -102.97 147.93 26.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.713 -0.617 . . . . 15.0 110.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.677 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.1 m-85 -102.02 127.43 48.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.65 . . . . 15.0 110.06 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -68.62 -44.24 74.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.883 -0.511 . . . . 15.0 110.555 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.88 121.99 8.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 15.0 110.568 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.677 HD11 ' CG ' ' A' ' 62' ' ' PHE . 41.3 mt -131.4 147.57 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.624 . . . . 15.0 109.447 173.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.8 mt -110.65 138.66 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 15.0 110.014 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -129.69 141.08 50.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.758 -0.589 . . . . 15.0 109.916 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.717 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.3 mtt85 -109.89 152.08 26.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.699 -0.626 . . . . 15.0 110.071 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -26.01 49.38 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.803 -0.919 . . . . 15.0 110.803 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.4 m -66.92 -46.05 76.03 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.469 -1.018 . . . . 15.0 110.732 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.35 -31.82 29.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.52 -0.738 . . . . 15.0 110.711 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD21 ' A' ' 14' ' ' LEU . 72.6 mt -65.47 141.62 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.57 -0.706 . . . . 15.0 109.892 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -101.7 -43.39 5.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.809 -0.557 . . . . 15.0 110.271 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -146.03 147.25 31.44 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.698 -0.626 . . . . 15.0 110.71 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.47 129.76 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.689 -0.632 . . . . 15.0 110.217 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -131.52 145.18 51.62 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.624 -0.673 . . . . 15.0 110.344 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.19 144.09 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.64 -0.663 . . . . 15.0 109.783 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.8 m -93.54 -35.78 12.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 15.0 110.256 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.18 152.08 61.03 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 120.175 -0.61 . . . . 15.0 110.256 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.51 148.52 73.06 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.629 1.331 . . . . 15.0 110.31 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.5 156.64 57.81 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.515 1.271 . . . . 15.0 110.26 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HE3' HG21 ' A' ' 5' ' ' THR . 37.7 mttm -95.47 156.79 37.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.607 -0.683 . . . . 15.0 110.083 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.81 137.67 46.09 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 O-C-N 123.665 1.35 . . . . 15.0 110.416 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -113.01 -27.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.711 -0.618 . . . . 15.0 110.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 83.2 mtp . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.986 -1.006 . . . . 15.0 110.239 178.571 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.548 HD23 ' HA3' ' A' ' 3' ' ' GLY . 14.9 tp . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.917 0.389 . . . . 15.0 110.127 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -103.89 33.78 3.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 15.0 110.467 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -97.2 143.23 25.78 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.772 . . . . 15.0 110.124 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.13 -41.03 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.455 1.239 . . . . 15.0 110.534 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -71.92 -35.18 69.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 15.0 109.954 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.548 ' HA3' HD23 ' A' ' -2' ' ' LEU . . . -70.23 -29.54 70.24 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.93 -1.268 . . . . 15.0 109.93 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.01 -42.23 98.29 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.862 -1.295 . . . . 15.0 109.862 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -143.02 122.91 7.81 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.674 -0.898 . . . . 15.0 110.263 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -68.9 149.05 71.89 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.276 1.145 . . . . 15.0 110.218 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -64.21 -33.82 76.68 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.618 -0.676 . . . . 15.0 110.156 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.409 ' HA ' HD23 ' A' ' 26' ' ' LEU . 84.0 mt -65.66 137.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.456 -0.777 . . . . 15.0 109.417 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.98 -2.21 59.81 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.805 -0.918 . . . . 15.0 110.805 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m -86.68 158.43 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.665 1.232 . . . . 15.0 110.405 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' HD12 ' A' ' 25' ' ' ILE . 30.2 mtmm -87.26 133.57 33.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.599 . . . . 15.0 110.123 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.9 mt -134.09 147.69 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.443 -0.786 . . . . 15.0 110.086 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -116.69 130.39 56.7 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.548 -0.538 . . . . 15.0 109.548 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.652 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -119.44 136.79 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.717 -0.614 . . . . 15.0 110.18 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -113.4 122.55 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.168 -0.679 . . . . 15.0 109.168 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -93.5 170.98 9.19 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.233 0.54 . . . . 15.0 110.755 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -61.17 -16.47 45.03 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.608 -0.682 . . . . 15.0 111.505 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.93 13.67 10.44 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.233 -0.917 . . . . 15.0 111.338 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 56.38 29.72 15.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.257 -0.902 . . . . 15.0 110.718 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 45' ' ' GLY . 86.2 mt -104.98 143.34 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.787 -0.82 . . . . 15.0 108.787 171.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -103.98 122.23 44.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.805 -0.559 . . . . 15.0 110.419 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -110.96 132.27 54.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.755 -0.591 . . . . 15.0 109.673 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.0 tt0 -115.97 140.62 49.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 15.0 109.794 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.56 -178.87 38.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.883 -1.687 . . . . 15.0 108.883 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.6 mm -109.07 142.56 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.43 -1.041 . . . . 15.0 109.78 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 29' ' ' ILE . 13.0 tp -66.24 109.21 2.57 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.736 -0.603 . . . . 15.0 110.258 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -91.9 -52.01 4.93 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.343 -0.543 . . . . 15.0 110.386 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -144.33 143.88 31.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.726 . . . . 15.0 110.517 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.834 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.24 125.11 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.744 -0.598 . . . . 15.0 109.702 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.1 97.48 6.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 15.0 109.776 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 -36.37 71.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 15.0 110.428 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -29.39 67.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.561 -0.712 . . . . 15.0 111.153 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 93.8 m-20 -116.14 14.08 15.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.528 -0.732 . . . . 15.0 111.544 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t 50.03 49.32 20.56 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.162 -0.962 . . . . 15.0 111.175 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.723 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -132.63 147.77 52.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.473 -0.767 . . . . 15.0 110.504 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.21 138.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.556 -0.715 . . . . 15.0 109.526 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.33 128.36 55.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.665 -0.647 . . . . 15.0 109.844 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 26' ' ' LEU . 95.3 mt -116.85 137.53 52.14 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.906 -0.496 . . . . 15.0 109.776 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.6 164.47 13.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.811 -0.556 . . . . 15.0 109.772 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 51.79 56.91 7.13 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.722 -0.611 . . . . 15.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -120.35 148.7 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.563 -0.711 . . . . 15.0 110.253 -174.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -139.55 150.67 45.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.739 -0.6 . . . . 15.0 110.291 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.5 p -98.5 131.22 44.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.819 -0.55 . . . . 15.0 109.804 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -71.66 -40.37 69.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.543 -0.723 . . . . 15.0 110.774 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 20' ' ' ILE . . . 167.74 -179.18 41.26 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.041 -1.224 . . . . 15.0 110.041 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.2 p -116.63 6.2 13.36 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.811 -0.817 . . . . 15.0 110.965 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.09 -19.34 61.34 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.245 -0.909 . . . . 15.0 111.514 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.07 -32.11 69.49 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.284 -0.885 . . . . 15.0 110.467 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.15 95.08 7.57 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.708 -0.62 . . . . 15.0 110.039 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.7 140.76 91.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.536 1.282 . . . . 15.0 110.945 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.5 p -129.51 165.16 22.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.71 -0.619 . . . . 15.0 110.141 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.69 -1.73 32.56 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.683 -0.635 . . . . 15.0 111.242 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -112.19 106.91 55.98 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.159 -0.963 . . . . 15.0 109.722 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -66.43 133.85 33.84 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.429 1.226 . . . . 15.0 110.691 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -97.77 129.96 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.596 . . . . 15.0 109.545 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.09 154.65 94.8 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.637 -0.664 . . . . 15.0 110.252 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -62.15 141.35 88.04 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.578 1.304 . . . . 15.0 110.568 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -126.78 121.23 31.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.654 -0.654 . . . . 15.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -117.26 31.23 6.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.723 -0.611 . . . . 15.0 110.269 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -127.27 163.05 24.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.576 -0.703 . . . . 15.0 110.138 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.1 m -110.24 154.92 22.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.694 -0.629 . . . . 15.0 110.198 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.689 ' CG ' HD11 ' A' ' 65' ' ' ILE . 89.9 m-85 -100.37 128.13 46.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.67 -0.644 . . . . 15.0 109.982 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -68.31 -41.99 80.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.871 -0.518 . . . . 15.0 110.674 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -150.47 122.01 7.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.491 -0.756 . . . . 15.0 110.536 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.689 HD11 ' CG ' ' A' ' 62' ' ' PHE . 96.4 mt -130.75 147.35 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.658 -0.651 . . . . 15.0 109.57 172.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -109.85 136.64 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.763 -0.586 . . . . 15.0 109.929 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -127.71 140.64 51.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.725 -0.61 . . . . 15.0 109.975 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.723 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.4 mtt85 -108.11 152.81 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 15.0 110.153 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.2 -25.99 48.86 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.731 -0.948 . . . . 15.0 110.731 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 m -66.56 -45.99 77.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.527 -0.984 . . . . 15.0 110.747 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.97 -30.33 31.71 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.606 -0.684 . . . . 15.0 110.726 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 14' ' ' LEU . 73.2 mt -68.71 139.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.586 -0.696 . . . . 15.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.83 -43.55 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.754 -0.591 . . . . 15.0 110.261 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.17 141.82 42.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.718 -0.614 . . . . 15.0 110.505 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.12 127.61 40.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.735 -0.603 . . . . 15.0 110.087 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -129.15 136.34 50.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 15.0 110.133 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.58 144.01 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.625 -0.672 . . . . 15.0 109.834 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 97.0 m -83.44 -37.09 23.65 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.67 -0.644 . . . . 15.0 110.039 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.2 117.51 68.88 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.721 -0.612 . . . . 15.0 109.872 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.91 150.93 84.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.299 1.157 . . . . 15.0 110.698 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -70.37 156.68 61.22 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.664 1.35 . . . . 15.0 110.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -97.05 157.85 34.3 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.743 -0.598 . . . . 15.0 110.136 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.08 139.01 49.39 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.621 1.327 . . . . 15.0 110.392 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -126.47 158.69 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.69 -0.631 . . . . 15.0 110.274 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.6 ttp . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.98 -1.01 . . . . 15.0 110.253 179.615 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.041 0.448 . . . . 15.0 110.135 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -162.04 178.04 9.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.694 -0.629 . . . . 15.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.19 150.03 38.44 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.715 -0.616 . . . . 15.0 109.994 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -60.67 -40.28 56.63 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.42 1.221 . . . . 15.0 110.735 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.9 m -69.25 -38.92 78.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.669 . . . . 15.0 110.077 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.31 -33.52 56.42 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.68 -1.368 . . . . 15.0 109.68 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.07 -34.61 87.15 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.965 -1.254 . . . . 15.0 109.965 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -108.28 122.88 39.14 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.697 -0.884 . . . . 15.0 110.346 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.07 149.09 40.84 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.375 1.198 . . . . 15.0 110.346 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -62.23 -33.6 74.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.642 -0.661 . . . . 15.0 110.276 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 26' ' ' LEU . 84.9 mt -65.29 138.5 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.388 -0.82 . . . . 15.0 109.351 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.33 -2.24 60.95 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.699 -0.961 . . . . 15.0 110.699 -173.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.5 m -82.92 159.62 22.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.294 . . . . 15.0 110.44 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -84.58 131.82 34.58 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.786 -0.571 . . . . 15.0 110.346 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.8 mt -133.86 147.33 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.523 -0.736 . . . . 15.0 109.93 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -117.18 130.27 56.49 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.505 -0.554 . . . . 15.0 109.505 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -119.11 135.68 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.736 -0.603 . . . . 15.0 110.322 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.4 mt -108.07 119.78 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.953 -0.758 . . . . 15.0 108.953 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -90.83 172.61 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.287 0.565 . . . . 15.0 110.902 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.25 -19.13 53.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.605 -0.684 . . . . 15.0 111.416 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 15.79 9.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.855 . . . . 15.0 111.318 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 57.8 29.27 17.19 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.289 -0.882 . . . . 15.0 110.786 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.443 HG12 HG22 ' A' ' 46' ' ' THR . 85.7 mt -105.1 146.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.07 120.68 42.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.759 -0.588 . . . . 15.0 110.465 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -112.03 133.98 53.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.827 -0.546 . . . . 15.0 109.713 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.1 tt0 -116.2 140.61 49.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.472 -0.767 . . . . 15.0 109.828 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.73 -178.82 38.98 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.962 -1.655 . . . . 15.0 108.962 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -107.39 141.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.466 -1.02 . . . . 15.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.82 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -66.23 108.93 2.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.748 -0.595 . . . . 15.0 110.201 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.83 -51.94 4.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.805 -0.559 . . . . 15.0 110.486 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.4 p -143.27 142.65 31.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.624 . . . . 15.0 110.481 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 HD21 ' A' ' 26' ' ' LEU . 73.3 mt -115.75 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 15.0 109.682 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.06 97.98 7.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.635 -0.665 . . . . 15.0 109.86 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -71.97 -36.12 69.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.78 -0.575 . . . . 15.0 110.456 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -58.75 -29.5 66.79 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.493 -0.754 . . . . 15.0 111.108 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -116.44 14.14 15.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.617 -0.677 . . . . 15.0 111.495 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m 49.9 49.56 20.02 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.174 -0.954 . . . . 15.0 111.152 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.725 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.4 p -132.54 147.79 52.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 15.0 110.539 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.59 137.87 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.661 . . . . 15.0 109.554 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.558 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.25 127.98 55.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.647 . . . . 15.0 109.888 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.3 mt -116.8 136.14 53.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.919 -0.488 . . . . 15.0 109.771 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.12 14.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.761 -0.587 . . . . 15.0 109.901 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 51.76 61.64 3.11 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.656 -0.653 . . . . 15.0 110.475 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -122.33 146.4 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.538 -0.727 . . . . 15.0 110.383 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -135.13 148.56 49.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.841 -0.537 . . . . 15.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.5 p -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 15.0 109.781 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -70.97 -40.35 72.0 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.072 -0.651 . . . . 15.0 110.589 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 170.94 33.2 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.789 -1.325 . . . . 15.0 109.789 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 55' ' ' ILE . 44.2 p -118.04 -19.65 9.02 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.775 -0.838 . . . . 15.0 110.938 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.23 -26.92 69.02 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.323 -0.861 . . . . 15.0 111.016 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.74 -31.8 69.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.381 -0.824 . . . . 15.0 110.458 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -120.53 95.07 49.03 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.719 -0.613 . . . . 15.0 109.877 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.92 131.6 35.79 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 O-C-N 123.401 1.211 . . . . 15.0 110.858 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 p -131.02 165.1 23.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.565 . . . . 15.0 110.023 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -77.83 -1.38 31.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.712 -0.618 . . . . 15.0 111.461 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -117.87 106.93 44.96 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.229 -0.919 . . . . 15.0 109.824 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.48 139.22 85.16 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.318 1.167 . . . . 15.0 110.933 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 46' ' ' THR . 50.8 mm -120.63 146.0 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.669 -0.645 . . . . 15.0 109.693 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.92 109.86 48.75 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.728 -0.607 . . . . 15.0 110.118 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.77 141.42 54.3 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.356 1.187 . . . . 15.0 110.401 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -130.9 151.26 51.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.742 -0.599 . . . . 15.0 110.182 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -99.95 31.75 3.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.744 -0.597 . . . . 15.0 110.323 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -111.73 151.98 28.3 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.606 -0.684 . . . . 15.0 110.214 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.4 m -103.05 146.87 27.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.654 -0.654 . . . . 15.0 110.111 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.11 133.57 46.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.637 -0.664 . . . . 15.0 110.139 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.73 -39.78 84.25 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.832 -0.543 . . . . 15.0 110.78 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.522 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.5 t80 -151.71 122.37 7.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 15.0 110.832 -175.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -129.4 147.24 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.628 -0.67 . . . . 15.0 109.59 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.5 mt -110.65 136.28 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.692 -0.63 . . . . 15.0 109.849 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -127.02 140.64 52.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.763 -0.586 . . . . 15.0 109.922 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HG2' HG22 ' A' ' 35' ' ' THR . 83.2 mtp180 -107.73 151.66 25.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.18 -26.01 48.77 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.753 -0.939 . . . . 15.0 110.753 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -66.45 -45.95 78.06 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.485 -1.009 . . . . 15.0 110.718 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.1 -31.88 30.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.644 -0.66 . . . . 15.0 110.738 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.64 HG12 HD21 ' A' ' 14' ' ' LEU . 71.4 mt -65.89 141.25 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.675 -0.641 . . . . 15.0 109.859 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -104.71 -43.18 5.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.76 -0.587 . . . . 15.0 110.251 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.6 147.35 34.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.609 -0.682 . . . . 15.0 110.647 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -131.0 130.66 43.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.706 -0.621 . . . . 15.0 110.248 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -129.78 140.43 51.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 15.0 110.304 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.23 144.0 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.654 -0.654 . . . . 15.0 109.844 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 99.7 m -91.21 -37.11 13.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.693 -0.629 . . . . 15.0 110.259 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.18 150.62 58.34 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 15.0 109.975 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 32.5 Cg_endo -69.18 136.3 34.17 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.592 1.311 . . . . 15.0 110.291 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 80' ' ' PRO . 16.6 Cg_exo -63.87 151.09 86.73 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.371 1.195 . . . . 15.0 110.491 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -102.05 157.14 34.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.725 -0.61 . . . . 15.0 110.213 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.88 141.16 83.46 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.579 1.305 . . . . 15.0 110.598 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -127.22 150.43 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 15.0 110.238 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 117.966 -1.016 . . . . 15.0 110.35 179.862 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.03 0.443 . . . . 15.0 110.202 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.42 -30.52 70.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.652 -0.655 . . . . 15.0 110.553 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.89 150.09 85.86 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 15.0 110.145 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.08 -41.01 14.18 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.547 1.288 . . . . 15.0 110.449 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.0 p -69.23 -34.09 74.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.67 -0.644 . . . . 15.0 110.067 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.99 -31.06 44.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.839 -1.304 . . . . 15.0 109.839 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.51 96.57 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.085 -1.206 . . . . 15.0 110.085 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -111.26 122.81 36.69 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.648 -0.913 . . . . 15.0 110.124 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.05 149.03 40.86 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.346 1.182 . . . . 15.0 110.388 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -66.19 -31.94 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.637 -0.664 . . . . 15.0 110.171 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.6 mt -64.16 137.54 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.365 -0.834 . . . . 15.0 109.622 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.15 -2.2 61.25 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.906 -0.877 . . . . 15.0 110.906 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m -95.85 153.88 17.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.079 -1.248 . . . . 15.0 110.216 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -87.0 133.5 33.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.69 -0.631 . . . . 15.0 110.437 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.89 147.45 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 15.0 109.991 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.7 t -110.83 130.17 55.65 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -119.83 130.65 55.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.845 -0.535 . . . . 15.0 110.325 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.71 119.33 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -92.26 170.61 9.67 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.307 0.575 . . . . 15.0 110.948 -171.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -60.6 -17.56 47.52 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.62 -0.675 . . . . 15.0 111.513 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.4 15.34 9.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.222 -0.923 . . . . 15.0 111.278 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 57.25 29.37 16.63 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 15.0 110.67 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.41 144.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -105.67 119.79 40.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.727 -0.608 . . . . 15.0 110.453 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -111.85 137.44 49.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.773 -0.58 . . . . 15.0 109.566 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.8 tt0 -121.42 140.49 52.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 15.0 109.938 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.87 39.84 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.124 -1.59 . . . . 15.0 109.124 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.49 142.37 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.495 -1.003 . . . . 15.0 109.708 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 29' ' ' ILE . 20.4 tp -65.21 112.51 3.47 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.721 -0.612 . . . . 15.0 110.295 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -96.03 -52.07 4.19 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.373 -0.531 . . . . 15.0 110.35 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -143.92 143.28 31.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.637 -0.664 . . . . 15.0 110.489 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.97 126.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.733 -0.604 . . . . 15.0 109.77 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -112.1 96.18 5.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.598 -0.689 . . . . 15.0 109.79 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.3 -36.78 74.54 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 15.0 110.369 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -58.91 -28.96 66.69 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.556 -0.715 . . . . 15.0 111.075 -171.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.16 13.99 15.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.722 . . . . 15.0 111.484 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t 49.96 47.27 23.51 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.241 -0.912 . . . . 15.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.2 p -131.43 149.56 52.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.447 -0.783 . . . . 15.0 110.471 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.41 140.28 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 15.0 109.649 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.05 129.12 56.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.689 -0.632 . . . . 15.0 109.935 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.4 mt -116.87 138.84 51.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.826 -0.435 . . . . 15.0 109.826 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.54 165.35 13.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.732 -0.605 . . . . 15.0 109.873 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 51.86 60.97 3.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.631 -0.668 . . . . 15.0 110.36 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -119.99 145.27 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 15.0 110.523 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.549 ' CG ' HG23 ' A' ' 61' ' ' THR . 25.6 mtt-85 -127.36 150.98 49.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 15.0 109.808 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.5 p -102.39 129.67 48.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.753 -0.592 . . . . 15.0 109.927 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -71.6 -40.01 70.12 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.116 -0.633 . . . . 15.0 110.416 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.81 166.36 26.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.774 -1.33 . . . . 15.0 109.774 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.68 HG21 HG13 ' A' ' 55' ' ' ILE . 37.4 p -118.1 6.26 12.05 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.734 -0.862 . . . . 15.0 111.27 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -55.19 -24.22 25.93 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.24 -0.913 . . . . 15.0 111.31 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -62.52 -32.89 73.9 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.511 -0.743 . . . . 15.0 110.378 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -135.99 94.2 14.66 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 15.0 110.038 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.09 134.99 55.92 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.421 1.222 . . . . 15.0 110.641 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.0 p -129.77 165.02 22.77 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.635 . . . . 15.0 110.202 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.9 -2.91 39.08 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.724 -0.61 . . . . 15.0 111.442 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -109.1 107.02 59.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.095 -1.003 . . . . 15.0 110.058 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.71 139.42 80.63 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.321 1.169 . . . . 15.0 110.647 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.68 HG13 HG21 ' A' ' 46' ' ' THR . 50.9 mm -95.5 143.45 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.675 -0.641 . . . . 15.0 109.783 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 158.09 86.38 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.722 -0.611 . . . . 15.0 110.216 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.66 165.11 6.63 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.587 1.309 . . . . 15.0 110.785 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -92.55 20.03 6.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.624 -0.673 . . . . 15.0 111.155 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.92 -34.55 73.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.227 -0.921 . . . . 15.0 109.96 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -103.37 149.58 24.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.707 -0.621 . . . . 15.0 110.095 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.549 HG23 ' CG ' ' A' ' 42' ' ' ARG . 18.9 m -105.94 163.3 12.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.792 -0.568 . . . . 15.0 110.295 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -96.48 125.24 40.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.671 -0.643 . . . . 15.0 109.883 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -67.56 -41.14 84.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.868 -0.52 . . . . 15.0 110.981 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -154.8 122.0 5.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.757 . . . . 15.0 110.676 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.6 mt -129.64 147.9 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.66 -0.65 . . . . 15.0 109.767 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.22 136.89 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.724 -0.61 . . . . 15.0 109.917 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.25 143.84 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.768 -0.583 . . . . 15.0 109.905 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.9 mtt85 -109.49 151.27 26.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.682 -0.637 . . . . 15.0 110.133 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.74 -26.02 56.83 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.697 -0.961 . . . . 15.0 110.697 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -66.76 -40.59 88.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.462 -1.022 . . . . 15.0 110.724 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -86.41 -31.78 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.617 -0.677 . . . . 15.0 110.712 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.69 138.78 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.592 -0.692 . . . . 15.0 109.956 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -99.88 -41.5 7.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.734 -0.604 . . . . 15.0 110.116 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -147.33 145.1 29.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.677 -0.639 . . . . 15.0 110.628 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -133.3 130.36 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.725 -0.609 . . . . 15.0 110.038 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 22.0 m -132.21 144.6 50.76 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.62 -0.675 . . . . 15.0 110.514 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.62 144.02 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.594 -0.691 . . . . 15.0 109.688 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.5 m -95.48 -36.53 11.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.66 . . . . 15.0 110.373 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -84.26 117.58 69.06 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.741 -0.599 . . . . 15.0 110.048 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.21 159.7 51.21 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.332 1.174 . . . . 15.0 110.331 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.84 155.86 68.19 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.677 1.356 . . . . 15.0 110.301 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -89.64 157.43 46.73 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.701 -0.625 . . . . 15.0 110.191 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.07 145.68 74.24 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.708 1.373 . . . . 15.0 110.456 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.39 -35.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.752 -0.593 . . . . 15.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 118.015 -0.993 . . . . 15.0 110.185 179.784 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.01 0.433 . . . . 15.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -150.81 -46.89 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.7 -0.625 . . . . 15.0 110.261 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -75.0 150.06 85.6 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.744 -0.598 . . . . 15.0 110.071 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.2 -32.13 52.59 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.569 1.3 . . . . 15.0 110.534 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -66.69 -32.65 74.09 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.609 -0.682 . . . . 15.0 110.21 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.43 -30.25 76.24 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.09 -1.204 . . . . 15.0 110.09 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.58 93.52 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.954 -1.259 . . . . 15.0 109.954 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 m -142.92 122.94 7.89 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.618 -0.931 . . . . 15.0 110.077 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.02 144.08 33.55 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.405 1.213 . . . . 15.0 110.384 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.465 ' C ' HD23 ' A' ' 26' ' ' LEU . 98.5 m-85 -69.13 -31.97 71.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.665 -0.647 . . . . 15.0 110.095 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.448 ' N ' HD23 ' A' ' 26' ' ' LEU . 85.7 mt -64.45 135.54 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.447 -0.783 . . . . 15.0 109.692 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.64 -2.15 62.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.977 -0.849 . . . . 15.0 110.977 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.2 m -99.47 153.98 18.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.035 -1.273 . . . . 15.0 110.534 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -83.72 132.54 34.85 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.752 -0.593 . . . . 15.0 110.035 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -132.66 145.99 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.52 -0.738 . . . . 15.0 110.114 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -115.07 129.93 56.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HG12 ' A' ' 72' ' ' ILE . 10.8 tp -121.9 136.3 54.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.675 -0.641 . . . . 15.0 110.355 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.11 121.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.021 -0.733 . . . . 15.0 109.021 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.69 172.43 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.309 0.576 . . . . 15.0 110.907 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -59.98 -19.26 51.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.629 -0.67 . . . . 15.0 111.405 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.02 16.76 7.75 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.257 -0.902 . . . . 15.0 111.215 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 57.48 28.42 15.47 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.237 -0.914 . . . . 15.0 110.867 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.809 HG12 HG22 ' A' ' 46' ' ' THR . 55.5 mt -105.0 147.23 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -105.64 121.38 43.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 15.0 110.526 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -112.32 136.23 52.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.833 -0.542 . . . . 15.0 109.786 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.4 tt0 -117.75 140.54 49.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 15.0 109.779 173.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.19 -178.89 39.27 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.029 -1.628 . . . . 15.0 109.029 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.18 143.03 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.386 -1.067 . . . . 15.0 109.793 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 29' ' ' ILE . 12.1 tp -65.95 114.97 5.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.763 -0.585 . . . . 15.0 110.19 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -97.62 -52.05 3.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.806 -0.559 . . . . 15.0 110.381 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -144.56 143.35 30.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.717 -0.614 . . . . 15.0 110.541 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -115.43 125.23 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.717 -0.614 . . . . 15.0 109.613 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.08 97.2 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.605 -0.684 . . . . 15.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -70.89 -36.56 72.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.707 -0.62 . . . . 15.0 110.383 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.87 -29.36 66.93 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.572 -0.705 . . . . 15.0 111.015 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.64 13.91 16.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 15.0 111.461 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t 50.06 47.21 23.76 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.195 -0.941 . . . . 15.0 111.174 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.68 HG22 ' HG2' ' A' ' 68' ' ' ARG . 16.8 p -131.86 148.72 52.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.501 -0.75 . . . . 15.0 110.606 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.61 138.22 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 15.0 109.535 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -110.51 128.52 55.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.646 -0.658 . . . . 15.0 109.905 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.9 mt -116.79 138.65 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.889 -0.507 . . . . 15.0 109.791 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.73 164.68 13.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.76 -0.587 . . . . 15.0 109.791 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 51.81 56.91 7.12 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.644 -0.66 . . . . 15.0 110.375 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.0 p -120.66 148.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.593 -0.692 . . . . 15.0 110.303 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -139.71 150.07 44.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.804 -0.56 . . . . 15.0 110.211 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.4 p -97.59 132.06 43.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.77 -0.581 . . . . 15.0 109.771 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -72.82 -40.2 66.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.552 -0.718 . . . . 15.0 110.569 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 171.16 33.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.856 -1.298 . . . . 15.0 109.856 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.827 HG21 HG13 ' A' ' 55' ' ' ILE . 43.8 p -118.01 3.44 12.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.744 -0.856 . . . . 15.0 111.066 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.77 -30.42 71.07 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.287 -0.883 . . . . 15.0 111.031 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.77 -33.69 73.34 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.329 -0.857 . . . . 15.0 110.52 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -141.24 95.05 7.51 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.753 -0.592 . . . . 15.0 110.038 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.06 139.29 89.9 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.385 1.203 . . . . 15.0 110.997 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.4 p -128.02 165.13 20.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.847 -0.533 . . . . 15.0 110.077 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.82 -1.88 33.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.664 -0.648 . . . . 15.0 111.315 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -107.94 106.97 59.7 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.222 -0.924 . . . . 15.0 109.939 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.84 140.68 74.8 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.403 1.212 . . . . 15.0 110.684 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.827 HG13 HG21 ' A' ' 46' ' ' THR . 50.0 mm -113.58 141.64 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.693 -0.629 . . . . 15.0 109.731 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.67 158.01 86.8 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.701 -0.624 . . . . 15.0 110.143 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.14 164.66 14.08 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 123.586 1.308 . . . . 15.0 110.713 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -89.22 144.67 25.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.698 -0.626 . . . . 15.0 110.112 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -157.62 -46.09 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.64 -0.663 . . . . 15.0 110.31 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.92 176.64 8.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.625 -0.672 . . . . 15.0 110.376 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 m -103.04 166.0 10.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.78 -0.575 . . . . 15.0 110.161 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.711 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.1 m-85 -102.02 128.11 48.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.604 -0.685 . . . . 15.0 110.078 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.09 -42.37 80.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.86 -0.525 . . . . 15.0 110.691 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -150.98 121.89 7.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.507 -0.746 . . . . 15.0 110.631 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.711 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.3 mt -130.73 147.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.681 -0.637 . . . . 15.0 109.698 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.04 135.74 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.719 -0.613 . . . . 15.0 109.901 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -125.74 140.77 52.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 15.0 109.991 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.68 ' HG2' HG22 ' A' ' 35' ' ' THR . 92.6 mtt-85 -104.37 151.07 23.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.679 -0.638 . . . . 15.0 110.087 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.13 -25.97 55.03 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -65.33 -45.0 86.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.446 -1.032 . . . . 15.0 110.778 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.96 -31.47 31.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.549 -0.72 . . . . 15.0 110.696 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.634 HG12 HD21 ' A' ' 14' ' ' LEU . 74.8 mt -65.88 136.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.5 -0.75 . . . . 15.0 109.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -104.88 -39.85 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 15.0 110.253 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.29 142.69 33.86 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.659 -0.65 . . . . 15.0 110.56 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.39 127.41 39.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.714 -0.616 . . . . 15.0 110.164 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -129.5 139.06 51.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 15.0 110.251 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.99 144.03 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 15.0 109.782 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.05 -37.14 16.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.661 -0.649 . . . . 15.0 110.184 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -84.31 117.51 68.9 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.597 -0.69 . . . . 15.0 109.868 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.07 154.39 62.49 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.318 1.167 . . . . 15.0 110.348 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -63.87 156.68 56.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.573 1.302 . . . . 15.0 110.454 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -86.65 142.56 34.87 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.697 -0.627 . . . . 15.0 109.964 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.75 133.17 28.72 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.405 1.213 . . . . 15.0 110.407 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.9 tp -129.56 139.21 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.739 -0.601 . . . . 15.0 110.082 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.2 mmm . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.94 -1.028 . . . . 15.0 110.22 179.773 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 20.4 tp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.906 0.384 . . . . 15.0 110.152 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.44 137.05 55.6 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.752 -0.593 . . . . 15.0 110.255 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -105.02 150.1 38.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 15.0 110.216 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.64 -29.3 60.53 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.497 1.261 . . . . 15.0 110.638 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -63.95 -30.54 71.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.561 -0.712 . . . . 15.0 110.422 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.1 69.92 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.367 -1.093 . . . . 15.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.41 -30.6 71.82 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.235 -1.146 . . . . 15.0 110.235 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -66.94 139.76 95.77 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.591 -0.946 . . . . 15.0 109.936 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.22 124.94 13.23 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.375 1.197 . . . . 15.0 110.672 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.25 -19.87 63.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.833 -0.542 . . . . 15.0 110.854 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' N ' HD23 ' A' ' 26' ' ' LEU . 87.3 mt -60.68 138.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.087 -1.008 . . . . 15.0 110.028 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.31 -2.11 74.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m -103.43 151.81 22.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.712 1.256 . . . . 15.0 110.67 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -78.54 130.02 35.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.874 -0.516 . . . . 15.0 110.1 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' CD1' HD13 ' A' ' 26' ' ' LEU . 93.6 mt -132.75 147.85 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.506 -0.746 . . . . 15.0 109.97 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 t -116.21 133.87 55.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.577 -0.527 . . . . 15.0 109.577 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 72' ' ' ILE . 11.1 tp -124.14 136.52 54.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.737 -0.602 . . . . 15.0 110.375 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.4 mt -108.81 122.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -94.3 172.93 7.9 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.277 0.56 . . . . 15.0 110.988 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.7 -20.01 53.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.624 -0.672 . . . . 15.0 111.466 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 16.91 8.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.35 -0.843 . . . . 15.0 111.271 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 58.03 28.23 16.0 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.301 -0.874 . . . . 15.0 110.86 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.594 HG12 HG22 ' A' ' 46' ' ' THR . 82.6 mt -105.02 147.76 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -106.08 121.54 44.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.779 -0.576 . . . . 15.0 110.403 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -112.18 136.78 51.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.769 -0.582 . . . . 15.0 109.756 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.9 tt0 -118.49 140.68 49.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.507 -0.745 . . . . 15.0 109.725 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.55 -178.9 38.94 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.11 -1.596 . . . . 15.0 109.11 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.6 139.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.568 -0.96 . . . . 15.0 109.54 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.821 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -66.03 115.4 6.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 15.0 110.253 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -97.94 -52.05 3.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.865 -0.522 . . . . 15.0 110.403 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.6 p -144.46 143.39 30.86 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.615 -0.678 . . . . 15.0 110.637 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.821 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -116.58 127.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.633 -0.667 . . . . 15.0 109.679 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -112.12 95.42 5.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 15.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -69.26 -38.04 78.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.79 -0.569 . . . . 15.0 110.419 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.53 -28.96 67.55 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.582 -0.699 . . . . 15.0 111.1 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' THR . 94.8 m-20 -114.26 13.91 17.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.473 -0.767 . . . . 15.0 111.554 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 m 50.0 45.65 25.09 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.171 -0.956 . . . . 15.0 111.309 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.742 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.4 p -131.88 149.74 52.36 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.463 -0.773 . . . . 15.0 110.666 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.86 140.64 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.582 -0.699 . . . . 15.0 109.603 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.07 129.47 56.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.621 -0.675 . . . . 15.0 110.015 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.9 mt -116.89 139.12 51.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.938 -0.477 . . . . 15.0 109.753 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.82 162.98 16.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.698 -0.626 . . . . 15.0 109.868 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 51.89 59.34 4.62 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.666 -0.647 . . . . 15.0 110.488 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.51 148.03 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.592 -0.693 . . . . 15.0 110.314 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -136.45 149.55 48.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.901 -0.499 . . . . 15.0 110.073 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -97.21 131.75 43.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.714 -0.616 . . . . 15.0 109.724 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -73.88 -40.37 63.24 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.543 -0.723 . . . . 15.0 110.702 -173.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 174.49 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.894 -1.283 . . . . 15.0 109.894 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.71 HG21 HG13 ' A' ' 55' ' ' ILE . 42.4 p -115.9 6.05 14.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.774 -0.839 . . . . 15.0 110.961 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -63.99 -27.01 68.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.236 -0.915 . . . . 15.0 111.123 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.62 -35.66 76.7 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.385 -0.822 . . . . 15.0 110.311 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -142.74 95.09 6.43 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.821 -0.55 . . . . 15.0 109.82 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.36 142.83 87.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.471 1.248 . . . . 15.0 110.702 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.1 p -122.13 165.1 16.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.827 -0.546 . . . . 15.0 110.094 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.82 -2.22 35.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.674 -0.641 . . . . 15.0 111.351 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -113.28 136.45 21.84 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.994 . . . . 15.0 109.972 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.39 142.98 51.11 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.442 1.233 . . . . 15.0 110.41 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 46' ' ' THR . 50.8 mm -114.12 145.99 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.638 -0.664 . . . . 15.0 109.689 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.41 158.12 59.95 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.639 -0.663 . . . . 15.0 110.461 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.41 165.05 9.9 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 O-C-N 123.519 1.273 . . . . 15.0 110.764 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 -107.36 32.4 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.682 -0.636 . . . . 15.0 110.533 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.66 31.17 4.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 15.0 110.35 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.71 152.0 41.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.655 -0.653 . . . . 15.0 110.154 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 m -110.46 141.64 43.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.656 -0.653 . . . . 15.0 110.173 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 65' ' ' ILE . 85.1 m-85 -102.06 128.04 48.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 15.0 110.066 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.2 -42.88 79.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.79 -0.569 . . . . 15.0 110.667 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.4 t80 -150.48 121.93 7.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 15.0 110.606 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' CG ' ' A' ' 62' ' ' PHE . 25.8 mt -130.87 147.75 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 15.0 109.554 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.6 mt -110.58 136.05 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.741 -0.599 . . . . 15.0 109.86 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -126.08 142.64 51.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.631 . . . . 15.0 109.949 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.8 mtt180 -107.34 152.2 24.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.646 -0.659 . . . . 15.0 110.143 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.01 55.02 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.7 m -65.56 -45.54 82.92 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.447 -1.031 . . . . 15.0 110.766 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.02 -31.59 30.94 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.63 -0.669 . . . . 15.0 110.637 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 14' ' ' LEU . 69.7 mt -66.66 138.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.545 -0.722 . . . . 15.0 109.814 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -105.29 -40.07 5.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.652 . . . . 15.0 110.17 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 15' ' ' ILE . 18.4 t0 -143.19 142.83 31.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 15.0 110.665 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -128.41 127.11 41.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.796 -0.565 . . . . 15.0 110.049 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -131.81 139.91 49.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.638 -0.664 . . . . 15.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.8 144.08 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.588 -0.695 . . . . 15.0 109.636 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -95.28 -37.11 11.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.604 -0.685 . . . . 15.0 110.272 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.49 117.48 49.03 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.639 -0.663 . . . . 15.0 110.17 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 145.73 35.08 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.294 1.155 . . . . 15.0 110.189 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.19 153.78 62.1 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.494 1.26 . . . . 15.0 110.262 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -98.2 154.7 37.56 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.796 -0.565 . . . . 15.0 110.137 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.31 149.51 75.57 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.632 1.333 . . . . 15.0 110.36 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 84' ' ' ILE . 5.3 mp -114.58 135.12 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.595 -0.69 . . . . 15.0 109.67 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.999 -1.0 . . . . 15.0 110.193 -179.926 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' -2' ' ' LEU . 7.0 tt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.992 0.425 . . . . 15.0 110.011 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLU . . . . . 0.421 ' N ' HD23 ' A' ' -2' ' ' LEU . 51.4 mt-10 -128.81 -57.32 1.18 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.628 -0.67 . . . . 15.0 110.448 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 1' ' ' PRO . 12.7 p-10 -90.48 144.74 31.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.625 -0.672 . . . . 15.0 110.426 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 0' ' ' ASP . 15.3 Cg_exo -64.47 -34.33 53.91 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.417 1.22 . . . . 15.0 110.745 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -65.6 -38.38 89.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.637 -0.664 . . . . 15.0 110.488 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.03 -37.62 60.16 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.424 -1.47 . . . . 15.0 109.424 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.96 -38.74 64.39 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.66 -1.376 . . . . 15.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -109.86 122.95 37.59 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.875 . . . . 15.0 110.387 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.96 149.16 52.68 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.355 1.187 . . . . 15.0 110.252 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -59.46 -29.79 68.06 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.605 -0.684 . . . . 15.0 110.458 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.97 138.64 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.385 -0.822 . . . . 15.0 109.445 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.9 -2.15 59.91 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.791 -0.924 . . . . 15.0 110.791 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -83.22 159.16 22.04 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.962 -1.317 . . . . 15.0 110.416 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -86.09 132.02 34.13 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.797 -0.564 . . . . 15.0 110.369 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 26' ' ' LEU . 94.5 mt -133.2 147.68 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 15.0 109.937 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -116.88 132.81 56.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.498 -0.556 . . . . 15.0 109.498 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 72' ' ' ILE . 10.9 tp -124.51 137.51 54.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.643 -0.661 . . . . 15.0 110.356 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.59 121.42 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.038 -0.727 . . . . 15.0 109.038 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -92.15 174.04 7.52 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.298 0.57 . . . . 15.0 110.94 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.54 -20.53 56.25 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.624 -0.673 . . . . 15.0 111.444 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.82 16.62 8.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.334 -0.854 . . . . 15.0 111.295 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 57.3 29.76 17.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.222 -0.924 . . . . 15.0 110.779 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 46' ' ' THR . 89.3 mt -105.1 146.71 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.996 -0.742 . . . . 15.0 108.996 172.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -104.12 119.91 39.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.823 -0.548 . . . . 15.0 110.428 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -111.44 136.32 50.75 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.756 -0.59 . . . . 15.0 109.791 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.643 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 tt0 -118.09 140.7 49.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.559 -0.713 . . . . 15.0 109.769 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.47 -178.92 38.91 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.937 -1.665 . . . . 15.0 108.937 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.0 mm -108.46 142.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.349 -1.089 . . . . 15.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 29' ' ' ILE . 20.5 tp -65.55 109.0 2.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.744 -0.597 . . . . 15.0 110.203 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -92.66 -52.05 4.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.801 -0.562 . . . . 15.0 110.439 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.59 142.91 31.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.638 -0.664 . . . . 15.0 110.422 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 26' ' ' LEU . 68.9 mt -116.72 125.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 15.0 109.661 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.17 97.3 6.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.573 -0.704 . . . . 15.0 109.781 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -71.45 -36.38 71.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.675 -0.641 . . . . 15.0 110.49 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.82 -29.79 67.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.461 -0.775 . . . . 15.0 111.043 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 93.4 m-20 -115.8 13.98 16.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.575 -0.703 . . . . 15.0 111.555 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t 49.89 48.75 21.36 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.154 -0.966 . . . . 15.0 111.266 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.711 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -131.81 148.33 52.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.477 -0.764 . . . . 15.0 110.484 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.42 139.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.66 -0.65 . . . . 15.0 109.662 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.4 128.94 56.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.77 -0.582 . . . . 15.0 109.911 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.7 mt -116.79 138.08 51.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.89 -0.506 . . . . 15.0 109.867 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.12 165.43 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.784 -0.573 . . . . 15.0 109.793 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 51.68 57.32 6.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.672 -0.642 . . . . 15.0 110.425 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -121.16 148.59 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 15.0 110.279 -173.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -140.7 152.31 45.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.724 -0.61 . . . . 15.0 110.196 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.4 p -97.42 131.26 44.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.771 -0.581 . . . . 15.0 109.795 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -70.89 -40.3 72.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.59 -0.694 . . . . 15.0 110.464 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.75 170.7 32.86 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.816 -1.314 . . . . 15.0 109.816 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 20' ' ' ILE . 71.2 p -118.01 -19.68 9.03 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.814 -0.815 . . . . 15.0 110.898 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.14 -29.53 70.87 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.282 -0.886 . . . . 15.0 110.864 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.32 -32.73 71.52 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.468 -0.77 . . . . 15.0 110.262 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 51' ' ' THR . 61.1 mtt180 -127.26 95.04 37.18 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.745 -0.597 . . . . 15.0 109.632 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -53.35 134.53 57.48 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 O-C-N 123.418 1.22 . . . . 15.0 111.482 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 49' ' ' ARG . 37.3 p -127.44 165.14 20.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.813 -0.554 . . . . 15.0 109.98 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.76 -1.66 32.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.664 -0.647 . . . . 15.0 111.319 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -113.98 106.9 52.89 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.093 -1.005 . . . . 15.0 109.929 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -66.69 131.98 27.47 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.413 1.217 . . . . 15.0 110.631 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.7 mm -124.22 144.84 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.724 -0.61 . . . . 15.0 109.618 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.07 155.97 40.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.681 -0.637 . . . . 15.0 110.279 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -62.23 143.69 94.53 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.506 1.266 . . . . 15.0 110.652 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -153.88 154.44 33.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.69 -0.631 . . . . 15.0 110.348 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -126.09 33.62 5.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.629 -0.669 . . . . 15.0 110.261 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.68 143.88 26.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.679 -0.638 . . . . 15.0 110.217 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 m -102.96 146.08 28.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.75 -0.593 . . . . 15.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.714 ' CG ' HD11 ' A' ' 65' ' ' ILE . 90.4 m-85 -102.08 128.66 48.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.744 -0.597 . . . . 15.0 110.108 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -68.14 -41.84 81.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.867 -0.521 . . . . 15.0 110.684 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -150.8 121.96 7.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 15.0 110.589 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.714 HD11 ' CG ' ' A' ' 62' ' ' PHE . 94.8 mt -131.02 147.09 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.678 -0.639 . . . . 15.0 109.487 173.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -110.14 139.19 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.655 -0.653 . . . . 15.0 109.993 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.85 142.86 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.712 -0.617 . . . . 15.0 109.941 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.711 ' HG2' HG22 ' A' ' 35' ' ' THR . 90.7 mtt180 -110.73 152.68 26.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 15.0 110.086 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.06 55.12 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.673 -0.971 . . . . 15.0 110.673 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -67.26 -40.79 86.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.44 -1.035 . . . . 15.0 110.795 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -88.34 -30.97 19.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.599 -0.688 . . . . 15.0 110.801 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 14' ' ' LEU . 70.6 mt -64.73 142.31 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.588 -0.695 . . . . 15.0 109.915 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -99.88 -44.14 6.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 15.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -146.86 147.17 30.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.686 -0.634 . . . . 15.0 110.705 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -129.18 129.95 45.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.728 -0.608 . . . . 15.0 110.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -131.46 138.89 49.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.647 -0.658 . . . . 15.0 110.346 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.75 144.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.691 -0.631 . . . . 15.0 109.792 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.3 t -90.86 -37.02 13.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.653 -0.654 . . . . 15.0 110.193 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -87.02 117.5 68.72 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 15.0 109.975 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.14 152.7 56.72 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.379 1.199 . . . . 15.0 110.343 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -64.16 156.59 58.41 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.527 1.277 . . . . 15.0 110.526 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -94.02 139.09 22.49 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.717 -0.614 . . . . 15.0 109.938 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.73 134.29 34.55 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.436 1.229 . . . . 15.0 110.488 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.5 139.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.709 -0.619 . . . . 15.0 110.15 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.026 -0.988 . . . . 15.0 110.171 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' -2' ' ' LEU . 7.2 tt . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.023 0.439 . . . . 15.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.85 -33.44 75.86 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.696 -0.628 . . . . 15.0 110.433 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.17 119.92 59.47 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.696 -0.628 . . . . 15.0 110.146 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.35 -33.67 47.02 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.348 1.183 . . . . 15.0 110.563 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 t -66.94 -39.0 87.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.613 -0.679 . . . . 15.0 110.407 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.89 -36.28 42.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.577 -1.409 . . . . 15.0 109.577 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.16 -35.31 77.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.299 . . . . 15.0 109.851 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -108.05 142.25 24.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.894 . . . . 15.0 110.304 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 149.09 42.73 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 O-C-N 123.375 1.198 . . . . 15.0 110.403 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.67 -44.59 90.23 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.621 -0.674 . . . . 15.0 110.404 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' HA ' HD23 ' A' ' 26' ' ' LEU . 83.7 mt -66.29 137.28 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.376 -0.828 . . . . 15.0 109.26 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.48 -2.19 62.63 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.815 -0.914 . . . . 15.0 110.815 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m -82.6 160.12 22.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.031 -1.276 . . . . 15.0 110.417 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -85.59 133.56 34.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.861 -0.524 . . . . 15.0 110.239 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.614 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.2 mt -133.98 147.09 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.514 -0.741 . . . . 15.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -115.54 133.81 55.67 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HG12 ' A' ' 72' ' ' ILE . 9.4 tp -125.69 137.17 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.712 -0.618 . . . . 15.0 110.424 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 87.5 mt -109.3 121.37 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.968 -0.753 . . . . 15.0 108.968 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.8 m -93.33 175.68 6.67 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.32 0.581 . . . . 15.0 111.01 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.15 -21.5 59.45 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.606 -0.684 . . . . 15.0 111.398 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 15.97 9.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.321 -0.862 . . . . 15.0 111.326 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.71 28.99 16.64 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.306 -0.871 . . . . 15.0 110.811 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 46' ' ' THR . 86.2 mt -105.0 149.59 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.151 -0.685 . . . . 15.0 109.151 172.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -106.35 121.19 43.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.798 -0.563 . . . . 15.0 110.608 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.44 141.75 45.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.802 -0.561 . . . . 15.0 109.809 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.2 tt0 -120.2 140.69 50.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.561 -0.712 . . . . 15.0 109.762 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.9 -178.94 37.88 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 108.866 -1.694 . . . . 15.0 108.866 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -109.37 143.02 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.421 -1.046 . . . . 15.0 109.742 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD21 HD11 ' A' ' 29' ' ' ILE . 12.6 tp -66.06 108.89 2.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.791 -0.568 . . . . 15.0 110.213 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -91.7 -52.02 4.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.795 -0.566 . . . . 15.0 110.407 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -144.11 142.43 30.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 15.0 110.439 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.813 HD11 HD21 ' A' ' 26' ' ' LEU . 74.6 mt -114.42 125.59 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.77 -0.581 . . . . 15.0 109.644 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -112.05 97.38 6.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.627 -0.671 . . . . 15.0 109.851 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.82 -36.25 70.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.702 -0.624 . . . . 15.0 110.546 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.79 -29.1 66.58 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.524 -0.735 . . . . 15.0 111.118 -171.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.535 ' O ' HG23 ' A' ' 35' ' ' THR . 94.6 m-20 -116.93 14.1 15.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.436 -0.79 . . . . 15.0 111.522 -176.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m 49.9 49.14 20.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.181 -0.95 . . . . 15.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.701 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.9 p -131.89 148.29 52.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.462 -0.774 . . . . 15.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.65 138.49 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.561 -0.712 . . . . 15.0 109.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.28 128.79 56.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 15.0 109.954 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.5 mt -116.84 137.22 52.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 15.0 109.801 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.03 164.12 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.739 -0.601 . . . . 15.0 109.785 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt 51.84 59.58 4.45 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.56 -0.712 . . . . 15.0 110.524 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -122.73 148.66 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.55 -0.719 . . . . 15.0 110.224 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -140.02 150.41 44.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.754 -0.591 . . . . 15.0 110.256 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -97.8 129.53 44.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.706 -0.621 . . . . 15.0 109.653 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -74.04 -40.52 62.79 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.846 -0.742 . . . . 15.0 110.738 -171.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.51 -173.78 42.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.847 -1.301 . . . . 15.0 109.847 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.514 HG22 HG12 ' A' ' 20' ' ' ILE . 40.5 p -117.95 5.36 12.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.822 -0.811 . . . . 15.0 110.909 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -66.23 -32.7 74.29 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.283 -0.885 . . . . 15.0 110.936 -175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -60.75 -33.7 73.32 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.413 -0.804 . . . . 15.0 110.429 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -139.11 95.1 9.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.718 -0.614 . . . . 15.0 109.994 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -57.32 148.2 72.54 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.482 1.254 . . . . 15.0 111.027 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.6 p -128.2 165.05 21.2 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 15.0 110.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -77.81 -1.76 33.1 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.649 -0.657 . . . . 15.0 111.516 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -112.45 133.43 21.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.167 -0.958 . . . . 15.0 109.937 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.96 131.87 21.84 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.34 1.179 . . . . 15.0 110.488 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mm -122.09 136.58 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.64 -0.662 . . . . 15.0 109.658 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.54 150.56 38.27 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.666 -0.646 . . . . 15.0 110.206 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.97 148.13 69.45 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.625 1.329 . . . . 15.0 110.398 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -152.24 146.61 25.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.759 -0.588 . . . . 15.0 110.327 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -120.48 33.1 5.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.735 -0.603 . . . . 15.0 110.31 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -96.58 145.86 25.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 15.0 110.161 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.6 m -103.04 144.9 30.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.673 -0.642 . . . . 15.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.5 m-85 -102.01 127.94 48.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.625 -0.672 . . . . 15.0 110.111 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.21 -42.65 79.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.851 -0.531 . . . . 15.0 110.692 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -150.14 121.9 8.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 15.0 110.608 -176.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.63 HD11 ' CG ' ' A' ' 62' ' ' PHE . 28.5 mt -130.93 147.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.705 -0.622 . . . . 15.0 109.505 173.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.45 137.94 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.696 -0.627 . . . . 15.0 109.999 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.41 141.49 51.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.805 -0.559 . . . . 15.0 109.819 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.701 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.7 mtt180 -108.72 152.2 25.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.714 -0.616 . . . . 15.0 110.046 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.46 -26.0 50.82 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.725 -0.95 . . . . 15.0 110.725 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 -45.99 76.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.401 -1.058 . . . . 15.0 110.743 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.1 -32.07 30.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.583 -0.698 . . . . 15.0 110.714 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.613 HG12 HD21 ' A' ' 14' ' ' LEU . 83.4 mt -65.84 140.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.587 -0.696 . . . . 15.0 109.911 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -100.7 -42.21 6.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 15.0 110.195 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.4 144.58 30.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.649 -0.657 . . . . 15.0 110.667 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.31 128.59 43.47 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.655 -0.653 . . . . 15.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -129.5 136.5 49.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.598 -0.689 . . . . 15.0 110.192 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.51 144.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.631 -0.668 . . . . 15.0 109.938 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 97.8 m -85.86 -36.97 19.65 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.671 -0.643 . . . . 15.0 110.055 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -84.28 151.67 60.02 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.71 -0.619 . . . . 15.0 109.958 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -67.96 154.74 72.01 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.614 1.323 . . . . 15.0 110.435 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.27 156.77 53.73 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.509 1.268 . . . . 15.0 110.522 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -81.47 150.24 66.61 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.69 -0.631 . . . . 15.0 109.956 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.23 153.62 63.81 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 O-C-N 123.517 1.272 . . . . 15.0 110.742 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -111.48 -26.64 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.657 -0.652 . . . . 15.0 110.602 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 117.968 -1.015 . . . . 15.0 110.198 178.352 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 120.987 0.422 . . . . 15.0 110.191 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -99.18 145.39 27.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 15.0 110.268 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.14 150.08 39.74 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.619 . . . . 15.0 110.049 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -66.05 -36.33 30.3 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.544 1.287 . . . . 15.0 110.455 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -70.54 -35.75 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 15.0 110.086 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.18 60.31 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.605 -1.398 . . . . 15.0 109.605 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.61 -33.18 83.7 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.967 -1.253 . . . . 15.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m -68.92 147.04 97.77 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.603 -0.939 . . . . 15.0 110.134 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 17.2 Cg_exo -63.08 149.18 92.25 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.484 1.255 . . . . 15.0 110.642 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 26' ' ' LEU . 60.0 t80 -62.54 -36.53 82.91 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.708 -0.62 . . . . 15.0 110.237 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.445 ' HA ' HD23 ' A' ' 26' ' ' LEU . 65.8 mt -64.85 137.81 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.483 -0.761 . . . . 15.0 109.401 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.85 -2.22 61.84 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 m -85.79 160.04 19.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.084 -1.245 . . . . 15.0 110.514 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.52 131.48 34.17 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 15.0 110.228 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.608 ' CD1' HD13 ' A' ' 26' ' ' LEU . 95.7 mt -132.62 145.01 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 15.0 109.928 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -115.72 127.45 55.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 11.3 tp -116.18 133.37 56.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 15.0 110.165 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -107.39 119.08 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.975 -0.75 . . . . 15.0 108.975 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -90.37 172.36 8.8 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.348 0.594 . . . . 15.0 110.808 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.37 -18.43 50.31 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.613 -0.679 . . . . 15.0 111.447 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 15.77 9.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.284 -0.885 . . . . 15.0 111.351 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.42 29.88 16.02 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.292 -0.88 . . . . 15.0 110.673 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.4 mt -104.07 143.27 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 172.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -102.77 119.36 38.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.78 -0.575 . . . . 15.0 110.391 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.3 130.55 55.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.822 -0.549 . . . . 15.0 109.625 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.0 tt0 -115.99 140.67 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 15.0 109.868 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.4 -178.87 39.38 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.035 -1.626 . . . . 15.0 109.035 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.3 mm -108.08 138.8 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.389 -1.065 . . . . 15.0 109.772 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 29' ' ' ILE . 12.9 tp -62.39 108.96 1.21 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.754 -0.592 . . . . 15.0 110.379 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -91.53 -52.09 4.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.767 -0.583 . . . . 15.0 110.379 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.79 143.51 31.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.632 -0.668 . . . . 15.0 110.453 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.828 HD11 HD21 ' A' ' 26' ' ' LEU . 73.6 mt -115.57 125.59 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.765 -0.584 . . . . 15.0 109.661 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -112.05 96.16 5.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 15.0 109.825 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -71.19 -37.12 72.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.716 -0.615 . . . . 15.0 110.418 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.12 -29.04 67.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.456 -0.778 . . . . 15.0 111.053 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 35' ' ' THR . 94.9 m-20 -116.25 13.99 15.75 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 15.0 111.56 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.79 48.19 22.0 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.362 -0.836 . . . . 15.0 111.464 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 33' ' ' ASN . 42.4 p -132.39 149.4 52.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 15.0 110.404 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.08 138.76 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.576 -0.703 . . . . 15.0 109.55 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.45 56.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.612 -0.68 . . . . 15.0 109.905 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.9 mt -116.83 137.72 52.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.94 -0.475 . . . . 15.0 109.892 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.35 164.05 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.742 -0.599 . . . . 15.0 109.833 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 51.81 56.0 8.47 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.605 -0.684 . . . . 15.0 110.482 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.5 p -116.79 146.62 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 15.0 110.386 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -134.92 150.34 50.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.75 -0.594 . . . . 15.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -98.96 132.45 44.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.725 -0.61 . . . . 15.0 109.973 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -71.72 -40.18 69.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.597 -0.689 . . . . 15.0 110.583 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.91 171.84 34.28 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.888 -1.285 . . . . 15.0 109.888 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -118.03 6.26 12.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.79 -0.829 . . . . 15.0 111.198 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.83 -23.86 46.95 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.202 -0.936 . . . . 15.0 111.313 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.49 -35.15 76.86 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.408 -0.807 . . . . 15.0 110.445 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -144.35 95.03 5.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.687 -0.633 . . . . 15.0 110.008 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.13 139.51 90.21 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 O-C-N 123.478 1.252 . . . . 15.0 110.969 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.5 p -122.36 165.11 16.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.725 -0.609 . . . . 15.0 110.195 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.85 -2.06 34.73 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.749 -0.594 . . . . 15.0 111.312 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -109.6 106.92 59.04 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.168 -0.958 . . . . 15.0 109.877 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.1 132.8 46.37 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.377 1.198 . . . . 15.0 110.874 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.72 138.4 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.743 -0.598 . . . . 15.0 109.599 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 158.06 87.84 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.767 -0.583 . . . . 15.0 110.16 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.92 161.74 41.05 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.633 1.333 . . . . 15.0 110.345 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -64.48 127.01 29.67 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.668 -0.645 . . . . 15.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -155.78 -51.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.219 -1.03 . . . . 15.0 108.219 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -106.86 163.03 13.29 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.372 0.878 . . . . 15.0 113.372 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.1 m -112.35 158.77 19.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.691 -0.631 . . . . 15.0 110.189 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.687 ' CG ' HD11 ' A' ' 65' ' ' ILE . 91.7 m-85 -98.59 129.65 45.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.696 -0.628 . . . . 15.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -67.63 -41.63 83.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.808 -0.558 . . . . 15.0 110.745 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -150.8 121.88 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.585 -0.697 . . . . 15.0 110.585 -176.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.6 mt -132.0 147.99 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.731 -0.606 . . . . 15.0 109.534 172.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -110.93 138.1 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.701 -0.624 . . . . 15.0 109.984 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.86 143.05 50.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.665 -0.647 . . . . 15.0 109.854 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 35' ' ' THR . 89.9 mtt180 -109.61 152.32 25.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.709 . . . . 15.0 110.166 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -26.05 55.66 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.759 -0.936 . . . . 15.0 110.759 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.6 p -66.7 -44.15 82.46 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.467 -1.019 . . . . 15.0 110.752 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.31 -31.86 26.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 15.0 110.673 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 64.9 mt -65.55 143.54 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.648 -0.658 . . . . 15.0 109.895 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -105.05 -45.2 4.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 15.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -144.03 148.26 34.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 15.0 110.578 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.65 131.0 46.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.186 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -128.29 143.26 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 15.0 110.28 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.27 144.11 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.58 -0.7 . . . . 15.0 109.872 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 31.2 m -88.02 -35.89 17.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.668 -0.645 . . . . 15.0 110.147 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.18 146.95 49.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.657 -0.652 . . . . 15.0 109.816 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.66 147.13 69.19 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.526 1.277 . . . . 15.0 110.468 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.72 156.76 52.98 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.614 1.323 . . . . 15.0 110.241 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.31 154.58 66.47 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.631 . . . . 15.0 110.016 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.48 138.85 47.3 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.653 1.344 . . . . 15.0 110.432 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.1 133.1 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.749 -0.594 . . . . 15.0 109.628 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.007 -0.997 . . . . 15.0 110.145 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 120.949 0.404 . . . . 15.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.51 -52.93 2.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.581 -0.699 . . . . 15.0 110.103 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -98.02 150.1 36.4 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.689 -0.632 . . . . 15.0 110.121 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -65.57 -33.2 46.69 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.539 1.284 . . . . 15.0 110.459 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 t -68.74 -33.94 74.76 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.709 -0.619 . . . . 15.0 110.176 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.58 71.63 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.343 . . . . 15.0 109.744 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.78 -42.94 85.77 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.839 -1.304 . . . . 15.0 109.839 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -104.21 124.11 38.47 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.667 -0.902 . . . . 15.0 110.099 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.15 133.85 32.1 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.382 1.201 . . . . 15.0 110.511 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.68 -32.04 71.57 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.699 -0.626 . . . . 15.0 110.151 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.424 ' HA ' HD23 ' A' ' 26' ' ' LEU . 65.4 mt -63.75 136.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.353 -0.842 . . . . 15.0 109.675 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.13 -2.11 68.33 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.4 m -96.01 154.0 17.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.101 -1.235 . . . . 15.0 110.602 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 25' ' ' ILE . 77.3 mttt -81.3 128.58 33.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.858 -0.526 . . . . 15.0 110.129 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 26' ' ' LEU . 95.9 mt -131.65 146.52 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.494 -0.754 . . . . 15.0 109.994 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.93 130.93 57.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.482 -0.562 . . . . 15.0 109.482 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 9.1 tp -119.43 135.01 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.795 -0.566 . . . . 15.0 110.259 -175.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.58 120.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -93.44 170.6 9.48 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.352 0.596 . . . . 15.0 110.862 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -60.6 -18.04 50.43 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.519 -0.738 . . . . 15.0 111.475 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 16.83 7.82 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.361 -0.837 . . . . 15.0 111.326 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.09 28.17 14.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 15.0 110.824 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -105.01 145.47 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -106.03 121.55 44.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.743 -0.598 . . . . 15.0 110.398 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.12 136.87 49.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.772 -0.58 . . . . 15.0 109.752 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.0 tt0 -120.1 140.66 50.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.804 . . . . 15.0 109.876 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 -178.96 39.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.171 -1.572 . . . . 15.0 109.171 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.473 HD12 ' HG2' ' A' ' 11' ' ' LYS . 15.8 mm -108.52 133.48 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.46 -1.023 . . . . 15.0 109.544 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.777 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -61.49 114.51 3.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.577 -0.702 . . . . 15.0 110.53 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -93.81 -52.08 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 15.0 110.379 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 22.5 p -146.45 145.27 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.597 -0.689 . . . . 15.0 110.595 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.777 HD11 HD21 ' A' ' 26' ' ' LEU . 75.7 mt -116.04 126.61 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.795 -0.566 . . . . 15.0 109.658 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.12 97.68 6.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.676 . . . . 15.0 109.825 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.91 -36.1 72.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.784 -0.572 . . . . 15.0 110.41 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -59.21 -29.28 67.38 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.584 -0.697 . . . . 15.0 111.102 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.17 14.02 15.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.638 -0.664 . . . . 15.0 111.516 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t 49.99 47.26 23.56 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.14 -0.975 . . . . 15.0 111.24 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.0 p -131.51 150.14 52.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.542 -0.724 . . . . 15.0 110.489 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.92 139.38 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.589 -0.694 . . . . 15.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.6 56.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.699 -0.625 . . . . 15.0 110.01 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 26' ' ' LEU . 21.7 mt -116.79 139.04 51.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.846 -0.428 . . . . 15.0 109.846 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 162.03 17.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.717 -0.615 . . . . 15.0 109.816 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 51.61 61.22 3.33 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.555 -0.715 . . . . 15.0 110.311 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 11.2 p -126.77 145.19 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.594 -0.691 . . . . 15.0 110.592 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -138.64 155.77 48.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.759 -0.588 . . . . 15.0 110.296 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.4 p -99.03 133.48 43.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.841 -0.537 . . . . 15.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -69.36 -40.07 77.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.671 . . . . 15.0 110.468 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.95 171.43 33.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.806 -1.317 . . . . 15.0 109.806 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.0 p -118.0 6.37 12.14 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.755 -0.85 . . . . 15.0 111.161 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -54.68 -22.84 14.98 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.247 -0.908 . . . . 15.0 111.488 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -60.44 -32.03 70.98 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.382 -0.824 . . . . 15.0 110.391 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -120.89 95.01 49.04 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.734 -0.604 . . . . 15.0 109.881 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.03 130.02 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.5 1.263 . . . . 15.0 110.571 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -132.72 165.13 25.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 15.0 110.106 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -77.95 -2.17 35.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.645 -0.66 . . . . 15.0 111.427 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -118.05 106.94 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.11 -0.994 . . . . 15.0 109.985 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.03 145.11 72.47 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.456 1.24 . . . . 15.0 110.465 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.3 mm -105.36 136.01 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.732 -0.605 . . . . 15.0 109.651 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.28 109.96 61.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.644 -0.66 . . . . 15.0 110.231 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -66.96 152.36 80.47 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.431 1.227 . . . . 15.0 110.342 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -118.59 153.62 33.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.734 -0.604 . . . . 15.0 110.274 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.02 -32.55 73.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.72 -0.613 . . . . 15.0 110.315 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -83.15 -171.2 3.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.61 -0.681 . . . . 15.0 110.18 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.5 t -134.81 172.09 13.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.691 -0.631 . . . . 15.0 110.368 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CG ' HD11 ' A' ' 65' ' ' ILE . 78.5 m-85 -86.79 133.16 33.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.705 -0.622 . . . . 15.0 109.859 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -69.09 -46.03 68.78 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.438 -0.505 . . . . 15.0 110.641 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -147.9 121.87 9.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.582 -0.699 . . . . 15.0 110.514 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.532 HD11 ' CG ' ' A' ' 62' ' ' PHE . 19.5 mt -132.27 147.98 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.705 -0.622 . . . . 15.0 109.432 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -112.36 138.86 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.648 -0.658 . . . . 15.0 110.094 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.1 144.71 51.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 15.0 109.815 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -108.7 151.8 25.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.7 -0.625 . . . . 15.0 110.237 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.08 -26.0 54.92 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -65.59 -45.3 83.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.551 -0.97 . . . . 15.0 110.715 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.01 -31.34 31.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 15.0 110.683 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 75.9 mt -66.5 140.72 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.592 -0.693 . . . . 15.0 109.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -104.02 -42.53 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 15.0 110.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -147.41 149.6 33.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.678 -0.639 . . . . 15.0 110.7 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -129.71 131.23 46.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.742 -0.599 . . . . 15.0 110.097 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m -131.62 142.71 49.94 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.584 -0.697 . . . . 15.0 110.343 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 144.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.636 . . . . 15.0 109.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 93.0 m -97.83 -37.08 9.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.685 . . . . 15.0 110.318 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -97.59 117.48 65.32 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.705 -0.622 . . . . 15.0 110.158 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.63 157.95 58.29 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.279 1.147 . . . . 15.0 110.283 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.08 145.78 94.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.558 1.294 . . . . 15.0 110.489 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -96.89 142.57 24.73 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.68 -0.638 . . . . 15.0 110.04 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.8 138.64 41.53 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.488 1.257 . . . . 15.0 110.433 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 tt -129.52 137.81 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 15.0 110.057 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.001 -0.999 . . . . 15.0 110.228 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 120.936 0.398 . . . . 15.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.56 -62.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 15.0 110.224 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.99 149.97 38.19 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.681 -0.637 . . . . 15.0 110.192 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.97 -32.23 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.603 1.317 . . . . 15.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -65.99 -34.92 79.2 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.584 -0.697 . . . . 15.0 110.362 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.69 -35.31 80.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.738 -1.345 . . . . 15.0 109.738 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.24 77.95 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.87 -1.292 . . . . 15.0 109.87 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -68.19 135.23 91.39 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.578 -0.954 . . . . 15.0 110.134 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.18 149.02 92.58 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.26 1.137 . . . . 15.0 110.668 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -65.0 -29.11 70.01 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.694 -0.629 . . . . 15.0 110.374 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.674 ' HA ' HD23 ' A' ' 26' ' ' LEU . 86.4 mt -63.1 137.79 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.363 -0.836 . . . . 15.0 109.615 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.65 -2.32 58.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.8 -0.92 . . . . 15.0 110.8 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.1 m -94.86 160.07 14.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.106 -1.232 . . . . 15.0 110.277 174.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -91.99 137.03 32.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.619 -0.676 . . . . 15.0 110.264 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.43 146.31 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 15.0 109.883 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -114.36 128.12 56.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.386 -0.598 . . . . 15.0 109.386 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 72' ' ' ILE . 11.0 tp -120.56 135.92 54.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 15.0 110.282 -175.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.4 mt -109.32 118.9 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -87.92 172.94 9.22 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.212 0.53 . . . . 15.0 110.781 -172.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -59.79 -18.44 43.52 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.606 -0.684 . . . . 15.0 111.601 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.52 15.47 10.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 15.0 111.286 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 56.17 28.58 13.31 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.191 -0.943 . . . . 15.0 110.776 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -101.87 142.9 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.82 -0.807 . . . . 15.0 108.82 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -100.84 120.8 40.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.744 -0.598 . . . . 15.0 110.467 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -112.73 132.35 55.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.837 -0.539 . . . . 15.0 109.591 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.7 mt-10 -117.92 140.65 49.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 15.0 109.907 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.85 39.38 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.944 -1.663 . . . . 15.0 108.944 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.4 mm -108.03 144.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -1.039 . . . . 15.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 29' ' ' ILE . 24.0 tp -66.15 113.49 4.56 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.807 -0.558 . . . . 15.0 110.21 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -94.25 -52.03 4.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.827 -0.546 . . . . 15.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 21.1 p -147.5 143.33 27.77 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 110.591 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 26' ' ' LEU . 78.2 mt -112.22 127.73 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.698 -0.627 . . . . 15.0 109.584 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -112.09 97.42 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.634 -0.666 . . . . 15.0 109.751 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.89 -35.74 72.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.703 -0.623 . . . . 15.0 110.405 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.56 -28.9 65.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.525 -0.734 . . . . 15.0 111.149 -171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -117.7 14.05 14.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.539 -0.725 . . . . 15.0 111.531 -176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t 49.92 48.69 21.47 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.104 -0.998 . . . . 15.0 111.257 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 33' ' ' ASN . 45.7 p -131.99 150.26 52.2 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.383 -0.823 . . . . 15.0 110.513 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.04 138.58 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 15.0 109.558 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -109.75 127.66 54.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.655 . . . . 15.0 109.918 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.8 mt -116.9 138.92 51.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.946 -0.471 . . . . 15.0 109.737 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.84 164.94 13.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.722 -0.611 . . . . 15.0 109.907 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 51.89 56.5 7.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.656 -0.653 . . . . 15.0 110.461 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.7 p -118.0 148.53 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.587 -0.695 . . . . 15.0 110.342 -174.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -137.43 153.29 50.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.791 -0.568 . . . . 15.0 110.229 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.9 p -101.87 133.87 45.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.731 -0.606 . . . . 15.0 110.006 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.06 -40.13 63.0 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.699 -0.626 . . . . 15.0 110.689 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 171.21 33.51 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.984 -1.246 . . . . 15.0 109.984 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.8 p -118.15 6.27 12.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.798 -0.824 . . . . 15.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.13 -23.56 35.33 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.128 -0.983 . . . . 15.0 111.472 -173.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.25 -31.68 71.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.467 -0.771 . . . . 15.0 110.573 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 51' ' ' THR . 12.4 mmt85 -123.29 95.02 46.11 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.571 -0.706 . . . . 15.0 110.095 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.79 129.95 34.58 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 O-C-N 123.463 1.244 . . . . 15.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 49' ' ' ARG . 21.8 p -132.27 165.2 24.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.759 -0.588 . . . . 15.0 110.197 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 -1.12 29.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.698 -0.626 . . . . 15.0 111.437 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -113.59 106.87 53.67 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 15.0 109.724 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.49 131.89 24.17 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.356 1.187 . . . . 15.0 110.648 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.9 mm -122.73 119.01 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.654 -0.654 . . . . 15.0 109.472 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.37 156.05 36.19 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 15.0 110.346 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.85 145.65 94.73 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.596 1.314 . . . . 15.0 110.576 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -125.2 159.66 31.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.731 -0.606 . . . . 15.0 110.188 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -98.91 29.13 3.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.671 -0.643 . . . . 15.0 110.576 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.0 141.53 51.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 15.0 110.131 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.4 m -103.15 159.77 15.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.689 -0.632 . . . . 15.0 110.132 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.14 130.39 44.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.747 -0.596 . . . . 15.0 110.037 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.77 -40.7 83.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.847 -0.533 . . . . 15.0 110.843 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.468 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -151.99 121.94 7.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.775 . . . . 15.0 110.814 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.7 mt -130.85 148.02 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.688 -0.632 . . . . 15.0 109.664 172.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.26 135.09 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.718 -0.614 . . . . 15.0 109.813 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -126.22 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.75 -0.594 . . . . 15.0 109.841 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.7 mtt180 -108.16 151.86 25.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 15.0 110.159 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -25.95 55.45 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.3 p -66.46 -45.06 81.03 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.501 -1.0 . . . . 15.0 110.685 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.94 -31.92 31.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.745 . . . . 15.0 110.682 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HD21 ' A' ' 14' ' ' LEU . 67.5 mt -65.88 140.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.599 -0.688 . . . . 15.0 109.869 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -106.35 -42.28 5.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.745 -0.597 . . . . 15.0 110.251 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -139.26 142.65 37.78 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.672 -0.642 . . . . 15.0 110.531 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -130.84 126.96 37.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.681 -0.637 . . . . 15.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -129.2 136.39 50.08 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.616 -0.678 . . . . 15.0 110.093 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.08 144.04 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.646 -0.659 . . . . 15.0 109.94 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.11 -37.05 34.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.68 -0.637 . . . . 15.0 109.956 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.27 117.6 69.11 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.664 -0.648 . . . . 15.0 109.785 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.87 110.12 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.295 1.155 . . . . 15.0 110.981 -175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.82 156.65 65.1 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.443 1.233 . . . . 15.0 110.245 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -97.86 160.06 29.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.719 -0.613 . . . . 15.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -62.41 147.19 95.3 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.608 1.32 . . . . 15.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 tt -154.74 51.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 15.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 ttp . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.052 -0.975 . . . . 15.0 110.181 179.892 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.947 0.403 . . . . 15.0 110.298 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -95.38 152.57 18.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.707 -0.621 . . . . 15.0 110.163 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.0 150.03 85.58 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.705 -0.622 . . . . 15.0 109.991 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.58 -34.69 92.17 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.455 1.239 . . . . 15.0 110.731 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p -69.53 -36.45 76.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.659 -0.65 . . . . 15.0 110.18 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.34 -35.16 34.28 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.598 -1.401 . . . . 15.0 109.598 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.53 83.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.985 -1.246 . . . . 15.0 109.985 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.2 m -86.03 122.87 72.54 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.536 -0.979 . . . . 15.0 110.12 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.37 149.08 90.75 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.277 1.146 . . . . 15.0 110.462 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -63.19 -35.22 79.57 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.67 -0.644 . . . . 15.0 110.268 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.0 mt -64.88 137.7 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.444 -0.785 . . . . 15.0 109.53 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 -2.31 63.25 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.835 -0.906 . . . . 15.0 110.835 -174.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.6 m -90.46 156.29 18.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.063 -1.257 . . . . 15.0 110.29 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -85.99 133.22 33.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.662 -0.649 . . . . 15.0 110.468 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 26' ' ' LEU . 91.2 mt -133.83 154.18 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.598 -0.689 . . . . 15.0 109.735 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.9 t -115.89 132.62 56.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.901 -0.499 . . . . 15.0 109.85 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 75' ' ' LEU . 6.0 tp -116.53 130.19 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.87 -0.519 . . . . 15.0 109.88 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.18 119.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.91 -0.774 . . . . 15.0 108.91 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m -92.64 170.85 9.41 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.331 0.586 . . . . 15.0 110.981 -170.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.6 -18.54 53.65 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.603 -0.685 . . . . 15.0 111.422 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.59 16.13 8.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 15.0 111.251 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 58.12 28.53 16.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.344 -0.848 . . . . 15.0 110.829 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.507 HG12 HG22 ' A' ' 46' ' ' THR . 87.0 mt -105.07 148.37 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 172.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -107.63 118.92 38.0 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.801 -0.562 . . . . 15.0 110.422 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.43 137.37 48.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.784 -0.573 . . . . 15.0 109.888 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.7 tm-20 -119.28 140.75 49.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 15.0 109.88 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.6 -178.9 38.97 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.072 -1.611 . . . . 15.0 109.072 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.21 135.16 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.516 -0.99 . . . . 15.0 109.708 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.799 HD21 HD11 ' A' ' 29' ' ' ILE . 12.5 tp -62.37 109.02 1.22 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.693 -0.629 . . . . 15.0 110.486 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.31 -52.07 5.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.819 -0.55 . . . . 15.0 110.356 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.5 p -144.52 144.17 31.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.622 -0.674 . . . . 15.0 110.538 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.799 HD11 HD21 ' A' ' 26' ' ' LEU . 74.1 mt -116.44 125.35 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.778 -0.576 . . . . 15.0 109.654 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -112.03 96.37 6.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.706 . . . . 15.0 109.896 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.0 m -70.65 -36.8 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.803 -0.561 . . . . 15.0 110.379 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.29 -29.28 67.48 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 15.0 111.131 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.43 14.05 16.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 15.0 111.547 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t 49.87 47.93 22.46 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.093 -1.005 . . . . 15.0 111.25 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.4 p -131.97 148.41 52.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.357 -0.839 . . . . 15.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.78 139.25 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.607 -0.683 . . . . 15.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -113.15 128.69 56.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.684 . . . . 15.0 110.005 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 26' ' ' LEU . 30.3 mt -116.77 136.6 52.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.901 -0.499 . . . . 15.0 109.879 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.97 162.35 16.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.698 -0.627 . . . . 15.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 51.86 59.62 4.42 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.608 -0.683 . . . . 15.0 110.384 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.58 147.14 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.601 -0.687 . . . . 15.0 110.333 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -137.38 150.86 47.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.776 -0.578 . . . . 15.0 110.033 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.9 p -95.98 130.23 43.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.771 -0.581 . . . . 15.0 109.741 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.19 -40.27 74.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.6 -0.687 . . . . 15.0 110.443 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.45 32.54 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.787 -1.325 . . . . 15.0 109.787 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 20' ' ' ILE . 45.5 p -118.06 -13.4 9.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.828 -0.807 . . . . 15.0 111.05 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -63.7 -28.95 70.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.903 . . . . 15.0 110.945 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.98 -32.16 70.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.442 -0.786 . . . . 15.0 110.399 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -123.46 95.14 45.61 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 15.0 109.837 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.08 134.58 50.1 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.38 1.2 . . . . 15.0 110.903 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 p -132.54 165.12 25.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.847 -0.533 . . . . 15.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.89 -1.47 31.94 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.62 -0.675 . . . . 15.0 111.453 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -116.93 106.99 46.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.192 -0.943 . . . . 15.0 109.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.69 134.45 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.316 1.167 . . . . 15.0 110.801 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG21 HG21 ' A' ' 46' ' ' THR . 51.3 mm -119.6 141.62 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.704 -0.622 . . . . 15.0 109.677 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.75 109.92 60.71 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 15.0 110.178 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -63.18 146.52 94.14 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.35 1.184 . . . . 15.0 110.566 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -123.45 133.62 54.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.709 -0.619 . . . . 15.0 110.249 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.95 -33.36 73.6 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 15.0 110.252 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.06 155.38 39.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.623 -0.673 . . . . 15.0 110.238 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -102.95 161.04 14.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.721 -0.612 . . . . 15.0 110.2 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.97 133.27 47.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.671 -0.643 . . . . 15.0 110.096 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -67.55 -38.92 84.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.872 -0.517 . . . . 15.0 110.864 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.4 t80 -152.21 122.04 7.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.46 -0.775 . . . . 15.0 110.824 -175.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.61 147.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.708 -0.62 . . . . 15.0 109.566 172.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.6 mt -110.8 137.76 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.723 -0.611 . . . . 15.0 109.927 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -129.47 142.64 50.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.718 -0.614 . . . . 15.0 109.905 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 35' ' ' THR . 91.3 mtt180 -110.35 152.15 26.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.621 -0.675 . . . . 15.0 110.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.94 55.12 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.5 p -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.436 -1.037 . . . . 15.0 110.75 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.13 -30.15 15.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.503 -0.748 . . . . 15.0 110.841 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.9 mt -63.52 138.37 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.453 -0.779 . . . . 15.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -98.86 -40.56 8.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.818 -0.551 . . . . 15.0 110.027 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.54 149.61 29.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.692 -0.63 . . . . 15.0 110.749 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 14' ' ' LEU . 40.8 tp -132.3 135.27 46.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.712 -0.617 . . . . 15.0 109.881 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -133.16 143.07 48.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.675 -0.641 . . . . 15.0 110.17 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.1 143.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.691 -0.63 . . . . 15.0 109.779 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.1 m -94.9 -37.02 11.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 15.0 110.345 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -84.31 160.88 56.14 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.725 -0.61 . . . . 15.0 110.192 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.5 112.71 2.68 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.716 1.377 . . . . 15.0 110.351 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.06 154.14 73.31 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.372 1.196 . . . . 15.0 110.316 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -102.11 164.1 16.44 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 15.0 110.377 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -62.72 147.08 95.18 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.718 1.378 . . . . 15.0 110.623 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' ILE . 3.7 tp -143.38 65.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.603 . . . . 15.0 110.006 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 118.0 -1.0 . . . . 15.0 110.317 -179.839 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.753 0.311 . . . . 0.19 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' HD12 ' A' ' 25' ' ' ILE . 60.9 mttm -82.84 133.2 35.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.034 -0.53 . . . . 2.07 110.402 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.0 mt -135.85 147.25 28.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 0.22 110.434 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.0 t -114.68 132.57 56.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.754 -0.657 . . . . 0.15 109.893 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -124.45 137.4 54.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.414 . . . . 0.34 110.519 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mt -111.96 122.02 65.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.373 -0.602 . . . . 0.17 109.373 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -93.17 169.89 10.06 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.452 0.47 . . . . 0.17 111.139 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -59.86 -20.96 60.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.044 -0.525 . . . . 2.62 111.971 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.05 13.66 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.122 0.416 . . . . 0.19 112.122 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 61.9 25.22 15.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.635 0.255 . . . . 1.63 111.271 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.02 142.89 17.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 109.475 -0.565 . . . . 0.21 109.475 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -104.42 121.08 42.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 2.39 110.619 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -113.6 139.8 48.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.018 -0.537 . . . . 0.16 110.1 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -121.61 140.67 51.96 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.0 -178.84 39.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.6 -1.0 . . . . 0.07 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 11' ' ' LYS . 10.9 mm -106.78 139.1 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.067 -0.345 . . . . 0.2 110.067 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.878 HD21 HD11 ' A' ' 29' ' ' ILE . 17.3 tp -65.95 109.06 2.39 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.25 110.492 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -91.59 -52.15 4.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.255 -0.429 . . . . 0.23 110.809 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 p -150.23 145.53 26.28 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.376 -0.375 . . . . 0.17 110.957 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.878 HD11 HD21 ' A' ' 26' ' ' LEU . 44.7 mt -118.45 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.25 110.077 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -112.1 95.01 5.22 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.067 -0.345 . . . . 1.1 110.067 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.7 m -67.87 -38.62 83.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.782 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.71 -32.15 68.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.311 -0.404 . . . . 1.97 111.615 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -112.64 13.94 20.01 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.163 0.431 . . . . 0.47 112.163 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.6 p 49.99 42.15 24.16 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.936 0.398 . . . . 1.14 111.598 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 68' ' ' ARG . 4.2 p -131.37 149.16 52.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.278 -0.419 . . . . 0.13 110.98 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.44 138.21 54.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.12 110.006 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.77 127.65 56.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.367 -0.379 . . . . 0.07 110.431 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.3 mt -116.93 139.48 50.6 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.112 -0.495 . . . . 0.42 110.138 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.11 159.48 22.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.06 110.134 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 55.94 55.14 7.24 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.191 0.52 . . . . 2.43 110.482 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -119.22 142.58 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.767 -0.651 . . . . 0.11 110.334 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -135.22 150.74 50.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 3.55 110.493 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 p -96.47 128.01 43.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.2 110.194 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.456 -0.338 . . . . 0.79 110.828 -174.307 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.612 0.244 . . . . 0.38 110.417 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.31 -40.5 89.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.164 -0.471 . . . . 2.54 111.251 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.8 t80 -146.85 121.94 10.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.728 0.299 . . . . 0.13 111.041 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.17 143.77 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.16 110.045 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -112.45 138.22 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.256 -0.429 . . . . 0.13 110.369 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -130.08 141.28 50.72 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.14 110.273 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' HG22 ' A' ' 35' ' ' THR . 75.7 mtm180 -102.15 149.11 24.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.414 -0.357 . . . . 2.11 110.295 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.86 50.4 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 111.946 -0.462 . . . . 0.11 111.946 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -67.09 -42.15 85.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.456 0.169 . . . . 1.24 111.15 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -32.05 30.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.56 -0.291 . . . . 1.09 111.229 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 14' ' ' LEU . 50.8 mt -65.51 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.13 110.392 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -103.93 -45.99 4.6 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.038 -0.528 . . . . 1.35 110.648 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -148.25 149.13 31.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.3 -0.409 . . . . 1.13 111.127 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt -131.39 129.2 41.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.982 -0.553 . . . . 0.51 110.17 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.463 0.199 0 CA-C-N 116.439 -0.346 . . . . 0.23 110.571 178.284 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.016 0.436 . . . . 15.0 110.553 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -82.07 128.46 34.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.853 -0.529 . . . . 15.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' HB2' ' A' ' 26' ' ' LEU . 89.8 mt -131.01 149.5 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 15.0 109.913 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.63 135.95 53.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.551 -0.537 . . . . 15.0 109.551 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 HG12 ' A' ' 72' ' ' ILE . 10.5 tp -127.07 137.0 52.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.717 -0.614 . . . . 15.0 110.258 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.63 123.4 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.014 -0.736 . . . . 15.0 109.014 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -93.55 172.83 8.02 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.305 0.574 . . . . 15.0 110.944 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.74 -19.8 52.46 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.63 -0.668 . . . . 15.0 111.444 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.76 16.14 8.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.803 . . . . 15.0 111.336 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.57 29.32 16.97 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.302 -0.874 . . . . 15.0 110.781 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.2 mt -105.09 147.59 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -105.78 118.93 37.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.785 -0.572 . . . . 15.0 110.509 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -111.52 140.71 45.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.812 -0.555 . . . . 15.0 109.765 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.1 tt0 -125.83 140.8 52.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.475 -0.766 . . . . 15.0 109.839 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.86 -178.84 39.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.128 -1.589 . . . . 15.0 109.128 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -107.28 133.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.436 -1.038 . . . . 15.0 109.736 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -61.61 114.66 3.4 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.751 -0.593 . . . . 15.0 110.474 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -95.72 -52.04 4.26 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.408 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -145.16 145.15 31.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.623 -0.673 . . . . 15.0 110.664 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.822 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -118.31 127.31 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.747 -0.595 . . . . 15.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.11 97.96 7.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 15.0 109.846 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -70.6 -36.57 73.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.719 -0.613 . . . . 15.0 110.484 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.09 -29.16 67.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.55 -0.719 . . . . 15.0 111.136 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.14 14.07 15.87 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.704 . . . . 15.0 111.539 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t 49.94 47.53 23.11 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.143 -0.973 . . . . 15.0 111.22 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 21.3 p -131.27 149.99 52.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.517 -0.739 . . . . 15.0 110.558 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.56 141.75 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.671 -0.643 . . . . 15.0 109.72 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.17 129.67 56.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.681 -0.637 . . . . 15.0 110.058 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 26' ' ' LEU . 22.1 mt -116.92 138.95 51.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.884 -0.51 . . . . 15.0 109.845 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.08 16.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.736 -0.603 . . . . 15.0 109.861 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.3 mttt 51.72 58.36 5.56 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.709 -0.619 . . . . 15.0 110.441 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.8 p -121.29 148.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.566 -0.709 . . . . 15.0 110.332 -173.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -138.62 153.91 48.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.81 -0.556 . . . . 15.0 110.128 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.3 p -101.24 131.84 47.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.832 -0.543 . . . . 15.0 109.856 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.687 . . . . 15.0 110.541 -174.181 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.0 m-85 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 120.921 0.391 . . . . 15.0 110.104 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -68.3 -43.37 77.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.769 -0.582 . . . . 15.0 110.579 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -149.92 122.02 8.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.543 -0.723 . . . . 15.0 110.609 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.636 HD11 ' CG ' ' A' ' 62' ' ' PHE . 30.4 mt -130.85 146.98 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.699 -0.626 . . . . 15.0 109.56 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.87 137.29 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.72 -0.612 . . . . 15.0 109.93 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.93 144.28 51.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.75 -0.594 . . . . 15.0 109.846 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 82.8 mtm180 -109.27 152.68 24.9 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 15.0 110.088 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.04 -26.0 54.83 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.9 m -65.98 -45.86 80.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.472 -1.017 . . . . 15.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.95 -31.02 31.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.693 -0.63 . . . . 15.0 110.807 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.579 HG12 HD21 ' A' ' 14' ' ' LEU . 73.0 mt -65.99 141.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.538 -0.726 . . . . 15.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -104.56 -42.54 5.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.781 -0.574 . . . . 15.0 110.198 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -145.88 145.95 30.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.695 -0.628 . . . . 15.0 110.679 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.74 129.12 45.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.804 -0.56 . . . . 15.0 110.13 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.629 -0.669 . . . . 15.0 110.428 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.016 0.436 . . . . 15.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -84.89 128.2 34.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.768 -0.583 . . . . 15.0 110.197 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.0 mt -132.19 150.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 15.0 109.988 -175.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 t -115.53 131.34 56.96 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.532 -0.544 . . . . 15.0 109.532 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.562 HD21 HG12 ' A' ' 72' ' ' ILE . 11.8 tp -118.82 134.9 54.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 15.0 110.285 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.5 mt -107.34 122.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.109 -0.701 . . . . 15.0 109.109 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -93.76 171.93 8.57 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.314 0.578 . . . . 15.0 110.87 -173.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -60.09 -19.05 51.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.614 -0.679 . . . . 15.0 111.441 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.23 16.69 8.14 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.353 -0.842 . . . . 15.0 111.275 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 57.1 28.44 14.94 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.28 -0.888 . . . . 15.0 110.827 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 90.0 mt -105.08 145.66 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.062 -0.718 . . . . 15.0 109.062 172.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -104.56 121.5 43.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.847 -0.533 . . . . 15.0 110.34 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.14 132.77 54.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.559 . . . . 15.0 109.654 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 9.3 tm-20 -115.96 140.58 49.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.532 -0.73 . . . . 15.0 109.886 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.05 -178.81 39.68 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.93 -1.668 . . . . 15.0 108.93 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -106.68 138.95 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.455 -1.026 . . . . 15.0 109.64 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 29' ' ' ILE . 19.0 tp -65.3 112.13 3.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.746 -0.596 . . . . 15.0 110.356 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -95.58 -52.11 4.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 15.0 110.489 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 18.1 p -144.31 142.54 30.48 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.573 -0.705 . . . . 15.0 110.604 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 26' ' ' LEU . 75.5 mt -116.27 126.55 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.805 -0.56 . . . . 15.0 109.609 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.09 95.28 5.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.609 -0.682 . . . . 15.0 109.792 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -69.33 -39.47 78.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.746 -0.596 . . . . 15.0 110.344 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -59.83 -29.27 68.14 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.549 -0.719 . . . . 15.0 111.063 -172.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' THR . 94.5 m-20 -111.17 12.35 21.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.464 -0.773 . . . . 15.0 111.555 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m 49.98 44.64 25.53 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.195 -0.941 . . . . 15.0 111.288 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.704 HG22 ' HG2' ' A' ' 68' ' ' ARG . 15.1 p -132.77 150.09 52.2 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.481 -0.762 . . . . 15.0 110.623 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.3 139.95 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.73 -0.606 . . . . 15.0 109.595 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.73 128.69 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.646 -0.659 . . . . 15.0 110.04 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.9 mt -116.84 138.85 51.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.895 -0.503 . . . . 15.0 109.726 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.76 162.36 16.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 15.0 109.89 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt 52.09 61.05 3.41 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.619 -0.675 . . . . 15.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.07 147.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 15.0 110.46 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -132.8 149.92 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.857 -0.527 . . . . 15.0 109.988 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 p -97.74 130.8 44.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.688 -0.633 . . . . 15.0 109.823 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 121.493 -0.754 . . . . 15.0 110.819 -174.072 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.962 -0.384 . . . . 15.0 109.962 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.71 -46.02 70.07 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.87 -0.519 . . . . 15.0 110.543 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.5 t80 -149.29 121.93 8.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.579 -0.701 . . . . 15.0 110.48 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 147.19 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.718 -0.613 . . . . 15.0 109.605 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.66 136.32 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.746 -0.596 . . . . 15.0 109.818 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -126.28 143.96 50.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 15.0 109.984 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.704 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -106.66 151.99 24.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 15.0 110.173 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.99 -25.93 54.54 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.751 -0.94 . . . . 15.0 110.751 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 m -65.57 -45.41 83.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.48 -1.012 . . . . 15.0 110.661 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.98 -31.28 31.23 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.543 -0.723 . . . . 15.0 110.677 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 14' ' ' LEU . 72.7 mt -66.17 144.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.563 -0.711 . . . . 15.0 109.902 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -106.71 -43.09 4.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.748 -0.595 . . . . 15.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.74 151.72 32.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.652 -0.655 . . . . 15.0 110.629 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.38 129.79 45.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.851 -0.531 . . . . 15.0 110.176 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.497 1.876 0 O-C-N 121.65 -0.656 . . . . 15.0 110.396 178.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 120.938 0.399 . . . . 15.0 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -92.12 133.74 35.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.75 -0.594 . . . . 15.0 110.287 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.6 mt -132.43 147.72 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.531 -0.731 . . . . 15.0 109.923 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -115.08 131.45 56.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.499 -0.556 . . . . 15.0 109.499 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -123.16 135.97 54.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.713 -0.617 . . . . 15.0 110.35 -175.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 74' ' ' ASP . 79.9 mt -108.83 120.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -91.53 171.64 9.05 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.334 0.587 . . . . 15.0 110.886 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -59.69 -18.99 46.75 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.617 -0.677 . . . . 15.0 111.643 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.03 17.21 8.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 15.0 111.257 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 58.0 28.86 16.85 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.254 -0.904 . . . . 15.0 110.835 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.8 mt -105.13 148.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -105.32 119.01 38.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.762 -0.586 . . . . 15.0 110.462 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.76 136.46 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.761 -0.587 . . . . 15.0 109.652 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.0 tt0 -122.81 140.57 52.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 15.0 110.007 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.93 -178.88 39.67 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.901 -1.68 . . . . 15.0 108.901 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.9 mm -107.27 140.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -1.059 . . . . 15.0 109.858 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 29' ' ' ILE . 21.0 tp -64.44 109.98 2.13 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.599 . . . . 15.0 110.344 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -93.39 -52.08 4.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.792 -0.567 . . . . 15.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -143.24 143.33 31.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.683 -0.635 . . . . 15.0 110.523 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 HD21 ' A' ' 26' ' ' LEU . 74.4 mt -116.83 125.62 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.775 -0.578 . . . . 15.0 109.656 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -112.03 98.21 7.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.603 -0.686 . . . . 15.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -71.32 -36.04 71.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.8 -0.563 . . . . 15.0 110.457 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.88 -29.88 67.33 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.544 -0.723 . . . . 15.0 111.078 -171.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.45 14.04 15.54 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.639 -0.663 . . . . 15.0 111.519 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t 49.88 48.69 21.44 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.246 -0.909 . . . . 15.0 111.229 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.3 p -131.39 149.58 52.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.571 -0.706 . . . . 15.0 110.514 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.0 t -131.49 139.68 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.663 -0.648 . . . . 15.0 109.687 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.74 128.47 56.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 15.0 109.957 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 59.7 mt -116.82 137.78 51.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.979 -0.451 . . . . 15.0 109.798 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.33 163.68 14.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.741 -0.599 . . . . 15.0 109.894 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 51.48 64.24 1.92 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 121.376 0.608 . . . . 15.0 110.439 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -123.9 145.51 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 15.0 110.347 -172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -127.98 149.34 50.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.864 -0.522 . . . . 15.0 109.801 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -99.32 125.18 44.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.663 -0.648 . . . . 15.0 109.602 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 N--CA 1.499 1.989 0 C-N-CA 120.055 -0.658 . . . . 15.0 110.643 -171.659 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 120.995 0.426 . . . . 15.0 110.18 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.35 -44.7 71.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.79 -0.569 . . . . 15.0 110.604 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.87 121.98 8.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.571 -0.706 . . . . 15.0 110.507 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.73 147.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.745 -0.597 . . . . 15.0 109.663 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -111.18 136.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.739 -0.601 . . . . 15.0 109.865 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.72 144.1 51.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 15.0 109.913 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 67.7 mtm180 -108.47 151.9 25.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 15.0 110.097 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.02 -25.94 54.65 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 110.746 -0.942 . . . . 15.0 110.746 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -66.09 -45.41 81.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.48 -1.012 . . . . 15.0 110.731 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -82.05 -31.58 30.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.584 -0.697 . . . . 15.0 110.626 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.602 HG12 HD21 ' A' ' 14' ' ' LEU . 66.9 mt -66.16 140.53 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.545 -0.722 . . . . 15.0 109.816 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -108.16 -42.28 4.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 15.0 110.344 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 15' ' ' ILE . 26.7 t70 -139.23 145.16 38.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 15.0 110.653 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -132.82 129.61 38.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.701 -0.625 . . . . 15.0 110.254 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.743 -0.598 . . . . 15.0 110.219 178.586 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 121.026 0.441 . . . . 15.0 110.33 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -86.87 129.89 34.69 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.681 -0.637 . . . . 15.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 HD12 HD13 ' A' ' 26' ' ' LEU . 92.7 mt -132.77 150.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.617 -0.677 . . . . 15.0 109.927 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.46 132.97 56.46 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -122.57 136.93 55.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.751 -0.593 . . . . 15.0 110.335 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.1 mt -109.47 121.68 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -93.22 171.49 8.9 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.279 0.561 . . . . 15.0 110.937 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -60.23 -19.12 53.14 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.594 -0.691 . . . . 15.0 111.396 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.12 16.83 7.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.342 -0.848 . . . . 15.0 111.271 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 57.6 28.39 15.58 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.295 -0.878 . . . . 15.0 110.818 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.3 mt -104.95 147.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -106.71 119.84 40.4 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.698 -0.626 . . . . 15.0 110.52 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.23 137.24 49.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.874 -0.516 . . . . 15.0 109.772 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.8 tt0 -121.29 140.69 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.745 . . . . 15.0 109.942 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.88 39.4 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.973 -1.651 . . . . 15.0 108.973 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.35 138.02 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.382 -1.069 . . . . 15.0 109.696 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.694 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -66.19 108.84 2.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.727 -0.608 . . . . 15.0 110.168 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -93.51 -52.16 4.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.882 -0.511 . . . . 15.0 110.509 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -141.69 141.34 33.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 15.0 110.492 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 HD21 ' A' ' 26' ' ' LEU . 78.6 mt -118.04 124.92 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.742 -0.599 . . . . 15.0 109.644 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -112.11 97.46 6.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.532 -0.73 . . . . 15.0 109.907 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.01 -36.19 74.92 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.767 -0.583 . . . . 15.0 110.434 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -59.22 -29.62 67.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.539 -0.726 . . . . 15.0 111.074 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -115.53 14.07 16.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.522 -0.737 . . . . 15.0 111.471 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 m 50.0 46.65 24.24 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.184 -0.948 . . . . 15.0 111.181 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.7 p -131.6 149.81 52.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.404 -0.81 . . . . 15.0 110.51 -177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.41 140.23 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 15.0 109.72 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.33 130.05 56.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.709 -0.619 . . . . 15.0 109.961 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 26' ' ' LEU . 92.4 mt -116.8 138.06 51.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.765 -0.458 . . . . 15.0 109.765 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 162.39 16.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.722 -0.611 . . . . 15.0 109.887 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.7 mttt 51.75 61.2 3.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.673 -0.642 . . . . 15.0 110.428 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -122.4 145.88 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.686 -0.634 . . . . 15.0 110.376 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -132.88 149.42 52.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.813 -0.554 . . . . 15.0 109.99 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -97.22 127.79 43.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.615 . . . . 15.0 109.649 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.554 -0.717 . . . . 15.0 110.615 -173.539 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.3 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.867 0.365 . . . . 15.0 110.153 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -68.46 -43.98 75.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.853 -0.53 . . . . 15.0 110.631 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -149.83 122.08 8.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.601 -0.687 . . . . 15.0 110.587 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.2 mt -130.71 147.83 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.618 -0.676 . . . . 15.0 109.564 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.22 137.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.776 -0.578 . . . . 15.0 109.885 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.87 145.65 51.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.771 -0.58 . . . . 15.0 109.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.745 ' HG2' HG22 ' A' ' 35' ' ' THR . 96.5 mtt180 -108.85 152.35 25.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.637 -0.664 . . . . 15.0 110.172 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.15 55.91 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.722 -0.951 . . . . 15.0 110.722 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 m -65.74 -45.24 83.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -1.047 . . . . 15.0 110.646 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.99 -31.44 31.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.552 -0.717 . . . . 15.0 110.669 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.614 HG12 HD21 ' A' ' 14' ' ' LEU . 71.1 mt -66.21 141.98 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.576 -0.702 . . . . 15.0 109.816 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -107.95 -43.4 4.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.761 -0.587 . . . . 15.0 110.287 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' HD12 ' A' ' 15' ' ' ILE . 19.5 t70 -141.81 147.41 37.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.666 -0.646 . . . . 15.0 110.674 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -132.37 129.48 39.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.606 . . . . 15.0 110.18 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 N--CA 1.497 1.917 0 O-C-N 121.627 -0.67 . . . . 15.0 110.362 178.884 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.014 0.435 . . . . 15.0 110.328 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -83.73 130.25 34.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.685 -0.635 . . . . 15.0 110.483 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.2 mt -130.61 149.39 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.749 -0.594 . . . . 15.0 109.908 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -112.32 133.91 54.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 72' ' ' ILE . 8.0 tp -123.31 133.3 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.78 -0.575 . . . . 15.0 110.319 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.8 mt -107.58 122.9 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -94.48 172.8 7.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.309 0.576 . . . . 15.0 110.903 -172.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.89 -19.56 52.18 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.608 -0.683 . . . . 15.0 111.48 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.38 15.39 9.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.27 -0.894 . . . . 15.0 111.316 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 58.02 27.5 14.92 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.341 -0.849 . . . . 15.0 110.813 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.3 mt -104.2 148.33 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.998 -0.741 . . . . 15.0 108.998 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 -107.27 121.35 44.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 15.0 110.557 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -112.02 138.48 48.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.875 -0.516 . . . . 15.0 109.711 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 35.6 mt-10 -120.44 140.7 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 15.0 109.899 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.01 -178.88 38.63 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.165 -1.574 . . . . 15.0 109.165 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.62 134.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -1.021 . . . . 15.0 109.772 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.814 HD21 HD11 ' A' ' 29' ' ' ILE . 12.0 tp -61.3 112.04 1.99 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.669 -0.644 . . . . 15.0 110.445 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -94.11 -52.0 4.58 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.347 -0.541 . . . . 15.0 110.378 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.3 p -143.77 143.63 31.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 15.0 110.531 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.814 HD11 HD21 ' A' ' 26' ' ' LEU . 74.2 mt -116.84 125.2 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.767 -0.583 . . . . 15.0 109.664 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -112.07 96.75 6.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 15.0 109.823 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.5 m -70.91 -36.26 72.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.756 -0.59 . . . . 15.0 110.438 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.87 -29.29 66.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.508 -0.745 . . . . 15.0 111.046 -171.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.08 14.03 15.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.58 -0.7 . . . . 15.0 111.571 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.0 m 49.97 48.0 22.49 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.207 -0.933 . . . . 15.0 111.248 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.1 p -131.95 148.54 52.53 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.459 -0.776 . . . . 15.0 110.489 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.09 139.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.595 -0.691 . . . . 15.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.62 128.85 56.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.681 -0.637 . . . . 15.0 109.971 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 26' ' ' LEU . 33.4 mt -116.86 138.14 51.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.944 -0.473 . . . . 15.0 109.918 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.59 164.03 14.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.737 -0.602 . . . . 15.0 109.855 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 51.51 58.54 5.39 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.407 0.622 . . . . 15.0 110.464 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.72 148.43 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.575 -0.703 . . . . 15.0 110.331 -173.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -137.53 148.83 46.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.829 -0.544 . . . . 15.0 110.029 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.6 p -96.59 131.61 43.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.799 -0.563 . . . . 15.0 109.653 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.499 2.02 0 O-C-N 121.615 -0.678 . . . . 15.0 110.641 -172.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.71 ' CG ' HD11 ' A' ' 65' ' ' ILE . 94.4 m-85 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 120.891 0.377 . . . . 15.0 110.029 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -44.1 76.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.879 -0.513 . . . . 15.0 110.562 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -150.08 122.03 8.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 15.0 110.571 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.71 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.6 mt -130.01 146.37 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.669 -0.644 . . . . 15.0 109.627 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.54 136.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.717 -0.615 . . . . 15.0 109.988 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.99 140.95 51.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.698 -0.626 . . . . 15.0 109.862 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 35' ' ' THR . 74.7 mtt85 -106.68 152.39 23.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.747 -0.596 . . . . 15.0 110.022 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.65 -26.07 52.3 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.745 -0.942 . . . . 15.0 110.745 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -66.29 -45.99 78.52 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.526 -0.985 . . . . 15.0 110.752 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.2 -31.94 30.11 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.576 -0.702 . . . . 15.0 110.678 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 14' ' ' LEU . 84.9 mt -67.24 141.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.573 -0.704 . . . . 15.0 109.817 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -100.85 -42.51 6.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.729 -0.607 . . . . 15.0 110.229 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -147.93 144.3 27.94 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.624 -0.673 . . . . 15.0 110.768 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -127.23 128.27 45.79 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.712 -0.617 . . . . 15.0 109.968 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.497 1.908 0 O-C-N 121.557 -0.714 . . . . 15.0 110.502 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.037 0.446 . . . . 15.0 110.657 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -78.38 127.67 32.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.846 -0.534 . . . . 15.0 110.199 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 26' ' ' LEU . 96.4 mt -130.97 144.73 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 15.0 109.867 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -113.03 132.34 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.617 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -121.25 136.01 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.803 -0.561 . . . . 15.0 110.231 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.96 121.42 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.92 172.69 8.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.352 0.596 . . . . 15.0 110.911 -171.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -59.97 -19.25 51.14 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.614 -0.679 . . . . 15.0 111.472 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.88 9.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.395 -0.815 . . . . 15.0 111.337 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.6 29.11 16.68 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.293 -0.879 . . . . 15.0 110.752 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.09 147.93 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.74 122.65 46.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.799 -0.563 . . . . 15.0 110.567 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.8 137.44 51.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 15.0 109.812 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.661 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.4 mm-40 -119.43 140.66 50.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.458 -0.776 . . . . 15.0 109.796 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.12 -178.95 38.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.21 -1.556 . . . . 15.0 109.21 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.82 134.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.485 -1.009 . . . . 15.0 109.72 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 29' ' ' ILE . 11.6 tp -61.45 114.61 3.32 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.694 -0.629 . . . . 15.0 110.546 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -95.62 -51.93 4.32 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.324 -0.55 . . . . 15.0 110.402 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 20.3 p -143.81 143.94 31.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.632 -0.668 . . . . 15.0 110.649 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.809 HD11 HD21 ' A' ' 26' ' ' LEU . 75.1 mt -117.2 124.63 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.67 -0.644 . . . . 15.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.09 98.14 7.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.648 -0.657 . . . . 15.0 109.844 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.707 -0.62 . . . . 15.0 110.423 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.8 -29.59 66.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.545 -0.722 . . . . 15.0 111.054 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.2 m-20 -116.14 14.07 15.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.49 -0.756 . . . . 15.0 111.434 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t 49.97 48.91 21.21 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.133 -0.979 . . . . 15.0 111.254 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.4 p -132.33 147.88 52.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.512 -0.743 . . . . 15.0 110.57 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.84 138.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.675 -0.64 . . . . 15.0 109.686 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -110.61 126.34 54.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.719 -0.613 . . . . 15.0 109.907 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 26' ' ' LEU . 26.5 mt -116.78 136.92 52.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.19 164.34 14.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.721 -0.612 . . . . 15.0 109.935 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 51.75 58.05 5.88 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.644 -0.66 . . . . 15.0 110.48 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -119.96 147.36 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 15.0 110.347 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -133.63 149.86 51.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.787 -0.571 . . . . 15.0 109.993 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.6 p -98.69 131.19 45.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.635 -0.666 . . . . 15.0 109.754 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 . . . . . 0 N--CA 1.499 2.014 0 O-C-N 121.515 -0.741 . . . . 15.0 110.69 -173.484 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.755 ' CG ' HD11 ' A' ' 65' ' ' ILE . 97.4 m-85 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.941 0.4 . . . . 15.0 110.119 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -68.09 -41.75 81.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.821 -0.549 . . . . 15.0 110.657 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.559 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 2.2 t80 -150.3 122.06 8.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.615 -0.678 . . . . 15.0 110.423 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.755 HD11 ' CG ' ' A' ' 62' ' ' PHE . 92.9 mt -129.6 144.58 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.685 -0.634 . . . . 15.0 109.481 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.54 133.42 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 109.785 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -123.83 140.53 52.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.705 -0.622 . . . . 15.0 109.893 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.8 mtt180 -105.25 152.02 23.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.652 -0.655 . . . . 15.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.66 -25.96 52.12 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -66.41 -43.06 86.79 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.483 -1.01 . . . . 15.0 110.729 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.9 -31.61 23.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.541 -0.724 . . . . 15.0 110.664 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.617 HG12 HD21 ' A' ' 14' ' ' LEU . 75.4 mt -66.37 141.46 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.582 -0.699 . . . . 15.0 109.887 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -105.26 -42.7 5.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.65 -0.656 . . . . 15.0 110.214 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.53 147.4 32.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.592 -0.692 . . . . 15.0 110.763 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -130.25 129.49 43.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.724 -0.61 . . . . 15.0 110.133 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.563 -0.711 . . . . 15.0 110.433 -179.854 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.9 m . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 121.109 0.481 . . . . 15.0 110.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -83.56 127.63 33.88 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.741 -0.599 . . . . 15.0 110.442 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.1 mt -131.21 151.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.629 -0.67 . . . . 15.0 109.892 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -115.79 133.26 56.21 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 72' ' ' ILE . 11.4 tp -121.6 136.15 54.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.733 -0.605 . . . . 15.0 110.197 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.23 123.44 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -95.78 169.76 9.78 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.343 0.592 . . . . 15.0 110.947 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -60.4 -18.35 50.04 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.616 -0.677 . . . . 15.0 111.513 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 17.58 7.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.245 -0.91 . . . . 15.0 111.276 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 58.12 27.63 15.26 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.309 -0.869 . . . . 15.0 110.844 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -105.0 146.23 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -106.18 120.64 42.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.786 -0.571 . . . . 15.0 110.323 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.83 132.91 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.851 -0.53 . . . . 15.0 109.791 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -118.77 140.71 49.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 15.0 109.812 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.98 -178.81 40.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.196 -1.562 . . . . 15.0 109.196 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -105.51 132.39 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.502 -0.999 . . . . 15.0 109.677 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 29' ' ' ILE . 18.2 tp -62.15 110.9 1.75 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.712 -0.618 . . . . 15.0 110.422 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -91.32 -52.09 4.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.786 -0.571 . . . . 15.0 110.481 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 23.0 p -144.64 143.65 30.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.641 -0.662 . . . . 15.0 110.581 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 26' ' ' LEU . 74.0 mt -116.45 125.78 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.629 . . . . 15.0 109.556 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.09 95.99 5.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 15.0 109.791 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -70.22 -37.08 74.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.772 -0.58 . . . . 15.0 110.389 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -59.12 -29.51 67.44 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.628 -0.67 . . . . 15.0 111.084 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -115.22 14.03 16.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.623 -0.673 . . . . 15.0 111.57 -177.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 m 49.93 46.88 23.93 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.174 -0.954 . . . . 15.0 111.256 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.662 HG22 ' HG2' ' A' ' 68' ' ' ARG . 14.7 p -131.81 150.08 52.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 15.0 110.561 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.24 139.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.678 -0.639 . . . . 15.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.86 128.16 56.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.687 -0.633 . . . . 15.0 109.956 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 26' ' ' LEU . 19.2 mt -116.81 138.85 51.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.991 -0.443 . . . . 15.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.76 161.71 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.625 . . . . 15.0 109.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 51.64 56.56 7.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.66 -0.65 . . . . 15.0 110.535 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -118.72 147.52 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.565 -0.71 . . . . 15.0 110.356 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -136.22 153.28 51.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.781 -0.574 . . . . 15.0 110.096 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.6 p -99.68 131.85 45.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.714 -0.616 . . . . 15.0 110.008 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.64 . . . . 15.0 110.438 -176.63 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CG ' HD11 ' A' ' 65' ' ' ILE . 26.5 m-85 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 120.964 0.412 . . . . 15.0 109.924 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.0 -44.37 76.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.8 -0.563 . . . . 15.0 110.686 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.9 t80 -148.59 121.99 9.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 15.0 110.572 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 62' ' ' PHE . 90.7 mt -131.36 147.32 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.715 -0.616 . . . . 15.0 109.517 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.51 138.39 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.65 -0.656 . . . . 15.0 109.917 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -128.99 145.35 51.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 15.0 109.908 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.2 mtp85 -107.16 152.45 24.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.694 -0.629 . . . . 15.0 110.131 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.02 56.35 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -65.95 -42.5 89.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.465 -1.021 . . . . 15.0 110.738 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.25 -31.12 23.29 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.595 -0.69 . . . . 15.0 110.696 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.528 HG12 HD21 ' A' ' 14' ' ' LEU . 65.7 mt -66.36 146.78 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.632 -0.668 . . . . 15.0 109.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.42 -44.65 4.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.734 -0.604 . . . . 15.0 110.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -148.43 149.8 32.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.668 -0.645 . . . . 15.0 110.769 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.48 129.38 46.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.804 -0.56 . . . . 15.0 110.149 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.498 1.926 0 O-C-N 121.573 -0.704 . . . . 15.0 110.479 179.387 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.041 0.448 . . . . 15.0 110.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 25' ' ' ILE . 98.7 mttt -83.94 130.6 34.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.806 -0.559 . . . . 15.0 110.256 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.643 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.1 mt -130.98 145.04 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.526 -0.734 . . . . 15.0 109.953 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.4 t -116.09 129.33 56.29 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 72' ' ' ILE . 10.7 tp -120.53 135.7 55.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.666 -0.646 . . . . 15.0 110.406 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.08 120.02 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -91.66 172.03 8.76 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.24 0.543 . . . . 15.0 110.951 -171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -59.25 -19.71 48.04 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.634 -0.666 . . . . 15.0 111.655 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.14 17.12 8.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.301 -0.874 . . . . 15.0 111.224 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.89 28.3 15.9 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.273 -0.892 . . . . 15.0 110.875 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 88.7 mt -105.05 147.13 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm105 -104.91 121.07 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 15.0 110.483 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.98 135.67 52.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.806 -0.559 . . . . 15.0 109.782 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.4 tt0 -118.0 140.56 49.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 15.0 109.805 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.66 -178.9 39.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.075 -1.61 . . . . 15.0 109.075 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.0 mm -108.9 142.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.456 -1.026 . . . . 15.0 109.742 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -64.7 114.47 4.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.739 -0.601 . . . . 15.0 110.269 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -98.06 -52.05 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.761 -0.587 . . . . 15.0 110.363 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.2 p -143.83 143.7 31.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.65 -0.656 . . . . 15.0 110.488 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 26' ' ' LEU . 70.2 mt -117.6 125.86 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.833 -0.542 . . . . 15.0 109.735 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -112.11 96.91 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 15.0 109.788 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.3 -37.54 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.766 -0.584 . . . . 15.0 110.53 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.79 -28.7 66.2 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.549 -0.719 . . . . 15.0 111.153 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -116.21 14.13 15.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.735 . . . . 15.0 111.556 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.9 48.07 22.31 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.41 -0.806 . . . . 15.0 111.289 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.2 p -131.83 147.24 52.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.522 -0.736 . . . . 15.0 110.44 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.71 139.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.592 -0.693 . . . . 15.0 109.695 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.53 128.81 56.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 15.0 109.916 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.1 mt -116.85 138.84 51.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.914 -0.491 . . . . 15.0 109.742 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.49 165.6 12.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 15.0 109.873 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 51.69 58.83 5.06 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.691 -0.63 . . . . 15.0 110.496 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 23' ' ' GLU . 15.0 p -121.0 147.37 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.64 -0.663 . . . . 15.0 110.337 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -135.2 150.0 50.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.599 . . . . 15.0 110.0 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.6 p -96.86 129.33 44.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 15.0 109.715 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 15.0 110.564 -173.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.677 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.1 m-85 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.908 0.385 . . . . 15.0 110.06 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -68.62 -44.24 74.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.883 -0.511 . . . . 15.0 110.555 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.88 121.99 8.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 15.0 110.568 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.677 HD11 ' CG ' ' A' ' 62' ' ' PHE . 41.3 mt -131.4 147.57 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.624 . . . . 15.0 109.447 173.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.8 mt -110.65 138.66 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 15.0 110.014 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -129.69 141.08 50.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.758 -0.589 . . . . 15.0 109.916 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.717 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.3 mtt85 -109.89 152.08 26.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.699 -0.626 . . . . 15.0 110.071 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -26.01 49.38 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.803 -0.919 . . . . 15.0 110.803 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.4 m -66.92 -46.05 76.03 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.469 -1.018 . . . . 15.0 110.732 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.35 -31.82 29.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.52 -0.738 . . . . 15.0 110.711 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD21 ' A' ' 14' ' ' LEU . 72.6 mt -65.47 141.62 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.57 -0.706 . . . . 15.0 109.892 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -101.7 -43.39 5.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.809 -0.557 . . . . 15.0 110.271 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -146.03 147.25 31.44 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.698 -0.626 . . . . 15.0 110.71 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.47 129.76 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.689 -0.632 . . . . 15.0 110.217 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.624 -0.673 . . . . 15.0 110.344 179.342 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.039 0.447 . . . . 15.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' HD12 ' A' ' 25' ' ' ILE . 30.2 mtmm -87.26 133.57 33.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.599 . . . . 15.0 110.123 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.9 mt -134.09 147.69 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.443 -0.786 . . . . 15.0 110.086 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -116.69 130.39 56.7 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.548 -0.538 . . . . 15.0 109.548 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.652 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -119.44 136.79 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.717 -0.614 . . . . 15.0 110.18 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -113.4 122.55 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.168 -0.679 . . . . 15.0 109.168 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -93.5 170.98 9.19 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.233 0.54 . . . . 15.0 110.755 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -61.17 -16.47 45.03 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.608 -0.682 . . . . 15.0 111.505 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.93 13.67 10.44 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.233 -0.917 . . . . 15.0 111.338 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 56.38 29.72 15.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.257 -0.902 . . . . 15.0 110.718 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.98 143.34 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.787 -0.82 . . . . 15.0 108.787 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -103.98 122.23 44.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.805 -0.559 . . . . 15.0 110.419 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -110.96 132.27 54.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.755 -0.591 . . . . 15.0 109.673 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.0 tt0 -115.97 140.62 49.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 15.0 109.794 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.56 -178.87 38.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.883 -1.687 . . . . 15.0 108.883 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.6 mm -109.07 142.56 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.43 -1.041 . . . . 15.0 109.78 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 29' ' ' ILE . 13.0 tp -66.24 109.21 2.57 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.736 -0.603 . . . . 15.0 110.258 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -91.9 -52.01 4.93 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.343 -0.543 . . . . 15.0 110.386 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -144.33 143.88 31.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.726 . . . . 15.0 110.517 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.834 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.24 125.11 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.744 -0.598 . . . . 15.0 109.702 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.1 97.48 6.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 15.0 109.776 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 -36.37 71.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 15.0 110.428 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -29.39 67.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.561 -0.712 . . . . 15.0 111.153 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 93.8 m-20 -116.14 14.08 15.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.528 -0.732 . . . . 15.0 111.544 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t 50.03 49.32 20.56 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.162 -0.962 . . . . 15.0 111.175 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.723 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -132.63 147.77 52.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.473 -0.767 . . . . 15.0 110.504 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.21 138.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.556 -0.715 . . . . 15.0 109.526 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.33 128.36 55.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.665 -0.647 . . . . 15.0 109.844 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 26' ' ' LEU . 95.3 mt -116.85 137.53 52.14 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.906 -0.496 . . . . 15.0 109.776 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.6 164.47 13.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.811 -0.556 . . . . 15.0 109.772 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 51.79 56.91 7.13 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.722 -0.611 . . . . 15.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -120.35 148.7 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.563 -0.711 . . . . 15.0 110.253 -174.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -139.55 150.67 45.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.739 -0.6 . . . . 15.0 110.291 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.5 p -98.5 131.22 44.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.819 -0.55 . . . . 15.0 109.804 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.543 -0.723 . . . . 15.0 110.774 -173.26 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.689 ' CG ' HD11 ' A' ' 65' ' ' ILE . 89.9 m-85 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 120.915 0.388 . . . . 15.0 109.982 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -68.31 -41.99 80.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.871 -0.518 . . . . 15.0 110.674 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -150.47 122.01 7.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.491 -0.756 . . . . 15.0 110.536 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.689 HD11 ' CG ' ' A' ' 62' ' ' PHE . 96.4 mt -130.75 147.35 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.658 -0.651 . . . . 15.0 109.57 172.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -109.85 136.64 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.763 -0.586 . . . . 15.0 109.929 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -127.71 140.64 51.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.725 -0.61 . . . . 15.0 109.975 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.723 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.4 mtt85 -108.11 152.81 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 15.0 110.153 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.2 -25.99 48.86 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.731 -0.948 . . . . 15.0 110.731 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 m -66.56 -45.99 77.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.527 -0.984 . . . . 15.0 110.747 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.97 -30.33 31.71 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.606 -0.684 . . . . 15.0 110.726 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 14' ' ' LEU . 73.2 mt -68.71 139.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.586 -0.696 . . . . 15.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.83 -43.55 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.754 -0.591 . . . . 15.0 110.261 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.17 141.82 42.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.718 -0.614 . . . . 15.0 110.505 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.12 127.61 40.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.735 -0.603 . . . . 15.0 110.087 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 15.0 110.133 178.144 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 121.094 0.473 . . . . 15.0 110.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -84.58 131.82 34.58 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.786 -0.571 . . . . 15.0 110.346 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.8 mt -133.86 147.33 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.523 -0.736 . . . . 15.0 109.93 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -117.18 130.27 56.49 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.505 -0.554 . . . . 15.0 109.505 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -119.11 135.68 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.736 -0.603 . . . . 15.0 110.322 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.4 mt -108.07 119.78 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.953 -0.758 . . . . 15.0 108.953 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -90.83 172.61 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.287 0.565 . . . . 15.0 110.902 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.25 -19.13 53.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.605 -0.684 . . . . 15.0 111.416 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 15.79 9.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.855 . . . . 15.0 111.318 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 57.8 29.27 17.19 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.289 -0.882 . . . . 15.0 110.786 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.1 146.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.07 120.68 42.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.759 -0.588 . . . . 15.0 110.465 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -112.03 133.98 53.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.827 -0.546 . . . . 15.0 109.713 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.1 tt0 -116.2 140.61 49.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.472 -0.767 . . . . 15.0 109.828 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.73 -178.82 38.98 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.962 -1.655 . . . . 15.0 108.962 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -107.39 141.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.466 -1.02 . . . . 15.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.82 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -66.23 108.93 2.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.748 -0.595 . . . . 15.0 110.201 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.83 -51.94 4.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.805 -0.559 . . . . 15.0 110.486 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.4 p -143.27 142.65 31.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.624 . . . . 15.0 110.481 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 HD21 ' A' ' 26' ' ' LEU . 73.3 mt -115.75 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 15.0 109.682 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.06 97.98 7.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.635 -0.665 . . . . 15.0 109.86 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -71.97 -36.12 69.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.78 -0.575 . . . . 15.0 110.456 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -58.75 -29.5 66.79 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.493 -0.754 . . . . 15.0 111.108 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -116.44 14.14 15.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.617 -0.677 . . . . 15.0 111.495 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m 49.9 49.56 20.02 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.174 -0.954 . . . . 15.0 111.152 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.725 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.4 p -132.54 147.79 52.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 15.0 110.539 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.59 137.87 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.661 . . . . 15.0 109.554 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.558 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.25 127.98 55.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.647 . . . . 15.0 109.888 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.3 mt -116.8 136.14 53.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.919 -0.488 . . . . 15.0 109.771 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.12 14.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.761 -0.587 . . . . 15.0 109.901 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 51.76 61.64 3.11 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.656 -0.653 . . . . 15.0 110.475 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -122.33 146.4 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.538 -0.727 . . . . 15.0 110.383 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -135.13 148.56 49.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.841 -0.537 . . . . 15.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.5 p -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 15.0 109.781 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 . . . . . 0 N--CA 1.499 2.017 0 C-N-CA 120.072 -0.651 . . . . 15.0 110.589 -174.138 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.011 0.434 . . . . 15.0 110.139 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.73 -39.78 84.25 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.832 -0.543 . . . . 15.0 110.78 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.522 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.5 t80 -151.71 122.37 7.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 15.0 110.832 -175.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -129.4 147.24 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.628 -0.67 . . . . 15.0 109.59 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.5 mt -110.65 136.28 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.692 -0.63 . . . . 15.0 109.849 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -127.02 140.64 52.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.763 -0.586 . . . . 15.0 109.922 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HG2' HG22 ' A' ' 35' ' ' THR . 83.2 mtp180 -107.73 151.66 25.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.18 -26.01 48.77 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.753 -0.939 . . . . 15.0 110.753 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -66.45 -45.95 78.06 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.485 -1.009 . . . . 15.0 110.718 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.1 -31.88 30.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.644 -0.66 . . . . 15.0 110.738 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.64 HG12 HD21 ' A' ' 14' ' ' LEU . 71.4 mt -65.89 141.25 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.675 -0.641 . . . . 15.0 109.859 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -104.71 -43.18 5.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.76 -0.587 . . . . 15.0 110.251 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.6 147.35 34.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.609 -0.682 . . . . 15.0 110.647 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -131.0 130.66 43.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.706 -0.621 . . . . 15.0 110.248 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 15.0 110.304 178.791 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 120.927 0.394 . . . . 15.0 110.216 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -87.0 133.5 33.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.69 -0.631 . . . . 15.0 110.437 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.89 147.45 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 15.0 109.991 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.7 t -110.83 130.17 55.65 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -119.83 130.65 55.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.845 -0.535 . . . . 15.0 110.325 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.71 119.33 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -92.26 170.61 9.67 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.307 0.575 . . . . 15.0 110.948 -171.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -60.6 -17.56 47.52 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.62 -0.675 . . . . 15.0 111.513 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.4 15.34 9.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.222 -0.923 . . . . 15.0 111.278 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 57.25 29.37 16.63 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 15.0 110.67 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.41 144.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -105.67 119.79 40.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.727 -0.608 . . . . 15.0 110.453 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -111.85 137.44 49.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.773 -0.58 . . . . 15.0 109.566 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.8 tt0 -121.42 140.49 52.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 15.0 109.938 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.87 39.84 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.124 -1.59 . . . . 15.0 109.124 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.49 142.37 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.495 -1.003 . . . . 15.0 109.708 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 29' ' ' ILE . 20.4 tp -65.21 112.51 3.47 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.721 -0.612 . . . . 15.0 110.295 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -96.03 -52.07 4.19 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.373 -0.531 . . . . 15.0 110.35 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -143.92 143.28 31.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.637 -0.664 . . . . 15.0 110.489 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.97 126.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.733 -0.604 . . . . 15.0 109.77 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -112.1 96.18 5.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.598 -0.689 . . . . 15.0 109.79 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.3 -36.78 74.54 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 15.0 110.369 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -58.91 -28.96 66.69 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.556 -0.715 . . . . 15.0 111.075 -171.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.16 13.99 15.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.722 . . . . 15.0 111.484 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t 49.96 47.27 23.51 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.241 -0.912 . . . . 15.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.2 p -131.43 149.56 52.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.447 -0.783 . . . . 15.0 110.471 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.41 140.28 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 15.0 109.649 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.05 129.12 56.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.689 -0.632 . . . . 15.0 109.935 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.4 mt -116.87 138.84 51.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.826 -0.435 . . . . 15.0 109.826 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.54 165.35 13.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.732 -0.605 . . . . 15.0 109.873 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 51.86 60.97 3.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.631 -0.668 . . . . 15.0 110.36 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -119.99 145.27 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 15.0 110.523 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -127.36 150.98 49.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 15.0 109.808 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.5 p -102.39 129.67 48.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.753 -0.592 . . . . 15.0 109.927 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 . . . . . 0 N--CA 1.499 2.001 0 C-N-CA 120.116 -0.633 . . . . 15.0 110.416 -176.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.883 -0.414 . . . . 15.0 109.883 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -67.56 -41.14 84.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.868 -0.52 . . . . 15.0 110.981 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -154.8 122.0 5.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.757 . . . . 15.0 110.676 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.6 mt -129.64 147.9 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.66 -0.65 . . . . 15.0 109.767 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.22 136.89 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.724 -0.61 . . . . 15.0 109.917 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.25 143.84 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.768 -0.583 . . . . 15.0 109.905 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.9 mtt85 -109.49 151.27 26.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.682 -0.637 . . . . 15.0 110.133 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.74 -26.02 56.83 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.697 -0.961 . . . . 15.0 110.697 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -66.76 -40.59 88.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.462 -1.022 . . . . 15.0 110.724 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -86.41 -31.78 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.617 -0.677 . . . . 15.0 110.712 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.69 138.78 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.592 -0.692 . . . . 15.0 109.956 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -99.88 -41.5 7.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.734 -0.604 . . . . 15.0 110.116 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -147.33 145.1 29.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.677 -0.639 . . . . 15.0 110.628 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -133.3 130.36 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.725 -0.609 . . . . 15.0 110.038 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 22.0 m . . . . . 0 N--CA 1.497 1.925 0 O-C-N 121.62 -0.675 . . . . 15.0 110.514 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.057 0.456 . . . . 15.0 110.534 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -83.72 132.54 34.85 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.752 -0.593 . . . . 15.0 110.035 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -132.66 145.99 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.52 -0.738 . . . . 15.0 110.114 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -115.07 129.93 56.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HG12 ' A' ' 72' ' ' ILE . 10.8 tp -121.9 136.3 54.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.675 -0.641 . . . . 15.0 110.355 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.11 121.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.021 -0.733 . . . . 15.0 109.021 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.69 172.43 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.309 0.576 . . . . 15.0 110.907 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -59.98 -19.26 51.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.629 -0.67 . . . . 15.0 111.405 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.02 16.76 7.75 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.257 -0.902 . . . . 15.0 111.215 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 57.48 28.42 15.47 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.237 -0.914 . . . . 15.0 110.867 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 55.5 mt -105.0 147.23 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 172.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -105.64 121.38 43.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 15.0 110.526 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -112.32 136.23 52.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.833 -0.542 . . . . 15.0 109.786 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.4 tt0 -117.75 140.54 49.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 15.0 109.779 173.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.19 -178.89 39.27 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.029 -1.628 . . . . 15.0 109.029 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.18 143.03 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.386 -1.067 . . . . 15.0 109.793 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 29' ' ' ILE . 12.1 tp -65.95 114.97 5.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.763 -0.585 . . . . 15.0 110.19 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -97.62 -52.05 3.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.806 -0.559 . . . . 15.0 110.381 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -144.56 143.35 30.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.717 -0.614 . . . . 15.0 110.541 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -115.43 125.23 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.717 -0.614 . . . . 15.0 109.613 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.08 97.2 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.605 -0.684 . . . . 15.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -70.89 -36.56 72.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.707 -0.62 . . . . 15.0 110.383 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.87 -29.36 66.93 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.572 -0.705 . . . . 15.0 111.015 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.64 13.91 16.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 15.0 111.461 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t 50.06 47.21 23.76 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.195 -0.941 . . . . 15.0 111.174 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.68 HG22 ' HG2' ' A' ' 68' ' ' ARG . 16.8 p -131.86 148.72 52.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.501 -0.75 . . . . 15.0 110.606 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.61 138.22 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 15.0 109.535 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -110.51 128.52 55.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.646 -0.658 . . . . 15.0 109.905 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.9 mt -116.79 138.65 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.889 -0.507 . . . . 15.0 109.791 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.73 164.68 13.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.76 -0.587 . . . . 15.0 109.791 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 51.81 56.91 7.12 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.644 -0.66 . . . . 15.0 110.375 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.0 p -120.66 148.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.593 -0.692 . . . . 15.0 110.303 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -139.71 150.07 44.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.804 -0.56 . . . . 15.0 110.211 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.4 p -97.59 132.06 43.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.77 -0.581 . . . . 15.0 109.771 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.552 -0.718 . . . . 15.0 110.569 -174.097 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.711 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.1 m-85 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 120.905 0.383 . . . . 15.0 110.078 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.09 -42.37 80.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.86 -0.525 . . . . 15.0 110.691 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -150.98 121.89 7.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.507 -0.746 . . . . 15.0 110.631 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.711 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.3 mt -130.73 147.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.681 -0.637 . . . . 15.0 109.698 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.04 135.74 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.719 -0.613 . . . . 15.0 109.901 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -125.74 140.77 52.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 15.0 109.991 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.68 ' HG2' HG22 ' A' ' 35' ' ' THR . 92.6 mtt-85 -104.37 151.07 23.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.679 -0.638 . . . . 15.0 110.087 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.13 -25.97 55.03 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -65.33 -45.0 86.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.446 -1.032 . . . . 15.0 110.778 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.96 -31.47 31.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.549 -0.72 . . . . 15.0 110.696 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.634 HG12 HD21 ' A' ' 14' ' ' LEU . 74.8 mt -65.88 136.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.5 -0.75 . . . . 15.0 109.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -104.88 -39.85 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 15.0 110.253 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.29 142.69 33.86 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.659 -0.65 . . . . 15.0 110.56 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.39 127.41 39.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.714 -0.616 . . . . 15.0 110.164 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 15.0 110.251 178.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.154 0.502 . . . . 15.0 110.67 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -78.54 130.02 35.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.874 -0.516 . . . . 15.0 110.1 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' CD1' HD13 ' A' ' 26' ' ' LEU . 93.6 mt -132.75 147.85 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.506 -0.746 . . . . 15.0 109.97 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 t -116.21 133.87 55.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.577 -0.527 . . . . 15.0 109.577 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 72' ' ' ILE . 11.1 tp -124.14 136.52 54.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.737 -0.602 . . . . 15.0 110.375 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.4 mt -108.81 122.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -94.3 172.93 7.9 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.277 0.56 . . . . 15.0 110.988 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.7 -20.01 53.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.624 -0.672 . . . . 15.0 111.466 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 16.91 8.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.35 -0.843 . . . . 15.0 111.271 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 58.03 28.23 16.0 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.301 -0.874 . . . . 15.0 110.86 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.6 mt -105.02 147.76 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -106.08 121.54 44.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.779 -0.576 . . . . 15.0 110.403 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -112.18 136.78 51.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.769 -0.582 . . . . 15.0 109.756 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.9 tt0 -118.49 140.68 49.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.507 -0.745 . . . . 15.0 109.725 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.55 -178.9 38.94 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.11 -1.596 . . . . 15.0 109.11 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.6 139.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.568 -0.96 . . . . 15.0 109.54 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.821 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -66.03 115.4 6.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 15.0 110.253 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -97.94 -52.05 3.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.865 -0.522 . . . . 15.0 110.403 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.6 p -144.46 143.39 30.86 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.615 -0.678 . . . . 15.0 110.637 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.821 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -116.58 127.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.633 -0.667 . . . . 15.0 109.679 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -112.12 95.42 5.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 15.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -69.26 -38.04 78.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.79 -0.569 . . . . 15.0 110.419 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.53 -28.96 67.55 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.582 -0.699 . . . . 15.0 111.1 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' THR . 94.8 m-20 -114.26 13.91 17.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.473 -0.767 . . . . 15.0 111.554 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 m 50.0 45.65 25.09 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.171 -0.956 . . . . 15.0 111.309 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.742 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.4 p -131.88 149.74 52.36 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.463 -0.773 . . . . 15.0 110.666 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.86 140.64 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.582 -0.699 . . . . 15.0 109.603 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.07 129.47 56.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.621 -0.675 . . . . 15.0 110.015 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.9 mt -116.89 139.12 51.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.938 -0.477 . . . . 15.0 109.753 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.82 162.98 16.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.698 -0.626 . . . . 15.0 109.868 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 51.89 59.34 4.62 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.666 -0.647 . . . . 15.0 110.488 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.51 148.03 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.592 -0.693 . . . . 15.0 110.314 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -136.45 149.55 48.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.901 -0.499 . . . . 15.0 110.073 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -97.21 131.75 43.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.714 -0.616 . . . . 15.0 109.724 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.543 -0.723 . . . . 15.0 110.702 -173.278 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 65' ' ' ILE . 85.1 m-85 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 120.898 0.38 . . . . 15.0 110.066 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.2 -42.88 79.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.79 -0.569 . . . . 15.0 110.667 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.4 t80 -150.48 121.93 7.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 15.0 110.606 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' CG ' ' A' ' 62' ' ' PHE . 25.8 mt -130.87 147.75 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 15.0 109.554 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.6 mt -110.58 136.05 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.741 -0.599 . . . . 15.0 109.86 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -126.08 142.64 51.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.631 . . . . 15.0 109.949 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.8 mtt180 -107.34 152.2 24.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.646 -0.659 . . . . 15.0 110.143 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.01 55.02 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.7 m -65.56 -45.54 82.92 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.447 -1.031 . . . . 15.0 110.766 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.02 -31.59 30.94 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.63 -0.669 . . . . 15.0 110.637 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 14' ' ' LEU . 69.7 mt -66.66 138.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.545 -0.722 . . . . 15.0 109.814 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -105.29 -40.07 5.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.652 . . . . 15.0 110.17 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 15' ' ' ILE . 18.4 t0 -143.19 142.83 31.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 15.0 110.665 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -128.41 127.11 41.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.796 -0.565 . . . . 15.0 110.049 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.497 1.901 0 O-C-N 121.638 -0.664 . . . . 15.0 110.394 179.705 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.028 0.442 . . . . 15.0 110.416 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -86.09 132.02 34.13 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.797 -0.564 . . . . 15.0 110.369 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 26' ' ' LEU . 94.5 mt -133.2 147.68 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 15.0 109.937 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -116.88 132.81 56.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.498 -0.556 . . . . 15.0 109.498 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 72' ' ' ILE . 10.9 tp -124.51 137.51 54.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.643 -0.661 . . . . 15.0 110.356 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.59 121.42 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.038 -0.727 . . . . 15.0 109.038 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -92.15 174.04 7.52 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.298 0.57 . . . . 15.0 110.94 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.54 -20.53 56.25 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.624 -0.673 . . . . 15.0 111.444 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.82 16.62 8.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.334 -0.854 . . . . 15.0 111.295 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 57.3 29.76 17.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.222 -0.924 . . . . 15.0 110.779 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 89.3 mt -105.1 146.71 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.996 -0.742 . . . . 15.0 108.996 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -104.12 119.91 39.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.823 -0.548 . . . . 15.0 110.428 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -111.44 136.32 50.75 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.756 -0.59 . . . . 15.0 109.791 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.643 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 tt0 -118.09 140.7 49.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.559 -0.713 . . . . 15.0 109.769 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.47 -178.92 38.91 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.937 -1.665 . . . . 15.0 108.937 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.0 mm -108.46 142.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.349 -1.089 . . . . 15.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 29' ' ' ILE . 20.5 tp -65.55 109.0 2.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.744 -0.597 . . . . 15.0 110.203 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -92.66 -52.05 4.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.801 -0.562 . . . . 15.0 110.439 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.59 142.91 31.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.638 -0.664 . . . . 15.0 110.422 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 26' ' ' LEU . 68.9 mt -116.72 125.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 15.0 109.661 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.17 97.3 6.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.573 -0.704 . . . . 15.0 109.781 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -71.45 -36.38 71.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.675 -0.641 . . . . 15.0 110.49 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.82 -29.79 67.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.461 -0.775 . . . . 15.0 111.043 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 93.4 m-20 -115.8 13.98 16.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.575 -0.703 . . . . 15.0 111.555 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t 49.89 48.75 21.36 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.154 -0.966 . . . . 15.0 111.266 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.711 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -131.81 148.33 52.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.477 -0.764 . . . . 15.0 110.484 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.42 139.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.66 -0.65 . . . . 15.0 109.662 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.4 128.94 56.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.77 -0.582 . . . . 15.0 109.911 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.7 mt -116.79 138.08 51.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.89 -0.506 . . . . 15.0 109.867 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.12 165.43 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.784 -0.573 . . . . 15.0 109.793 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 51.68 57.32 6.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.672 -0.642 . . . . 15.0 110.425 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -121.16 148.59 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 15.0 110.279 -173.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -140.7 152.31 45.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.724 -0.61 . . . . 15.0 110.196 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.4 p -97.42 131.26 44.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.771 -0.581 . . . . 15.0 109.795 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 N--CA 1.498 1.956 0 O-C-N 121.59 -0.694 . . . . 15.0 110.464 -173.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.714 ' CG ' HD11 ' A' ' 65' ' ' ILE . 90.4 m-85 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 120.95 0.405 . . . . 15.0 110.108 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -68.14 -41.84 81.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.867 -0.521 . . . . 15.0 110.684 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -150.8 121.96 7.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 15.0 110.589 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.714 HD11 ' CG ' ' A' ' 62' ' ' PHE . 94.8 mt -131.02 147.09 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.678 -0.639 . . . . 15.0 109.487 173.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -110.14 139.19 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.655 -0.653 . . . . 15.0 109.993 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.85 142.86 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.712 -0.617 . . . . 15.0 109.941 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.711 ' HG2' HG22 ' A' ' 35' ' ' THR . 90.7 mtt180 -110.73 152.68 26.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 15.0 110.086 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.06 55.12 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.673 -0.971 . . . . 15.0 110.673 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -67.26 -40.79 86.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.44 -1.035 . . . . 15.0 110.795 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -88.34 -30.97 19.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.599 -0.688 . . . . 15.0 110.801 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 14' ' ' LEU . 70.6 mt -64.73 142.31 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.588 -0.695 . . . . 15.0 109.915 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -99.88 -44.14 6.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 15.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -146.86 147.17 30.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.686 -0.634 . . . . 15.0 110.705 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -129.18 129.95 45.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.728 -0.608 . . . . 15.0 110.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.647 -0.658 . . . . 15.0 110.346 178.428 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.97 0.414 . . . . 15.0 110.417 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -85.59 133.56 34.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.861 -0.524 . . . . 15.0 110.239 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.614 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.2 mt -133.98 147.09 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.514 -0.741 . . . . 15.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -115.54 133.81 55.67 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HG12 ' A' ' 72' ' ' ILE . 9.4 tp -125.69 137.17 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.712 -0.618 . . . . 15.0 110.424 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 87.5 mt -109.3 121.37 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.968 -0.753 . . . . 15.0 108.968 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.8 m -93.33 175.68 6.67 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.32 0.581 . . . . 15.0 111.01 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.15 -21.5 59.45 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.606 -0.684 . . . . 15.0 111.398 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 15.97 9.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.321 -0.862 . . . . 15.0 111.326 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.71 28.99 16.64 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.306 -0.871 . . . . 15.0 110.811 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.0 149.59 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.151 -0.685 . . . . 15.0 109.151 172.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -106.35 121.19 43.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.798 -0.563 . . . . 15.0 110.608 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.44 141.75 45.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.802 -0.561 . . . . 15.0 109.809 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.2 tt0 -120.2 140.69 50.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.561 -0.712 . . . . 15.0 109.762 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.9 -178.94 37.88 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 108.866 -1.694 . . . . 15.0 108.866 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -109.37 143.02 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.421 -1.046 . . . . 15.0 109.742 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.813 HD21 HD11 ' A' ' 29' ' ' ILE . 12.6 tp -66.06 108.89 2.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.791 -0.568 . . . . 15.0 110.213 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -91.7 -52.02 4.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.795 -0.566 . . . . 15.0 110.407 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -144.11 142.43 30.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 15.0 110.439 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.813 HD11 HD21 ' A' ' 26' ' ' LEU . 74.6 mt -114.42 125.59 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.77 -0.581 . . . . 15.0 109.644 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -112.05 97.38 6.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.627 -0.671 . . . . 15.0 109.851 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.82 -36.25 70.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.702 -0.624 . . . . 15.0 110.546 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.79 -29.1 66.58 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.524 -0.735 . . . . 15.0 111.118 -171.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.535 ' O ' HG23 ' A' ' 35' ' ' THR . 94.6 m-20 -116.93 14.1 15.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.436 -0.79 . . . . 15.0 111.522 -176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m 49.9 49.14 20.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.181 -0.95 . . . . 15.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.701 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.9 p -131.89 148.29 52.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.462 -0.774 . . . . 15.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.65 138.49 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.561 -0.712 . . . . 15.0 109.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.28 128.79 56.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 15.0 109.954 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.5 mt -116.84 137.22 52.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 15.0 109.801 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.03 164.12 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.739 -0.601 . . . . 15.0 109.785 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt 51.84 59.58 4.45 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.56 -0.712 . . . . 15.0 110.524 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -122.73 148.66 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.55 -0.719 . . . . 15.0 110.224 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -140.02 150.41 44.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.754 -0.591 . . . . 15.0 110.256 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -97.8 129.53 44.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.706 -0.621 . . . . 15.0 109.653 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 119.846 -0.742 . . . . 15.0 110.738 -171.917 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.5 m-85 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 120.877 0.37 . . . . 15.0 110.111 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.21 -42.65 79.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.851 -0.531 . . . . 15.0 110.692 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -150.14 121.9 8.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 15.0 110.608 -176.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.63 HD11 ' CG ' ' A' ' 62' ' ' PHE . 28.5 mt -130.93 147.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.705 -0.622 . . . . 15.0 109.505 173.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.45 137.94 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.696 -0.627 . . . . 15.0 109.999 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.41 141.49 51.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.805 -0.559 . . . . 15.0 109.819 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.701 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.7 mtt180 -108.72 152.2 25.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.714 -0.616 . . . . 15.0 110.046 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.46 -26.0 50.82 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.725 -0.95 . . . . 15.0 110.725 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 -45.99 76.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.401 -1.058 . . . . 15.0 110.743 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.1 -32.07 30.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.583 -0.698 . . . . 15.0 110.714 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.613 HG12 HD21 ' A' ' 14' ' ' LEU . 83.4 mt -65.84 140.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.587 -0.696 . . . . 15.0 109.911 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -100.7 -42.21 6.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 15.0 110.195 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.4 144.58 30.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.649 -0.657 . . . . 15.0 110.667 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.31 128.59 43.47 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.655 -0.653 . . . . 15.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.598 -0.689 . . . . 15.0 110.192 178.187 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 m . . . . . 0 N--CA 1.499 1.991 0 CA-C-O 121.078 0.465 . . . . 15.0 110.514 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.52 131.48 34.17 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 15.0 110.228 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.608 ' CD1' HD13 ' A' ' 26' ' ' LEU . 95.7 mt -132.62 145.01 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 15.0 109.928 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -115.72 127.45 55.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 11.3 tp -116.18 133.37 56.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 15.0 110.165 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -107.39 119.08 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.975 -0.75 . . . . 15.0 108.975 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -90.37 172.36 8.8 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.348 0.594 . . . . 15.0 110.808 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.37 -18.43 50.31 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.613 -0.679 . . . . 15.0 111.447 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 15.77 9.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.284 -0.885 . . . . 15.0 111.351 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.42 29.88 16.02 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.292 -0.88 . . . . 15.0 110.673 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.4 mt -104.07 143.27 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 172.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -102.77 119.36 38.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.78 -0.575 . . . . 15.0 110.391 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.3 130.55 55.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.822 -0.549 . . . . 15.0 109.625 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.0 tt0 -115.99 140.67 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 15.0 109.868 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.4 -178.87 39.38 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.035 -1.626 . . . . 15.0 109.035 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.3 mm -108.08 138.8 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.389 -1.065 . . . . 15.0 109.772 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 29' ' ' ILE . 12.9 tp -62.39 108.96 1.21 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.754 -0.592 . . . . 15.0 110.379 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -91.53 -52.09 4.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.767 -0.583 . . . . 15.0 110.379 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.79 143.51 31.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.632 -0.668 . . . . 15.0 110.453 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.828 HD11 HD21 ' A' ' 26' ' ' LEU . 73.6 mt -115.57 125.59 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.765 -0.584 . . . . 15.0 109.661 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -112.05 96.16 5.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 15.0 109.825 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -71.19 -37.12 72.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.716 -0.615 . . . . 15.0 110.418 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.12 -29.04 67.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.456 -0.778 . . . . 15.0 111.053 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 35' ' ' THR . 94.9 m-20 -116.25 13.99 15.75 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 15.0 111.56 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.79 48.19 22.0 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.362 -0.836 . . . . 15.0 111.464 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 33' ' ' ASN . 42.4 p -132.39 149.4 52.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 15.0 110.404 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.08 138.76 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.576 -0.703 . . . . 15.0 109.55 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.45 56.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.612 -0.68 . . . . 15.0 109.905 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.9 mt -116.83 137.72 52.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.94 -0.475 . . . . 15.0 109.892 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.35 164.05 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.742 -0.599 . . . . 15.0 109.833 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 51.81 56.0 8.47 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.605 -0.684 . . . . 15.0 110.482 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.5 p -116.79 146.62 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 15.0 110.386 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -134.92 150.34 50.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.75 -0.594 . . . . 15.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -98.96 132.45 44.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.725 -0.61 . . . . 15.0 109.973 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.597 -0.689 . . . . 15.0 110.583 -175.78 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.687 ' CG ' HD11 ' A' ' 65' ' ' ILE . 91.7 m-85 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 120.947 0.403 . . . . 15.0 109.937 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -67.63 -41.63 83.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.808 -0.558 . . . . 15.0 110.745 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -150.8 121.88 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.585 -0.697 . . . . 15.0 110.585 -176.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.6 mt -132.0 147.99 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.731 -0.606 . . . . 15.0 109.534 172.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -110.93 138.1 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.701 -0.624 . . . . 15.0 109.984 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.86 143.05 50.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.665 -0.647 . . . . 15.0 109.854 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 35' ' ' THR . 89.9 mtt180 -109.61 152.32 25.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.709 . . . . 15.0 110.166 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -26.05 55.66 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.759 -0.936 . . . . 15.0 110.759 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.6 p -66.7 -44.15 82.46 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.467 -1.019 . . . . 15.0 110.752 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.31 -31.86 26.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 15.0 110.673 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 64.9 mt -65.55 143.54 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.648 -0.658 . . . . 15.0 109.895 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -105.05 -45.2 4.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 15.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -144.03 148.26 34.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 15.0 110.578 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.65 131.0 46.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.186 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 15.0 110.28 178.593 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.079 0.466 . . . . 15.0 110.602 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 25' ' ' ILE . 77.3 mttt -81.3 128.58 33.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.858 -0.526 . . . . 15.0 110.129 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 26' ' ' LEU . 95.9 mt -131.65 146.52 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.494 -0.754 . . . . 15.0 109.994 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.93 130.93 57.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.482 -0.562 . . . . 15.0 109.482 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 9.1 tp -119.43 135.01 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.795 -0.566 . . . . 15.0 110.259 -175.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.58 120.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -93.44 170.6 9.48 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.352 0.596 . . . . 15.0 110.862 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -60.6 -18.04 50.43 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.519 -0.738 . . . . 15.0 111.475 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 16.83 7.82 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.361 -0.837 . . . . 15.0 111.326 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.09 28.17 14.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 15.0 110.824 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -105.01 145.47 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -106.03 121.55 44.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.743 -0.598 . . . . 15.0 110.398 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.12 136.87 49.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.772 -0.58 . . . . 15.0 109.752 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.0 tt0 -120.1 140.66 50.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.804 . . . . 15.0 109.876 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 -178.96 39.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.171 -1.572 . . . . 15.0 109.171 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.473 HD12 ' HG2' ' A' ' 11' ' ' LYS . 15.8 mm -108.52 133.48 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.46 -1.023 . . . . 15.0 109.544 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.777 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -61.49 114.51 3.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.577 -0.702 . . . . 15.0 110.53 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -93.81 -52.08 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 15.0 110.379 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 22.5 p -146.45 145.27 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.597 -0.689 . . . . 15.0 110.595 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.777 HD11 HD21 ' A' ' 26' ' ' LEU . 75.7 mt -116.04 126.61 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.795 -0.566 . . . . 15.0 109.658 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.12 97.68 6.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.676 . . . . 15.0 109.825 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.91 -36.1 72.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.784 -0.572 . . . . 15.0 110.41 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -59.21 -29.28 67.38 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.584 -0.697 . . . . 15.0 111.102 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.17 14.02 15.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.638 -0.664 . . . . 15.0 111.516 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t 49.99 47.26 23.56 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.14 -0.975 . . . . 15.0 111.24 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.0 p -131.51 150.14 52.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.542 -0.724 . . . . 15.0 110.489 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.92 139.38 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.589 -0.694 . . . . 15.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.6 56.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.699 -0.625 . . . . 15.0 110.01 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 26' ' ' LEU . 21.7 mt -116.79 139.04 51.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.846 -0.428 . . . . 15.0 109.846 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 162.03 17.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.717 -0.615 . . . . 15.0 109.816 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 51.61 61.22 3.33 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.555 -0.715 . . . . 15.0 110.311 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 11.2 p -126.77 145.19 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.594 -0.691 . . . . 15.0 110.592 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -138.64 155.77 48.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.759 -0.588 . . . . 15.0 110.296 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.4 p -99.03 133.48 43.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.841 -0.537 . . . . 15.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.671 . . . . 15.0 110.468 -176.58 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CG ' HD11 ' A' ' 65' ' ' ILE . 78.5 m-85 . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 109.859 -0.423 . . . . 15.0 109.859 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -69.09 -46.03 68.78 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.438 -0.505 . . . . 15.0 110.641 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -147.9 121.87 9.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.582 -0.699 . . . . 15.0 110.514 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.532 HD11 ' CG ' ' A' ' 62' ' ' PHE . 19.5 mt -132.27 147.98 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.705 -0.622 . . . . 15.0 109.432 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -112.36 138.86 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.648 -0.658 . . . . 15.0 110.094 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.1 144.71 51.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 15.0 109.815 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -108.7 151.8 25.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.7 -0.625 . . . . 15.0 110.237 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.08 -26.0 54.92 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -65.59 -45.3 83.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.551 -0.97 . . . . 15.0 110.715 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.01 -31.34 31.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 15.0 110.683 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 75.9 mt -66.5 140.72 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.592 -0.693 . . . . 15.0 109.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -104.02 -42.53 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 15.0 110.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -147.41 149.6 33.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.678 -0.639 . . . . 15.0 110.7 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -129.71 131.23 46.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.742 -0.599 . . . . 15.0 110.097 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.584 -0.697 . . . . 15.0 110.343 179.374 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 120.937 0.399 . . . . 15.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -91.99 137.03 32.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.619 -0.676 . . . . 15.0 110.264 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.43 146.31 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 15.0 109.883 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -114.36 128.12 56.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.386 -0.598 . . . . 15.0 109.386 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 72' ' ' ILE . 11.0 tp -120.56 135.92 54.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 15.0 110.282 -175.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.4 mt -109.32 118.9 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -87.92 172.94 9.22 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.212 0.53 . . . . 15.0 110.781 -172.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -59.79 -18.44 43.52 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.606 -0.684 . . . . 15.0 111.601 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.52 15.47 10.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 15.0 111.286 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 56.17 28.58 13.31 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.191 -0.943 . . . . 15.0 110.776 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -101.87 142.9 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.82 -0.807 . . . . 15.0 108.82 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -100.84 120.8 40.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.744 -0.598 . . . . 15.0 110.467 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -112.73 132.35 55.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.837 -0.539 . . . . 15.0 109.591 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.7 mt-10 -117.92 140.65 49.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 15.0 109.907 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.85 39.38 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.944 -1.663 . . . . 15.0 108.944 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.4 mm -108.03 144.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -1.039 . . . . 15.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 29' ' ' ILE . 24.0 tp -66.15 113.49 4.56 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.807 -0.558 . . . . 15.0 110.21 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -94.25 -52.03 4.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.827 -0.546 . . . . 15.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 21.1 p -147.5 143.33 27.77 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 110.591 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 26' ' ' LEU . 78.2 mt -112.22 127.73 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.698 -0.627 . . . . 15.0 109.584 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -112.09 97.42 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.634 -0.666 . . . . 15.0 109.751 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.89 -35.74 72.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.703 -0.623 . . . . 15.0 110.405 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.56 -28.9 65.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.525 -0.734 . . . . 15.0 111.149 -171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -117.7 14.05 14.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.539 -0.725 . . . . 15.0 111.531 -176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t 49.92 48.69 21.47 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.104 -0.998 . . . . 15.0 111.257 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 33' ' ' ASN . 45.7 p -131.99 150.26 52.2 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.383 -0.823 . . . . 15.0 110.513 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.04 138.58 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 15.0 109.558 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -109.75 127.66 54.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.655 . . . . 15.0 109.918 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.8 mt -116.9 138.92 51.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.946 -0.471 . . . . 15.0 109.737 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.84 164.94 13.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.722 -0.611 . . . . 15.0 109.907 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 51.89 56.5 7.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.656 -0.653 . . . . 15.0 110.461 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.7 p -118.0 148.53 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.587 -0.695 . . . . 15.0 110.342 -174.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -137.43 153.29 50.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.791 -0.568 . . . . 15.0 110.229 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.9 p -101.87 133.87 45.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.731 -0.606 . . . . 15.0 110.006 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.699 -0.626 . . . . 15.0 110.689 -175.674 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 120.986 0.422 . . . . 15.0 110.037 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.77 -40.7 83.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.847 -0.533 . . . . 15.0 110.843 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.468 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -151.99 121.94 7.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.775 . . . . 15.0 110.814 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.7 mt -130.85 148.02 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.688 -0.632 . . . . 15.0 109.664 172.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.26 135.09 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.718 -0.614 . . . . 15.0 109.813 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -126.22 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.75 -0.594 . . . . 15.0 109.841 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.7 mtt180 -108.16 151.86 25.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 15.0 110.159 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -25.95 55.45 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.3 p -66.46 -45.06 81.03 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.501 -1.0 . . . . 15.0 110.685 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.94 -31.92 31.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.745 . . . . 15.0 110.682 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HD21 ' A' ' 14' ' ' LEU . 67.5 mt -65.88 140.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.599 -0.688 . . . . 15.0 109.869 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -106.35 -42.28 5.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.745 -0.597 . . . . 15.0 110.251 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -139.26 142.65 37.78 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.672 -0.642 . . . . 15.0 110.531 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -130.84 126.96 37.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.681 -0.637 . . . . 15.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.616 -0.678 . . . . 15.0 110.093 177.416 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.038 0.447 . . . . 15.0 110.29 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -85.99 133.22 33.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.662 -0.649 . . . . 15.0 110.468 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 26' ' ' LEU . 91.2 mt -133.83 154.18 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.598 -0.689 . . . . 15.0 109.735 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.9 t -115.89 132.62 56.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.901 -0.499 . . . . 15.0 109.85 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 75' ' ' LEU . 6.0 tp -116.53 130.19 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.87 -0.519 . . . . 15.0 109.88 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.18 119.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.91 -0.774 . . . . 15.0 108.91 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m -92.64 170.85 9.41 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.331 0.586 . . . . 15.0 110.981 -170.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.6 -18.54 53.65 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.603 -0.685 . . . . 15.0 111.422 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.59 16.13 8.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 15.0 111.251 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 58.12 28.53 16.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.344 -0.848 . . . . 15.0 110.829 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.0 mt -105.07 148.37 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 172.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -107.63 118.92 38.0 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.801 -0.562 . . . . 15.0 110.422 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.43 137.37 48.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.784 -0.573 . . . . 15.0 109.888 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.7 tm-20 -119.28 140.75 49.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 15.0 109.88 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.6 -178.9 38.97 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.072 -1.611 . . . . 15.0 109.072 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.21 135.16 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.516 -0.99 . . . . 15.0 109.708 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.799 HD21 HD11 ' A' ' 29' ' ' ILE . 12.5 tp -62.37 109.02 1.22 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.693 -0.629 . . . . 15.0 110.486 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.31 -52.07 5.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.819 -0.55 . . . . 15.0 110.356 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.5 p -144.52 144.17 31.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.622 -0.674 . . . . 15.0 110.538 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.799 HD11 HD21 ' A' ' 26' ' ' LEU . 74.1 mt -116.44 125.35 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.778 -0.576 . . . . 15.0 109.654 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -112.03 96.37 6.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.706 . . . . 15.0 109.896 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.0 m -70.65 -36.8 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.803 -0.561 . . . . 15.0 110.379 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.29 -29.28 67.48 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 15.0 111.131 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.43 14.05 16.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 15.0 111.547 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t 49.87 47.93 22.46 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.093 -1.005 . . . . 15.0 111.25 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.4 p -131.97 148.41 52.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.357 -0.839 . . . . 15.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.78 139.25 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.607 -0.683 . . . . 15.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -113.15 128.69 56.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.684 . . . . 15.0 110.005 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 26' ' ' LEU . 30.3 mt -116.77 136.6 52.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.901 -0.499 . . . . 15.0 109.879 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.97 162.35 16.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.698 -0.627 . . . . 15.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 51.86 59.62 4.42 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.608 -0.683 . . . . 15.0 110.384 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.58 147.14 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.601 -0.687 . . . . 15.0 110.333 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -137.38 150.86 47.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.776 -0.578 . . . . 15.0 110.033 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.9 p -95.98 130.23 43.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.771 -0.581 . . . . 15.0 109.741 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 N--CA 1.499 2.013 0 O-C-N 121.6 -0.687 . . . . 15.0 110.443 -174.549 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.943 0.401 . . . . 15.0 110.096 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -67.55 -38.92 84.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.872 -0.517 . . . . 15.0 110.864 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.4 t80 -152.21 122.04 7.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.46 -0.775 . . . . 15.0 110.824 -175.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.61 147.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.708 -0.62 . . . . 15.0 109.566 172.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.6 mt -110.8 137.76 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.723 -0.611 . . . . 15.0 109.927 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -129.47 142.64 50.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.718 -0.614 . . . . 15.0 109.905 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 35' ' ' THR . 91.3 mtt180 -110.35 152.15 26.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.621 -0.675 . . . . 15.0 110.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.94 55.12 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.5 p -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.436 -1.037 . . . . 15.0 110.75 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.13 -30.15 15.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.503 -0.748 . . . . 15.0 110.841 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.9 mt -63.52 138.37 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.453 -0.779 . . . . 15.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -98.86 -40.56 8.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.818 -0.551 . . . . 15.0 110.027 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.54 149.61 29.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.692 -0.63 . . . . 15.0 110.749 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 14' ' ' LEU . 40.8 tp -132.3 135.27 46.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.712 -0.617 . . . . 15.0 109.881 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.675 -0.641 . . . . 15.0 110.17 178.251 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.587 0.232 . . . . 10.09 110.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.8 155.21 42.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.243 -0.435 . . . . 7.65 110.583 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -74.91 150.1 85.83 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.186 -0.461 . . . . 6.09 110.539 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.26 -38.96 50.98 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.697 1.598 . . . . 5.77 112.131 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.1 m -67.53 -37.59 82.96 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.291 -0.413 . . . . 4.71 110.581 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.83 77.76 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.301 -0.719 . . . . 3.93 111.301 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.3 -35.67 91.29 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.397 -0.681 . . . . 3.59 111.397 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -96.39 122.91 56.37 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.438 -0.208 . . . . 2.87 110.438 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.15 134.91 20.03 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.594 1.53 . . . . 1.74 112.168 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.449 ' C ' HD23 ' A' ' 26' ' ' LEU . 97.6 m-85 -68.99 -36.96 78.45 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.288 -0.414 . . . . 3.81 110.545 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.449 ' N ' HD23 ' A' ' 26' ' ' LEU . 61.9 mt -66.53 133.09 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.245 -0.434 . . . . 0.5 109.995 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.14 -2.09 63.32 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 116.116 -0.493 . . . . 0.35 112.399 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -102.99 156.7 17.49 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.554 0.677 . . . . 0.19 110.772 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HG2' HD12 ' A' ' 25' ' ' ILE . 60.9 mttm -82.84 133.2 35.14 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.034 -0.53 . . . . 2.07 110.402 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 59.0 mt -135.85 147.25 28.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 0.22 110.434 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.0 t -114.68 132.57 56.36 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.754 -0.657 . . . . 0.15 109.893 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.608 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -124.45 137.4 54.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.414 . . . . 0.34 110.519 -175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mt -111.96 122.02 65.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 109.373 -0.602 . . . . 0.17 109.373 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 m -93.17 169.89 10.06 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.452 0.47 . . . . 0.17 111.139 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -59.86 -20.96 60.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.044 -0.525 . . . . 2.62 111.971 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.05 13.66 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.122 0.416 . . . . 0.19 112.122 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 61.9 25.22 15.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.635 0.255 . . . . 1.63 111.271 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.02 142.89 17.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 109.475 -0.565 . . . . 0.21 109.475 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -104.42 121.08 42.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.427 -0.351 . . . . 2.39 110.619 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -113.6 139.8 48.71 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.018 -0.537 . . . . 0.16 110.1 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.4 tt0 -121.61 140.67 51.96 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.0 -178.84 39.68 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.6 -1.0 . . . . 0.07 110.6 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 11' ' ' LYS . 10.9 mm -106.78 139.1 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 110.067 -0.345 . . . . 0.2 110.067 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.878 HD21 HD11 ' A' ' 29' ' ' ILE . 17.3 tp -65.95 109.06 2.39 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.252 -0.431 . . . . 0.25 110.492 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -91.59 -52.15 4.91 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.255 -0.429 . . . . 0.23 110.809 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.2 p -150.23 145.53 26.28 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.376 -0.375 . . . . 0.17 110.957 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.878 HD11 HD21 ' A' ' 26' ' ' LEU . 44.7 mt -118.45 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.25 110.077 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -112.1 95.01 5.22 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 110.067 -0.345 . . . . 1.1 110.067 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.7 m -67.87 -38.62 83.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.782 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.71 -32.15 68.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.311 -0.404 . . . . 1.97 111.615 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -112.64 13.94 20.01 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.163 0.431 . . . . 0.47 112.163 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.6 p 49.99 42.15 24.16 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.936 0.398 . . . . 1.14 111.598 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HG2' ' A' ' 68' ' ' ARG . 4.2 p -131.37 149.16 52.66 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.278 -0.419 . . . . 0.13 110.98 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.8 t -129.44 138.21 54.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 115.986 -0.552 . . . . 0.12 110.006 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.77 127.65 56.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.367 -0.379 . . . . 0.07 110.431 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.3 mt -116.93 139.48 50.6 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.112 -0.495 . . . . 0.42 110.138 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.11 159.48 22.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.235 -0.439 . . . . 0.06 110.134 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 55.94 55.14 7.24 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.191 0.52 . . . . 2.43 110.482 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -119.22 142.58 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.767 -0.651 . . . . 0.11 110.334 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -135.22 150.74 50.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.09 -0.504 . . . . 3.55 110.493 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 p -96.47 128.01 43.0 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.2 110.194 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -69.45 -40.31 77.25 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.456 -0.338 . . . . 0.79 110.828 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 167.96 29.23 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.204 -0.758 . . . . 0.31 111.204 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.9 p -115.63 -30.6 6.12 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.524 0.202 . . . . 0.76 110.998 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -58.51 -27.2 64.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.582 -0.281 . . . . 2.31 111.557 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.84 -33.23 68.42 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.674 0.273 . . . . 3.09 110.865 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' THR . 20.4 mmt180 -119.22 94.97 48.97 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.109 -0.496 . . . . 5.19 110.173 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -50.51 130.36 29.39 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 121.982 1.788 . . . . 2.46 112.845 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ARG . 75.0 p -129.8 165.01 22.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.085 -0.507 . . . . 2.72 110.377 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -77.9 -4.07 44.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.235 -0.439 . . . . 3.83 112.069 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -118.09 106.87 44.63 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 110.555 -0.165 . . . . 5.15 110.555 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.83 131.94 44.87 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.595 1.53 . . . . 3.39 112.221 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.2 mm -119.35 130.75 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.206 -0.452 . . . . 2.26 110.102 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.61 82.53 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 3.04 110.492 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.01 135.82 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.701 1.601 . . . . 3.02 112.045 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -134.8 131.26 37.28 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.168 -0.469 . . . . 6.95 110.511 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -112.79 31.81 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.24 -0.437 . . . . 3.22 110.777 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.3 147.61 30.04 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.363 -0.38 . . . . 2.32 110.489 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -102.93 142.63 33.72 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.172 -0.467 . . . . 0.76 110.438 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.08 132.41 47.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.225 -0.443 . . . . 0.38 110.417 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -66.31 -40.5 89.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.164 -0.471 . . . . 2.54 111.251 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.8 t80 -146.85 121.94 10.11 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.728 0.299 . . . . 0.13 111.041 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 69.0 mt -134.17 143.77 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.16 110.045 172.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.9 mt -112.45 138.22 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.256 -0.429 . . . . 0.13 110.369 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -130.08 141.28 50.72 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.035 -0.529 . . . . 0.14 110.273 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HG2' HG22 ' A' ' 35' ' ' THR . 75.7 mtm180 -102.15 149.11 24.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.414 -0.357 . . . . 2.11 110.295 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.68 -27.86 50.4 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 111.946 -0.462 . . . . 0.11 111.946 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -67.09 -42.15 85.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.456 0.169 . . . . 1.24 111.15 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.95 -32.05 30.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.56 -0.291 . . . . 1.09 111.229 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.608 HG12 HD21 ' A' ' 14' ' ' LEU . 50.8 mt -65.51 144.48 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.13 110.392 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -103.93 -45.99 4.6 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.038 -0.528 . . . . 1.35 110.648 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -148.25 149.13 31.35 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.3 -0.409 . . . . 1.13 111.127 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt -131.39 129.2 41.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.982 -0.553 . . . . 0.51 110.17 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.1 m -132.45 136.01 46.44 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.439 -0.346 . . . . 0.23 110.571 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.9 t -98.79 143.94 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.369 -0.378 . . . . 0.53 110.136 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 80.3 m -93.76 -37.09 11.97 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.291 -0.413 . . . . 1.22 110.81 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -90.85 117.52 67.99 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.374 -0.376 . . . . 2.29 110.523 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.38 156.41 9.42 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 121.767 1.644 . . . . 2.55 112.181 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.11 135.87 21.52 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.718 1.612 . . . . 4.24 111.983 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -88.56 152.18 49.09 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.185 -0.462 . . . . 7.85 110.617 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 140.52 93.95 Favored 'Trans proline' 0 N--CA 1.5 1.868 0 C-N-CA 121.896 1.73 . . . . 8.72 112.153 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.93 153.74 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.208 -0.451 . . . . 10.88 110.644 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 74.1 mtm . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.924 -1.036 . . . . 13.63 110.527 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.566 HD11 ' CA ' ' A' ' 4' ' ' GLY . 7.5 tt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 120.992 0.425 . . . . 15.0 110.151 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.33 -50.16 3.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.695 -0.628 . . . . 15.0 110.224 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . 0.533 ' O ' HD21 ' A' ' -2' ' ' LEU . 9.1 p-10 -104.98 150.07 38.3 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.578 -0.701 . . . . 15.0 110.379 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.43 -31.91 88.54 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 O-C-N 123.401 1.211 . . . . 15.0 110.757 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 t -65.24 -31.81 73.16 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.616 -0.678 . . . . 15.0 110.515 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.47 -32.43 81.72 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.95 -1.26 . . . . 15.0 109.95 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.566 ' CA ' HD11 ' A' ' -2' ' ' LEU . . . -65.93 -33.49 85.82 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.944 -1.262 . . . . 15.0 109.944 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.0 m -89.9 123.02 67.27 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.615 -0.932 . . . . 15.0 110.053 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.31 130.58 20.15 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.351 1.185 . . . . 15.0 110.41 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' C ' HD23 ' A' ' 26' ' ' LEU . 97.4 m-85 -69.08 -32.39 71.8 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.683 -0.636 . . . . 15.0 110.215 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.55 133.91 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.422 -0.799 . . . . 15.0 109.763 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.63 -2.12 66.89 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -101.36 148.41 25.18 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 118.768 1.284 . . . . 15.0 110.553 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 tttt -82.07 128.46 34.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.853 -0.529 . . . . 15.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.531 HD12 ' HB2' ' A' ' 26' ' ' LEU . 89.8 mt -131.01 149.5 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 15.0 109.913 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.63 135.95 53.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.551 -0.537 . . . . 15.0 109.551 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD21 HG12 ' A' ' 72' ' ' ILE . 10.5 tp -127.07 137.0 52.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.717 -0.614 . . . . 15.0 110.258 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.7 mt -109.63 123.4 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.014 -0.736 . . . . 15.0 109.014 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -93.55 172.83 8.02 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.305 0.574 . . . . 15.0 110.944 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -59.74 -19.8 52.46 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.63 -0.668 . . . . 15.0 111.444 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 51' ' ' THR . . . -89.76 16.14 8.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.416 -0.803 . . . . 15.0 111.336 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.57 29.32 16.97 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.302 -0.874 . . . . 15.0 110.781 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 46' ' ' THR . 70.2 mt -105.09 147.59 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 172.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -105.78 118.93 37.85 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.785 -0.572 . . . . 15.0 110.509 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -111.52 140.71 45.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.812 -0.555 . . . . 15.0 109.765 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.63 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.1 tt0 -125.83 140.8 52.37 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.475 -0.766 . . . . 15.0 109.839 174.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.86 -178.84 39.06 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.128 -1.589 . . . . 15.0 109.128 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.9 mm -107.28 133.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.436 -1.038 . . . . 15.0 109.736 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -61.61 114.66 3.4 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.751 -0.593 . . . . 15.0 110.474 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -95.72 -52.04 4.26 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.408 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -145.16 145.15 31.25 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.623 -0.673 . . . . 15.0 110.664 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.822 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -118.31 127.31 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.747 -0.595 . . . . 15.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.11 97.96 7.01 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.64 -0.662 . . . . 15.0 109.846 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -70.6 -36.57 73.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.719 -0.613 . . . . 15.0 110.484 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.09 -29.16 67.15 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.55 -0.719 . . . . 15.0 111.136 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.552 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.14 14.07 15.87 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.573 -0.704 . . . . 15.0 111.539 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t 49.94 47.53 23.11 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.143 -0.973 . . . . 15.0 111.22 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 21.3 p -131.27 149.99 52.33 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.517 -0.739 . . . . 15.0 110.558 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.56 141.75 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.671 -0.643 . . . . 15.0 109.72 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.17 129.67 56.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.681 -0.637 . . . . 15.0 110.058 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 26' ' ' LEU . 22.1 mt -116.92 138.95 51.19 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.884 -0.51 . . . . 15.0 109.845 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.08 16.49 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.736 -0.603 . . . . 15.0 109.861 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 76.3 mttt 51.72 58.36 5.56 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.709 -0.619 . . . . 15.0 110.441 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.8 p -121.29 148.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.566 -0.709 . . . . 15.0 110.332 -173.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -138.62 153.91 48.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.81 -0.556 . . . . 15.0 110.128 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.3 p -101.24 131.84 47.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.832 -0.543 . . . . 15.0 109.856 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -70.84 -40.19 72.52 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.6 -0.687 . . . . 15.0 110.541 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.78 169.9 31.88 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.809 -1.316 . . . . 15.0 109.809 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.705 HG21 HG21 ' A' ' 55' ' ' ILE . 45.8 p -117.98 -28.28 5.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.787 -0.831 . . . . 15.0 110.618 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -62.98 -29.9 71.17 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.446 -0.784 . . . . 15.0 110.892 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.42 -32.52 71.43 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.552 -0.717 . . . . 15.0 110.325 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 51' ' ' THR . 32.3 mtt180 -120.38 95.09 49.03 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.792 -0.567 . . . . 15.0 109.779 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.19 132.34 46.33 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 O-C-N 123.423 1.223 . . . . 15.0 111.024 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.548 HG21 ' O ' ' A' ' 18' ' ' ALA . 33.9 p -127.69 165.11 20.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.897 -0.502 . . . . 15.0 110.044 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -77.85 -1.6 32.42 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.71 -0.619 . . . . 15.0 111.487 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -114.88 115.0 43.83 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.183 -0.948 . . . . 15.0 109.853 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -65.72 132.04 29.45 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.385 1.202 . . . . 15.0 110.622 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG21 HG21 ' A' ' 46' ' ' THR . 51.6 mm -121.28 146.02 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.672 -0.642 . . . . 15.0 109.665 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -90.42 150.68 43.27 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.687 -0.633 . . . . 15.0 110.081 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.11 145.91 62.49 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 O-C-N 123.611 1.322 . . . . 15.0 110.35 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -155.2 151.85 28.66 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.701 -0.624 . . . . 15.0 110.336 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -133.93 33.19 3.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.691 -0.631 . . . . 15.0 110.258 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -99.96 158.55 15.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.654 -0.654 . . . . 15.0 110.156 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.4 m -102.91 141.93 34.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.724 -0.61 . . . . 15.0 110.176 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.0 m-85 -102.02 128.27 48.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.648 -0.658 . . . . 15.0 110.104 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -68.3 -43.37 77.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.769 -0.582 . . . . 15.0 110.579 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -149.92 122.02 8.29 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.543 -0.723 . . . . 15.0 110.609 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.636 HD11 ' CG ' ' A' ' 62' ' ' PHE . 30.4 mt -130.85 146.98 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.699 -0.626 . . . . 15.0 109.56 173.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.9 mt -109.87 137.29 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.72 -0.612 . . . . 15.0 109.93 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -128.93 144.28 51.13 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.75 -0.594 . . . . 15.0 109.846 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 82.8 mtm180 -109.27 152.68 24.9 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.615 -0.678 . . . . 15.0 110.088 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.04 -26.0 54.83 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.9 m -65.98 -45.86 80.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.472 -1.017 . . . . 15.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.95 -31.02 31.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.693 -0.63 . . . . 15.0 110.807 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.579 HG12 HD21 ' A' ' 14' ' ' LEU . 73.0 mt -65.99 141.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.538 -0.726 . . . . 15.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -104.56 -42.54 5.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.781 -0.574 . . . . 15.0 110.198 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -145.88 145.95 30.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.695 -0.628 . . . . 15.0 110.679 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.74 129.12 45.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.804 -0.56 . . . . 15.0 110.13 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -135.42 142.74 45.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.629 -0.669 . . . . 15.0 110.428 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.19 144.05 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.658 -0.651 . . . . 15.0 109.684 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.46 -37.05 7.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.525 -0.734 . . . . 15.0 110.358 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -155.57 139.17 11.12 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 15.0 110.206 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.6 175.86 2.59 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 123.315 1.166 . . . . 15.0 110.503 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.94 156.71 52.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.659 1.347 . . . . 15.0 110.547 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -80.32 157.59 72.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.68 -0.637 . . . . 15.0 110.178 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -67.2 148.54 80.82 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.663 1.349 . . . . 15.0 110.423 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.91 -35.0 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.772 -0.58 . . . . 15.0 109.699 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.018 -0.992 . . . . 15.0 110.247 179.776 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 108.441 -0.948 . . . . 15.0 108.441 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 68.65 166.24 0.26 Allowed 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.599 -0.889 . . . . 15.0 108.599 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.13 149.55 38.27 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.211 -1.033 . . . . 15.0 108.211 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -66.03 -33.17 42.32 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 O-C-N 123.618 1.325 . . . . 15.0 110.529 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -67.11 -35.8 80.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.68 -0.638 . . . . 15.0 110.222 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.11 -34.38 75.84 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.78 -1.328 . . . . 15.0 109.78 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.74 -36.86 88.17 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 15.0 109.825 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -99.46 141.38 22.72 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.646 -0.914 . . . . 15.0 110.195 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -73.75 144.13 34.67 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 123.47 1.247 . . . . 15.0 110.36 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.404 ' C ' HD23 ' A' ' 26' ' ' LEU . 98.5 m-85 -69.04 -33.31 73.4 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.674 -0.641 . . . . 15.0 110.123 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.82 134.23 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.399 -0.813 . . . . 15.0 109.733 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.7 -2.06 64.24 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m -98.62 152.29 19.77 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.256 . . . . 15.0 110.599 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -84.89 128.2 34.51 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.768 -0.583 . . . . 15.0 110.197 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.0 mt -132.19 150.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 15.0 109.988 -175.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.2 t -115.53 131.34 56.96 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.532 -0.544 . . . . 15.0 109.532 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.562 HD21 HG12 ' A' ' 72' ' ' ILE . 11.8 tp -118.82 134.9 54.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 15.0 110.285 -176.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.5 mt -107.34 122.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 109.109 -0.701 . . . . 15.0 109.109 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -93.76 171.93 8.57 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.314 0.578 . . . . 15.0 110.87 -173.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.9 tptt -60.09 -19.05 51.31 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.614 -0.679 . . . . 15.0 111.441 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.23 16.69 8.14 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.353 -0.842 . . . . 15.0 111.275 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 57.1 28.44 14.94 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.28 -0.888 . . . . 15.0 110.827 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 45' ' ' GLY . 90.0 mt -105.08 145.66 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.062 -0.718 . . . . 15.0 109.062 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.9 ttt85 -104.56 121.5 43.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.847 -0.533 . . . . 15.0 110.34 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.14 132.77 54.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.559 . . . . 15.0 109.654 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 9.3 tm-20 -115.96 140.58 49.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.532 -0.73 . . . . 15.0 109.886 176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.05 -178.81 39.68 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.93 -1.668 . . . . 15.0 108.93 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.2 mm -106.68 138.95 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.455 -1.026 . . . . 15.0 109.64 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.927 HD21 HD11 ' A' ' 29' ' ' ILE . 19.0 tp -65.3 112.13 3.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.746 -0.596 . . . . 15.0 110.356 -177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -95.58 -52.11 4.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.841 -0.537 . . . . 15.0 110.489 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 18.1 p -144.31 142.54 30.48 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.573 -0.705 . . . . 15.0 110.604 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 26' ' ' LEU . 75.5 mt -116.27 126.55 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.805 -0.56 . . . . 15.0 109.609 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -112.09 95.28 5.38 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.609 -0.682 . . . . 15.0 109.792 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -69.33 -39.47 78.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.746 -0.596 . . . . 15.0 110.344 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -59.83 -29.27 68.14 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.549 -0.719 . . . . 15.0 111.063 -172.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' THR . 94.5 m-20 -111.17 12.35 21.86 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.464 -0.773 . . . . 15.0 111.555 -177.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m 49.98 44.64 25.53 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.195 -0.941 . . . . 15.0 111.288 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.704 HG22 ' HG2' ' A' ' 68' ' ' ARG . 15.1 p -132.77 150.09 52.2 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.481 -0.762 . . . . 15.0 110.623 -177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.3 139.95 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.73 -0.606 . . . . 15.0 109.595 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.73 128.69 56.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.646 -0.659 . . . . 15.0 110.04 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.9 mt -116.84 138.85 51.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.895 -0.503 . . . . 15.0 109.726 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.76 162.36 16.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.704 -0.622 . . . . 15.0 109.89 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt 52.09 61.05 3.41 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.619 -0.675 . . . . 15.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.07 147.06 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.625 -0.672 . . . . 15.0 110.46 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.673 ' CG ' HG23 ' A' ' 61' ' ' THR . 81.7 mtp180 -132.8 149.92 52.22 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.857 -0.527 . . . . 15.0 109.988 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 p -97.74 130.8 44.68 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.688 -0.633 . . . . 15.0 109.823 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -73.96 -40.33 63.1 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.493 -0.754 . . . . 15.0 110.819 -174.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 20' ' ' ILE . . . 167.83 175.28 37.5 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.985 -1.246 . . . . 15.0 109.985 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.642 HG21 HG13 ' A' ' 55' ' ' ILE . 38.5 p -118.1 6.23 12.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.706 -0.879 . . . . 15.0 111.073 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -57.53 -23.21 49.06 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.251 -0.906 . . . . 15.0 111.419 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -60.51 -33.22 72.31 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.43 -0.794 . . . . 15.0 110.45 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -144.06 95.13 5.69 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.789 -0.57 . . . . 15.0 109.949 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.6 137.1 66.94 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.371 1.195 . . . . 15.0 110.74 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.2 p -123.79 165.19 17.73 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.815 -0.553 . . . . 15.0 110.134 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -77.77 -1.62 32.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.689 -0.632 . . . . 15.0 111.298 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -108.6 106.95 59.66 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.125 -0.984 . . . . 15.0 109.827 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.22 141.65 83.26 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 O-C-N 123.426 1.224 . . . . 15.0 110.811 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.642 HG13 HG21 ' A' ' 46' ' ' THR . 51.0 mm -104.06 142.4 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.762 -0.586 . . . . 15.0 109.592 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.64 155.67 92.46 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.637 -0.664 . . . . 15.0 110.214 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -62.34 165.04 15.97 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.612 1.322 . . . . 15.0 110.601 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -66.96 136.84 55.96 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.752 -0.593 . . . . 15.0 110.129 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -150.25 -62.2 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.684 -0.635 . . . . 15.0 110.361 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -118.39 167.6 11.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.71 -0.619 . . . . 15.0 110.457 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.673 HG23 ' CG ' ' A' ' 42' ' ' ARG . 34.5 m -103.03 162.68 12.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.814 -0.554 . . . . 15.0 110.01 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -98.05 125.52 43.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.639 -0.663 . . . . 15.0 109.962 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -68.71 -46.02 70.07 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.87 -0.519 . . . . 15.0 110.543 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.5 t80 -149.29 121.93 8.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.579 -0.701 . . . . 15.0 110.48 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 147.19 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.718 -0.613 . . . . 15.0 109.605 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.66 136.32 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.746 -0.596 . . . . 15.0 109.818 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -126.28 143.96 50.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.747 -0.596 . . . . 15.0 109.984 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.704 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -106.66 151.99 24.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.638 -0.664 . . . . 15.0 110.173 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.99 -25.93 54.54 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.751 -0.94 . . . . 15.0 110.751 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.0 m -65.57 -45.41 83.39 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.48 -1.012 . . . . 15.0 110.661 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.98 -31.28 31.23 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.543 -0.723 . . . . 15.0 110.677 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.562 HG12 HD21 ' A' ' 14' ' ' LEU . 72.7 mt -66.17 144.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.563 -0.711 . . . . 15.0 109.902 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -106.71 -43.09 4.79 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.748 -0.595 . . . . 15.0 110.192 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -150.74 151.72 32.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.652 -0.655 . . . . 15.0 110.629 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.38 129.79 45.2 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.851 -0.531 . . . . 15.0 110.176 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m -131.79 143.17 50.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.65 -0.656 . . . . 15.0 110.396 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.44 144.05 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.68 -0.637 . . . . 15.0 109.738 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 94.2 m -98.51 -37.14 9.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.603 -0.686 . . . . 15.0 110.343 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.15 117.48 63.13 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.656 -0.652 . . . . 15.0 110.115 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -76.67 151.31 32.09 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.397 1.209 . . . . 15.0 110.301 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -69.77 151.99 69.15 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.554 1.291 . . . . 15.0 110.229 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -101.45 161.76 22.59 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.609 -0.682 . . . . 15.0 110.228 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -62.92 141.63 85.09 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.643 1.338 . . . . 15.0 110.591 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.5 mt -120.64 134.43 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.678 -0.638 . . . . 15.0 109.658 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.983 -1.008 . . . . 15.0 110.217 179.9 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.0 0.429 . . . . 15.0 110.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -116.45 167.31 11.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.683 -0.635 . . . . 15.0 110.106 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -89.5 150.1 43.78 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.67 -0.644 . . . . 15.0 110.121 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -61.72 -33.28 86.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 O-C-N 123.454 1.239 . . . . 15.0 110.729 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.3 p -67.74 -36.23 80.16 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.655 -0.653 . . . . 15.0 110.369 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.39 -36.91 54.5 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.557 -1.417 . . . . 15.0 109.557 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.3 76.27 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.847 -1.301 . . . . 15.0 109.847 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.5 m -71.43 144.79 89.58 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.925 . . . . 15.0 110.196 -177.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 16.5 Cg_exo -63.87 149.12 91.38 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.348 1.183 . . . . 15.0 110.562 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.84 -30.43 71.49 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.722 -0.611 . . . . 15.0 110.429 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.6 mt -64.32 135.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.373 -0.829 . . . . 15.0 109.595 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.18 -2.22 61.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.86 -0.896 . . . . 15.0 110.86 -174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.5 m -93.15 159.46 15.28 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.31 . . . . 15.0 110.347 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.8 tttt -92.12 133.74 35.48 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.75 -0.594 . . . . 15.0 110.287 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 26' ' ' LEU . 90.6 mt -132.43 147.72 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.531 -0.731 . . . . 15.0 109.923 -177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.2 t -115.08 131.45 56.92 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.499 -0.556 . . . . 15.0 109.499 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.602 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -123.16 135.97 54.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.713 -0.617 . . . . 15.0 110.35 -175.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 74' ' ' ASP . 79.9 mt -108.83 120.49 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.986 -0.746 . . . . 15.0 108.986 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -91.53 171.64 9.05 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.334 0.587 . . . . 15.0 110.886 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -59.69 -18.99 46.75 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.617 -0.677 . . . . 15.0 111.643 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.03 17.21 8.25 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 15.0 111.257 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 58.0 28.86 16.85 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.254 -0.904 . . . . 15.0 110.835 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.555 HG12 HG22 ' A' ' 46' ' ' THR . 88.8 mt -105.13 148.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 172.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -105.32 119.01 38.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.762 -0.586 . . . . 15.0 110.462 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -111.76 136.46 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.761 -0.587 . . . . 15.0 109.652 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.0 tt0 -122.81 140.57 52.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 15.0 110.007 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.93 -178.88 39.67 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 108.901 -1.68 . . . . 15.0 108.901 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.9 mm -107.27 140.57 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -1.059 . . . . 15.0 109.858 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.897 HD21 HD11 ' A' ' 29' ' ' ILE . 21.0 tp -64.44 109.98 2.13 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.741 -0.599 . . . . 15.0 110.344 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -93.39 -52.08 4.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.792 -0.567 . . . . 15.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -143.24 143.33 31.7 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.683 -0.635 . . . . 15.0 110.523 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.897 HD11 HD21 ' A' ' 26' ' ' LEU . 74.4 mt -116.83 125.62 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.775 -0.578 . . . . 15.0 109.656 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -112.03 98.21 7.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.603 -0.686 . . . . 15.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -71.32 -36.04 71.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.8 -0.563 . . . . 15.0 110.457 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -58.88 -29.88 67.33 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.544 -0.723 . . . . 15.0 111.078 -171.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.55 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.45 14.04 15.54 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.639 -0.663 . . . . 15.0 111.519 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 t 49.88 48.69 21.44 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.246 -0.909 . . . . 15.0 111.229 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.728 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.3 p -131.39 149.58 52.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.571 -0.706 . . . . 15.0 110.514 -178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.0 t -131.49 139.68 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.663 -0.648 . . . . 15.0 109.687 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.74 128.47 56.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.639 -0.663 . . . . 15.0 109.957 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 59.7 mt -116.82 137.78 51.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.979 -0.451 . . . . 15.0 109.798 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.33 163.68 14.97 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.741 -0.599 . . . . 15.0 109.894 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 51.48 64.24 1.92 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-O 121.376 0.608 . . . . 15.0 110.439 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -123.9 145.51 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.596 -0.69 . . . . 15.0 110.347 -172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -127.98 149.34 50.39 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.864 -0.522 . . . . 15.0 109.801 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.8 p -99.32 125.18 44.92 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.663 -0.648 . . . . 15.0 109.602 174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -70.35 -40.27 74.16 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.055 -0.658 . . . . 15.0 110.643 -171.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 169.13 30.79 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.918 -1.273 . . . . 15.0 109.918 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 20' ' ' ILE . 70.2 p -118.06 -19.46 9.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.911 -0.758 . . . . 15.0 110.946 175.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.5 -29.28 70.58 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.319 -0.863 . . . . 15.0 110.956 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -60.01 -32.9 71.31 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.445 -0.784 . . . . 15.0 110.252 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' THR . 62.2 mtt180 -125.21 94.97 42.42 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.825 -0.547 . . . . 15.0 109.766 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.48 132.63 47.17 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.388 1.204 . . . . 15.0 111.1 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 49' ' ' ARG . 33.1 p -128.97 165.17 21.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.803 -0.56 . . . . 15.0 110.035 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.83 -1.85 33.6 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.664 -0.648 . . . . 15.0 111.352 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -109.54 106.91 59.09 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.14 -0.975 . . . . 15.0 109.976 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.8 138.77 54.66 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.389 1.205 . . . . 15.0 110.516 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.4 mm -122.4 145.96 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.653 -0.654 . . . . 15.0 109.826 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -92.59 158.04 38.99 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.71 -0.619 . . . . 15.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.54 161.12 36.55 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 O-C-N 123.586 1.309 . . . . 15.0 110.543 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -128.71 145.68 51.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.697 -0.627 . . . . 15.0 110.471 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -115.08 -31.86 5.9 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.75 -0.593 . . . . 15.0 110.485 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.93 166.38 11.31 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.593 -0.692 . . . . 15.0 110.348 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.6 m -102.96 169.31 8.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.761 -0.587 . . . . 15.0 109.884 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -101.92 125.46 48.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.495 -0.753 . . . . 15.0 110.18 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.35 -44.7 71.06 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.79 -0.569 . . . . 15.0 110.604 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.87 121.98 8.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.571 -0.706 . . . . 15.0 110.507 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -130.73 147.82 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.745 -0.597 . . . . 15.0 109.663 173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.0 mt -111.18 136.93 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.739 -0.601 . . . . 15.0 109.865 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -127.72 144.1 51.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.663 -0.648 . . . . 15.0 109.913 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.728 ' HG2' HG22 ' A' ' 35' ' ' THR . 67.7 mtm180 -108.47 151.9 25.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 15.0 110.097 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.02 -25.94 54.65 Favored Glycine 0 N--CA 1.5 2.94 0 N-CA-C 110.746 -0.942 . . . . 15.0 110.746 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -66.09 -45.41 81.3 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.48 -1.012 . . . . 15.0 110.731 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -82.05 -31.58 30.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.584 -0.697 . . . . 15.0 110.626 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.602 HG12 HD21 ' A' ' 14' ' ' LEU . 66.9 mt -66.16 140.53 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.545 -0.722 . . . . 15.0 109.816 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -108.16 -42.28 4.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 15.0 110.344 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 15' ' ' ILE . 26.7 t70 -139.23 145.16 38.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.593 -0.692 . . . . 15.0 110.653 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -132.82 129.61 38.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.701 -0.625 . . . . 15.0 110.254 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -130.48 142.59 50.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.743 -0.598 . . . . 15.0 110.219 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -102.26 144.08 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.626 -0.671 . . . . 15.0 109.893 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -88.21 -34.6 17.73 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.716 -0.615 . . . . 15.0 110.177 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -84.18 154.92 63.76 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.622 -0.674 . . . . 15.0 109.879 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -58.24 111.01 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 O-C-N 123.638 1.336 . . . . 15.0 111.048 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -75.63 152.68 38.17 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 O-C-N 123.448 1.236 . . . . 15.0 110.129 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -102.16 158.64 31.37 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.528 -0.733 . . . . 15.0 110.15 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -62.62 141.1 84.61 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 O-C-N 123.548 1.289 . . . . 15.0 110.659 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.5 tt -66.45 -31.27 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.67 -0.644 . . . . 15.0 110.386 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.983 -1.008 . . . . 15.0 110.241 179.513 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.601 HD11 ' HA3' ' A' ' 4' ' ' GLY . 7.9 tt . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 120.959 0.409 . . . . 15.0 110.202 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -97.03 -58.92 1.9 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.761 -0.587 . . . . 15.0 110.188 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . 0.59 ' O ' HD21 ' A' ' -2' ' ' LEU . 6.3 t70 -105.0 138.73 19.59 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.709 -0.619 . . . . 15.0 110.009 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.1 -41.01 14.11 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 O-C-N 123.489 1.258 . . . . 15.0 110.517 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.1 p -69.53 -33.81 73.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.642 -0.661 . . . . 15.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.61 -34.29 67.29 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.699 -1.361 . . . . 15.0 109.699 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.601 ' HA3' HD11 ' A' ' -2' ' ' LEU . . . -67.58 -38.32 90.27 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.749 -1.341 . . . . 15.0 109.749 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.5 m -117.84 122.97 30.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.635 -0.921 . . . . 15.0 110.166 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -70.69 149.01 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.158 0 O-C-N 123.377 1.198 . . . . 15.0 110.23 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -62.6 -24.97 67.85 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.599 -0.688 . . . . 15.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.7 mt -64.82 139.87 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 121.24 -0.913 . . . . 15.0 109.17 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -2.1 66.72 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.799 -0.92 . . . . 15.0 110.799 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -76.55 159.94 29.9 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.046 -1.267 . . . . 15.0 110.33 176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -86.87 129.89 34.69 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.681 -0.637 . . . . 15.0 110.317 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 HD12 HD13 ' A' ' 26' ' ' LEU . 92.7 mt -132.77 150.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.617 -0.677 . . . . 15.0 109.927 -177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -115.46 132.97 56.46 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.614 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -122.57 136.93 55.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.751 -0.593 . . . . 15.0 110.335 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.1 mt -109.47 121.68 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -93.22 171.49 8.9 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.279 0.561 . . . . 15.0 110.937 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -60.23 -19.12 53.14 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.594 -0.691 . . . . 15.0 111.396 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.12 16.83 7.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.342 -0.848 . . . . 15.0 111.271 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 57.6 28.39 15.58 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.295 -0.878 . . . . 15.0 110.818 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 46' ' ' THR . 87.3 mt -104.95 147.53 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -106.71 119.84 40.4 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.698 -0.626 . . . . 15.0 110.52 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.23 137.24 49.18 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.874 -0.516 . . . . 15.0 109.772 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.8 tt0 -121.29 140.69 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.507 -0.745 . . . . 15.0 109.942 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.88 39.4 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.973 -1.651 . . . . 15.0 108.973 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -105.35 138.02 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.382 -1.069 . . . . 15.0 109.696 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.694 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -66.19 108.84 2.41 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.727 -0.608 . . . . 15.0 110.168 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -93.51 -52.16 4.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.882 -0.511 . . . . 15.0 110.509 -175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -141.69 141.34 33.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.554 -0.716 . . . . 15.0 110.492 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.694 HD11 HD21 ' A' ' 26' ' ' LEU . 78.6 mt -118.04 124.92 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.742 -0.599 . . . . 15.0 109.644 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -112.11 97.46 6.67 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.532 -0.73 . . . . 15.0 109.907 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.01 -36.19 74.92 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.767 -0.583 . . . . 15.0 110.434 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -59.22 -29.62 67.64 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.539 -0.726 . . . . 15.0 111.074 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.553 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -115.53 14.07 16.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.522 -0.737 . . . . 15.0 111.471 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 m 50.0 46.65 24.24 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.184 -0.948 . . . . 15.0 111.181 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.7 p -131.6 149.81 52.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.404 -0.81 . . . . 15.0 110.51 -177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.41 140.23 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 15.0 109.72 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.33 130.05 56.08 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.709 -0.619 . . . . 15.0 109.961 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 26' ' ' LEU . 92.4 mt -116.8 138.06 51.76 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.765 -0.458 . . . . 15.0 109.765 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.66 162.39 16.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.722 -0.611 . . . . 15.0 109.887 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 82.7 mttt 51.75 61.2 3.34 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.673 -0.642 . . . . 15.0 110.428 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.8 p -122.4 145.88 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.686 -0.634 . . . . 15.0 110.376 -173.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' CG ' HG23 ' A' ' 61' ' ' THR . 81.0 mtp180 -132.88 149.42 52.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.813 -0.554 . . . . 15.0 109.99 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -97.22 127.79 43.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.615 . . . . 15.0 109.649 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -68.9 -40.24 79.25 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.554 -0.717 . . . . 15.0 110.615 -173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.72 170.24 32.25 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.758 -1.337 . . . . 15.0 109.758 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.454 HG21 HG21 ' A' ' 55' ' ' ILE . 39.8 p -118.03 -30.8 5.24 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.796 -0.826 . . . . 15.0 110.485 176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.64 -28.53 69.97 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.507 -0.746 . . . . 15.0 110.901 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -60.25 -32.34 71.06 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.44 -0.788 . . . . 15.0 110.314 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' THR . 31.5 mtt180 -118.97 95.15 49.1 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.746 -0.596 . . . . 15.0 109.704 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -55.09 134.7 65.24 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 O-C-N 123.426 1.224 . . . . 15.0 111.374 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 49' ' ' ARG . 19.1 p -132.82 165.14 25.29 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.874 -0.516 . . . . 15.0 110.03 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -77.8 -2.14 34.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.666 -0.646 . . . . 15.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -116.84 106.85 47.17 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 15.0 109.99 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -62.66 134.06 45.47 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 123.324 1.171 . . . . 15.0 110.798 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.454 HG21 HG21 ' A' ' 46' ' ' THR . 50.8 mm -121.86 146.0 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.679 -0.638 . . . . 15.0 109.655 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.46 157.78 36.71 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.641 -0.662 . . . . 15.0 110.292 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -62.8 152.33 79.18 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.505 1.266 . . . . 15.0 110.624 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -138.74 -50.06 0.54 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.733 -0.605 . . . . 15.0 110.268 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 52.43 39.3 27.36 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.681 -0.637 . . . . 15.0 110.984 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -117.54 154.63 31.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.657 -0.652 . . . . 15.0 110.131 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.404 HG23 ' CG ' ' A' ' 42' ' ' ARG . 23.9 m -102.97 135.54 44.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.643 -0.66 . . . . 15.0 110.086 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.676 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.3 m-85 -102.12 133.05 47.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 15.0 110.153 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -68.46 -43.98 75.85 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.853 -0.53 . . . . 15.0 110.631 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -149.83 122.08 8.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.601 -0.687 . . . . 15.0 110.587 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.676 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.2 mt -130.71 147.83 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.618 -0.676 . . . . 15.0 109.564 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.22 137.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.776 -0.578 . . . . 15.0 109.885 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -128.87 145.65 51.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.771 -0.58 . . . . 15.0 109.95 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.745 ' HG2' HG22 ' A' ' 35' ' ' THR . 96.5 mtt180 -108.85 152.35 25.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.637 -0.664 . . . . 15.0 110.172 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.33 -26.15 55.91 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.722 -0.951 . . . . 15.0 110.722 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 m -65.74 -45.24 83.34 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -1.047 . . . . 15.0 110.646 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -81.99 -31.44 31.09 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.552 -0.717 . . . . 15.0 110.669 -177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.614 HG12 HD21 ' A' ' 14' ' ' LEU . 71.1 mt -66.21 141.98 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.576 -0.702 . . . . 15.0 109.816 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -107.95 -43.4 4.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.761 -0.587 . . . . 15.0 110.287 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' HD12 ' A' ' 15' ' ' ILE . 19.5 t70 -141.81 147.41 37.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.666 -0.646 . . . . 15.0 110.674 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -132.37 129.48 39.45 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.73 -0.606 . . . . 15.0 110.18 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.5 m -131.62 141.46 49.64 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.627 -0.67 . . . . 15.0 110.362 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.21 144.06 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.668 -0.645 . . . . 15.0 109.774 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.1 m -94.18 -37.01 11.78 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.633 -0.667 . . . . 15.0 110.267 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -84.19 117.48 68.8 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.621 -0.675 . . . . 15.0 110.006 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.53 156.01 65.11 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.395 1.208 . . . . 15.0 110.383 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.51 152.2 75.1 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.654 1.344 . . . . 15.0 110.268 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -97.09 164.34 18.05 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.643 -0.66 . . . . 15.0 110.189 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -66.79 148.55 82.79 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.758 1.399 . . . . 15.0 110.418 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.54 HD12 ' N ' ' A' ' 84' ' ' ILE . 5.3 mp -111.85 135.44 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.752 -0.592 . . . . 15.0 109.67 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 118.026 -0.988 . . . . 15.0 110.3 179.76 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' -2' ' ' LEU . 6.3 mp . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 112.682 0.623 . . . . 15.0 112.682 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -137.03 92.07 2.69 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.692 -0.63 . . . . 15.0 111.966 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -105.06 150.07 38.34 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.69 -0.631 . . . . 15.0 110.109 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -66.03 -41.07 14.24 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.536 1.282 . . . . 15.0 110.36 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -72.58 -37.41 68.17 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.653 -0.655 . . . . 15.0 109.834 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.63 -27.55 73.24 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.998 -1.241 . . . . 15.0 109.998 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.23 -34.34 87.76 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.17 -1.172 . . . . 15.0 110.17 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -108.39 122.83 39.2 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.631 -0.923 . . . . 15.0 110.042 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.12 134.68 19.76 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.409 1.215 . . . . 15.0 110.375 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -69.01 -36.29 77.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 15.0 109.922 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.0 mt -65.85 135.42 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.524 -0.735 . . . . 15.0 109.495 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.49 -2.08 60.58 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.832 -0.907 . . . . 15.0 110.832 -175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.3 m -95.97 150.16 20.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.276 . . . . 15.0 110.328 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -83.73 130.25 34.95 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.685 -0.635 . . . . 15.0 110.483 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.52 ' CD1' HD13 ' A' ' 26' ' ' LEU . 89.2 mt -130.61 149.39 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.749 -0.594 . . . . 15.0 109.908 -177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -112.32 133.91 54.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 HG12 ' A' ' 72' ' ' ILE . 8.0 tp -123.31 133.3 54.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.78 -0.575 . . . . 15.0 110.319 -176.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.8 mt -107.58 122.9 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -94.48 172.8 7.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.309 0.576 . . . . 15.0 110.903 -172.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -59.89 -19.56 52.18 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.608 -0.683 . . . . 15.0 111.48 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.38 15.39 9.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.27 -0.894 . . . . 15.0 111.316 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 58.02 27.5 14.92 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.341 -0.849 . . . . 15.0 110.813 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 46' ' ' THR . 84.3 mt -104.2 148.33 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.998 -0.741 . . . . 15.0 108.998 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 -107.27 121.35 44.38 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.709 -0.619 . . . . 15.0 110.557 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -112.02 138.48 48.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.875 -0.516 . . . . 15.0 109.711 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 41' ' ' VAL . 35.6 mt-10 -120.44 140.7 51.0 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.48 -0.763 . . . . 15.0 109.899 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.01 -178.88 38.63 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.165 -1.574 . . . . 15.0 109.165 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.62 134.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.464 -1.021 . . . . 15.0 109.772 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.814 HD21 HD11 ' A' ' 29' ' ' ILE . 12.0 tp -61.3 112.04 1.99 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.669 -0.644 . . . . 15.0 110.445 -177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -94.11 -52.0 4.58 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.347 -0.541 . . . . 15.0 110.378 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.3 p -143.77 143.63 31.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.681 -0.637 . . . . 15.0 110.531 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.814 HD11 HD21 ' A' ' 26' ' ' LEU . 74.2 mt -116.84 125.2 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.767 -0.583 . . . . 15.0 109.664 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -112.07 96.75 6.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 15.0 109.823 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.5 m -70.91 -36.26 72.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.756 -0.59 . . . . 15.0 110.438 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -58.87 -29.29 66.86 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.508 -0.745 . . . . 15.0 111.046 -171.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 3.7 m-20 -116.08 14.03 15.94 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.58 -0.7 . . . . 15.0 111.571 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.0 m 49.97 48.0 22.49 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.207 -0.933 . . . . 15.0 111.248 -176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.1 p -131.95 148.54 52.53 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.459 -0.776 . . . . 15.0 110.489 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.09 139.73 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.595 -0.691 . . . . 15.0 109.597 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.62 128.85 56.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.681 -0.637 . . . . 15.0 109.971 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.548 HD23 ' HA ' ' A' ' 26' ' ' LEU . 33.4 mt -116.86 138.14 51.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.944 -0.473 . . . . 15.0 109.918 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.59 164.03 14.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.737 -0.602 . . . . 15.0 109.855 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.5 mttp 51.51 58.54 5.39 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.407 0.622 . . . . 15.0 110.464 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -121.72 148.43 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.575 -0.703 . . . . 15.0 110.331 -173.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -137.53 148.83 46.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.829 -0.544 . . . . 15.0 110.029 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.6 p -96.59 131.61 43.05 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.799 -0.563 . . . . 15.0 109.653 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.92 -40.37 63.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.615 -0.678 . . . . 15.0 110.641 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.68 173.06 35.43 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.941 -1.264 . . . . 15.0 109.941 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.566 HG22 HG12 ' A' ' 20' ' ' ILE . 41.3 p -114.4 -20.06 10.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.701 -0.882 . . . . 15.0 110.741 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -61.53 -30.14 70.45 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.375 -0.828 . . . . 15.0 110.832 -177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -60.17 -32.35 70.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.484 -0.76 . . . . 15.0 110.168 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -120.97 95.08 49.02 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.796 -0.565 . . . . 15.0 109.739 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.08 132.84 54.42 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.501 1.264 . . . . 15.0 111.252 -174.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.8 p -118.13 165.01 14.29 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.827 -0.546 . . . . 15.0 109.996 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.66 -13.49 59.89 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.694 -0.629 . . . . 15.0 111.212 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.564 HH11 HD11 ' A' ' 55' ' ' ILE . 10.5 ptt85 -118.22 139.04 26.22 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.219 -0.926 . . . . 15.0 110.082 177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 53' ' ' ARG . 9.5 Cg_exo -67.64 149.6 79.31 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.182 1.096 . . . . 15.0 110.408 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.564 HD11 HH11 ' A' ' 53' ' ' ARG . 51.2 mm -113.64 139.99 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.674 -0.641 . . . . 15.0 109.551 175.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.35 96.81 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.544 -0.722 . . . . 15.0 110.152 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -63.68 143.17 86.2 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.544 1.286 . . . . 15.0 110.601 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -158.26 132.86 8.25 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.732 -0.605 . . . . 15.0 110.308 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -142.66 32.94 1.43 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.709 -0.619 . . . . 15.0 110.276 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -109.68 170.25 8.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.543 -0.723 . . . . 15.0 110.197 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.2 m -102.98 143.13 32.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.629 -0.669 . . . . 15.0 110.12 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.71 ' CG ' HD11 ' A' ' 65' ' ' ILE . 94.4 m-85 -102.04 127.85 48.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.689 -0.632 . . . . 15.0 110.029 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -44.1 76.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.879 -0.513 . . . . 15.0 110.562 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -150.08 122.03 8.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 15.0 110.571 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.71 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.6 mt -130.01 146.37 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.669 -0.644 . . . . 15.0 109.627 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -109.54 136.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.717 -0.615 . . . . 15.0 109.988 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.99 140.95 51.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.698 -0.626 . . . . 15.0 109.862 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 35' ' ' THR . 74.7 mtt85 -106.68 152.39 23.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.747 -0.596 . . . . 15.0 110.022 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.65 -26.07 52.3 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.745 -0.942 . . . . 15.0 110.745 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.8 t -66.29 -45.99 78.52 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.526 -0.985 . . . . 15.0 110.752 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -82.2 -31.94 30.11 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.576 -0.702 . . . . 15.0 110.678 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.633 HG12 HD21 ' A' ' 14' ' ' LEU . 84.9 mt -67.24 141.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 121.573 -0.704 . . . . 15.0 109.817 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -100.85 -42.51 6.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.729 -0.607 . . . . 15.0 110.229 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -147.93 144.3 27.94 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.624 -0.673 . . . . 15.0 110.768 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -127.23 128.27 45.79 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.712 -0.617 . . . . 15.0 109.968 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -135.9 142.24 44.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.557 -0.714 . . . . 15.0 110.502 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.37 144.05 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.665 -0.647 . . . . 15.0 109.492 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 28.7 p -114.66 -29.64 6.73 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.532 -0.73 . . . . 15.0 110.983 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -84.26 117.45 68.74 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.582 -0.698 . . . . 15.0 110.119 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.65 161.99 33.35 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 O-C-N 123.406 1.214 . . . . 15.0 110.428 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -68.05 152.97 76.13 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.705 1.371 . . . . 15.0 110.173 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -86.25 154.08 56.99 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.652 -0.655 . . . . 15.0 110.221 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.24 145.65 66.91 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.651 1.342 . . . . 15.0 110.371 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 pt -123.68 152.49 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.64 -0.663 . . . . 15.0 110.236 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 117.965 -1.016 . . . . 15.0 110.132 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' -2' ' ' LEU . 6.6 mp . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 120.95 0.405 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -109.75 147.97 32.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.73 -0.606 . . . . 15.0 110.248 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -104.39 148.64 36.3 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.667 -0.646 . . . . 15.0 110.127 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.61 -32.46 69.36 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.467 1.246 . . . . 15.0 110.552 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.2 p -66.73 -30.98 71.35 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.724 -0.61 . . . . 15.0 110.497 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.5 -35.46 81.53 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.733 -1.347 . . . . 15.0 109.733 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.55 -35.33 74.77 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.739 -1.344 . . . . 15.0 109.739 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.0 m -96.68 142.44 24.54 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.606 -0.938 . . . . 15.0 110.063 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.99 131.43 22.32 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 123.432 1.227 . . . . 15.0 110.338 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' HB3' HD22 ' A' ' 26' ' ' LEU . 97.7 m-85 -68.98 -33.91 74.45 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.667 -0.646 . . . . 15.0 110.118 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.4 ' N ' HD23 ' A' ' 26' ' ' LEU . 85.4 mt -65.08 133.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.42 -0.8 . . . . 15.0 109.833 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.06 68.35 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.029 -0.828 . . . . 15.0 111.029 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.0 m -101.66 151.26 22.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.248 . . . . 15.0 110.657 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -78.38 127.67 32.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.846 -0.534 . . . . 15.0 110.199 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 26' ' ' LEU . 96.4 mt -130.97 144.73 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.581 -0.699 . . . . 15.0 109.867 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.5 t -113.03 132.34 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.617 HD21 HG12 ' A' ' 72' ' ' ILE . 10.2 tp -121.25 136.01 55.04 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.803 -0.561 . . . . 15.0 110.231 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.96 121.42 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.951 -0.759 . . . . 15.0 108.951 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.92 172.69 8.16 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.352 0.596 . . . . 15.0 110.911 -171.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -59.97 -19.25 51.14 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.614 -0.679 . . . . 15.0 111.472 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.88 9.65 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.395 -0.815 . . . . 15.0 111.337 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.6 29.11 16.68 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.293 -0.879 . . . . 15.0 110.752 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 46' ' ' THR . 81.9 mt -105.09 147.93 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -106.74 122.65 46.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.799 -0.563 . . . . 15.0 110.567 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -113.8 137.44 51.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 15.0 109.812 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.4 mm-40 -119.43 140.66 50.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.458 -0.776 . . . . 15.0 109.796 174.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.12 -178.95 38.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.21 -1.556 . . . . 15.0 109.21 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.82 134.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.485 -1.009 . . . . 15.0 109.72 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 29' ' ' ILE . 11.6 tp -61.45 114.61 3.32 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.694 -0.629 . . . . 15.0 110.546 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -95.62 -51.93 4.32 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.324 -0.55 . . . . 15.0 110.402 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.605 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 20.3 p -143.81 143.94 31.56 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.632 -0.668 . . . . 15.0 110.649 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.809 HD11 HD21 ' A' ' 26' ' ' LEU . 75.1 mt -117.2 124.63 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.67 -0.644 . . . . 15.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.09 98.14 7.14 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.648 -0.657 . . . . 15.0 109.844 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.56 -35.99 70.79 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.707 -0.62 . . . . 15.0 110.423 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.8 -29.59 66.96 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.545 -0.722 . . . . 15.0 111.054 -171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.2 m-20 -116.14 14.07 15.88 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.49 -0.756 . . . . 15.0 111.434 -177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t 49.97 48.91 21.21 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.133 -0.979 . . . . 15.0 111.254 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.4 p -132.33 147.88 52.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.512 -0.743 . . . . 15.0 110.57 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.84 138.53 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.675 -0.64 . . . . 15.0 109.686 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.605 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -110.61 126.34 54.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.719 -0.613 . . . . 15.0 109.907 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 26' ' ' LEU . 26.5 mt -116.78 136.92 52.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.832 -0.433 . . . . 15.0 109.832 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.19 164.34 14.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.721 -0.612 . . . . 15.0 109.935 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 51.75 58.05 5.88 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.644 -0.66 . . . . 15.0 110.48 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -119.96 147.36 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.633 -0.667 . . . . 15.0 110.347 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -133.63 149.86 51.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.787 -0.571 . . . . 15.0 109.993 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.6 p -98.69 131.19 45.05 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.635 -0.666 . . . . 15.0 109.754 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -73.27 -40.32 64.68 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.515 -0.741 . . . . 15.0 110.69 -173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.92 34.21 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.804 -1.318 . . . . 15.0 109.804 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.422 HG22 HG12 ' A' ' 20' ' ' ILE . 48.4 p -118.06 -17.01 9.75 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.772 -0.84 . . . . 15.0 110.901 175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -63.57 -26.67 68.8 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.275 -0.891 . . . . 15.0 111.13 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -59.41 -31.79 69.59 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.487 -0.758 . . . . 15.0 110.411 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' O ' HG23 ' A' ' 51' ' ' THR . 7.3 mmt180 -128.3 95.03 34.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.801 -0.562 . . . . 15.0 109.848 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.33 135.32 69.44 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.472 1.248 . . . . 15.0 111.113 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 49' ' ' ARG . 47.0 p -131.21 165.11 24.06 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.545 . . . . 15.0 109.99 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -77.84 -1.43 31.58 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.55 -0.719 . . . . 15.0 111.411 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HE ' HD11 ' A' ' 55' ' ' ILE . 1.4 tmm_? -110.35 106.91 58.34 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.234 -0.916 . . . . 15.0 109.827 176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.06 136.49 48.4 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 O-C-N 123.356 1.187 . . . . 15.0 110.747 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.483 HD11 ' HE ' ' A' ' 53' ' ' ARG . 51.8 mm -118.25 143.63 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.711 -0.618 . . . . 15.0 109.638 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -89.89 155.08 47.8 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.667 -0.646 . . . . 15.0 110.17 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -62.65 137.19 62.43 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.537 1.283 . . . . 15.0 110.649 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -139.22 127.61 22.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.69 -0.631 . . . . 15.0 110.216 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -117.56 32.15 6.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.631 -0.668 . . . . 15.0 110.357 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 158.11 18.44 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 15.0 110.195 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.4 m -103.03 146.79 27.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.694 -0.629 . . . . 15.0 110.021 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.755 ' CG ' HD11 ' A' ' 65' ' ' ILE . 97.4 m-85 -101.95 126.37 48.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.72 -0.613 . . . . 15.0 110.119 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -68.09 -41.75 81.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.821 -0.549 . . . . 15.0 110.657 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.559 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 2.2 t80 -150.3 122.06 8.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.615 -0.678 . . . . 15.0 110.423 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.755 HD11 ' CG ' ' A' ' 62' ' ' PHE . 92.9 mt -129.6 144.58 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.685 -0.634 . . . . 15.0 109.481 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.9 mt -109.54 133.42 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 109.785 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -123.83 140.53 52.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.705 -0.622 . . . . 15.0 109.893 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.8 mtt180 -105.25 152.02 23.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.652 -0.655 . . . . 15.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.66 -25.96 52.12 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.1 p -66.41 -43.06 86.79 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.483 -1.01 . . . . 15.0 110.729 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -84.9 -31.61 23.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.541 -0.724 . . . . 15.0 110.664 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.617 HG12 HD21 ' A' ' 14' ' ' LEU . 75.4 mt -66.37 141.46 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.582 -0.699 . . . . 15.0 109.887 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -105.26 -42.7 5.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.65 -0.656 . . . . 15.0 110.214 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -145.53 147.4 32.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.592 -0.692 . . . . 15.0 110.763 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -130.25 129.49 43.39 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.724 -0.61 . . . . 15.0 110.133 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -133.81 145.38 49.69 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.563 -0.711 . . . . 15.0 110.433 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.5 t -93.15 144.06 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.701 -0.625 . . . . 15.0 109.676 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 93.1 m -101.67 -37.06 8.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.63 -0.669 . . . . 15.0 110.656 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -100.07 148.89 35.47 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.672 -0.643 . . . . 15.0 110.417 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.24 163.7 34.32 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 O-C-N 123.501 1.264 . . . . 15.0 110.278 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.74 134.6 44.59 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.556 1.292 . . . . 15.0 110.432 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 pttt -102.13 164.63 15.39 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.668 -0.645 . . . . 15.0 110.355 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -62.71 143.38 92.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.583 1.307 . . . . 15.0 110.52 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 84' ' ' ILE . 5.3 mp -94.92 -34.72 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.767 -0.583 . . . . 15.0 109.723 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 117.98 -1.01 . . . . 15.0 110.144 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.584 HD12 ' CA ' ' A' ' 3' ' ' GLY . 85.6 mt . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 121.02 0.438 . . . . 15.0 110.207 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.29 -32.77 74.38 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.661 -0.65 . . . . 15.0 110.432 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.66 150.0 58.52 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.692 -0.63 . . . . 15.0 110.184 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.0 -35.72 33.26 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.54 1.284 . . . . 15.0 110.497 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -67.74 -34.13 76.24 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.631 -0.668 . . . . 15.0 110.236 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.584 ' CA ' HD12 ' A' ' -2' ' ' LEU . . . -68.76 -33.65 76.13 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.796 -1.321 . . . . 15.0 109.796 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.17 -35.42 90.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.814 -1.315 . . . . 15.0 109.814 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.8 m -133.62 122.89 17.04 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.672 -0.899 . . . . 15.0 110.121 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.75 149.01 53.69 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.334 1.176 . . . . 15.0 110.351 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.42 -33.6 76.34 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.655 . . . . 15.0 110.17 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.3 mt -64.7 137.24 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 15.0 109.546 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.17 -2.16 63.3 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.9 m -91.4 153.06 20.14 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.131 -1.217 . . . . 15.0 110.43 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -83.56 127.63 33.88 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.741 -0.599 . . . . 15.0 110.442 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 26' ' ' LEU . 91.1 mt -131.21 151.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.629 -0.67 . . . . 15.0 109.892 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.9 t -115.79 133.26 56.21 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 72' ' ' ILE . 11.4 tp -121.6 136.15 54.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.733 -0.605 . . . . 15.0 110.197 -176.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.23 123.44 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -95.78 169.76 9.78 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.343 0.592 . . . . 15.0 110.947 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.2 tptm -60.4 -18.35 50.04 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.616 -0.677 . . . . 15.0 111.513 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 17.58 7.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.245 -0.91 . . . . 15.0 111.276 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 58.12 27.63 15.26 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.309 -0.869 . . . . 15.0 110.844 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -105.0 146.23 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -106.18 120.64 42.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.786 -0.571 . . . . 15.0 110.323 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -110.83 132.91 53.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.851 -0.53 . . . . 15.0 109.791 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 41.4 tt0 -118.77 140.71 49.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.493 -0.754 . . . . 15.0 109.812 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.98 -178.81 40.15 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.196 -1.562 . . . . 15.0 109.196 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.7 mm -105.51 132.39 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.502 -0.999 . . . . 15.0 109.677 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 29' ' ' ILE . 18.2 tp -62.15 110.9 1.75 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.712 -0.618 . . . . 15.0 110.422 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -91.32 -52.09 4.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.786 -0.571 . . . . 15.0 110.481 -177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 23.0 p -144.64 143.65 30.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.641 -0.662 . . . . 15.0 110.581 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.815 HD11 HD21 ' A' ' 26' ' ' LEU . 74.0 mt -116.45 125.78 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.693 -0.629 . . . . 15.0 109.556 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.09 95.99 5.78 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.64 -0.663 . . . . 15.0 109.791 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 m -70.22 -37.08 74.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.772 -0.58 . . . . 15.0 110.389 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -59.12 -29.51 67.44 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.628 -0.67 . . . . 15.0 111.084 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -115.22 14.03 16.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.623 -0.673 . . . . 15.0 111.57 -177.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 m 49.93 46.88 23.93 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.174 -0.954 . . . . 15.0 111.256 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.662 HG22 ' HG2' ' A' ' 68' ' ' ARG . 14.7 p -131.81 150.08 52.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.435 -0.791 . . . . 15.0 110.561 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.24 139.73 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.678 -0.639 . . . . 15.0 109.629 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.86 128.16 56.38 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.687 -0.633 . . . . 15.0 109.956 178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 26' ' ' LEU . 19.2 mt -116.81 138.85 51.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.991 -0.443 . . . . 15.0 109.818 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.76 161.71 18.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.701 -0.625 . . . . 15.0 109.881 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 51.64 56.56 7.68 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.66 -0.65 . . . . 15.0 110.535 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -118.72 147.52 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.565 -0.71 . . . . 15.0 110.356 -173.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -136.22 153.28 51.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.781 -0.574 . . . . 15.0 110.096 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.6 p -99.68 131.85 45.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.714 -0.616 . . . . 15.0 110.008 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -68.85 -40.09 79.57 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.64 . . . . 15.0 110.438 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.87 169.74 31.75 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.884 -1.287 . . . . 15.0 109.884 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.715 HG21 HG13 ' A' ' 55' ' ' ILE . 37.0 p -118.04 6.33 12.11 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.841 -0.799 . . . . 15.0 111.155 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -53.95 -25.42 20.55 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.296 -0.877 . . . . 15.0 111.286 -174.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -63.47 -33.74 76.23 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.47 -0.769 . . . . 15.0 110.054 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.3 mtp85 -144.53 92.5 5.99 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.737 -0.602 . . . . 15.0 109.829 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.4 138.62 61.2 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 O-C-N 123.473 1.249 . . . . 15.0 110.659 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.0 p -127.78 165.05 20.84 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.695 -0.628 . . . . 15.0 110.082 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.89 -3.08 39.9 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.689 -0.632 . . . . 15.0 111.375 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -100.36 124.85 41.44 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 15.0 110.051 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.0 139.97 48.63 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 O-C-N 123.337 1.177 . . . . 15.0 110.43 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.715 HG13 HG21 ' A' ' 46' ' ' THR . 51.5 mm -111.74 145.99 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.685 -0.634 . . . . 15.0 109.687 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.71 156.73 88.38 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.75 -0.594 . . . . 15.0 110.213 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -62.22 157.97 42.26 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.578 1.304 . . . . 15.0 110.742 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -62.02 -27.71 69.07 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.709 -0.619 . . . . 15.0 110.942 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -62.46 -34.41 76.76 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.585 -0.697 . . . . 15.0 110.586 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -80.45 141.76 34.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.69 -0.631 . . . . 15.0 110.028 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -125.69 153.73 43.45 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.727 -0.608 . . . . 15.0 110.394 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CG ' HD11 ' A' ' 65' ' ' ILE . 26.5 m-85 -102.01 136.37 41.96 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.747 -0.595 . . . . 15.0 109.924 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.0 -44.37 76.74 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.8 -0.563 . . . . 15.0 110.686 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.9 t80 -148.59 121.99 9.06 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.542 -0.724 . . . . 15.0 110.572 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.607 HD11 ' CG ' ' A' ' 62' ' ' PHE . 90.7 mt -131.36 147.32 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.715 -0.616 . . . . 15.0 109.517 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 82.1 mt -111.51 138.39 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.65 -0.656 . . . . 15.0 109.917 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -128.99 145.35 51.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.724 -0.61 . . . . 15.0 109.908 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.2 mtp85 -107.16 152.45 24.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.694 -0.629 . . . . 15.0 110.131 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.02 56.35 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.0 p -65.95 -42.5 89.91 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.465 -1.021 . . . . 15.0 110.738 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.25 -31.12 23.29 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.595 -0.69 . . . . 15.0 110.696 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.528 HG12 HD21 ' A' ' 14' ' ' LEU . 65.7 mt -66.36 146.78 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.632 -0.668 . . . . 15.0 109.75 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -107.42 -44.65 4.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.734 -0.604 . . . . 15.0 110.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -148.43 149.8 32.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.668 -0.645 . . . . 15.0 110.769 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.6 tt -128.48 129.38 46.0 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.804 -0.56 . . . . 15.0 110.149 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -134.47 143.92 47.79 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.573 -0.704 . . . . 15.0 110.479 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.54 144.13 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.669 -0.644 . . . . 15.0 109.629 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.7 t -114.98 -37.04 4.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 15.0 110.57 -175.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -96.61 117.47 65.98 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.68 . . . . 15.0 110.287 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.72 176.99 9.07 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.358 1.188 . . . . 15.0 110.267 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.8 153.79 70.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.577 1.304 . . . . 15.0 110.48 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -90.11 161.14 38.71 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.69 -0.631 . . . . 15.0 110.212 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.5 147.09 95.38 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.687 1.362 . . . . 15.0 110.596 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 pt -124.78 160.37 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.743 -0.598 . . . . 15.0 110.198 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 55.0 ttp . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.977 -1.011 . . . . 15.0 110.204 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.552 ' N ' HD12 ' A' ' -2' ' ' LEU . 6.3 mp . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 120.993 0.425 . . . . 15.0 110.192 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -116.31 155.67 28.01 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 15.0 110.267 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -97.59 150.08 36.4 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.726 -0.609 . . . . 15.0 110.104 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -65.08 -39.37 24.14 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 O-C-N 123.46 1.242 . . . . 15.0 110.539 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -68.87 -36.98 78.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.596 -0.69 . . . . 15.0 110.125 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.15 75.13 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.676 -0.97 . . . . 15.0 110.676 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.39 -32.26 82.32 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.178 -1.19 . . . . 15.0 110.226 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.595 HG21 ' HE3' ' A' ' 82' ' ' LYS . 22.5 m -87.42 122.91 70.47 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.533 -0.981 . . . . 15.0 110.011 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.1 148.12 39.2 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.389 1.205 . . . . 15.0 110.44 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' C ' HD23 ' A' ' 26' ' ' LEU . 97.4 m-85 -68.96 -30.46 68.9 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.644 -0.66 . . . . 15.0 110.137 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 26' ' ' LEU . 85.6 mt -63.1 138.14 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.344 -0.847 . . . . 15.0 109.707 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.03 -2.21 61.45 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.1 m -95.32 151.96 18.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.085 -1.244 . . . . 15.0 110.472 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' HD12 ' A' ' 25' ' ' ILE . 98.7 mttt -83.94 130.6 34.89 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.806 -0.559 . . . . 15.0 110.256 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.643 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.1 mt -130.98 145.04 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.526 -0.734 . . . . 15.0 109.953 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.4 t -116.09 129.33 56.29 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 72' ' ' ILE . 10.7 tp -120.53 135.7 55.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.666 -0.646 . . . . 15.0 110.406 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.08 120.02 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.979 -0.749 . . . . 15.0 108.979 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -91.66 172.03 8.76 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.24 0.543 . . . . 15.0 110.951 -171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -59.25 -19.71 48.04 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.634 -0.666 . . . . 15.0 111.655 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -91.14 17.12 8.53 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.301 -0.874 . . . . 15.0 111.224 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.89 28.3 15.9 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.273 -0.892 . . . . 15.0 110.875 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 HG22 ' A' ' 46' ' ' THR . 88.7 mt -105.05 147.13 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.051 -0.722 . . . . 15.0 109.051 172.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm105 -104.91 121.07 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.706 -0.621 . . . . 15.0 110.483 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -111.98 135.67 52.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.806 -0.559 . . . . 15.0 109.782 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.4 tt0 -118.0 140.56 49.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 15.0 109.805 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.66 -178.9 39.0 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.075 -1.61 . . . . 15.0 109.075 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.0 mm -108.9 142.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.456 -1.026 . . . . 15.0 109.742 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -64.7 114.47 4.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.739 -0.601 . . . . 15.0 110.269 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -98.06 -52.05 3.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.761 -0.587 . . . . 15.0 110.363 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.2 p -143.83 143.7 31.44 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.65 -0.656 . . . . 15.0 110.488 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 26' ' ' LEU . 70.2 mt -117.6 125.86 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.833 -0.542 . . . . 15.0 109.735 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -112.11 96.91 6.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.601 -0.687 . . . . 15.0 109.788 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.3 -37.54 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.766 -0.584 . . . . 15.0 110.53 -176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -58.79 -28.7 66.2 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.549 -0.719 . . . . 15.0 111.153 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -116.21 14.13 15.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.525 -0.735 . . . . 15.0 111.556 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.9 48.07 22.31 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.41 -0.806 . . . . 15.0 111.289 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.717 HG22 ' HG2' ' A' ' 68' ' ' ARG . 20.2 p -131.83 147.24 52.47 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.522 -0.736 . . . . 15.0 110.44 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.71 139.29 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.592 -0.693 . . . . 15.0 109.695 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.53 128.81 56.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 15.0 109.916 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.1 mt -116.85 138.84 51.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.914 -0.491 . . . . 15.0 109.742 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.49 165.6 12.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.76 -0.588 . . . . 15.0 109.873 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 51.69 58.83 5.06 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.691 -0.63 . . . . 15.0 110.496 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 23' ' ' GLU . 15.0 p -121.0 147.37 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.64 -0.663 . . . . 15.0 110.337 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.472 ' CG ' HG23 ' A' ' 61' ' ' THR . 62.2 mtt85 -135.2 150.0 50.03 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.599 . . . . 15.0 110.0 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.6 p -96.86 129.33 44.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.7 -0.625 . . . . 15.0 109.715 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -70.55 -40.28 73.47 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.628 -0.67 . . . . 15.0 110.564 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.82 172.04 34.43 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.844 -1.303 . . . . 15.0 109.844 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 HG12 ' A' ' 20' ' ' ILE . 63.0 p -118.09 -21.08 8.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.855 -0.791 . . . . 15.0 110.829 175.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -63.18 -25.14 68.2 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.399 -0.813 . . . . 15.0 111.056 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.33 -31.75 69.45 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.372 -0.83 . . . . 15.0 110.362 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 51' ' ' THR . 13.4 mmm180 -123.23 95.06 46.17 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.778 -0.576 . . . . 15.0 109.751 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.28 132.11 50.3 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 O-C-N 123.443 1.233 . . . . 15.0 111.384 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 49' ' ' ARG . 21.0 p -129.4 165.13 22.17 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.834 -0.541 . . . . 15.0 110.062 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.74 -2.25 35.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.674 -0.642 . . . . 15.0 111.371 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -115.22 106.97 50.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 15.0 109.923 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -62.34 132.25 37.72 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.395 1.208 . . . . 15.0 110.772 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.0 mm -120.43 141.35 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.627 -0.671 . . . . 15.0 109.667 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.87 152.26 50.93 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.642 -0.661 . . . . 15.0 110.185 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.01 144.7 58.98 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.603 1.318 . . . . 15.0 110.342 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -132.21 133.43 44.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.707 -0.62 . . . . 15.0 110.198 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -110.7 31.62 5.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.673 -0.642 . . . . 15.0 110.368 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -112.63 154.6 25.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.649 -0.657 . . . . 15.0 110.167 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.472 HG23 ' CG ' ' A' ' 42' ' ' ARG . 24.5 m -102.97 147.93 26.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.713 -0.617 . . . . 15.0 110.032 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.677 ' CG ' HD11 ' A' ' 65' ' ' ILE . 98.1 m-85 -102.02 127.43 48.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.659 -0.65 . . . . 15.0 110.06 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -68.62 -44.24 74.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.883 -0.511 . . . . 15.0 110.555 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.513 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.0 t80 -148.88 121.99 8.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.517 -0.739 . . . . 15.0 110.568 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.677 HD11 ' CG ' ' A' ' 62' ' ' PHE . 41.3 mt -131.4 147.57 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.701 -0.624 . . . . 15.0 109.447 173.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.8 mt -110.65 138.66 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.767 -0.583 . . . . 15.0 110.014 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -129.69 141.08 50.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.758 -0.589 . . . . 15.0 109.916 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.717 ' HG2' HG22 ' A' ' 35' ' ' THR . 72.3 mtt85 -109.89 152.08 26.24 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.699 -0.626 . . . . 15.0 110.071 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.26 -26.01 49.38 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.803 -0.919 . . . . 15.0 110.803 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.4 m -66.92 -46.05 76.03 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.469 -1.018 . . . . 15.0 110.732 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.35 -31.82 29.61 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.52 -0.738 . . . . 15.0 110.711 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD21 ' A' ' 14' ' ' LEU . 72.6 mt -65.47 141.62 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.57 -0.706 . . . . 15.0 109.892 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -101.7 -43.39 5.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.809 -0.557 . . . . 15.0 110.271 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -146.03 147.25 31.44 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.698 -0.626 . . . . 15.0 110.71 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.47 129.76 45.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.689 -0.632 . . . . 15.0 110.217 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 m -131.52 145.18 51.62 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.624 -0.673 . . . . 15.0 110.344 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.19 144.09 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.64 -0.663 . . . . 15.0 109.783 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.8 m -93.54 -35.78 12.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.674 -0.641 . . . . 15.0 110.256 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.18 152.08 61.03 Favored Pre-proline 0 N--CA 1.499 2.01 0 C-N-CA 120.175 -0.61 . . . . 15.0 110.256 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.51 148.52 73.06 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.629 1.331 . . . . 15.0 110.31 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.5 156.64 57.81 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.515 1.271 . . . . 15.0 110.26 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.595 ' HE3' HG21 ' A' ' 5' ' ' THR . 37.7 mttm -95.47 156.79 37.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.607 -0.683 . . . . 15.0 110.083 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.81 137.67 46.09 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 O-C-N 123.665 1.35 . . . . 15.0 110.416 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -113.01 -27.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.711 -0.618 . . . . 15.0 110.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 83.2 mtp . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 117.986 -1.006 . . . . 15.0 110.239 178.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.548 HD23 ' HA3' ' A' ' 3' ' ' GLY . 14.9 tp . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.917 0.389 . . . . 15.0 110.127 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -103.89 33.78 3.29 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.716 -0.615 . . . . 15.0 110.467 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -97.2 143.23 25.78 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.464 -0.772 . . . . 15.0 110.124 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.13 -41.03 13.92 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.455 1.239 . . . . 15.0 110.534 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -71.92 -35.18 69.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.707 -0.621 . . . . 15.0 109.954 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.548 ' HA3' HD23 ' A' ' -2' ' ' LEU . . . -70.23 -29.54 70.24 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.93 -1.268 . . . . 15.0 109.93 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.01 -42.23 98.29 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.862 -1.295 . . . . 15.0 109.862 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 m -143.02 122.91 7.81 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.674 -0.898 . . . . 15.0 110.263 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -68.9 149.05 71.89 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.276 1.145 . . . . 15.0 110.218 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -64.21 -33.82 76.68 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.618 -0.676 . . . . 15.0 110.156 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.409 ' HA ' HD23 ' A' ' 26' ' ' LEU . 84.0 mt -65.66 137.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.456 -0.777 . . . . 15.0 109.417 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.98 -2.21 59.81 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.805 -0.918 . . . . 15.0 110.805 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m -86.68 158.43 19.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 118.665 1.232 . . . . 15.0 110.405 176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HG2' HD12 ' A' ' 25' ' ' ILE . 30.2 mtmm -87.26 133.57 33.66 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.599 . . . . 15.0 110.123 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.62 ' CD1' HD13 ' A' ' 26' ' ' LEU . 90.9 mt -134.09 147.69 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.443 -0.786 . . . . 15.0 110.086 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.5 t -116.69 130.39 56.7 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.548 -0.538 . . . . 15.0 109.548 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.652 HD21 HG12 ' A' ' 72' ' ' ILE . 10.1 tp -119.44 136.79 54.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.717 -0.614 . . . . 15.0 110.18 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -113.4 122.55 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.168 -0.679 . . . . 15.0 109.168 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.2 m -93.5 170.98 9.19 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.233 0.54 . . . . 15.0 110.755 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -61.17 -16.47 45.03 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.608 -0.682 . . . . 15.0 111.505 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.93 13.67 10.44 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.233 -0.917 . . . . 15.0 111.338 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 56.38 29.72 15.65 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.257 -0.902 . . . . 15.0 110.718 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 45' ' ' GLY . 86.2 mt -104.98 143.34 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.787 -0.82 . . . . 15.0 108.787 171.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -103.98 122.23 44.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.805 -0.559 . . . . 15.0 110.419 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -110.96 132.27 54.34 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.755 -0.591 . . . . 15.0 109.673 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.0 tt0 -115.97 140.62 49.07 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.524 -0.735 . . . . 15.0 109.794 175.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.56 -178.87 38.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.883 -1.687 . . . . 15.0 108.883 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.541 HD12 ' HG2' ' A' ' 11' ' ' LYS . 17.6 mm -109.07 142.56 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.43 -1.041 . . . . 15.0 109.78 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 29' ' ' ILE . 13.0 tp -66.24 109.21 2.57 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.736 -0.603 . . . . 15.0 110.258 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -91.9 -52.01 4.93 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.343 -0.543 . . . . 15.0 110.386 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.499 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -144.33 143.88 31.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.726 . . . . 15.0 110.517 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.834 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.24 125.11 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.744 -0.598 . . . . 15.0 109.702 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.1 97.48 6.69 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.569 -0.707 . . . . 15.0 109.776 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 -36.37 71.42 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 15.0 110.428 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -59.18 -29.39 67.43 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.561 -0.712 . . . . 15.0 111.153 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 93.8 m-20 -116.14 14.08 15.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.528 -0.732 . . . . 15.0 111.544 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t 50.03 49.32 20.56 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.162 -0.962 . . . . 15.0 111.175 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.723 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -132.63 147.77 52.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.473 -0.767 . . . . 15.0 110.504 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.21 138.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.556 -0.715 . . . . 15.0 109.526 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.33 128.36 55.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.665 -0.647 . . . . 15.0 109.844 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 26' ' ' LEU . 95.3 mt -116.85 137.53 52.14 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.906 -0.496 . . . . 15.0 109.776 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.6 164.47 13.63 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.811 -0.556 . . . . 15.0 109.772 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 51.79 56.91 7.13 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.722 -0.611 . . . . 15.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.6 p -120.35 148.7 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.563 -0.711 . . . . 15.0 110.253 -174.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -139.55 150.67 45.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.739 -0.6 . . . . 15.0 110.291 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.5 p -98.5 131.22 44.92 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.819 -0.55 . . . . 15.0 109.804 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -71.66 -40.37 69.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.543 -0.723 . . . . 15.0 110.774 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 20' ' ' ILE . . . 167.74 -179.18 41.26 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.041 -1.224 . . . . 15.0 110.041 178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.2 p -116.63 6.2 13.36 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.811 -0.817 . . . . 15.0 110.965 175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.09 -19.34 61.34 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.245 -0.909 . . . . 15.0 111.514 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.07 -32.11 69.49 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.284 -0.885 . . . . 15.0 110.467 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -141.15 95.08 7.57 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.708 -0.62 . . . . 15.0 110.039 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.7 140.76 91.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.536 1.282 . . . . 15.0 110.945 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.5 p -129.51 165.16 22.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.71 -0.619 . . . . 15.0 110.141 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.69 -1.73 32.56 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.683 -0.635 . . . . 15.0 111.242 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.8 mmt-85 -112.19 106.91 55.98 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.159 -0.963 . . . . 15.0 109.722 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -66.43 133.85 33.84 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.429 1.226 . . . . 15.0 110.691 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -97.77 129.96 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.747 -0.596 . . . . 15.0 109.545 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.09 154.65 94.8 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.637 -0.664 . . . . 15.0 110.252 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -62.15 141.35 88.04 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 O-C-N 123.578 1.304 . . . . 15.0 110.568 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -126.78 121.23 31.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.654 -0.654 . . . . 15.0 110.262 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -117.26 31.23 6.85 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.723 -0.611 . . . . 15.0 110.269 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -127.27 163.05 24.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.576 -0.703 . . . . 15.0 110.138 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.1 m -110.24 154.92 22.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.694 -0.629 . . . . 15.0 110.198 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.689 ' CG ' HD11 ' A' ' 65' ' ' ILE . 89.9 m-85 -100.37 128.13 46.51 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.67 -0.644 . . . . 15.0 109.982 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -68.31 -41.99 80.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.871 -0.518 . . . . 15.0 110.674 -177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -150.47 122.01 7.97 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.491 -0.756 . . . . 15.0 110.536 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.689 HD11 ' CG ' ' A' ' 62' ' ' PHE . 96.4 mt -130.75 147.35 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.658 -0.651 . . . . 15.0 109.57 172.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.7 mt -109.85 136.64 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.763 -0.586 . . . . 15.0 109.929 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -127.71 140.64 51.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.725 -0.61 . . . . 15.0 109.975 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.723 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.4 mtt85 -108.11 152.81 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 15.0 110.153 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.2 -25.99 48.86 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.731 -0.948 . . . . 15.0 110.731 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 m -66.56 -45.99 77.53 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.527 -0.984 . . . . 15.0 110.747 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.97 -30.33 31.71 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.606 -0.684 . . . . 15.0 110.726 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 14' ' ' LEU . 73.2 mt -68.71 139.6 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.586 -0.696 . . . . 15.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.83 -43.55 4.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.754 -0.591 . . . . 15.0 110.261 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -137.17 141.82 42.17 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.718 -0.614 . . . . 15.0 110.505 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.12 127.61 40.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.735 -0.603 . . . . 15.0 110.087 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -129.15 136.34 50.06 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 15.0 110.133 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.58 144.01 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.625 -0.672 . . . . 15.0 109.834 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 97.0 m -83.44 -37.09 23.65 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.67 -0.644 . . . . 15.0 110.039 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.2 117.51 68.88 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.721 -0.612 . . . . 15.0 109.872 176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.91 150.93 84.2 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.299 1.157 . . . . 15.0 110.698 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -70.37 156.68 61.22 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.664 1.35 . . . . 15.0 110.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -97.05 157.85 34.3 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.743 -0.598 . . . . 15.0 110.136 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -67.08 139.01 49.39 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.621 1.327 . . . . 15.0 110.392 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -126.47 158.69 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.69 -0.631 . . . . 15.0 110.274 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.6 ttp . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.98 -1.01 . . . . 15.0 110.253 179.615 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.041 0.448 . . . . 15.0 110.135 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -162.04 178.04 9.2 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.694 -0.629 . . . . 15.0 110.34 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.19 150.03 38.44 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.715 -0.616 . . . . 15.0 109.994 178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -60.67 -40.28 56.63 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.42 1.221 . . . . 15.0 110.735 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.9 m -69.25 -38.92 78.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.669 . . . . 15.0 110.077 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.31 -33.52 56.42 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.68 -1.368 . . . . 15.0 109.68 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.07 -34.61 87.15 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.965 -1.254 . . . . 15.0 109.965 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -108.28 122.88 39.14 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.697 -0.884 . . . . 15.0 110.346 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.07 149.09 40.84 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.375 1.198 . . . . 15.0 110.346 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -62.23 -33.6 74.89 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.642 -0.661 . . . . 15.0 110.276 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 26' ' ' LEU . 84.9 mt -65.29 138.5 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.388 -0.82 . . . . 15.0 109.351 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.33 -2.24 60.95 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.699 -0.961 . . . . 15.0 110.699 -173.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.5 m -82.92 159.62 22.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.0 -1.294 . . . . 15.0 110.44 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -84.58 131.82 34.58 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.786 -0.571 . . . . 15.0 110.346 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.8 mt -133.86 147.33 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.523 -0.736 . . . . 15.0 109.93 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.3 t -117.18 130.27 56.49 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.505 -0.554 . . . . 15.0 109.505 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.64 HD21 HG12 ' A' ' 72' ' ' ILE . 11.2 tp -119.11 135.68 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.736 -0.603 . . . . 15.0 110.322 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.4 mt -108.07 119.78 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.953 -0.758 . . . . 15.0 108.953 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -90.83 172.61 8.5 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.287 0.565 . . . . 15.0 110.902 -171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.25 -19.13 53.35 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.605 -0.684 . . . . 15.0 111.416 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.86 15.79 9.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.331 -0.855 . . . . 15.0 111.318 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 57.8 29.27 17.19 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.289 -0.882 . . . . 15.0 110.786 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.443 HG12 HG22 ' A' ' 46' ' ' THR . 85.7 mt -105.1 146.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -105.07 120.68 42.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.759 -0.588 . . . . 15.0 110.465 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -112.03 133.98 53.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.827 -0.546 . . . . 15.0 109.713 176.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.1 tt0 -116.2 140.61 49.12 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.472 -0.767 . . . . 15.0 109.828 175.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.73 -178.82 38.98 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.962 -1.655 . . . . 15.0 108.962 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -107.39 141.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.466 -1.02 . . . . 15.0 109.654 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.82 HD21 HD11 ' A' ' 29' ' ' ILE . 13.1 tp -66.23 108.93 2.46 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.748 -0.595 . . . . 15.0 110.201 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -91.83 -51.94 4.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.805 -0.559 . . . . 15.0 110.486 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.558 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.4 p -143.27 142.65 31.43 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.624 . . . . 15.0 110.481 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.82 HD11 HD21 ' A' ' 26' ' ' LEU . 73.3 mt -115.75 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.727 -0.608 . . . . 15.0 109.682 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -112.06 97.98 7.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.635 -0.665 . . . . 15.0 109.86 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -71.97 -36.12 69.72 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.78 -0.575 . . . . 15.0 110.456 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -58.75 -29.5 66.79 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.493 -0.754 . . . . 15.0 111.108 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.538 ' O ' HG23 ' A' ' 35' ' ' THR . 93.9 m-20 -116.44 14.14 15.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.617 -0.677 . . . . 15.0 111.495 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m 49.9 49.56 20.02 Favored 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.174 -0.954 . . . . 15.0 111.152 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.725 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.4 p -132.54 147.79 52.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 15.0 110.539 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.59 137.87 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.661 . . . . 15.0 109.554 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.558 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.25 127.98 55.79 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.664 -0.647 . . . . 15.0 109.888 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 26' ' ' LEU . 90.3 mt -116.8 136.14 53.19 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.919 -0.488 . . . . 15.0 109.771 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.53 163.12 14.87 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.761 -0.587 . . . . 15.0 109.901 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 64.4 mttm 51.76 61.64 3.11 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.656 -0.653 . . . . 15.0 110.475 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.9 p -122.33 146.4 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.538 -0.727 . . . . 15.0 110.383 -173.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -135.13 148.56 49.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.841 -0.537 . . . . 15.0 109.993 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.5 p -96.15 130.12 43.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.742 -0.599 . . . . 15.0 109.781 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -70.97 -40.35 72.0 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.072 -0.651 . . . . 15.0 110.589 -174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 170.94 33.2 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.789 -1.325 . . . . 15.0 109.789 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 55' ' ' ILE . 44.2 p -118.04 -19.65 9.02 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.775 -0.838 . . . . 15.0 110.938 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.23 -26.92 69.02 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.323 -0.861 . . . . 15.0 111.016 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.74 -31.8 69.96 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.381 -0.824 . . . . 15.0 110.458 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -120.53 95.07 49.03 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.719 -0.613 . . . . 15.0 109.877 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.92 131.6 35.79 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 O-C-N 123.401 1.211 . . . . 15.0 110.858 -175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 p -131.02 165.1 23.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.565 . . . . 15.0 110.023 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -77.83 -1.38 31.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.712 -0.618 . . . . 15.0 111.461 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 61.8 ttm-85 -117.87 106.93 44.96 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.229 -0.919 . . . . 15.0 109.824 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.48 139.22 85.16 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 O-C-N 123.318 1.167 . . . . 15.0 110.933 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 46' ' ' THR . 50.8 mm -120.63 146.0 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.669 -0.645 . . . . 15.0 109.693 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.92 109.86 48.75 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.728 -0.607 . . . . 15.0 110.118 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.77 141.42 54.3 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.356 1.187 . . . . 15.0 110.401 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -130.9 151.26 51.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.742 -0.599 . . . . 15.0 110.182 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -99.95 31.75 3.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.744 -0.597 . . . . 15.0 110.323 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -111.73 151.98 28.3 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.606 -0.684 . . . . 15.0 110.214 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.4 m -103.05 146.87 27.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.654 -0.654 . . . . 15.0 110.111 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.11 133.57 46.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.637 -0.664 . . . . 15.0 110.139 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.73 -39.78 84.25 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.832 -0.543 . . . . 15.0 110.78 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.522 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.5 t80 -151.71 122.37 7.44 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.5 -0.75 . . . . 15.0 110.832 -175.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.3 mt -129.4 147.24 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.628 -0.67 . . . . 15.0 109.59 172.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.5 mt -110.65 136.28 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.692 -0.63 . . . . 15.0 109.849 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -127.02 140.64 52.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.763 -0.586 . . . . 15.0 109.922 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HG2' HG22 ' A' ' 35' ' ' THR . 83.2 mtp180 -107.73 151.66 25.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.016 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.18 -26.01 48.77 Favored Glycine 0 N--CA 1.501 2.968 0 N-CA-C 110.753 -0.939 . . . . 15.0 110.753 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -66.45 -45.95 78.06 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.485 -1.009 . . . . 15.0 110.718 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.1 -31.88 30.49 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.644 -0.66 . . . . 15.0 110.738 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.64 HG12 HD21 ' A' ' 14' ' ' LEU . 71.4 mt -65.89 141.25 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.675 -0.641 . . . . 15.0 109.859 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -104.71 -43.18 5.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.76 -0.587 . . . . 15.0 110.251 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -143.6 147.35 34.25 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.609 -0.682 . . . . 15.0 110.647 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -131.0 130.66 43.64 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.706 -0.621 . . . . 15.0 110.248 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -129.78 140.43 51.06 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.72 -0.612 . . . . 15.0 110.304 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -102.23 144.0 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.654 -0.654 . . . . 15.0 109.844 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 99.7 m -91.21 -37.11 13.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.693 -0.629 . . . . 15.0 110.259 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -84.18 150.62 58.34 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 15.0 109.975 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 32.5 Cg_endo -69.18 136.3 34.17 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.592 1.311 . . . . 15.0 110.291 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 80' ' ' PRO . 16.6 Cg_exo -63.87 151.09 86.73 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.371 1.195 . . . . 15.0 110.491 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -102.05 157.14 34.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.725 -0.61 . . . . 15.0 110.213 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.88 141.16 83.46 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 O-C-N 123.579 1.305 . . . . 15.0 110.598 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -127.22 150.43 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.652 -0.655 . . . . 15.0 110.238 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 117.966 -1.016 . . . . 15.0 110.35 179.862 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.03 0.443 . . . . 15.0 110.202 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.42 -30.52 70.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.652 -0.655 . . . . 15.0 110.553 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.89 150.09 85.86 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.622 -0.674 . . . . 15.0 110.145 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -66.08 -41.01 14.18 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.547 1.288 . . . . 15.0 110.449 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.0 p -69.23 -34.09 74.3 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.67 -0.644 . . . . 15.0 110.067 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.99 -31.06 44.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.839 -1.304 . . . . 15.0 109.839 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.28 -38.51 96.57 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 110.085 -1.206 . . . . 15.0 110.085 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -111.26 122.81 36.69 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.648 -0.913 . . . . 15.0 110.124 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.05 149.03 40.86 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.346 1.182 . . . . 15.0 110.388 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -66.19 -31.94 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.637 -0.664 . . . . 15.0 110.171 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.6 mt -64.16 137.54 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.365 -0.834 . . . . 15.0 109.622 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.15 -2.2 61.25 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.906 -0.877 . . . . 15.0 110.906 -175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.7 m -95.85 153.88 17.52 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.079 -1.248 . . . . 15.0 110.216 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -87.0 133.5 33.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.69 -0.631 . . . . 15.0 110.437 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.89 147.45 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.591 -0.693 . . . . 15.0 109.991 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.7 t -110.83 130.17 55.65 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.2 tp -119.83 130.65 55.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.845 -0.535 . . . . 15.0 110.325 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.71 119.33 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m -92.26 170.61 9.67 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.307 0.575 . . . . 15.0 110.948 -171.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -60.6 -17.56 47.52 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.62 -0.675 . . . . 15.0 111.513 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.4 15.34 9.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.222 -0.923 . . . . 15.0 111.278 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 57.25 29.37 16.63 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 15.0 110.67 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.41 144.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.897 -0.779 . . . . 15.0 108.897 172.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -105.67 119.79 40.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.727 -0.608 . . . . 15.0 110.453 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -111.85 137.44 49.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.773 -0.58 . . . . 15.0 109.566 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 41' ' ' VAL . 36.8 tt0 -121.42 140.49 52.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 15.0 109.938 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.87 39.84 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.124 -1.59 . . . . 15.0 109.124 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.49 142.37 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.495 -1.003 . . . . 15.0 109.708 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 29' ' ' ILE . 20.4 tp -65.21 112.51 3.47 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.721 -0.612 . . . . 15.0 110.295 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -96.03 -52.07 4.19 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.373 -0.531 . . . . 15.0 110.35 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.5 p -143.92 143.28 31.19 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.637 -0.664 . . . . 15.0 110.489 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 26' ' ' LEU . 72.7 mt -116.97 126.05 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.733 -0.604 . . . . 15.0 109.77 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -112.1 96.18 5.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.598 -0.689 . . . . 15.0 109.79 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.6 m -70.3 -36.78 74.54 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.816 -0.553 . . . . 15.0 110.369 -176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -58.91 -28.96 66.69 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.556 -0.715 . . . . 15.0 111.075 -171.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.16 13.99 15.83 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.544 -0.722 . . . . 15.0 111.484 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t 49.96 47.27 23.51 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.241 -0.912 . . . . 15.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.2 p -131.43 149.56 52.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.447 -0.783 . . . . 15.0 110.471 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.41 140.28 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.628 -0.67 . . . . 15.0 109.649 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -113.05 129.12 56.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.689 -0.632 . . . . 15.0 109.935 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.4 mt -116.87 138.84 51.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.826 -0.435 . . . . 15.0 109.826 -178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.54 165.35 13.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.732 -0.605 . . . . 15.0 109.873 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.4 tptt 51.86 60.97 3.46 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 121.631 -0.668 . . . . 15.0 110.36 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.1 p -119.99 145.27 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.565 -0.709 . . . . 15.0 110.523 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.549 ' CG ' HG23 ' A' ' 61' ' ' THR . 25.6 mtt-85 -127.36 150.98 49.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 15.0 109.808 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.5 p -102.39 129.67 48.92 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.753 -0.592 . . . . 15.0 109.927 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -71.6 -40.01 70.12 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.116 -0.633 . . . . 15.0 110.416 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.81 166.36 26.76 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.774 -1.33 . . . . 15.0 109.774 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.68 HG21 HG13 ' A' ' 55' ' ' ILE . 37.4 p -118.1 6.26 12.05 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.734 -0.862 . . . . 15.0 111.27 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -55.19 -24.22 25.93 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.24 -0.913 . . . . 15.0 111.31 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -62.52 -32.89 73.9 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.511 -0.743 . . . . 15.0 110.378 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -135.99 94.2 14.66 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.663 -0.648 . . . . 15.0 110.038 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -61.09 134.99 55.92 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.421 1.222 . . . . 15.0 110.641 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.0 p -129.77 165.02 22.77 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.635 . . . . 15.0 110.202 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.9 -2.91 39.08 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.724 -0.61 . . . . 15.0 111.442 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -109.1 107.02 59.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.095 -1.003 . . . . 15.0 110.058 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.71 139.42 80.63 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.321 1.169 . . . . 15.0 110.647 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.68 HG13 HG21 ' A' ' 46' ' ' THR . 50.9 mm -95.5 143.45 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.675 -0.641 . . . . 15.0 109.783 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 158.09 86.38 Favored Pre-proline 0 N--CA 1.499 1.975 0 O-C-N 121.722 -0.611 . . . . 15.0 110.216 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.66 165.11 6.63 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 123.587 1.309 . . . . 15.0 110.785 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -92.55 20.03 6.72 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.624 -0.673 . . . . 15.0 111.155 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.92 -34.55 73.63 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.227 -0.921 . . . . 15.0 109.96 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -103.37 149.58 24.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.707 -0.621 . . . . 15.0 110.095 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.549 HG23 ' CG ' ' A' ' 42' ' ' ARG . 18.9 m -105.94 163.3 12.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.792 -0.568 . . . . 15.0 110.295 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -96.48 125.24 40.83 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.671 -0.643 . . . . 15.0 109.883 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -67.56 -41.14 84.71 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.868 -0.52 . . . . 15.0 110.981 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.8 t80 -154.8 122.0 5.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.757 . . . . 15.0 110.676 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.6 mt -129.64 147.9 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.66 -0.65 . . . . 15.0 109.767 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.22 136.89 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.724 -0.61 . . . . 15.0 109.917 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -129.25 143.84 51.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.768 -0.583 . . . . 15.0 109.905 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.731 ' HG2' HG22 ' A' ' 35' ' ' THR . 73.9 mtt85 -109.49 151.27 26.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.682 -0.637 . . . . 15.0 110.133 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.74 -26.02 56.83 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.697 -0.961 . . . . 15.0 110.697 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -66.76 -40.59 88.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.462 -1.022 . . . . 15.0 110.724 -177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -86.41 -31.78 21.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.617 -0.677 . . . . 15.0 110.712 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -64.69 138.78 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.592 -0.692 . . . . 15.0 109.956 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -99.88 -41.5 7.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.734 -0.604 . . . . 15.0 110.116 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -147.33 145.1 29.21 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.677 -0.639 . . . . 15.0 110.628 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -133.3 130.36 38.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.725 -0.609 . . . . 15.0 110.038 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 22.0 m -132.21 144.6 50.76 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.62 -0.675 . . . . 15.0 110.514 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.62 144.02 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.594 -0.691 . . . . 15.0 109.688 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.5 m -95.48 -36.53 11.28 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.643 -0.66 . . . . 15.0 110.373 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -84.26 117.58 69.06 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.741 -0.599 . . . . 15.0 110.048 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.21 159.7 51.21 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.332 1.174 . . . . 15.0 110.331 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.84 155.86 68.19 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.677 1.356 . . . . 15.0 110.301 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -89.64 157.43 46.73 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.701 -0.625 . . . . 15.0 110.191 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.07 145.68 74.24 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 O-C-N 123.708 1.373 . . . . 15.0 110.456 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.0 mt -70.39 -35.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.752 -0.593 . . . . 15.0 109.615 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 118.015 -0.993 . . . . 15.0 110.185 179.784 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.01 0.433 . . . . 15.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -150.81 -46.89 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.7 -0.625 . . . . 15.0 110.261 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -75.0 150.06 85.6 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.744 -0.598 . . . . 15.0 110.071 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -65.2 -32.13 52.59 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.569 1.3 . . . . 15.0 110.534 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -66.69 -32.65 74.09 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.609 -0.682 . . . . 15.0 110.21 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.43 -30.25 76.24 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 110.09 -1.204 . . . . 15.0 110.09 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.58 93.52 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.954 -1.259 . . . . 15.0 109.954 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.1 m -142.92 122.94 7.89 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.618 -0.931 . . . . 15.0 110.077 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.02 144.08 33.55 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.405 1.213 . . . . 15.0 110.384 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.465 ' C ' HD23 ' A' ' 26' ' ' LEU . 98.5 m-85 -69.13 -31.97 71.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.665 -0.647 . . . . 15.0 110.095 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.448 ' N ' HD23 ' A' ' 26' ' ' LEU . 85.7 mt -64.45 135.54 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.447 -0.783 . . . . 15.0 109.692 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.64 -2.15 62.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.977 -0.849 . . . . 15.0 110.977 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.2 m -99.47 153.98 18.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.035 -1.273 . . . . 15.0 110.534 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt -83.72 132.54 34.85 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.752 -0.593 . . . . 15.0 110.035 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' CD1' HD13 ' A' ' 26' ' ' LEU . 91.8 mt -132.66 145.99 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.52 -0.738 . . . . 15.0 110.114 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.2 t -115.07 129.93 56.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HG12 ' A' ' 72' ' ' ILE . 10.8 tp -121.9 136.3 54.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.675 -0.641 . . . . 15.0 110.355 -175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.11 121.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.021 -0.733 . . . . 15.0 109.021 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -92.69 172.43 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.309 0.576 . . . . 15.0 110.907 -171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -59.98 -19.26 51.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.629 -0.67 . . . . 15.0 111.405 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.02 16.76 7.75 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.257 -0.902 . . . . 15.0 111.215 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 57.48 28.42 15.47 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.237 -0.914 . . . . 15.0 110.867 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.809 HG12 HG22 ' A' ' 46' ' ' THR . 55.5 mt -105.0 147.23 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -105.64 121.38 43.87 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 15.0 110.526 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -112.32 136.23 52.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.833 -0.542 . . . . 15.0 109.786 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.4 tt0 -117.75 140.54 49.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.455 -0.778 . . . . 15.0 109.779 173.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.19 -178.89 39.27 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.029 -1.628 . . . . 15.0 109.029 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.18 143.03 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.386 -1.067 . . . . 15.0 109.793 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 29' ' ' ILE . 12.1 tp -65.95 114.97 5.54 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.763 -0.585 . . . . 15.0 110.19 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -97.62 -52.05 3.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.806 -0.559 . . . . 15.0 110.381 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.5 p -144.56 143.35 30.77 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.717 -0.614 . . . . 15.0 110.541 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -115.43 125.23 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.717 -0.614 . . . . 15.0 109.613 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.08 97.2 6.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.605 -0.684 . . . . 15.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -70.89 -36.56 72.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.707 -0.62 . . . . 15.0 110.383 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -58.87 -29.36 66.93 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.572 -0.705 . . . . 15.0 111.015 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.64 13.91 16.37 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.503 -0.748 . . . . 15.0 111.461 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t 50.06 47.21 23.76 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.195 -0.941 . . . . 15.0 111.174 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.68 HG22 ' HG2' ' A' ' 68' ' ' ARG . 16.8 p -131.86 148.72 52.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.501 -0.75 . . . . 15.0 110.606 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.61 138.22 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.64 -0.663 . . . . 15.0 109.535 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -110.51 128.52 55.67 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.646 -0.658 . . . . 15.0 109.905 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.9 mt -116.79 138.65 51.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.889 -0.507 . . . . 15.0 109.791 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.73 164.68 13.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.76 -0.587 . . . . 15.0 109.791 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 51.81 56.91 7.12 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.644 -0.66 . . . . 15.0 110.375 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.0 p -120.66 148.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.593 -0.692 . . . . 15.0 110.303 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -139.71 150.07 44.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.804 -0.56 . . . . 15.0 110.211 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.4 p -97.59 132.06 43.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.77 -0.581 . . . . 15.0 109.771 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -72.82 -40.2 66.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.552 -0.718 . . . . 15.0 110.569 -174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 171.16 33.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.856 -1.298 . . . . 15.0 109.856 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.827 HG21 HG13 ' A' ' 55' ' ' ILE . 43.8 p -118.01 3.44 12.12 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.744 -0.856 . . . . 15.0 111.066 174.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -65.77 -30.42 71.07 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.287 -0.883 . . . . 15.0 111.031 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.77 -33.69 73.34 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.329 -0.857 . . . . 15.0 110.52 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -141.24 95.05 7.51 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.753 -0.592 . . . . 15.0 110.038 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.06 139.29 89.9 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 O-C-N 123.385 1.203 . . . . 15.0 110.997 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.4 p -128.02 165.13 20.9 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.847 -0.533 . . . . 15.0 110.077 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.82 -1.88 33.75 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.664 -0.648 . . . . 15.0 111.315 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -107.94 106.97 59.7 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.222 -0.924 . . . . 15.0 109.939 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.84 140.68 74.8 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.403 1.212 . . . . 15.0 110.684 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.827 HG13 HG21 ' A' ' 46' ' ' THR . 50.0 mm -113.58 141.64 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.693 -0.629 . . . . 15.0 109.731 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.67 158.01 86.8 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.701 -0.624 . . . . 15.0 110.143 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -61.14 164.66 14.08 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 O-C-N 123.586 1.308 . . . . 15.0 110.713 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -89.22 144.67 25.94 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.698 -0.626 . . . . 15.0 110.112 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -157.62 -46.09 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.64 -0.663 . . . . 15.0 110.31 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.92 176.64 8.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.625 -0.672 . . . . 15.0 110.376 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 m -103.04 166.0 10.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.78 -0.575 . . . . 15.0 110.161 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.711 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.1 m-85 -102.02 128.11 48.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.604 -0.685 . . . . 15.0 110.078 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.09 -42.37 80.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.86 -0.525 . . . . 15.0 110.691 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.517 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.2 t80 -150.98 121.89 7.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.507 -0.746 . . . . 15.0 110.631 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.711 HD11 ' CG ' ' A' ' 62' ' ' PHE . 95.3 mt -130.73 147.96 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.681 -0.637 . . . . 15.0 109.698 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.04 135.74 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.719 -0.613 . . . . 15.0 109.901 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -125.74 140.77 52.41 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.636 -0.665 . . . . 15.0 109.991 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.68 ' HG2' HG22 ' A' ' 35' ' ' THR . 92.6 mtt-85 -104.37 151.07 23.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.679 -0.638 . . . . 15.0 110.087 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.13 -25.97 55.03 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.717 -0.953 . . . . 15.0 110.717 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -65.33 -45.0 86.0 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.446 -1.032 . . . . 15.0 110.778 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.96 -31.47 31.19 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.549 -0.72 . . . . 15.0 110.696 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.634 HG12 HD21 ' A' ' 14' ' ' LEU . 74.8 mt -65.88 136.14 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.5 -0.75 . . . . 15.0 109.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -104.88 -39.85 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 15.0 110.253 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -141.29 142.69 33.86 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.659 -0.65 . . . . 15.0 110.56 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -130.39 127.41 39.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.714 -0.616 . . . . 15.0 110.164 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.6 m -129.5 139.06 51.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.61 -0.681 . . . . 15.0 110.251 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.9 t -100.99 144.03 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.645 -0.659 . . . . 15.0 109.782 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.05 -37.14 16.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.661 -0.649 . . . . 15.0 110.184 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -84.31 117.51 68.9 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.597 -0.69 . . . . 15.0 109.868 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.07 154.39 62.49 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.318 1.167 . . . . 15.0 110.348 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -63.87 156.68 56.67 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 O-C-N 123.573 1.302 . . . . 15.0 110.454 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -86.65 142.56 34.87 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.697 -0.627 . . . . 15.0 109.964 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.75 133.17 28.72 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.405 1.213 . . . . 15.0 110.407 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.9 tp -129.56 139.21 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.739 -0.601 . . . . 15.0 110.082 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 87.2 mmm . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 117.94 -1.028 . . . . 15.0 110.22 179.773 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 20.4 tp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.906 0.384 . . . . 15.0 110.152 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.44 137.05 55.6 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.752 -0.593 . . . . 15.0 110.255 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -105.02 150.1 38.35 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 15.0 110.216 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.64 -29.3 60.53 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 O-C-N 123.497 1.261 . . . . 15.0 110.638 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -63.95 -30.54 71.61 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.561 -0.712 . . . . 15.0 110.422 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.1 69.92 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.367 -1.093 . . . . 15.0 110.367 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.41 -30.6 71.82 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 110.235 -1.146 . . . . 15.0 110.235 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -66.94 139.76 95.77 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.591 -0.946 . . . . 15.0 109.936 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.22 124.94 13.23 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.375 1.197 . . . . 15.0 110.672 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.25 -19.87 63.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.833 -0.542 . . . . 15.0 110.854 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' N ' HD23 ' A' ' 26' ' ' LEU . 87.3 mt -60.68 138.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.087 -1.008 . . . . 15.0 110.028 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.31 -2.11 74.1 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.996 -0.842 . . . . 15.0 110.996 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.7 m -103.43 151.81 22.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 118.712 1.256 . . . . 15.0 110.67 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -78.54 130.02 35.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.874 -0.516 . . . . 15.0 110.1 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' CD1' HD13 ' A' ' 26' ' ' LEU . 93.6 mt -132.75 147.85 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.506 -0.746 . . . . 15.0 109.97 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.5 t -116.21 133.87 55.54 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.577 -0.527 . . . . 15.0 109.577 175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 72' ' ' ILE . 11.1 tp -124.14 136.52 54.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.737 -0.602 . . . . 15.0 110.375 -175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 74' ' ' ASP . 81.4 mt -108.81 122.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.073 -0.714 . . . . 15.0 109.073 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.3 m -94.3 172.93 7.9 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.277 0.56 . . . . 15.0 110.988 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -59.7 -20.01 53.49 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.624 -0.672 . . . . 15.0 111.466 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.46 16.91 8.02 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.35 -0.843 . . . . 15.0 111.271 -178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 58.03 28.23 16.0 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.301 -0.874 . . . . 15.0 110.86 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.594 HG12 HG22 ' A' ' 46' ' ' THR . 82.6 mt -105.02 147.76 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 172.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -106.08 121.54 44.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.779 -0.576 . . . . 15.0 110.403 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -112.18 136.78 51.15 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.769 -0.582 . . . . 15.0 109.756 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 33.9 tt0 -118.49 140.68 49.49 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.507 -0.745 . . . . 15.0 109.725 174.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.55 -178.9 38.94 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.11 -1.596 . . . . 15.0 109.11 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.6 139.08 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.568 -0.96 . . . . 15.0 109.54 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.821 HD21 HD11 ' A' ' 29' ' ' ILE . 11.1 tp -66.03 115.4 6.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 15.0 110.253 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -97.94 -52.05 3.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.865 -0.522 . . . . 15.0 110.403 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.6 p -144.46 143.39 30.86 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.615 -0.678 . . . . 15.0 110.637 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.821 HD11 HD21 ' A' ' 26' ' ' LEU . 75.6 mt -116.58 127.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.633 -0.667 . . . . 15.0 109.679 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -112.12 95.42 5.45 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.679 -0.638 . . . . 15.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 m -69.26 -38.04 78.21 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.79 -0.569 . . . . 15.0 110.419 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.53 -28.96 67.55 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.582 -0.699 . . . . 15.0 111.1 -172.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' THR . 94.8 m-20 -114.26 13.91 17.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.473 -0.767 . . . . 15.0 111.554 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.5 m 50.0 45.65 25.09 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.171 -0.956 . . . . 15.0 111.309 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.742 HG22 ' HG2' ' A' ' 68' ' ' ARG . 17.4 p -131.88 149.74 52.36 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.463 -0.773 . . . . 15.0 110.666 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.9 t -132.86 140.64 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.582 -0.699 . . . . 15.0 109.603 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -112.07 129.47 56.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.621 -0.675 . . . . 15.0 110.015 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.9 mt -116.89 139.12 51.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.938 -0.477 . . . . 15.0 109.753 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.82 162.98 16.16 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.698 -0.626 . . . . 15.0 109.868 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt 51.89 59.34 4.62 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.666 -0.647 . . . . 15.0 110.488 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.51 148.03 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.592 -0.693 . . . . 15.0 110.314 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -136.45 149.55 48.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.901 -0.499 . . . . 15.0 110.073 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.5 p -97.21 131.75 43.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.714 -0.616 . . . . 15.0 109.724 177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -73.88 -40.37 63.24 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.543 -0.723 . . . . 15.0 110.702 -173.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.66 174.49 36.7 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.894 -1.283 . . . . 15.0 109.894 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.71 HG21 HG13 ' A' ' 55' ' ' ILE . 42.4 p -115.9 6.05 14.16 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.774 -0.839 . . . . 15.0 110.961 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -63.99 -27.01 68.83 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.236 -0.915 . . . . 15.0 111.123 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -60.62 -35.66 76.7 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.385 -0.822 . . . . 15.0 110.311 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -142.74 95.09 6.43 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.821 -0.55 . . . . 15.0 109.82 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.36 142.83 87.15 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.471 1.248 . . . . 15.0 110.702 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.1 p -122.13 165.1 16.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.827 -0.546 . . . . 15.0 110.094 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -77.82 -2.22 35.43 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.674 -0.641 . . . . 15.0 111.351 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -113.28 136.45 21.84 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.109 -0.994 . . . . 15.0 109.972 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.39 142.98 51.11 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.442 1.233 . . . . 15.0 110.41 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.71 HG13 HG21 ' A' ' 46' ' ' THR . 50.8 mm -114.12 145.99 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.638 -0.664 . . . . 15.0 109.689 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.41 158.12 59.95 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.639 -0.663 . . . . 15.0 110.461 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -59.41 165.05 9.9 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 O-C-N 123.519 1.273 . . . . 15.0 110.764 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 -107.36 32.4 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.682 -0.636 . . . . 15.0 110.533 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.66 31.17 4.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 15.0 110.35 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -142.71 152.0 41.9 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.655 -0.653 . . . . 15.0 110.154 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.0 m -110.46 141.64 43.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.656 -0.653 . . . . 15.0 110.173 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 65' ' ' ILE . 85.1 m-85 -102.06 128.04 48.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 15.0 110.066 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.2 -42.88 79.23 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.79 -0.569 . . . . 15.0 110.667 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 5.4 t80 -150.48 121.93 7.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.523 -0.735 . . . . 15.0 110.606 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD11 ' CG ' ' A' ' 62' ' ' PHE . 25.8 mt -130.87 147.75 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 15.0 109.554 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.6 mt -110.58 136.05 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.741 -0.599 . . . . 15.0 109.86 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -126.08 142.64 51.43 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.631 . . . . 15.0 109.949 176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.8 mtt180 -107.34 152.2 24.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.646 -0.659 . . . . 15.0 110.143 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.01 55.02 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.7 m -65.56 -45.54 82.92 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.447 -1.031 . . . . 15.0 110.766 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.02 -31.59 30.94 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.63 -0.669 . . . . 15.0 110.637 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 14' ' ' LEU . 69.7 mt -66.66 138.03 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.545 -0.722 . . . . 15.0 109.814 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -105.29 -40.07 5.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.656 -0.652 . . . . 15.0 110.17 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 15' ' ' ILE . 18.4 t0 -143.19 142.83 31.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 15.0 110.665 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -128.41 127.11 41.94 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.796 -0.565 . . . . 15.0 110.049 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -131.81 139.91 49.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.638 -0.664 . . . . 15.0 110.394 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.8 144.08 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.588 -0.695 . . . . 15.0 109.636 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.5 t -95.28 -37.11 11.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.604 -0.685 . . . . 15.0 110.272 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.49 117.48 49.03 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.639 -0.663 . . . . 15.0 110.17 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.23 145.73 35.08 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.294 1.155 . . . . 15.0 110.189 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -71.19 153.78 62.1 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.494 1.26 . . . . 15.0 110.262 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -98.2 154.7 37.56 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.796 -0.565 . . . . 15.0 110.137 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -68.31 149.51 75.57 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.632 1.333 . . . . 15.0 110.36 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 84' ' ' ILE . 5.3 mp -114.58 135.12 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.595 -0.69 . . . . 15.0 109.67 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 13.1 mmt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 117.999 -1.0 . . . . 15.0 110.193 -179.926 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' -2' ' ' LEU . 7.0 tt . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.992 0.425 . . . . 15.0 110.011 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . 0.421 ' N ' HD23 ' A' ' -2' ' ' LEU . 51.4 mt-10 -128.81 -57.32 1.18 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.628 -0.67 . . . . 15.0 110.448 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 1' ' ' PRO . 12.7 p-10 -90.48 144.74 31.19 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 121.625 -0.672 . . . . 15.0 110.426 -177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 0' ' ' ASP . 15.3 Cg_exo -64.47 -34.33 53.91 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 O-C-N 123.417 1.22 . . . . 15.0 110.745 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.2 p -65.6 -38.38 89.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.637 -0.664 . . . . 15.0 110.488 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.03 -37.62 60.16 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.424 -1.47 . . . . 15.0 109.424 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.96 -38.74 64.39 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.66 -1.376 . . . . 15.0 109.66 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -109.86 122.95 37.59 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.875 . . . . 15.0 110.387 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.96 149.16 52.68 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.355 1.187 . . . . 15.0 110.252 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -59.46 -29.79 68.06 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.605 -0.684 . . . . 15.0 110.458 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.97 138.64 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.385 -0.822 . . . . 15.0 109.445 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.9 -2.15 59.91 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.791 -0.924 . . . . 15.0 110.791 -173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.2 m -83.22 159.16 22.04 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.962 -1.317 . . . . 15.0 110.416 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -86.09 132.02 34.13 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.797 -0.564 . . . . 15.0 110.369 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 26' ' ' LEU . 94.5 mt -133.2 147.68 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 15.0 109.937 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -116.88 132.81 56.6 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.498 -0.556 . . . . 15.0 109.498 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.603 HD21 HG12 ' A' ' 72' ' ' ILE . 10.9 tp -124.51 137.51 54.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.643 -0.661 . . . . 15.0 110.356 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.6 mt -108.59 121.42 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 109.038 -0.727 . . . . 15.0 109.038 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.9 m -92.15 174.04 7.52 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.298 0.57 . . . . 15.0 110.94 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.54 -20.53 56.25 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.624 -0.673 . . . . 15.0 111.444 -177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.82 16.62 8.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.334 -0.854 . . . . 15.0 111.295 -178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 57.3 29.76 17.35 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.222 -0.924 . . . . 15.0 110.779 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG12 HG22 ' A' ' 46' ' ' THR . 89.3 mt -105.1 146.71 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.996 -0.742 . . . . 15.0 108.996 172.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -104.12 119.91 39.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.823 -0.548 . . . . 15.0 110.428 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -111.44 136.32 50.75 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.756 -0.59 . . . . 15.0 109.791 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.643 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.3 tt0 -118.09 140.7 49.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.559 -0.713 . . . . 15.0 109.769 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.47 -178.92 38.91 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.937 -1.665 . . . . 15.0 108.937 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.0 mm -108.46 142.93 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.349 -1.089 . . . . 15.0 109.874 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 29' ' ' ILE . 20.5 tp -65.55 109.0 2.2 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.744 -0.597 . . . . 15.0 110.203 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -92.66 -52.05 4.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.801 -0.562 . . . . 15.0 110.439 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.59 142.91 31.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.638 -0.664 . . . . 15.0 110.422 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 26' ' ' LEU . 68.9 mt -116.72 125.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.78 -0.575 . . . . 15.0 109.661 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -112.17 97.3 6.55 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.573 -0.704 . . . . 15.0 109.781 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.2 m -71.45 -36.38 71.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.675 -0.641 . . . . 15.0 110.49 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -58.82 -29.79 67.15 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.461 -0.775 . . . . 15.0 111.043 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' THR . 93.4 m-20 -115.8 13.98 16.21 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.575 -0.703 . . . . 15.0 111.555 -176.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t 49.89 48.75 21.36 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.154 -0.966 . . . . 15.0 111.266 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.711 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.6 p -131.81 148.33 52.55 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.477 -0.764 . . . . 15.0 110.484 -178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -131.42 139.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.66 -0.65 . . . . 15.0 109.662 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -112.4 128.94 56.45 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.77 -0.582 . . . . 15.0 109.911 177.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 26' ' ' LEU . 94.7 mt -116.79 138.08 51.74 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.89 -0.506 . . . . 15.0 109.867 -178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.12 165.43 12.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.784 -0.573 . . . . 15.0 109.793 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.1 mttm 51.68 57.32 6.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.672 -0.642 . . . . 15.0 110.425 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.4 p -121.16 148.59 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.535 -0.728 . . . . 15.0 110.279 -173.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -140.7 152.31 45.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.724 -0.61 . . . . 15.0 110.196 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 38.4 p -97.42 131.26 44.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.771 -0.581 . . . . 15.0 109.795 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -70.89 -40.3 72.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.59 -0.694 . . . . 15.0 110.464 -173.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.75 170.7 32.86 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.816 -1.314 . . . . 15.0 109.816 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.506 HG22 HG12 ' A' ' 20' ' ' ILE . 71.2 p -118.01 -19.68 9.03 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.814 -0.815 . . . . 15.0 110.898 176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.14 -29.53 70.87 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.282 -0.886 . . . . 15.0 110.864 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.32 -32.73 71.52 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.468 -0.77 . . . . 15.0 110.262 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 51' ' ' THR . 61.1 mtt180 -127.26 95.04 37.18 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.745 -0.597 . . . . 15.0 109.632 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -53.35 134.53 57.48 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 O-C-N 123.418 1.22 . . . . 15.0 111.482 -172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 49' ' ' ARG . 37.3 p -127.44 165.14 20.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.813 -0.554 . . . . 15.0 109.98 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.76 -1.66 32.46 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.664 -0.647 . . . . 15.0 111.319 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -113.98 106.9 52.89 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.093 -1.005 . . . . 15.0 109.929 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -66.69 131.98 27.47 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.413 1.217 . . . . 15.0 110.631 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.7 mm -124.22 144.84 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.724 -0.61 . . . . 15.0 109.618 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.07 155.97 40.76 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.681 -0.637 . . . . 15.0 110.279 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -62.23 143.69 94.53 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.506 1.266 . . . . 15.0 110.652 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -153.88 154.44 33.88 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.69 -0.631 . . . . 15.0 110.348 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -126.09 33.62 5.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.629 -0.669 . . . . 15.0 110.261 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -95.68 143.88 26.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.679 -0.638 . . . . 15.0 110.217 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 m -102.96 146.08 28.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.75 -0.593 . . . . 15.0 110.117 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.714 ' CG ' HD11 ' A' ' 65' ' ' ILE . 90.4 m-85 -102.08 128.66 48.45 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.744 -0.597 . . . . 15.0 110.108 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -68.14 -41.84 81.06 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.867 -0.521 . . . . 15.0 110.684 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.5 t80 -150.8 121.96 7.75 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.601 -0.687 . . . . 15.0 110.589 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.714 HD11 ' CG ' ' A' ' 62' ' ' PHE . 94.8 mt -131.02 147.09 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.678 -0.639 . . . . 15.0 109.487 173.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -110.14 139.19 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.655 -0.653 . . . . 15.0 109.993 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -131.85 142.86 49.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.712 -0.617 . . . . 15.0 109.941 175.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.711 ' HG2' HG22 ' A' ' 35' ' ' THR . 90.7 mtt180 -110.73 152.68 26.29 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.62 -0.675 . . . . 15.0 110.086 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.1 -26.06 55.12 Favored Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.673 -0.971 . . . . 15.0 110.673 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -67.26 -40.79 86.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.44 -1.035 . . . . 15.0 110.795 -177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -88.34 -30.97 19.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.599 -0.688 . . . . 15.0 110.801 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.603 HG12 HD21 ' A' ' 14' ' ' LEU . 70.6 mt -64.73 142.31 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.588 -0.695 . . . . 15.0 109.915 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.5 tttp -99.88 -44.14 6.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 15.0 110.264 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -146.86 147.17 30.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.686 -0.634 . . . . 15.0 110.705 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -129.18 129.95 45.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.728 -0.608 . . . . 15.0 110.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.3 m -131.46 138.89 49.22 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.647 -0.658 . . . . 15.0 110.346 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.75 144.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.691 -0.631 . . . . 15.0 109.792 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 5.3 t -90.86 -37.02 13.85 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.653 -0.654 . . . . 15.0 110.193 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -87.02 117.5 68.72 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.623 -0.673 . . . . 15.0 109.975 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -72.14 152.7 56.72 Favored 'Trans proline' 0 N--CA 1.486 1.081 0 O-C-N 123.379 1.199 . . . . 15.0 110.343 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -64.16 156.59 58.41 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.527 1.277 . . . . 15.0 110.526 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.4 tptt -94.02 139.09 22.49 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.717 -0.614 . . . . 15.0 109.938 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.73 134.29 34.55 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.436 1.229 . . . . 15.0 110.488 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 tt -128.5 139.92 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.709 -0.619 . . . . 15.0 110.15 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.497 1.885 0 CA-C-O 118.026 -0.988 . . . . 15.0 110.171 179.842 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.416 ' O ' HD23 ' A' ' -2' ' ' LEU . 7.2 tt . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.023 0.439 . . . . 15.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.85 -33.44 75.86 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.696 -0.628 . . . . 15.0 110.433 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.17 119.92 59.47 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.696 -0.628 . . . . 15.0 110.146 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -65.35 -33.67 47.02 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.348 1.183 . . . . 15.0 110.563 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 t -66.94 -39.0 87.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.613 -0.679 . . . . 15.0 110.407 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.89 -36.28 42.34 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.577 -1.409 . . . . 15.0 109.577 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.16 -35.31 77.4 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.851 -1.299 . . . . 15.0 109.851 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -108.05 142.25 24.89 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.679 -0.894 . . . . 15.0 110.304 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.7 149.09 42.73 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 O-C-N 123.375 1.198 . . . . 15.0 110.403 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -58.67 -44.59 90.23 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.621 -0.674 . . . . 15.0 110.404 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' HA ' HD23 ' A' ' 26' ' ' LEU . 83.7 mt -66.29 137.28 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.376 -0.828 . . . . 15.0 109.26 177.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.48 -2.19 62.63 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.815 -0.914 . . . . 15.0 110.815 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 m -82.6 160.12 22.58 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.031 -1.276 . . . . 15.0 110.417 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -85.59 133.56 34.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.861 -0.524 . . . . 15.0 110.239 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.614 ' CD1' HD13 ' A' ' 26' ' ' LEU . 92.2 mt -133.98 147.09 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.514 -0.741 . . . . 15.0 109.964 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -115.54 133.81 55.67 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.467 -0.568 . . . . 15.0 109.467 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.613 HD21 HG12 ' A' ' 72' ' ' ILE . 9.4 tp -125.69 137.17 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.712 -0.618 . . . . 15.0 110.424 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 87.5 mt -109.3 121.37 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.968 -0.753 . . . . 15.0 108.968 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.8 m -93.33 175.68 6.67 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.32 0.581 . . . . 15.0 111.01 -170.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -59.15 -21.5 59.45 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.606 -0.684 . . . . 15.0 111.398 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.44 15.97 9.71 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.321 -0.862 . . . . 15.0 111.326 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 57.71 28.99 16.64 Favored 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.306 -0.871 . . . . 15.0 110.811 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 46' ' ' THR . 86.2 mt -105.0 149.59 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.151 -0.685 . . . . 15.0 109.151 172.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -106.35 121.19 43.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.798 -0.563 . . . . 15.0 110.608 -176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -112.44 141.75 45.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.802 -0.561 . . . . 15.0 109.809 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.2 tt0 -120.2 140.69 50.78 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.561 -0.712 . . . . 15.0 109.762 173.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.9 -178.94 37.88 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 108.866 -1.694 . . . . 15.0 108.866 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.4 mm -109.37 143.02 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.421 -1.046 . . . . 15.0 109.742 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD21 HD11 ' A' ' 29' ' ' ILE . 12.6 tp -66.06 108.89 2.38 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.791 -0.568 . . . . 15.0 110.213 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -91.7 -52.02 4.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.795 -0.566 . . . . 15.0 110.407 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 17.8 p -144.11 142.43 30.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.637 -0.664 . . . . 15.0 110.439 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.813 HD11 HD21 ' A' ' 26' ' ' LEU . 74.6 mt -114.42 125.59 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.77 -0.581 . . . . 15.0 109.644 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -112.05 97.38 6.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.627 -0.671 . . . . 15.0 109.851 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -71.82 -36.25 70.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.702 -0.624 . . . . 15.0 110.546 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.79 -29.1 66.58 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.524 -0.735 . . . . 15.0 111.118 -171.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.535 ' O ' HG23 ' A' ' 35' ' ' THR . 94.6 m-20 -116.93 14.1 15.04 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.436 -0.79 . . . . 15.0 111.522 -176.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m 49.9 49.14 20.78 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.181 -0.95 . . . . 15.0 111.186 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.701 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.9 p -131.89 148.29 52.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.462 -0.774 . . . . 15.0 110.401 -178.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.65 138.49 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.561 -0.712 . . . . 15.0 109.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -111.28 128.79 56.05 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.603 -0.686 . . . . 15.0 109.954 177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 26' ' ' LEU . 93.5 mt -116.84 137.22 52.36 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.899 -0.501 . . . . 15.0 109.801 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.03 164.12 14.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.739 -0.601 . . . . 15.0 109.785 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt 51.84 59.58 4.45 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.56 -0.712 . . . . 15.0 110.524 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.6 p -122.73 148.66 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.55 -0.719 . . . . 15.0 110.224 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -140.02 150.41 44.38 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.754 -0.591 . . . . 15.0 110.256 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -97.8 129.53 44.79 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.706 -0.621 . . . . 15.0 109.653 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -74.04 -40.52 62.79 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 119.846 -0.742 . . . . 15.0 110.738 -171.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.51 -173.78 42.6 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.847 -1.301 . . . . 15.0 109.847 178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.514 HG22 HG12 ' A' ' 20' ' ' ILE . 40.5 p -117.95 5.36 12.13 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.822 -0.811 . . . . 15.0 110.909 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -66.23 -32.7 74.29 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.283 -0.885 . . . . 15.0 110.936 -175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -60.75 -33.7 73.32 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.413 -0.804 . . . . 15.0 110.429 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 25.1 mtt-85 -139.11 95.1 9.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.718 -0.614 . . . . 15.0 109.994 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -57.32 148.2 72.54 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.482 1.254 . . . . 15.0 111.027 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.6 p -128.2 165.05 21.2 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.815 -0.553 . . . . 15.0 110.096 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -77.81 -1.76 33.1 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.649 -0.657 . . . . 15.0 111.516 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -112.45 133.43 21.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.167 -0.958 . . . . 15.0 109.937 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.96 131.87 21.84 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.34 1.179 . . . . 15.0 110.488 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mm -122.09 136.58 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.64 -0.662 . . . . 15.0 109.658 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -94.54 150.56 38.27 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.666 -0.646 . . . . 15.0 110.206 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -68.97 148.13 69.45 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.625 1.329 . . . . 15.0 110.398 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -152.24 146.61 25.56 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.759 -0.588 . . . . 15.0 110.327 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -120.48 33.1 5.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.735 -0.603 . . . . 15.0 110.31 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -96.58 145.86 25.35 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 15.0 110.161 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.6 m -103.04 144.9 30.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.673 -0.642 . . . . 15.0 110.134 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.63 ' CG ' HD11 ' A' ' 65' ' ' ILE . 96.5 m-85 -102.01 127.94 48.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.625 -0.672 . . . . 15.0 110.111 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.21 -42.65 79.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.851 -0.531 . . . . 15.0 110.692 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.4 t80 -150.14 121.9 8.1 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 15.0 110.608 -176.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.63 HD11 ' CG ' ' A' ' 62' ' ' PHE . 28.5 mt -130.93 147.39 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.705 -0.622 . . . . 15.0 109.505 173.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.45 137.94 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.696 -0.627 . . . . 15.0 109.999 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.41 141.49 51.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.805 -0.559 . . . . 15.0 109.819 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.701 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.7 mtt180 -108.72 152.2 25.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.714 -0.616 . . . . 15.0 110.046 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.46 -26.0 50.82 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.725 -0.95 . . . . 15.0 110.725 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -66.9 -45.99 76.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.401 -1.058 . . . . 15.0 110.743 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.1 -32.07 30.39 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.583 -0.698 . . . . 15.0 110.714 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.613 HG12 HD21 ' A' ' 14' ' ' LEU . 83.4 mt -65.84 140.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.587 -0.696 . . . . 15.0 109.911 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -100.7 -42.21 6.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.665 -0.647 . . . . 15.0 110.195 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.4 144.58 30.74 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.649 -0.657 . . . . 15.0 110.667 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.31 128.59 43.47 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.655 -0.653 . . . . 15.0 110.148 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -129.5 136.5 49.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.598 -0.689 . . . . 15.0 110.192 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.3 t -108.51 144.07 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.631 -0.668 . . . . 15.0 109.938 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 97.8 m -85.86 -36.97 19.65 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.671 -0.643 . . . . 15.0 110.055 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -84.28 151.67 60.02 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.71 -0.619 . . . . 15.0 109.958 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -67.96 154.74 72.01 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 O-C-N 123.614 1.323 . . . . 15.0 110.435 -176.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.27 156.77 53.73 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.509 1.268 . . . . 15.0 110.522 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -81.47 150.24 66.61 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.69 -0.631 . . . . 15.0 109.956 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.23 153.62 63.81 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 O-C-N 123.517 1.272 . . . . 15.0 110.742 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 pt -111.48 -26.64 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.657 -0.652 . . . . 15.0 110.602 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 68.7 mtm . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 117.968 -1.015 . . . . 15.0 110.198 178.352 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 19.2 tp . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 120.987 0.422 . . . . 15.0 110.191 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -99.18 145.39 27.25 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.665 -0.647 . . . . 15.0 110.268 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -92.14 150.08 39.74 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.709 -0.619 . . . . 15.0 110.049 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -66.05 -36.33 30.3 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.544 1.287 . . . . 15.0 110.455 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -70.54 -35.75 73.3 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.751 -0.593 . . . . 15.0 110.086 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.32 -35.18 60.31 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.605 -1.398 . . . . 15.0 109.605 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.61 -33.18 83.7 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.967 -1.253 . . . . 15.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 15.5 m -68.92 147.04 97.77 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.603 -0.939 . . . . 15.0 110.134 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 17.2 Cg_exo -63.08 149.18 92.25 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.484 1.255 . . . . 15.0 110.642 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 26' ' ' LEU . 60.0 t80 -62.54 -36.53 82.91 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.708 -0.62 . . . . 15.0 110.237 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.445 ' HA ' HD23 ' A' ' 26' ' ' LEU . 65.8 mt -64.85 137.81 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.483 -0.761 . . . . 15.0 109.401 178.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.85 -2.22 61.84 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 64.1 m -85.79 160.04 19.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.084 -1.245 . . . . 15.0 110.514 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.52 131.48 34.17 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.714 -0.616 . . . . 15.0 110.228 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.608 ' CD1' HD13 ' A' ' 26' ' ' LEU . 95.7 mt -132.62 145.01 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.546 -0.721 . . . . 15.0 109.928 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.1 t -115.72 127.45 55.15 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 11.3 tp -116.18 133.37 56.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 15.0 110.165 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.2 mt -107.39 119.08 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.975 -0.75 . . . . 15.0 108.975 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -90.37 172.36 8.8 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.348 0.594 . . . . 15.0 110.808 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.37 -18.43 50.31 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.613 -0.679 . . . . 15.0 111.447 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.17 15.77 9.71 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.284 -0.885 . . . . 15.0 111.351 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.42 29.88 16.02 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.292 -0.88 . . . . 15.0 110.673 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 84.4 mt -104.07 143.27 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.891 -0.781 . . . . 15.0 108.891 172.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -102.77 119.36 38.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.78 -0.575 . . . . 15.0 110.391 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -110.3 130.55 55.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.822 -0.549 . . . . 15.0 109.625 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 41' ' ' VAL . 39.0 tt0 -115.99 140.67 49.03 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 15.0 109.868 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.4 -178.87 39.38 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.035 -1.626 . . . . 15.0 109.035 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.3 mm -108.08 138.8 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.389 -1.065 . . . . 15.0 109.772 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.828 HD21 HD11 ' A' ' 29' ' ' ILE . 12.9 tp -62.39 108.96 1.21 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.754 -0.592 . . . . 15.0 110.379 -177.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -91.53 -52.09 4.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.767 -0.583 . . . . 15.0 110.379 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 16.8 p -143.79 143.51 31.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.632 -0.668 . . . . 15.0 110.453 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.828 HD11 HD21 ' A' ' 26' ' ' LEU . 73.6 mt -115.57 125.59 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.765 -0.584 . . . . 15.0 109.661 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -112.05 96.16 5.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.613 -0.68 . . . . 15.0 109.825 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.9 m -71.19 -37.12 72.14 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.716 -0.615 . . . . 15.0 110.418 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.12 -29.04 67.1 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.456 -0.778 . . . . 15.0 111.053 -171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' O ' HG23 ' A' ' 35' ' ' THR . 94.9 m-20 -116.25 13.99 15.75 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.532 -0.73 . . . . 15.0 111.56 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.5 p 49.79 48.19 22.0 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.362 -0.836 . . . . 15.0 111.464 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 33' ' ' ASN . 42.4 p -132.39 149.4 52.36 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.461 -0.775 . . . . 15.0 110.404 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.08 138.76 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.576 -0.703 . . . . 15.0 109.55 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.45 56.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.612 -0.68 . . . . 15.0 109.905 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.9 mt -116.83 137.72 52.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.94 -0.475 . . . . 15.0 109.892 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.35 164.05 14.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.742 -0.599 . . . . 15.0 109.833 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.8 mttp 51.81 56.0 8.47 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.605 -0.684 . . . . 15.0 110.482 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.5 p -116.79 146.62 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 15.0 110.386 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -134.92 150.34 50.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.75 -0.594 . . . . 15.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -98.96 132.45 44.27 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.725 -0.61 . . . . 15.0 109.973 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -71.72 -40.18 69.61 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.597 -0.689 . . . . 15.0 110.583 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.91 171.84 34.28 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.888 -1.285 . . . . 15.0 109.888 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -118.03 6.26 12.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.79 -0.829 . . . . 15.0 111.198 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -56.83 -23.86 46.95 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.202 -0.936 . . . . 15.0 111.313 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -61.49 -35.15 76.86 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.408 -0.807 . . . . 15.0 110.445 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -144.35 95.03 5.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.687 -0.633 . . . . 15.0 110.008 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.13 139.51 90.21 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 O-C-N 123.478 1.252 . . . . 15.0 110.969 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.5 p -122.36 165.11 16.8 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.725 -0.609 . . . . 15.0 110.195 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -77.85 -2.06 34.73 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.749 -0.594 . . . . 15.0 111.312 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -109.6 106.92 59.04 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.168 -0.958 . . . . 15.0 109.877 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.1 132.8 46.37 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 O-C-N 123.377 1.198 . . . . 15.0 110.874 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.72 138.4 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.743 -0.598 . . . . 15.0 109.599 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 158.06 87.84 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.767 -0.583 . . . . 15.0 110.16 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -66.92 161.74 41.05 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.633 1.333 . . . . 15.0 110.345 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -64.48 127.01 29.67 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.668 -0.645 . . . . 15.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -155.78 -51.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.219 -1.03 . . . . 15.0 108.219 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -106.86 163.03 13.29 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 113.372 0.878 . . . . 15.0 113.372 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.1 m -112.35 158.77 19.39 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.691 -0.631 . . . . 15.0 110.189 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.687 ' CG ' HD11 ' A' ' 65' ' ' ILE . 91.7 m-85 -98.59 129.65 45.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.696 -0.628 . . . . 15.0 109.937 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -67.63 -41.63 83.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.808 -0.558 . . . . 15.0 110.745 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -150.8 121.88 7.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.585 -0.697 . . . . 15.0 110.585 -176.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.687 HD11 ' CG ' ' A' ' 62' ' ' PHE . 91.6 mt -132.0 147.99 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.731 -0.606 . . . . 15.0 109.534 172.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.4 mt -110.93 138.1 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.701 -0.624 . . . . 15.0 109.984 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.86 143.05 50.79 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.665 -0.647 . . . . 15.0 109.854 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' HG2' HG22 ' A' ' 35' ' ' THR . 89.9 mtt180 -109.61 152.32 25.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.709 . . . . 15.0 110.166 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -26.05 55.66 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.759 -0.936 . . . . 15.0 110.759 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.6 p -66.7 -44.15 82.46 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.467 -1.019 . . . . 15.0 110.752 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.31 -31.86 26.63 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 15.0 110.673 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 64.9 mt -65.55 143.54 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.648 -0.658 . . . . 15.0 109.895 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -105.05 -45.2 4.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 15.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -144.03 148.26 34.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.678 -0.639 . . . . 15.0 110.578 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.5 tt -129.65 131.0 46.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.623 -0.673 . . . . 15.0 110.186 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.9 m -128.29 143.26 51.0 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 15.0 110.28 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.27 144.11 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.58 -0.7 . . . . 15.0 109.872 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 31.2 m -88.02 -35.89 17.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.668 -0.645 . . . . 15.0 110.147 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.18 146.95 49.36 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.657 -0.652 . . . . 15.0 109.816 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.66 147.13 69.19 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.526 1.277 . . . . 15.0 110.468 -174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.72 156.76 52.98 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.614 1.323 . . . . 15.0 110.241 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -83.31 154.58 66.47 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.691 -0.631 . . . . 15.0 110.016 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.48 138.85 47.3 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.653 1.344 . . . . 15.0 110.432 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.1 133.1 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.749 -0.594 . . . . 15.0 109.628 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 118.007 -0.997 . . . . 15.0 110.145 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 10.8 tp . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 120.949 0.404 . . . . 15.0 110.425 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.51 -52.93 2.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.581 -0.699 . . . . 15.0 110.103 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -98.02 150.1 36.4 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.689 -0.632 . . . . 15.0 110.121 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -65.57 -33.2 46.69 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.539 1.284 . . . . 15.0 110.459 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 t -68.74 -33.94 74.76 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.709 -0.619 . . . . 15.0 110.176 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.58 71.63 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.744 -1.343 . . . . 15.0 109.744 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.78 -42.94 85.77 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.839 -1.304 . . . . 15.0 109.839 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.0 m -104.21 124.11 38.47 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.667 -0.902 . . . . 15.0 110.099 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.15 133.85 32.1 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 O-C-N 123.382 1.201 . . . . 15.0 110.511 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -68.68 -32.04 71.57 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.699 -0.626 . . . . 15.0 110.151 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.424 ' HA ' HD23 ' A' ' 26' ' ' LEU . 65.4 mt -63.75 136.97 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.353 -0.842 . . . . 15.0 109.675 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.13 -2.11 68.33 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.4 m -96.01 154.0 17.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.101 -1.235 . . . . 15.0 110.602 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HG2' HD12 ' A' ' 25' ' ' ILE . 77.3 mttt -81.3 128.58 33.97 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.858 -0.526 . . . . 15.0 110.129 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 26' ' ' LEU . 95.9 mt -131.65 146.52 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.494 -0.754 . . . . 15.0 109.994 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -114.93 130.93 57.01 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.482 -0.562 . . . . 15.0 109.482 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 72' ' ' ILE . 9.1 tp -119.43 135.01 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.795 -0.566 . . . . 15.0 110.259 -175.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.58 120.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.08 -0.711 . . . . 15.0 109.08 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -93.44 170.6 9.48 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.352 0.596 . . . . 15.0 110.862 -172.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -60.6 -18.04 50.43 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.519 -0.738 . . . . 15.0 111.475 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.18 16.83 7.82 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.361 -0.837 . . . . 15.0 111.326 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 57.09 28.17 14.53 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 15.0 110.824 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.0 mt -105.01 145.47 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -106.03 121.55 44.35 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.743 -0.598 . . . . 15.0 110.398 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -111.12 136.87 49.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.772 -0.58 . . . . 15.0 109.752 177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 41' ' ' VAL . 42.0 tt0 -120.1 140.66 50.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.414 -0.804 . . . . 15.0 109.876 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.3 -178.96 39.39 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.171 -1.572 . . . . 15.0 109.171 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.473 HD12 ' HG2' ' A' ' 11' ' ' LYS . 15.8 mm -108.52 133.48 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.46 -1.023 . . . . 15.0 109.544 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.777 HD21 HD11 ' A' ' 29' ' ' ILE . 11.2 tp -61.49 114.51 3.27 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.577 -0.702 . . . . 15.0 110.53 -175.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -93.81 -52.08 4.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 15.0 110.379 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 22.5 p -146.45 145.27 30.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.597 -0.689 . . . . 15.0 110.595 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.777 HD11 HD21 ' A' ' 26' ' ' LEU . 75.7 mt -116.04 126.61 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.795 -0.566 . . . . 15.0 109.658 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.12 97.68 6.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.619 -0.676 . . . . 15.0 109.825 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.91 -36.1 72.55 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.784 -0.572 . . . . 15.0 110.41 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -59.21 -29.28 67.38 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.584 -0.697 . . . . 15.0 111.102 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 35' ' ' THR . 94.0 m-20 -116.17 14.02 15.83 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.638 -0.664 . . . . 15.0 111.516 -177.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t 49.99 47.26 23.56 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.14 -0.975 . . . . 15.0 111.24 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 68' ' ' ARG . 19.0 p -131.51 150.14 52.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.542 -0.724 . . . . 15.0 110.489 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.92 139.38 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.589 -0.694 . . . . 15.0 109.609 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -111.59 128.6 56.09 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.699 -0.625 . . . . 15.0 110.01 178.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 26' ' ' LEU . 21.7 mt -116.79 139.04 51.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.846 -0.428 . . . . 15.0 109.846 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.71 162.03 17.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.717 -0.615 . . . . 15.0 109.816 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.3 tttt 51.61 61.22 3.33 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.555 -0.715 . . . . 15.0 110.311 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 23' ' ' GLU . 11.2 p -126.77 145.19 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.594 -0.691 . . . . 15.0 110.592 -172.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -138.64 155.77 48.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.759 -0.588 . . . . 15.0 110.296 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.4 p -99.03 133.48 43.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.841 -0.537 . . . . 15.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -69.36 -40.07 77.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.627 -0.671 . . . . 15.0 110.468 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.95 171.43 33.87 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.806 -1.317 . . . . 15.0 109.806 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.0 p -118.0 6.37 12.14 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.755 -0.85 . . . . 15.0 111.161 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -54.68 -22.84 14.98 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.247 -0.908 . . . . 15.0 111.488 -174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -60.44 -32.03 70.98 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.382 -0.824 . . . . 15.0 110.391 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -120.89 95.01 49.04 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.734 -0.604 . . . . 15.0 109.881 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.03 130.02 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 O-C-N 123.5 1.263 . . . . 15.0 110.571 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -132.72 165.13 25.23 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 15.0 110.106 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -77.95 -2.17 35.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.645 -0.66 . . . . 15.0 111.427 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -118.05 106.94 44.59 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.11 -0.994 . . . . 15.0 109.985 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.03 145.11 72.47 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.456 1.24 . . . . 15.0 110.465 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.3 mm -105.36 136.01 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.732 -0.605 . . . . 15.0 109.651 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.28 109.96 61.56 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.644 -0.66 . . . . 15.0 110.231 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -66.96 152.36 80.47 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 O-C-N 123.431 1.227 . . . . 15.0 110.342 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -118.59 153.62 33.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.734 -0.604 . . . . 15.0 110.274 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.02 -32.55 73.84 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.72 -0.613 . . . . 15.0 110.315 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -83.15 -171.2 3.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.61 -0.681 . . . . 15.0 110.18 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.5 t -134.81 172.09 13.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.691 -0.631 . . . . 15.0 110.368 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' CG ' HD11 ' A' ' 65' ' ' ILE . 78.5 m-85 -86.79 133.16 33.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.705 -0.622 . . . . 15.0 109.859 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -69.09 -46.03 68.78 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.438 -0.505 . . . . 15.0 110.641 -175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.2 t80 -147.9 121.87 9.41 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.582 -0.699 . . . . 15.0 110.514 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.532 HD11 ' CG ' ' A' ' 62' ' ' PHE . 19.5 mt -132.27 147.98 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.705 -0.622 . . . . 15.0 109.432 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.5 mt -112.36 138.86 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.648 -0.658 . . . . 15.0 110.094 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.1 144.71 51.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 15.0 109.815 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 35' ' ' THR . 95.4 mtt180 -108.7 151.8 25.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.7 -0.625 . . . . 15.0 110.237 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.08 -26.0 54.92 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.692 -0.963 . . . . 15.0 110.692 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 m -65.59 -45.3 83.74 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.551 -0.97 . . . . 15.0 110.715 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -82.01 -31.34 31.1 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.581 -0.699 . . . . 15.0 110.683 -177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 14' ' ' LEU . 75.9 mt -66.5 140.72 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.592 -0.693 . . . . 15.0 109.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -104.02 -42.53 5.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.796 -0.565 . . . . 15.0 110.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -147.41 149.6 33.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.678 -0.639 . . . . 15.0 110.7 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.462 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -129.71 131.23 46.26 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.742 -0.599 . . . . 15.0 110.097 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.6 m -131.62 142.71 49.94 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.584 -0.697 . . . . 15.0 110.343 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 144.1 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.683 -0.636 . . . . 15.0 109.729 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 93.0 m -97.83 -37.08 9.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.604 -0.685 . . . . 15.0 110.318 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -97.59 117.48 65.32 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.705 -0.622 . . . . 15.0 110.158 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.63 157.95 58.29 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 O-C-N 123.279 1.147 . . . . 15.0 110.283 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.08 145.78 94.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 O-C-N 123.558 1.294 . . . . 15.0 110.489 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -96.89 142.57 24.73 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.68 -0.638 . . . . 15.0 110.04 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -68.8 138.64 41.53 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.488 1.257 . . . . 15.0 110.433 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.9 tt -129.52 137.81 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 15.0 110.057 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 118.001 -0.999 . . . . 15.0 110.228 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 120.936 0.398 . . . . 15.0 110.262 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.56 -62.48 0.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.65 -0.656 . . . . 15.0 110.224 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.99 149.97 38.19 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.681 -0.637 . . . . 15.0 110.192 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.97 -32.23 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.244 0 O-C-N 123.603 1.317 . . . . 15.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -65.99 -34.92 79.2 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.584 -0.697 . . . . 15.0 110.362 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.69 -35.31 80.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.738 -1.345 . . . . 15.0 109.738 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.24 77.95 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.87 -1.292 . . . . 15.0 109.87 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 m -68.19 135.23 91.39 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.578 -0.954 . . . . 15.0 110.134 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -63.18 149.02 92.58 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 O-C-N 123.26 1.137 . . . . 15.0 110.668 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -65.0 -29.11 70.01 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.694 -0.629 . . . . 15.0 110.374 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.674 ' HA ' HD23 ' A' ' 26' ' ' LEU . 86.4 mt -63.1 137.79 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.363 -0.836 . . . . 15.0 109.615 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.65 -2.32 58.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.8 -0.92 . . . . 15.0 110.8 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 65.1 m -94.86 160.07 14.76 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.106 -1.232 . . . . 15.0 110.277 174.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -91.99 137.03 32.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.619 -0.676 . . . . 15.0 110.264 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.43 146.31 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 15.0 109.883 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.0 t -114.36 128.12 56.19 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.386 -0.598 . . . . 15.0 109.386 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 72' ' ' ILE . 11.0 tp -120.56 135.92 54.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.657 -0.652 . . . . 15.0 110.282 -175.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.4 mt -109.32 118.9 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.954 -0.758 . . . . 15.0 108.954 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -87.92 172.94 9.22 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.212 0.53 . . . . 15.0 110.781 -172.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -59.79 -18.44 43.52 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.606 -0.684 . . . . 15.0 111.601 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -90.52 15.47 10.75 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.365 -0.834 . . . . 15.0 111.286 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 56.17 28.58 13.31 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.191 -0.943 . . . . 15.0 110.776 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -101.87 142.9 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.82 -0.807 . . . . 15.0 108.82 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -100.84 120.8 40.66 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.744 -0.598 . . . . 15.0 110.467 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -112.73 132.35 55.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.837 -0.539 . . . . 15.0 109.591 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 41' ' ' VAL . 34.7 mt-10 -117.92 140.65 49.42 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.501 -0.749 . . . . 15.0 109.907 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.43 -178.85 39.38 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.944 -1.663 . . . . 15.0 108.944 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.4 mm -108.03 144.15 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -1.039 . . . . 15.0 109.755 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 29' ' ' ILE . 24.0 tp -66.15 113.49 4.56 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.807 -0.558 . . . . 15.0 110.21 -178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -94.25 -52.03 4.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.827 -0.546 . . . . 15.0 110.297 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 21.1 p -147.5 143.33 27.77 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.672 -0.643 . . . . 15.0 110.591 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 26' ' ' LEU . 78.2 mt -112.22 127.73 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.698 -0.627 . . . . 15.0 109.584 179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -112.09 97.42 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.634 -0.666 . . . . 15.0 109.751 176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.8 m -70.89 -35.74 72.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.703 -0.623 . . . . 15.0 110.405 -176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.56 -28.9 65.95 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.525 -0.734 . . . . 15.0 111.149 -171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 35' ' ' THR . 94.4 m-20 -117.7 14.05 14.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.539 -0.725 . . . . 15.0 111.531 -176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.4 t 49.92 48.69 21.47 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.104 -0.998 . . . . 15.0 111.257 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 33' ' ' ASN . 45.7 p -131.99 150.26 52.2 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.383 -0.823 . . . . 15.0 110.513 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.04 138.58 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.613 -0.68 . . . . 15.0 109.558 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' HB1' ' CZ ' ' A' ' 64' ' ' TYR . . . -109.75 127.66 54.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.653 -0.655 . . . . 15.0 109.918 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 26' ' ' LEU . 92.8 mt -116.9 138.92 51.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.946 -0.471 . . . . 15.0 109.737 -178.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.84 164.94 13.4 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.722 -0.611 . . . . 15.0 109.907 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 51.89 56.5 7.71 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.656 -0.653 . . . . 15.0 110.461 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 23' ' ' GLU . 13.7 p -118.0 148.53 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.587 -0.695 . . . . 15.0 110.342 -174.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -137.43 153.29 50.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.791 -0.568 . . . . 15.0 110.229 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.9 p -101.87 133.87 45.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.731 -0.606 . . . . 15.0 110.006 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.06 -40.13 63.0 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.699 -0.626 . . . . 15.0 110.689 -175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.8 171.21 33.51 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.984 -1.246 . . . . 15.0 109.984 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.8 p -118.15 6.27 12.02 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.798 -0.824 . . . . 15.0 111.034 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.13 -23.56 35.33 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.128 -0.983 . . . . 15.0 111.472 -173.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.25 -31.68 71.48 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.467 -0.771 . . . . 15.0 110.573 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 51' ' ' THR . 12.4 mmt85 -123.29 95.02 46.11 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.571 -0.706 . . . . 15.0 110.095 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.79 129.95 34.58 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 O-C-N 123.463 1.244 . . . . 15.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 49' ' ' ARG . 21.8 p -132.27 165.2 24.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.759 -0.588 . . . . 15.0 110.197 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.81 -1.12 29.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.698 -0.626 . . . . 15.0 111.437 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -113.59 106.87 53.67 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.244 -0.91 . . . . 15.0 109.724 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.49 131.89 24.17 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.356 1.187 . . . . 15.0 110.648 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.9 mm -122.73 119.01 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.654 -0.654 . . . . 15.0 109.472 176.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.37 156.05 36.19 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.671 -0.643 . . . . 15.0 110.346 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.85 145.65 94.73 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 O-C-N 123.596 1.314 . . . . 15.0 110.576 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -125.2 159.66 31.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.731 -0.606 . . . . 15.0 110.188 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -98.91 29.13 3.94 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.671 -0.643 . . . . 15.0 110.576 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.0 141.53 51.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.551 -0.718 . . . . 15.0 110.131 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.4 m -103.15 159.77 15.24 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.689 -0.632 . . . . 15.0 110.132 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.14 130.39 44.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.747 -0.596 . . . . 15.0 110.037 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.77 -40.7 83.99 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.847 -0.533 . . . . 15.0 110.843 -175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.468 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 4.1 t80 -151.99 121.94 7.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.775 . . . . 15.0 110.814 -175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 89.7 mt -130.85 148.02 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.688 -0.632 . . . . 15.0 109.664 172.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.26 135.09 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.718 -0.614 . . . . 15.0 109.813 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -126.22 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.75 -0.594 . . . . 15.0 109.841 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 35' ' ' THR . 94.7 mtt180 -108.16 151.86 25.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 15.0 110.159 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.3 -25.95 55.45 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.693 -0.963 . . . . 15.0 110.693 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.3 p -66.46 -45.06 81.03 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.501 -1.0 . . . . 15.0 110.685 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -81.94 -31.92 31.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.745 . . . . 15.0 110.682 -176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.639 HG12 HD21 ' A' ' 14' ' ' LEU . 67.5 mt -65.88 140.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.599 -0.688 . . . . 15.0 109.869 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.7 tttt -106.35 -42.28 5.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.745 -0.597 . . . . 15.0 110.251 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -139.26 142.65 37.78 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.672 -0.642 . . . . 15.0 110.531 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.4 tt -130.84 126.96 37.61 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.681 -0.637 . . . . 15.0 110.19 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -129.2 136.39 50.08 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.616 -0.678 . . . . 15.0 110.093 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.08 144.04 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.646 -0.659 . . . . 15.0 109.94 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 96.2 m -80.11 -37.05 34.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.68 -0.637 . . . . 15.0 109.956 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.27 117.6 69.11 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.664 -0.648 . . . . 15.0 109.785 175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -58.87 110.12 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 O-C-N 123.295 1.155 . . . . 15.0 110.981 -175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -67.82 156.65 65.1 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.443 1.233 . . . . 15.0 110.245 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -97.86 160.06 29.39 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.719 -0.613 . . . . 15.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -62.41 147.19 95.3 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.608 1.32 . . . . 15.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 tt -154.74 51.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.633 -0.667 . . . . 15.0 110.096 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.9 ttp . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.052 -0.975 . . . . 15.0 110.181 179.892 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 82.4 mt . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.947 0.403 . . . . 15.0 110.298 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -95.38 152.57 18.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.707 -0.621 . . . . 15.0 110.163 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -75.0 150.03 85.58 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.705 -0.622 . . . . 15.0 109.991 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.58 -34.69 92.17 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.455 1.239 . . . . 15.0 110.731 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.9 p -69.53 -36.45 76.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.659 -0.65 . . . . 15.0 110.18 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.34 -35.16 34.28 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.598 -1.401 . . . . 15.0 109.598 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.53 83.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.985 -1.246 . . . . 15.0 109.985 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.2 m -86.03 122.87 72.54 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.536 -0.979 . . . . 15.0 110.12 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.37 149.08 90.75 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.277 1.146 . . . . 15.0 110.462 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -63.19 -35.22 79.57 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.67 -0.644 . . . . 15.0 110.268 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.0 mt -64.88 137.7 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.444 -0.785 . . . . 15.0 109.53 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.24 -2.31 63.25 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.835 -0.906 . . . . 15.0 110.835 -174.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.6 m -90.46 156.29 18.31 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.063 -1.257 . . . . 15.0 110.29 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -85.99 133.22 33.93 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.662 -0.649 . . . . 15.0 110.468 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 HD13 ' A' ' 26' ' ' LEU . 91.2 mt -133.83 154.18 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.598 -0.689 . . . . 15.0 109.735 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.9 t -115.89 132.62 56.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.901 -0.499 . . . . 15.0 109.85 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.541 HD12 HD13 ' A' ' 75' ' ' LEU . 6.0 tp -116.53 130.19 56.61 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.87 -0.519 . . . . 15.0 109.88 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.7 mt -106.18 119.04 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.91 -0.774 . . . . 15.0 108.91 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m -92.64 170.85 9.41 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.331 0.586 . . . . 15.0 110.981 -170.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.6 -18.54 53.65 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.603 -0.685 . . . . 15.0 111.422 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.59 16.13 8.3 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.275 -0.89 . . . . 15.0 111.251 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 58.12 28.53 16.55 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.344 -0.848 . . . . 15.0 110.829 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.507 HG12 HG22 ' A' ' 46' ' ' THR . 87.0 mt -105.07 148.37 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 172.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -107.63 118.92 38.0 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.801 -0.562 . . . . 15.0 110.422 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -110.43 137.37 48.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.784 -0.573 . . . . 15.0 109.888 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 41' ' ' VAL . 6.7 tm-20 -119.28 140.75 49.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 15.0 109.88 174.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.6 -178.9 38.97 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.072 -1.611 . . . . 15.0 109.072 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.21 135.16 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.516 -0.99 . . . . 15.0 109.708 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.799 HD21 HD11 ' A' ' 29' ' ' ILE . 12.5 tp -62.37 109.02 1.22 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.693 -0.629 . . . . 15.0 110.486 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -89.31 -52.07 5.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.819 -0.55 . . . . 15.0 110.356 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 37' ' ' ALA . 19.5 p -144.52 144.17 31.2 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.622 -0.674 . . . . 15.0 110.538 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.799 HD11 HD21 ' A' ' 26' ' ' LEU . 74.1 mt -116.44 125.35 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.778 -0.576 . . . . 15.0 109.654 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -112.03 96.37 6.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.57 -0.706 . . . . 15.0 109.896 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.0 m -70.65 -36.8 73.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.803 -0.561 . . . . 15.0 110.379 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -59.29 -29.28 67.48 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.502 -0.749 . . . . 15.0 111.131 -171.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.544 ' O ' HG23 ' A' ' 35' ' ' THR . 94.1 m-20 -115.43 14.05 16.63 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 15.0 111.547 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t 49.87 47.93 22.46 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.093 -1.005 . . . . 15.0 111.25 -176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.73 HG22 ' HG2' ' A' ' 68' ' ' ARG . 18.4 p -131.97 148.41 52.52 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.357 -0.839 . . . . 15.0 110.561 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -130.78 139.25 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.607 -0.683 . . . . 15.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . . . -113.15 128.69 56.56 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.606 -0.684 . . . . 15.0 110.005 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 26' ' ' LEU . 30.3 mt -116.77 136.6 52.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.901 -0.499 . . . . 15.0 109.879 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.97 162.35 16.53 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.698 -0.627 . . . . 15.0 109.886 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 51.86 59.62 4.42 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.608 -0.683 . . . . 15.0 110.384 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 23' ' ' GLU . 14.7 p -121.58 147.14 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.601 -0.687 . . . . 15.0 110.333 -173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -137.38 150.86 47.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.776 -0.578 . . . . 15.0 110.033 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.9 p -95.98 130.23 43.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.771 -0.581 . . . . 15.0 109.741 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.19 -40.27 74.72 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.6 -0.687 . . . . 15.0 110.443 -174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 167.74 170.45 32.54 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.787 -1.325 . . . . 15.0 109.787 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 20' ' ' ILE . 45.5 p -118.06 -13.4 9.98 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.828 -0.807 . . . . 15.0 111.05 176.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -63.7 -28.95 70.25 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.256 -0.903 . . . . 15.0 110.945 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.98 -32.16 70.58 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.442 -0.786 . . . . 15.0 110.399 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.4 mmt-85 -123.46 95.14 45.61 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 15.0 109.837 177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.08 134.58 50.1 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.38 1.2 . . . . 15.0 110.903 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.6 p -132.54 165.12 25.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.847 -0.533 . . . . 15.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -77.89 -1.47 31.94 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.62 -0.675 . . . . 15.0 111.453 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -116.93 106.99 46.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.192 -0.943 . . . . 15.0 109.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.69 134.45 54.2 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.316 1.167 . . . . 15.0 110.801 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG21 HG21 ' A' ' 46' ' ' THR . 51.3 mm -119.6 141.62 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.704 -0.622 . . . . 15.0 109.677 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.75 109.92 60.71 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 15.0 110.178 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -63.18 146.52 94.14 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.35 1.184 . . . . 15.0 110.566 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -123.45 133.62 54.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.709 -0.619 . . . . 15.0 110.249 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.95 -33.36 73.6 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.67 -0.644 . . . . 15.0 110.252 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -68.06 155.38 39.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.623 -0.673 . . . . 15.0 110.238 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -102.95 161.04 14.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.721 -0.612 . . . . 15.0 110.2 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.97 133.27 47.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.671 -0.643 . . . . 15.0 110.096 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -67.55 -38.92 84.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.872 -0.517 . . . . 15.0 110.864 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CZ ' ' HB1' ' A' ' 37' ' ' ALA . 3.4 t80 -152.21 122.04 7.0 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.46 -0.775 . . . . 15.0 110.824 -175.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.61 147.08 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.708 -0.62 . . . . 15.0 109.566 172.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.6 mt -110.8 137.76 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.723 -0.611 . . . . 15.0 109.927 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -129.47 142.64 50.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.718 -0.614 . . . . 15.0 109.905 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.73 ' HG2' HG22 ' A' ' 35' ' ' THR . 91.3 mtt180 -110.35 152.15 26.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.621 -0.675 . . . . 15.0 110.107 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.94 55.12 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.5 p -66.92 -36.47 82.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.436 -1.037 . . . . 15.0 110.75 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -93.13 -30.15 15.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.503 -0.748 . . . . 15.0 110.841 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.9 mt -63.52 138.37 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.453 -0.779 . . . . 15.0 110.174 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -98.86 -40.56 8.04 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.818 -0.551 . . . . 15.0 110.027 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.54 149.61 29.4 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.692 -0.63 . . . . 15.0 110.749 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD13 HD12 ' A' ' 14' ' ' LEU . 40.8 tp -132.3 135.27 46.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.712 -0.617 . . . . 15.0 109.881 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.4 m -133.16 143.07 48.99 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.675 -0.641 . . . . 15.0 110.17 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.1 143.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.691 -0.63 . . . . 15.0 109.779 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 98.1 m -94.9 -37.02 11.39 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 15.0 110.345 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -84.31 160.88 56.14 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.725 -0.61 . . . . 15.0 110.192 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.5 112.71 2.68 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.716 1.377 . . . . 15.0 110.351 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.06 154.14 73.31 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.372 1.196 . . . . 15.0 110.316 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -102.11 164.1 16.44 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.703 -0.623 . . . . 15.0 110.377 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -62.72 147.08 95.18 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 O-C-N 123.718 1.378 . . . . 15.0 110.623 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' ILE . 3.7 tp -143.38 65.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.603 . . . . 15.0 110.006 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 118.0 -1.0 . . . . 15.0 110.317 -179.839 . . . . . . . . 0 0 . 1 stop_ save_